‫תשע"ב‬/'‫ג‬
11/2011
‫ד' בכסלו התשע"ב‬
November 30 ,1122
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents renewed for 20 years
Changes in particulars entered in
register
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled
1
4
251
432
431
434
444
474
444
444
445
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שחודשו לעשרים שנה‬
‫שינויים בפרטים רשומים בפנקס‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-54145-5
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬11 ‫הודעה לפי סעיף‬
1611
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬25 ‫הדרישות שנקבעו בתקנה‬
:1611-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
12/21/1882
161525
SYSTEM INCLUDING A BLADE FOR
CUTTING MARGINS OF ROLL PAPER
URI FREIMAN
‫מנגנון הכולל סכין לחיתוך שוליים של גליל‬
‫נייר מדבקות‬
‫אורי פריימן‬
510121
11/82/1822
PIPE-SHAPED PRODUCT WITH
BALLISTIC PROTECTION
FALCK SCHMIDT DEFENCE SYSTEMS
A/S
DK
PA201070022 25/01/2010
21/8//1822
512515
‫אלמנט גלילי עם הגנה בליסטית‬
G06K )5010.01(
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
512521
AIMING SYSTEM FOR WEAPON
TRIJICON, INC.
US
61/360008
30/06/2010
21/2211//
18/8//1822
US
4
F41A )5010.01(
‫זיהוי משתמשים בזמן אמת באמצעות‬
‫חתימות תנועת ידם‬
REAL-TIME USER IDENTIFICATION
BY HAND MOTION SIGNATURES
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
21/8//1822
B23C )5010.01(
F41G )5010.01(
‫מערכת מכוונת לנשק‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/8//1822
512521
CONTACT LENS STORAGE CASE
SURFACE DISINFECTION
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/357786
23/06/2010
21/222/12
12/8//1822
US
21/8//1822
512526
LENS WITH CONICAL FRUSTUM
MENISCUS WALL
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/359548
29/06/2010
21/21/28/
82/8//1822
US
21/8//1822
512551
VEHICLE ARMOR
INTERNATIONAL TRUCK
INTELLECTUAL PROPERTY
COMPANY, LLC.
US
61/357665
23/06/2010
2//8//1822
5
512511
A45C )5010.01(
‫קופסת אחסון לחיטוי עדשות מגע‬
G02F )5010.01(
‫עדשות עם קיר מניסקוס קטום קוני‬
F41H )5010.01(
‫שריון לכלי רכב‬
G08B )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
PROGRAMMABLE CONTROLLER
FOR A FIRE PREVENTION SYSTEM
KIDDE TECHNOLOGIES, INC.
US
12/817565
17/06/2010
2//8//1822
512154
METHOD AND SYSTEM FOR
BOOSTING THE SUPPLY OF POWER
AMPLIFIER
FLEISCHER DAVID LEONARDO
2//8//1822
‫בקר הניתן לתכנות למערכת למניעת אש‬
‫שיטה ומערכת להאצת אספקת העוצמה‬
‫במגברי כח‬
512141
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
2//8//1822
512142
SYSTEM FOR AUTOMATIC
ALIGNMENT, STABILIZATION, AND
FOCUS FOR AN OFF-AXIS
TELESCOPE
RAYTHEON COMPANY
US
12/869295
26/08/2010
6
H03F )5010.01(
‫דוד לאונרדו פליישר‬
H03M )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
G01B )5010.01(
‫ ייצוב‬,‫מערכת ליישור אוטומטית‬
‫והתמקדות לטלסקופ שסוטה מהציר‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//8//1822
512155
TRANSESOPHAGEAL
ECHOCARDIOGRAPHY CAPSULE
BIOSENSE WEBSTER, INC.
US
61/357703
23/06/2010
21/2/22/1
21/8//1822
US
2//8//1822
512151
INERT GAS PURGING SYSTEM FOR
AN ORC HEAT RECOVERY BOILER
GENERAL ELECTRIC COMPANY
US
12/827105
30/06/2010
18/8//1822
512115
KEY GENERATION USING MULTIPLE
SETS OF SECRET SHARES
NDS LIMITED
18/8//1822
512115
ARTICLES INCLUDING RESIN
BONDED SORBENT COMPOSITIONS
MULTISORB TECHNOLOGIES, INC.
US
11/635750
07/12/2006
7
A61B )5010.01(
‫קפסולה להדמייה אולטרסונית של הלב‬
‫דרך הוושט‬
F28D )5010.01(
‫מערכת לטיהור על ידי שימוש בגזים‬
‫ להחזרת חום‬ORC ‫אצילים עבור דוד‬
H04L )5010.01(
‫יצירה והפקת מפתחות ממערכת סודות‬
B01J )5010.01(
‫פריטים המכילים תערובות סופגות‬
‫המקושרות בשרף‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
12/8//1822
512115
DELIVERY DEVICE FOR DISPENSING
PHARMACEUTICAL DOSAGE FORMS
INTO DISSOLUTION TESTING
APPARATUS
ROHM AND HAAS COMPANY
US
61/398750
30/06/2010
12/8//1822
‫התקן נתינה להנפקת צורות מינון רוקחיות‬
‫לתוך מערכת בדיקת התפרקות‬
512106
IMPROVED THROUGHPUT SOLAR
STILL
‫שמעון בן דור‬
512116
TARGET DETECTION FROM A SLOW
MOVING RADAR PLATFORM
RAYTHEON COMPANY
US
12/887047
21/09/2010
11/8//1822
512154
COATED POWDER PARTICLES
ROHM AND HAAS COMPANY
US
61/360968
02/07/2010
8
B01D )5010.01(
‫מזקקה סולארית בעלת תפוקה משופרת‬
RONALD SILVER
11/8//1822
A61K )5010.01(
G01S )5010.01(
‫איתור מטרה מפלטפורמת מכ"ם שנעה‬
‫באיטיות‬
B01F )5010.01(
‫חלקיקי אבקה מצופים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/8//1822
512122
‫מערכת הגנה פעילה לרכבים קרביים‬
‫קלים‬
ACTIVE DEFENCE SYSTEM FOR LIGHT
COMBAT VEHICLES
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102010025801.6 01/07/2010
11/8//1822
512121
B26B )5010.01(
MANUAL RAZOR WITH BLADE
GUARD
EITAN HARONI
11/8//1822
‫סכין גילוח עם שומר להב‬
‫איתן הרוני‬
512142
METHOD FOR CONTROLLING A
GUIDED MISSILE WHICH IS DRIVEN
BY A MOTOR
DIEHL BGT DEFENCE GMBH & CO. KG
DE
10201032281.4 26/07/2010
11/8//1822
F41F )5010.01(
‫שיטה לשליטה בטיל מונחה המונע ע"י‬
‫מנוע‬
512154
QUICK FASTENING DEVICE FOR
TELEVISION SETS
OMB S.R.L.
IT
MI2010A001160 25/06/2010
9
G01J )5010.01(
H04N )5010.01(
‫מכשיר להצמדה מהירה של מקלטי‬
‫טלוויזיה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/8//1822
512151
AN APPARATUS AND METHOD FOR
REHABILITATING AN INJURED LIMB
REHABIT-TEC LTD
11/8//1822
11/8//1822
‫התקן ושיטה לשיקום איבר פגוע‬
‫טק בע"מ‬-‫ריהביט‬
512115
WIRELESS MOBILE INTERFACE
DEVICE FOR WASHING MACHINES
SHMUEL PILC
COMB AND BLADE - PERSONAL
HAIR SALON
H04W )5010.01(
‫מכשיר ממשק אלחוטי נייד למכונת כביסה‬
‫שמואל פילץ‬
512115
NAVIGATION FILTER FOR A
NAVIGATION SYSTEM USING
TERRAIN CORRELATION
THALES
FR
10/02675
25/06/2010
11/8//1822
A63B )5010.01(
512115
G01S )5010.01(
‫מסנן ניווט למערכת ניווט שמשמש‬
‫במתאם שטח‬
G09B )5010.01(
‫סכין מסרק‬
‫צנעני אלימלך‬
10
November 30, 2011-‫ד' בכסלו התשע"ב‬
12/8//1822
512161
‫זכוכית תלת מיימדיות כלליות‬
UNIVERSAL 3D GLASSES
XpanD, INC
US
61/359612
29/06/2010
12/8//1822
512102
DORANT FOR FIRE SUPPRESSION
SYSTEM
KIDDE TECHNOLOGIES, INC.
US
12/835865
14/07/2010
12/8//1822
12/8//1822
11
G05D )5010.01(
‫שיטה משופרת לסיוע בהטסת כלי תעופה‬
512155
THREAT DETECTION SYSTEMS AND
METHODS USING POSITIONSENSING PHOTODIODES
OPTICS 1, INC.
US
12/803539
29/06/2010
A62C )5010.01(
‫ריחן למערכת דיכוי שריפות‬
512151
AN IMPROVED PILOTING
ASSISTANCE METHOD FOR
AIRCRAFT
EUROCOPTER, S.A.S.
FR
1002991
16/07/2010
G02B )5010.01(
G01S )5010.01(
‫מערכות ושיטות מעקב אחר סכנה תוך‬
‫שימוש בפוטודיודות הרגישות למיקום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
18/8//1822
512114
‫מתקן ריסוס‬
SPRAYING DEVICE
JOEDAN AG
18/8//1822
512114
AN APPARATUS AND METHOD FOR
ELECTRONIC LOCK KEY INDICATOR
HILLEL WEINSTEIN
US
12/882236
15/09/2010
18/8//1822
H04W )5010.01(
‫שיטה להגנה על שירותים וציוד ברשתות‬
‫תקשורת‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
512601
UNIVERSAL 3D GLASSES
XpanD, INC
US
61/361695
06/07/2010
12
E05B )5010.01(
‫מערכת ושיטה לחיווי אלקטרוני של נעילה‬
‫על מפתח‬
512162
TECHNIQUE FOR PROTECTING
SERVICE AND EQUIPMENT IN
COMMUNICATION NETWORKS
ECI TELECOM LTD.
81/81/1822
B05D )5010.01(
G02B )5010.01(
‫ כלליות‬D2 ‫זכוכית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/81/1822
512615
G02B )5010.01(
LOW-ABERRATION OPTICAL
WINDOW
RAYTHEON COMPANY
US
12/874919
02/09/2010
81/81/1822
‫חלון אופטי בעל אברציה נמוכה‬
512612
DUAL FIELD OF VIEW REFRACTIVE
OPTICAL SYSTEM WITH EXTERNAL
PUPIL AND INTERNAL
STABILIZATION
RAYTHEON COMPANY
US
12/874680
02/09/2010
81/81/1822
G02B )5010.01(
‫מערכת אופטית רפרקטיבית בעלת שדה‬
‫ראייה כפול עם אישון חיצוני וייצוב פנימי‬
512611
–‫תרכובות חדשות לשימוש רפואי כ‬
EFFECTORS PEPTIDASE
NOVEL COMPOUNDS FOR MEDICAL
USE AS PEPTIDASE EFFECTORS
IMTM GMBH
EP
10171196.8 29/07/2010
8//81/1822
512625
SMOKE GRENADE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102010026641.8 09/07/2010
13
C07D )5010.01(
F42B )5010.01(
‫רימון עשן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
512622
8//81/1822
MOUNTING APPARATUS FOR A
MODULAR SMOKE GRENADE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102010026639.6 09/07/2010
512624
8//81/1822
METHOD FOR CONTROLLING A
WARSHOT MISSILE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102010026428.8 08/07/2010
2818288/118101
11/22/1828
DE
8//81/1822
512621
SYSTEMS AND METHODS OF 4d
ELECTROMAGNETIC TOMOGRAPHIC
(EMT) DIFFERENTIAL (DYNAMIC)
FUSED IMAGING
EMIMAGING LTD
US
61/362634
08/07/2010
21/211812
18/8//1822
US
8//81/1822
14
512645
F42B )5010.01(
‫התקן להרכבת רימון עשן מודלורי‬
F42B )5010.01(
‫שיטה לשלוט בטיל ירי מלחמתי‬
G03B )5010.01(
‫מערכת ושיטה לטומוגרפיה‬
‫ – מימדית‬EMT) 4( ‫אלקטרומגנטית‬
‫דיפרנציאלית (דינמית) להדמיה אחידה‬
F24D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
MAINTAINABLE TUBULAR SOLAR
PANEL WATER HEATER COLLECTOR
SYSTEM AND METHOD FOR
REMOVAL OF SCALE DEPOSIT
THEREFROM
GOLOSOVKER, MORDECHAI
8//81/1822
512655
MULTIBAND DISMOUNT ANTENNA
HARRIS CORPORATION
US
12/846207
29/07/2010
81/81/1822
512615
ADJUSTABLE WORK SURFACE
SYSTEM
YOSEF RUVINSKY
US
61/632711
09/07/2010
81/81/1822
512611
ROTATING CUTTING TOOL
CERATIZIT AUSTRIA GESELLSCHAFT
M.B.H
IT
GM454/2010 19/07/2010
15
‫שיטה ומערכת המאפשרות ניקוי אבנית‬
‫מצנרת בקולט סולרי לחימום מים‬
‫מרדכי גלוסובקר‬
H01Q )5010.01(
‫אנטנה רב ערוצית הניתנת להורדה‬
A47B )5010.01(
‫מערכת משטח עבודה מתכווננת‬
‫יוסף רובינסקי‬
B23C )5010.01(
‫כלי חיתוך מסתובב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/81/1822
512661
METHOD AND SYSTEM FOR SIGNAL
DISTORTION CHARACTERIZATION
AND PREDISTORTION
COMPENSATION USING MUTUAL
COUPLING IN A RADIO FREQUENCY
TRANSMIT/RECEIVE SYSTEM
RAYTHEON COMPANY
US
12/841383
22/07/2010
21/81/1822
514040
A44C )5010.01(
‫מערכת ושיטה לייצור אוטומטי של תעודות‬
‫מראש עבור אבנים יקרות‬
514055
COMPOSITION FOR POST CHEMICALMECHANICAL POLISHING CLEANING
BASF SE
TW
098102676
22/01/2009
16
A61B )5010.01(
‫גלאי אסימטרי בעל מספר מועט של‬
‫חלקים עבור טומוגרפיה ממוחשבת ושיטה‬
‫לייצורו‬
SYSTEM AND METHOD FOR
AUTOMATED GENERATION OF
GEMSTONE PRE-CERTIFICATES
OFER DAVIDOV
US
13/164393
20/06/2011
8//82/1828
‫שיטה ומערכת לאפיון עיוות אותות וקיזוז‬
‫טרום–עיוותי המשתמשות בצימוד הדדי‬
‫קליטה גל רדיו‬/‫במערכת שידור‬
514056
ASYMMETRIC DE-POPULATED
DETECTOR FOR COMPUTED
TOMOGRAPHY AND METHOD OF
MAKING SAME
GENERAL ELECTRIC COMPANY
US
12/837035
15/07/2010
21/81/1822
H04L )5010.01(
C11D )5010.01(
‫תכשיר לניקוי והברקה כימיים–מכאניים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
188/2888/11/02
CN
PCT/EP/2010/050078
WO/2010/084033
21/81/1822
11/82/188/
514015
LIQUID MENISCUS LENS WITH
CONVEX TORUS-SEGMENT
MENISCUS WALL
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/367895
27/07/2010
21/2/118/
18/8//1822
US
21/81/1822
21/81/1822
G02B )5010.01(
‫עדשות מניסקוס נוזליות עם קיר מניסקוס‬
‫קמור בעל מקטע קעור‬
514011
LASER CRYSTAL COMPONENTS
JOINED WITH THERMAL
MANAGEMENT
RAYTHEON COMPANY
US
12/881952
14/09/2011
17
‫עדשות מניסקוס נוזליות עם קיר מניסקוס‬
‫קמור בעל מקטע בולט‬
514012
LIQUID MENISCUS LENS WITH
CONCAVE TORUS-SEGMENT
MENISCUS WALL
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/368868
29/07/2010
21/2/112/
18/8//1822
US
G02B )5010.01(
F41G )5010.01(
‫רכיבי גביש מחוברים עם התקני ניהול‬
‫תרמי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514016
21/81/1822
OBJECT PROTECTION METHOD AND
DEVICE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102010027584.0 20/07/2010
21/81/1822
‫שיטה ומתקן להגנת אובייקט‬
514011
OBSTETRICAL VACUUM
EXTRACTOR WITH OVER-TRACTION
RELEASE
MICHAEL G. ROSS
US
12/849291
03/08/2010
21/81/1822
NONINVASIVE DETECTION OF
MECONIUM IN AMNIOTIC FLUID
GIDEON MOR
18
A61B )5010.01(
‫שולפן ריק ללידה עם שחרור במצב של‬
‫משיכת יתר‬
514016
F42B )5010.01(
‫גילוי חומר נפץ‬
EXPLOSIVE MATERIAL DETECTION
RAYTHEON COMPANY
US
12/884428
17/09/2010
21/81/1822
B60R )5010.01(
514061
A61B )5010.01(
‫איתור לא–פולשני של מקוניום במי שפיר‬
‫גדעון מור‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1822
514105
‫מנטרל רחב טווח‬
‫אורלב נחום‬
WIDE AREA NEUTRALIZER
ORLEV NAHUM
21/81/1822
514104
514112
FILM-FORMING PIGMENTS AND
COATING SYSTEM INCLUDING THE
SAME
SILBERLINE MANUFATURING CO.
INC
21/81/1822
B41M )5010.01(
‫פיגמנטים להרכבת סרטים ומערכת ציפוי‬
‫הכוללת אותם‬
514114
COLORED SYSTEM
SILBERLINE MANUFATURING CO.
INC
US
12/839982
20/07/2010
19
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
21/81/1822
C23C )5010.01(
B41J )5010.01(
‫שיטת צביעה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1822
514150
SIDE ILLUMUNATED, MULTI POINT,
MULTI PARAMETER OPTICAL FIBOR
SENSOR
CLAUDIO O. EGALON
US
61/148564
30/01/2009
22/81/1822
514121
ADVANCED HEAT EXCHANGER
RAYTHEON COMPANY
US
12/888306
22/09/2010
22/81/1822
514141
514150
FAST-STEERING, DEFORMABLE
MIRROR SYSTEM AND METHOD FOR
MANUFACTURING THE SAME
RAYTHEON COMPANY
US
12/887364
21/09/2010
20
‫ רב‬,‫חיישן מסוג אופטי מואר מן הצד‬
‫ רב פרמטרי‬,‫נקודתי‬
‫קלאדיו אגלון‬
F28D )5010.01(
‫מחליף חום מתקדם‬
B65D )5010.01(
‫מתלה שקיות נילון‬
‫ד"ר אבו אחמד עזמי‬
NYLON BAGS HANGER
DR ABU AHMAD AZMI
22/81/1822
G01B )5010.01(
G02B )5010.01(
‫מערכת מראות מהירה היגוי וברת–עיוות‬
‫ושיטה לייצורה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/81/1822
514151
METHOD AND APPARATUS FOR
THREE-DIMENSIONAL IMAGE
RECONSTRUCTION
RAYTHEON COMPANY
US
12/888166
22/09/2010
2//81/1822
2//81/1822
SYSTEM AND METHOD FOR
MONITORING AND CONTROLLING
HEATING/COOLING SYSTEMS
SASSON YUVAL HACHAM
21
H04B )5010.01(
‫התקן תקשורת אל–חוטי עם פענוח כפול‬
‫ושיטות לכך‬
514115
HIGH FREQUENCY AUTOMATIC
LINK ESTABLISHMENT
COMMUNICATION SYSTEM WITH
WIDEBAND PROBE AND RELATED
METHOD
HARRIS CORPORATION
US
12/855043
12/08/2010
2//81/1822
‫שיטה והתקן לשחזור דמות תלת–מימדית‬
514111
WIRELESS COMMUNICATIONS
DEVICE WITH MULTIPLE
DEMODULATORS AND RELATED
METHODS
HARRIS CORPORATION
US
12/855483
12/08/2010
G06T )5010.01(
H04B )5010.01(
‫מערכת תקשרות בעלת תדירות גבוהה‬
‫ויצירת קשר אוטומטית עם בוחן רב ערוצי‬
‫ושיטות הקשורות לכך‬
514116
H05B )5010.01(
‫שיטה ומערכת לניטור ושליטה על‬
‫חימום‬/‫מערכות קירור‬
‫ששון יובל חכם‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//81/1822
514160
METHOD FOR SOFT MODULATION
IN A WIRELESS
TELECOMMUNICATION NETWORK
DESIGNART NETWORKS LTD
US
61/365392
19/07/2010
18/81/1822
‫שיטה למודולציה רכה ברשת תקשורת‬
‫רחק‬
‫דזיינארט נטוורקס בע"מ‬
514161
DISPOSABLE BAG FOR CREATING
ICE POPS
H04W )5010.01(
A23G )5010.01(
‫שקית ניילון לעשייה עצמית של קרחונים‬
‫פתרונות עדכניים חדשניים‬-‫חברת פענח‬
‫בע"מ‬
18/81/1822
514552
HARNESSING MOBILE CONTAINERS
FOR FIREFIGHTING SYSTEM AND
METHOD
ACHSAN KADMANI
11/81/1822
A MANUAL FOOD PROCESSING
APPLIANCE
22
514514
A62C )5010.01(
‫ריתום מיכלים נעים לכיבוי אש–התקן‬
‫ושיטה‬
‫אחסאן קדמאני‬
A47J )5010.01(
‫מעבד מזון ידני‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫יעקב צרפתי‬
JACOB ZARFATY
1//81/1822
514515
FIRE EXTINGUISHING SYSTEM FOR
AN ORGANIC RANKINE CYCLE
HYDROCARBON EVAPORATOR
GENERAL ELECTRIC COMPANY
US
US12/847578 30/07/2010
1//81/1822
514516
POINTER DETECTION APPARATUS,
POSITION DETECTION SENSOR, AND
MANUFACTURING METHOD FOR
POSITION DETECTION SENSOR
WACOM CO, LTD
2010JP
20/08/2010
184668
11/81/1822
REMOVABLE ELEVATOR
CONTROLLER+REMOVABLE
CONTROL PANEL
ZAHI BASO
23
514204
A62C )5010.01(
‫מערכת לכיבוי אש עבור מאיד פחמימן‬
‫בעל מחזור רנקין אורגני‬
G01S )5010.01(
‫ חיישן לאיתור‬,‫מערכת לגילוי פוינטרים‬
‫מיקום ושיטת ייצור עבור חיישן לאיתור‬
‫מיקום‬
B66B )5010.01(
‫פנל‬+‫פיקוד ניידת למעלית‬/‫תיבת חשמל‬
‫קריאות פנים נשלף‬
‫צחי בסו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/81/1822
514201
SERVICE DEVICE FOR
MAINTENANCE OF A SOLAR PANEL
ARRANGEMENT
FACHHOCHSCHULE REGENSBURG
EP
10012717.4 01/10/2010
11/81/1822
514212
PROJECTILE STABILIZATION USING
THE EARTH'S MAGNETIC FIELD AS
A REFERENCE
FOR SERVO TECHNOLOGIES LTD
11/81/1822
514250
FLASH SUPPRESSOR
SILVER SHADOW ADVANCED
SECURITY SYSTEMS LTD
24
‫מכשיר שרות לתחזוקה של סידור לוח‬
‫סולרי‬
F42B )5010.01(
‫ניהוג פגז ע"י ראש מיוצב בייחוס לשדה‬
‫המגנטי והגרוויטציוני של כדור הארץ‬
‫פור סרוו טכנולוגיות בע"מ‬
F41A )5010.01(
‫כוסית גזים‬
‫סילבר שדו מערכות בטחוניותמתקדמות‬
‫בע"מ‬
BOLT CARRIER KEY
SILVER SHADOW ADVANCED
SECURITY SYSTEMS LTD
11/81/1822
F24J )5010.01(
514251
F41A )5010.01(
‫סתרשף‬
‫סילבר שדו מערכות בטחוניותמתקדמות‬
‫בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
1//82/1828
514250
‫בד מוספג‬
IMPREGNATED CLOTH
CONCRETE CANVAS TECHNOLOGY
LTD
EP
09001199.0 29/01/2009
PCT/GB/2010/000156
WO/2010/086618
82/82/1822
514215
AUTOMATIC DEVICE AND KIT FOR
INSERTING A CANNULA TO A
PREDETERMINED DEPTH WITHIN A
BONE,
WAISMED LTD
82/82/1822
81/82/1822
IMPROVED DISSOLUTION TEST
EQUIPMENT
ROHM AND HAAS COMPANY
25
A61B )5010.01(
‫מכשיר אוטומטי וערכה להחדרת צינורות‬
‫ ללא‬,‫לעומק קבוע מראש לתוך העצם‬
‫התחשבות בעובי הרקמה בעל העצם‬
‫וויסמד בע"מ‬
514212
HIGH VOLTAGE ELECTRIC POWER
GENERATING SYSTEM WITH
PERMANENT MAGNET GENERATOR
PROTECTION
HAMILTON SUNDSTRAND
CORPORATION
US
12/906824
18/10/2010
C09D )5010.01(
H02K )5010.01(
‫ עם‬,‫ גבוה‬DC ‫מערכת לייצור חשמל במתח‬
‫הגנת גנרטור בעל מגנט קבוע‬
514264
G01N )5010.01(
‫ציוד משופר לבחינת התפרקות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/400889
04/08/2010
81/82/1822
514416
‫מנקה בריכות עם מברשת‬
‫אי שירותי בריכות ישראל בע"מ‬.‫אס‬.‫פי‬
POOL CLEANER WITH BRUSH
P.S.I. POOL SERVICES ISRAEL LTD
12/81/1828
514421
ANAMORPHIC RELAYED IMAGES
HAVING MULTIPLE ROTATIONALLY
SYMMETRIC POWERED MIRRORS
RAYTHEON COMPANY
US
12/901294
08/10/2010
PCT/US/2010/029437
WO/2010/120530
81/82/1822
514415
METHOD AND SYSTEM FOR
COOLING A FIBER LASER OR
AMPLIFIER
RAYTHEON COMPANY
US
12/900141
07/10/2010
81/82/1822
514411
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
26
E04H )5010.01(
G02B )5010.01(
‫מדמה משודר אנאמורפי בעל מראות‬
‫מנועות סימטריות סיבובית מרובות‬
H01S )5010.01(
‫שיטה ומערכת לקירור לייזר סיבים או‬
‫מגבר‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
82/82/1822
514502
BIPOLAR ION GENERATOR WITH
AUTOMATIC CLEANING OF
IONIZING ELECTRODES
YEFIM RISKIN
12/8//1822
‫גנראטור יונים דו–קוטבי עם ניקוי אוטומטי‬
‫של אלקטרודות מייננות‬
‫יפים ריסקין‬
514512
SYSTEM AND METHOD FOR
CAPTURING ILLUMINATION
REFLECTED IN MULTIPLE
DIRECTIONS
SEMICONDUCTOR TECHNOLOGIES
& INSTRUMENTS PTE LTD (SG)
201005085SG
13/07/2010
4
82/82/1822
514515
SHAFT SPEED AND VIBRATION
SENSOR APPARATUS
HAMILTON SUNDSTRAND
CORPORATION
US
12/938970
03/11/2010
82/82/1822
27
H02K )5010.01(
514520
G06K )5010.01(
‫מערכת ושיטה ללכידת תאורה‬
‫המשתקפת בכיוונים רבים‬
G01H )5010.01(
‫ מהירות ותנודות‬,‫מערכת חיישני מוט‬
H04W )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
INITIATING COMMUNICATIONS
BETWEEN A CELLULAR A
CELLULAR MOBILE PHONE AND A
LANDLINE
ZAP ELECTRICAL ENGINEERING
LTD
US
61/513600
31/07/2011
22/81/1828
514522
A FAN ASSEMBLY
DYSON TECHNOLOGY LIMITED
GB
0903695.5
04/03/2009
PCT/GB/2010/050270
WO/2010/100452
8//82/1822
514512
A METHOD FOR CONSTRUCTING
CONCRETE FLOORS COMPRISING
NON-FLOATING LIGHT FILLER
BLOCKS
GIVATI ELIAU
28/82/1822
‫זפ הנדסת חשמל בע"מ‬
F04D )5010.01(
‫הרכבה של מאוורר‬
E04B )5010.01(
‫שיטה לביצוע תקרות בטון עם מילוי‬
‫בלוקים קלים ללא ציפה‬
‫גבעתי אליהו‬
514511
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
28
‫יזימת תקשורת בין טלפון סלולרי נייד‬
‫לרשת קווי יבשה‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514111
22/82/1822
DUST REMOVAL FROM SOLAR
CELLS
DAVID E. ASHPIS
1//81/1828
‫הסרת אבק מתאים סולאריים‬
514121
IR CAMERA SYSTEM AND METHOD
SELEX GALILEO LTD
GB
0903293.9
27/02/2009
PCT/EP/2010/052483
WO/2010/097461
11/81/1828
514125
IR DETECTOR SYSTEM AND
METHOD
SELEX GALILEO LTD
GB
0903091.7
24/02/2009
PCT/EP/2010/052291
WO/2010/097390
11/81/1828
IR DETECTOR SYSTEM
SELEX GALILEO LTD
GB
0903095.8
PCT/EP/2010/052289
WO/2010/097389
1//28/188/
29
H01L )5010.01(
514122
G03C )5010.01(
‫מערכת ושיטה למצלמת אינפרא–אדום‬
G01J )5010.01(
‫מערכת גלאי אינפרא–אדום ושיטה‬
G01J )5010.01(
‫מערכת גלאי אינפרא–אדום‬
24/02/2009
514124
B64D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
+28V AIRCRAFT TRANSIENT
SUPPRESSION
RAYTHEON COMPANY
US
12/393746
26/02/2009
PCT/US/2009/062064
WO/2010/098795
21/82/1822
514121
SCENE BASED NON-UNIFORMITY
CORRECTION FOR INFRARED
DETECTOR ARRAYS
RAYTHEON COMPANY
US
12/907390
19/10/2010
21/82/1822
514121
CATHETER WITH THIN PRESSURE
SENSING DISTAL TIP
BIOSENSE WEBSTER, INC.
US
12/857342
16/08/2010
21/82/1822
514126
A UNIQUE DEVICE FOR INCREAING
THE EFFICIENCY OF RADIOATION IN
SOLAR PANELS AND FOR CLEANING
GLASS SURFACES BY MEANS OF A
CONTROLLED SPRINKLER SYSTEM
URI ADAM
30
+V28 ‫דיכוי ארעי לכלי טייס‬
G01J )5010.01(
‫תיקון אי–אחידות מבוסס–סזנה למערכי‬
‫גלאי אינפרא–אדום‬
A61M )5010.01(
‫צנתר בעל קצה רחוק עם שכבה דקה‬
‫רגישה ללחץ‬
B05B )5010.01(
‫"טל"–מתקן שטיפה ייחודי עם בקרה‬
‫ממחושבת לפנלים סולריים ולמשטחי‬
‫זכוכית שונים‬
‫אורי אדם‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1828
514142
SPECIFIC BINDING PROTEINS AND
USES THEREOF
LUDWIG INSTITUTE FOR CANCER
RESEARCH LTD
US
12/388504
18/02/2009
PCT/US/2010/024407
WO/2010/096434
2//8//1828
514144
FORMULATIONS OF 4-AMINO-2-(2,6DIOXOPIPERIDINE-3YL)ISOINDOLINE-1,3-DIONE
C07K )5010.01(
‫חלבונים קושרים ספציפיים ושימושים‬
‫שלהם‬
A61K )5010.01(
–1,5(–5–‫–אמינו‬4 ‫פורמולציות של‬
–2,1–‫)איזואינדולין‬YL–2–‫דיאוקסופיפרידין‬
‫דיאון‬
CELGENE CORPORATION
US
61/179678
19/05/2009
PCT/US/2010/035357
WO/2010/013596
2//82/1822
514111
SURGICAL ENDOSCOPE AND
PROCESS FOR EXCHANGING
SURGICAL TOOLS IN A SURGICAL
ENDOSCOPE
SOCIEDADE BENEFICENTE DE
SENHORAS HOSPITAL SIRIO
LIBANES
US
12/899116
06/10/2010
2//82/1822
31
514111
A61B )5010.01(
‫אנדוסקופ כירורגי ותהליך להחלפת כלי‬
‫ניתוח באנדוסקופ כירורגי‬
G09B )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫התקנים ושיטות לתצוגה ובחירה ויזואלית‬
‫ (תגובה קולית‬IVR ‫של תפריטי‬
)‫אינטראקטיבית‬
‫בך‬-‫צבי אור‬
SYSTEMS AND METHODS FOR
VISUAL PRESENTATION AND
SELECTION OF IVR MENU
ZVI OR-BACH
US
12/879318
21/811221
US
21/8112/2
US
21/8111/2
US
21/8112//
US
21/811/8/
US
21/81//11
US
21/22121/
US
81/81/1828
10/09/2010
82/81/1822
82/81/1822
82/81/1822
82/81/1822
82/81/1822
22/81/1822
11/8//1822
514111
DEVICE AND METHOD FOR
TREATING CELLS
TECHNISCHE UNIVERSITEIT
EINDHOVEN
EP
09154239.9 03/03/2009
/2/2///2/
81/81/188/
US
1881//2
2//21/188/
NL
PCT/NL/2010/050106
WO/2010/101461
2//82/1822
514111
COMPRESSION SLEEVE WITH
IMPROVED POSITION RETENTION
TYCO HEALTHCARE GROUP LP
US
12/881245
14/09/2010
8//81/1828
32
514116
C12N )5010.01(
‫מכשיר ושיטה לטיפול בתאים‬
B25B )5010.01(
‫שרוול דחיסה עם עמדת אחיזה משופרת‬
A61M )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מערכת ליצירת תרסיס ניקוטין מבוסס‬
‫טבק‬
TOBACCO=BASED NICOTINE
AEROSOL GENERATION SYSTEM
PHILIP MORRIS PRODUCTS S.A.
US
61/160904
17/03/2009
PCT/US/2010/026614
WO/2010/107613
8//81/1828
514110
CONTROLLED-FRICTION SLIDING
DEVICE, SUCH AS A DM=AMPER,
WHICH CAN OPERATE IN TWO
DIRECTIONS
MESSIER-BUGATTI-DOWTY
FR
0901682
06/04/2009
PCT/EP/2010/054540
WO/2010/115896
2//82/1822
‫התקן מחליק מבוקר חיכוך כמו עמם‬
‫המסוגל לפעול בשני כיוונים‬
514111
514115
AGOMELATINE HYDROHALIDE
COMPLEX AND PREPARATION
METHOD THEREOF
LES LABORATOIRES SERVIER
CN
200910046782.1 27/02/2009
PCT/CN/2010/070780
WO/2010/097052
33
G03B )5010.01(
‫שילוב מסגרות הדמייה‬
INTEGRATING IMAGE FRAMES
RAYTHEON COMPANY
US
12/943467
10/11/2010
1//81/1828
F16F )5010.01(
C07C )5010.01(
‫תצמיד אגומלאטין הידרוכלוריד ושיטה‬
‫להכנתו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514112
8//81/1828
NEW CRYSTALLINE FORM VI OF
AGOMELATINE, PREPARATION
METHOD AND APPLICATION THEREOF
LES LABORATOIRES SERVIER
CN
200910047329.2 10/03/2009
PCT/CN/2010/070931
WO/2010/102554
2//82/1822
,‫צורה גבישית חדשה של אגומלאטין‬
‫שיטה להכנתו ושימוש בו‬
514115
SYSTEM AND APPARATUS FOR
HORTICULTURE
DEERE & COMPANY
US
12/859877
20/08/2010
2//82/1822
514111
34
A01N )5010.01(
‫יישום קוטל מזיקים רובוטי‬
514111
NOVEL SUBSTITUTED
BENZOXAZOLE, BENZIMIDAZOLE,
OXAZOLOPYRIDINE AND
IMIDAZOPYRIDINE DERIVATIVES
AS GAMMA SECRETASE
MODULATORS
ORTHO-MCNEIL-JANSSEN
PHARMACEUTICALS, INC.
EP
09153188.9 19/02/2009
8/2/118/01
11/8//188/
EP
PCT/EP/2010/051843
A01G )5010.01(
‫מערכת ושיטות בתחום הגינון‬
ROBOTIC PESTICIDE APPLICATION
DEERE & COMPANY
US
12/859913
20/08/2010
2//81/1828
C07C )5010.01(
C07D )5010.01(
,‫תולדות חדשות מותמרות של בנזוקסאזול‬
‫בנזאימידאזול אוקסאזולופירידין‬
‫ואימידאזופירידין כמאפנני גאמא סקראטז‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/094647
1//82/1828
514111
DETECTION DEVICE AND METHOD
FOR MONITORING BED BUG
INFESTATION
BAYER CROPSCIENCE LP
US
12/392417
25/02/2009
PCT/US/2010/021950
WO/2010/098917
2//81/188/
‫מכשיר זיהוי ושיטה לניטור טפילות של‬
‫פשפשים‬
514116
SYSTEM FOR REMOTELY
CONTROLLING SIGHTS AND
TARGET DESIGNATORS
INNOVATIVE WIRELESS
TECHNOLOGIES, INC.
A01M )5010.01(
H02J )5010.01(
‫מערכת לבקרה מרחוק של מצייני כוונות‬
‫ויעדים‬
PCT/RU/2009/000075
WO/2010/093279
21/81/1828
514160
ASSAY FOR DETERMINING
EPIGENETIC PROFILES OF MARKERS
OF FRAGILE X ALLELES
MURDOCH CHILDRENS RESEARCH
INSTITUTE
AU
2009900668 17/02/2009
188//82812
22/81/188/
AU
PCT/AU/2010/000169
WO/2010/094061
21/81/1828
35
514161
C12Q )5010.01(
‫בוחן לקביעת פרופילים אפיגנטיים של‬
‫ שביר‬X ‫סמני אללים של‬
C25B )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
ELECTROLYTIC CELL AND METHOD
OF USE THEREOF
MCALISTER TECHNOLOGIES, LLC
US
61/153253
17/02/2009
/2/11111/
11/82/188/
US
/2/181181
21/81/1828
US
PCT/US/2010/024497
WO/2010/096503
21/81/1828
514165
APPARATUS AND METHOD FOR
CONTROLLING NUCLEATION
DURING ELECTROLYSIS
MCALISTER TECHNOLOGIES, LLC
US
61/153253
17/02/2009
/2/11111/
11/82/188/
US
/2/181181
21/81/1828
US
PCT/US/2010/024498
WO/2010/096504
21/81/1828
‫תא אלקטרוליטי ושיטה לשימוש בו‬
‫מערכת ושיטה לבקרת התגרענות במהלך‬
‫אלקטרוליזה‬
514162
APPARATUS AND METHOD FOR GAS
CAPTURE DURING ELECTROLYSIS
MCALISTER TECHNOLOGIES, LLC
US
61/153253
17/02/2009
/2/11111/
11/82/188/
US
/2/181181
21/81/1828
US
PCT/US/2010/024499
WO/2010/096505
21/81/1828
514164
METHOD FOR ANALYSING THE
REAL-TIME CAPABILITY OF A
SYSTEM
INCHRON GMBH
US
61/152828
16/02/2009
36
H01M )5010.01(
C25B )5010.01(
‫מערכת ושיטה ללכידת גז במהלך‬
‫אלקטרוליזה‬
G06F )5010.01(
‫מערכת לניתוח יכולות זמן אמיתי של‬
‫מערכת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PCT/EP/2010/051783
WO/2010/092146
2//81/1828
514165
EMPLOYMENT OF A TEXT MESSAGE
BY A USER OF A FIRST MOBILE
TELEPHONE TO INVOKE A PROCESS
THAT PROVIDES INFORMATION TO
A USER OF A SECOND MOBILE
TELEPHONE
COMVERSE LTD.
US
61/152787
16/02/2009
PCT/IB/2010/000418
WO/2010/092484
2//81/1828
CONTEXT-AWARE
COMMUNICATIONS
COMVERSE LTD.
US
61/152839
/2/1//111
US
PCT/IB/2010/000463
WO/2010/092486
21/81/1828
‫שימוש במיסרון על–ידי משתמש במכשיר‬
‫טלפון ראשון להנעת תהליך המספק מידע‬
‫למשתמש במכשיר טלפון שני‬
514161
37
‫קומברס בע"מ‬
G06Q )5010.01(
‫תקשורת מוטות קישור‬
‫קומברס בע"מ‬
16/02/2009
28/22/188/
514161
BREASTFEEDING MILK
CONSUMPTION MEASURING DEVICE
INNOVIA MEDICAL LTD
US
61/152977
17/02/2009
PCT/IL/2010/000142
WO/2010/095133
21/81/1828
H04W )5010.01(
514161
A61B )5010.01(
‫התקן למדידת כמות צריכת חלב בהנקה‬
‫אינוביה מדיקל בע"מ‬
A23L )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מזון המכיל פרולקטין‬
FOOD CONTAINING PROLACTION
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
61/153080
17/02/2009
PCT/IL/2010/000139
WO/2010/095130
81/81/1828
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
514166
INSULIN FORMULATIONS FOR
RAPID UPTAKE
BIODEL, INC.
US
12/397219
03/03/2009
PCT/US/2010/026073
WO/2010/102020
11/81/188/
A61K )5010.01(
‫פורמולציות אינסולין לספיגה מהירה‬
514101
WASTEWATER TREATMENT
APPARATUS AND METHOD
BOYDEL WASTEWATER
TECHNOLOGIES INC
C02F )5010.01(
‫התקן ושיטה לטיפול במי ביוב‬
PCT/CA/2009/000219
WO/2010/096891
18/81/188/
514105
OIL REACTOR VACUUM PUMP HAVING
HYDRAULIC GASKET FOR CATALYTIC
OILING REACTIONS FROM
PREVIOUSLY CONDITIONED SLURRYLIKE RESIDUES AND METHOD
THEREFOR
KOCH CHRISTIAN
DE
102009012486.1 20/02/2009
PCT/DE/2009/000246
WO/2010/063248
38
C10G )5010.01(
‫משאבת ואקום לכור שמן בעלת‬
‫שסתום הידראולי לתגובות שימון‬
‫מזורזות המותנות מראש במשקעים‬
‫דלילים ושיטה לכך‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//82/1822
514102
A METHOD AND SYSTEM OF
TRACKING VEHICLES PARKING AT
A PREDETERMINED LOCATION
TEL KERBIS
81/81/1828
21/81/1828
‫שיטה ומערכת למעקב אחרי רכבים חונים‬
‫במיקום הנקבע מראש‬
‫און‬-‫עומר בית‬
514104
OXAZOLE PYRIDINE DERIVATIVES,
THEIR PREPARATION AND
PHARMACEUTICAL COMPOSITION
CONTAINING THEM
MERCK SERONO S.A.
EP
09154174.8 03/03/2009
/2/2///2/
81/81/188/
US
PCT/EP/2010/052613
WO/2010/100142
WATER PURIFICATION AND
ENHANCEMENT SYSTEMS
39
C07D )5010.01(
‫ הכנתן ותכשירי‬,‫תולדות אוקסאזול פירידין‬
‫רוקחות המכילים אותן‬
514101
COMPOSITIONS AND METHODS FOR
PREVENTING CARDIAC
ARRHYTHMIA
CORMATRIX CARDIOVASCULAR,
INC.
US
61/153402
18/02/2009
PCT/US/2010/024441
WO/2010/096458
22/81/1828
G07B )5010.01(
514101
A61K )5010.01(
‫תרכובות ושיטות למניעת הפרעה בקצב‬
‫הלב‬
B01D )5010.01(
‫מערכות לטיהור מים ולשיפורים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
THE WATER INITIATIVE, LLC
US
61/154070
20/02/2009
PCT/US/2010/024531
WO/2010/096521
514101
2//81/1828
A DERMACEUTICAL GEL MADE USING
SODIUM FUSIDATE & A PROCESS TO
MAKE IT
VANANGAMUDI, SULUR,
SUBRAMANIAM
IN
356/MUM/2009 18/02/2009
PCT/IB/2010/050684
WO/2010/095090
514106
2//81/1828
A PROCESS TO MAKE FUSIDIC ACID
CREAM
VANANGAMUDI, SULUR,
SUBRAMANIAM
IN
358/MUM/2009 18/02/2009
PCT/IB/2010/050685
WO/2010/095091
21/81/1828
514110
OPHTHALMIC LENS WITH OPTICAL
SECTORS
OCULENTIS B.V.
NL
2002540
17/02/2009
/2/2/1811
21/81/188/
US
PCT/NL/2010/050078
WO/2010/095938
40
A61K )5010.01(
‫ג'ל לטיפול בעור עשוי תוך שימוש‬
‫בנתרן פיוזידייט ותהליך לייצורו‬
A61K )5010.01(
‫תהליך לייצור משחה של חומצה‬
‫פיוזידייטית‬
G02C )5010.01(
‫עדשה עינית עם סקטורים אופטיים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/82/1822
514111
CORRECTING FRAME-TO-FRAME
IMAGE CHANGES DUE TO MOTION
FOR THREE DIMENSIONAL (3-D)
PERSISTENT OBSERVATIONS
RAYTHEON COMPANY
US
12/908540
20/10/2010
‫תיקון שינויי דמות מתמונה כתוצאה‬
‫מתנועה לתצפיות מתמידות תלת–מימדיות‬
514115
2//81/1828
514114
ANTIBODIES CONTAINING
THERAPEUTIC TPO/EPO MIMETIC
PEPTIDES
ALEXION PHARMACEUTICALS, INC.
US
61/208487
24/02/2009
PCT/US/2010/024546
WO/2010/099019
2//81/1828
41
C07K )5010.01(
‫נוגדנים המכילים פפטידים טיפוליים חקייני‬
EPO/TPO
514115
COMPOUND FOR THE TREATMENT
OF TUBERCULOSIS
ASTRAZENECA AB
US
61/160385
16/03/2009
PCT/GB/2010/050445
WO/2010/106355
F22D )5010.01(
,‫ בהזנת מים‬,‫מכשיר לעיבוי גזים‬
‫לתחנת כוח תרמית סולרית‬
FEED WATER DEGASIFIER FOR A
SOLAR THERMAL POWER STATION
FLAGSOL GMBH
DE
102009010020.2 21/02/2009
PCT/EP/2010/052163
WO/2010/094783
22/81/1828
G06T )5010.01(
A61K )5010.01(
‫תרכובת לטיפול בשחפת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514111
8//81/1828
APPARATUS AND METHOD FOR
MANUFACTURING SLABS WITH A
VEINED EFFECT
TONCELLI, LUCA
IT
TV2009A000036 10/03/2009
PCT/IB/2010/050998
WO/2010/103456
81/81/1828
‫מתקן ושיטה לייצור לוחות אבן עם‬
‫אפקט של פסים‬
514111
CHEMICAL PROCESS FOR THE
PRODUCTION OF HALOALKENONE
ETHERS
SYNGENTA PARTICIPATIONS AG
GB
0903749.0
04/03/2009
PCT/EP/2010/001267
WO/2010/099922
12/81/1828
2//81/1828
42
C07C )5010.01(
‫תהליך כימי להכנת אתרי הלואלקנון‬
514116
CHEMICALLY RESISTANT
MEMBRANES, COATINGS AND
FILMS AND METHODS FOR THEIR
PREPARATION
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/202328
19/02/2009
PCT/IL/2010/000148
WO/2010/095139
B28B )5010.01(
B01D )5010.01(
‫ ציפויים‬,‫ממברנות בעלות עמידות כימית‬
‫ופילמים שלהם ושיטות להכנתם‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
514150
C07D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
PYRIDOCARBAZOLE TYPE
COMPOUNDS AND APPLICATIONS
THEREOF
INSTITUT CURIE
FR
0900786
PCT/IB/2010/000538
WO/2010/095042
‫תרכובות מסוג פירידוקרבאזול ויישומים‬
‫שלהן‬
20/02/2009
12/81/1828
514151
NOVEL KINASE-START GENE
CONFERRING RESISTANCE TO
PLANT DISEASE AND TRANSGENIC
PLANTS COMPRISING IT
THE UNITED STATES OF AMERICA,
AS REPRESENTED BY THE
SECRETARY OF AGRICULTURE
US
61/153773
19/02/2009
PCT/IL/2010/000147
WO/2010/095138
22/82/1822
11/81/1828
HUMANIZED ANTIBODIES THAT
BIND TO CD19 AND THEIR USES
GLENMARK PHARMACEUTICALS
S.A.
43
‫ חדש המעניק עמידות‬START–‫גן קינאזה‬
‫למחלת צמחים וצמחים טרנסגניים‬
‫המכילים אותו‬
‫החברה הכלכלית של אוניברסיטת‬-‫כרמל‬
‫חיפה בע"מ‬
514154
COMPENSATION OF THERMALLY
INDUCED REFRACTIVE INDEX
DISTORTIONS IN AN OPTICAL GAIN
MEDIUM OR OTHER OPTICAL
ELEMENT
RAYTHEON COMPANY
US
12/915737
29/10/2010
C12N )5010.01(
G02B )5010.01(
‫קיזוז עיוותי אינדקס רפרקציה שנגרמו‬
‫תרמית במדיום הגברה אופטית או אלמנט‬
‫אופטי אחר‬
514155
C07K )5010.01(
CD16–‫נוגדנים מואנשים שנקשרים ל‬
‫ושימושים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/154524
PCT/IB/2010/000353
WO/2010/095031
12/81/1828
23/02/2009
514151
NIBBLING MECHANISM FOR
CONSTRUCTION MATERIAL
IZHAK STERN ENGINEERS LTD
US
61/153875
19/02/2009
/2/1/1211
12/82/188/
US
PCT/IL/2010/000146
WO/2010/095137
11/81/1828
‫מנגנון כרסום לחומר בניה‬
‫ מהנדסים בע"מ‬.‫ע‬.‫ד‬.‫יצחק שטרן י‬
514151
C07D )5010.01(
‫–איזופרופילפניל גלוסיטול‬4 ‫תרכובות‬
SGLT1 ‫כמעכבי‬
4 -ISOPROPYLPHENYL GLUCITOL
COMPOUNDS AS SGLT1 INHIBITORS
TAISHO PHARMACEUTICAL CO.,
LTD.
2009JP
23/02/2009
038776
PCT/JP/2010/053187
WO/2010/095768
21/82/1828
514151
MULTIPURPOSE ACIDIC, ORGANIC
SOLVENT BASED
MICROELECTRONIC CLEANING
COMPOSITION
AVANTOR PERFORMANCE
MATERIALS, INC.
US
61/155309
25/02/2009
PCT/US/2010/020974
WO/2010/098899
44
B23B )5010.01(
G03F )5010.01(
‫תכשיר ניקוי חומצתי רב–תכליתי מבוסס‬
‫ממס אורגני למיקרואלקטרוניקה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514156
22/21/188/
OXYNTOMODULIN ANALOGS
MERCK SHARP & DOHME CORP.
US
PCT/US2009/034448 19/02/2009
PCT/US/2009/068678
WO/2010/096142
‫אנלוגים של אוקסינטומודולין‬
514120
C11D )5010.01(
22/81/1828
STRIPPING COMPOSITIONS FOR
CLEANING ION IMPLANTED
PHOTORESIST FROM
SEMICONDUCTOR DEVICE WAFERS
AVANTOR PERFORMANCE
MATERIALS, INC.
US
61/155206
25/02/2009
/2/111288
22/82/188/
US
PCT/US/2010/024529
WO/2010/099017
11/81/1828
USES OF NK RECEPTOR
ANTAGONISTS
NOVARTIS AG
US
61/154973
PCT/EP/2010/052273
WO/2010/097381
2//81/1828
‫תכשירי קילוף לניקוי פוטורזיסט מושתל‬
‫יונים מפרוסות של התקן מוליך למחצה‬
514121
A61K )5010.01(
NK–‫שימושים באנטגוניסטים לרצפטור ל‬
24/02/2009
514124
DUAL FIELD-OF-VIEW OPTICAL
IMAGING SYSTEM WITH DUAL
FOCUS LENS
THALES CANADA INC.
US
61/154182
20/02/2009
PCT/CA/2010/000237
WO/2010/094133
45
A61K )5010.01(
G02B )5010.01(
–‫מערכת הדמיה אופטית כפולת שדה‬
‫ראייה עם עדשה כפולת מוקד‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//81/1828
514125
CONDENSING UNIT HAVING FLUID
INJECTION
EMERSON CLIMATE
TECHNOLOGIES, INC.
US
61/153452
18/02/2009
21/18/818
21/81/1828
US
PCT/US/2010/024283
WO/2010/096378
12/81/1828
‫יחידת עיבוי הכוללת הזרקת זורם‬
514121
NIBBLING MECHANISM FOR
CONSTRUCTION MATERIAL
IZHAK STERN ENGINEERS LTD
US
61/153875
19/02/2009
/2/1/1211
12/82/188/
US
PCT/IL/2010/000146
WO/2010/095137
22/81/1828
TREATMENT OF INSULINRESISTANT DISORDERS
GENENTECH, INC.
46
B23B )5010.01(
‫מנגנון כרסום לחומר בניה‬
‫ מהנדסים בע"מ‬.‫ע‬.‫ד‬.‫יצחק שטרן י‬
514140
B01D )5010.01(
‫תהליך לניקוי של אמורולפין‬
‫הידרוכלוריד‬
PROCESS FOR THE PURIFICATION OF
AMOROLFINE HYDROCHLORIDE
SYNTECO S.P.A. - PRODOTTI DI
SINTESI PER L'INDUSTRIA CHIMICA E
FARMACEUTICA
IT
FI2009A000032 20/02/2009
PCT/EP/2010/052047
WO/2010/094739
18/81/1828
F24F )5010.01(
514145
A61K )5010.01(
‫טיפול באי–סדרים העמידים בפני אינסולין‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/165677
PCT/US/2010/029280
WO/2010/114859
21/81/1828
01/04/2009
514141
SUBSTITUTED PYRIMIDINES FOR
THE TREATMENT OF CANCER
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09155515.1 18/03/2009
282/112201
28/81/1828
EP
PCT/EP/2010/053451
WO/2010/106097
22/81/1828
‫פירימידינים מותמרים לטיפול בסרטן‬
514141
METHOD OR SYSTEM USING
BIOMARKERS FOR THE
MONITORING OF A TREATMENT
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09154964.2 12/03/2009
PCT/EP/2010/053063
WO/2010/103058
2//81/1828
22/81/1828
47
G01N )5010.01(
‫שיטה או מערכת המשתמשים בסמנים‬
‫ביולוגים לניטור טיפול‬
514141
MERCHANT ALERT SYSTEM AND
METHOD FOR FRAUD PREVENTION
MOQOM LIMITED
IE
S2009/0139 20/02/2009
PCT/IE/2010/000008
WO/2010/095122
C07D )5010.01(
G06Q )5010.01(
‫מערכת אזעקה עבור סוחר ושיטה למניעת‬
‫הונאה‬
514146
A61K )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
PHARMACEUTICAL COMBINATIONS
COMPRISING RDEA119/BAY 869766
FOR THE TREATMENT OF SPECIFIC
CANCERS
ARDEA BIOSCIENCES, INC.
US
61/159403
11/03/2009
PCT/US/2010/027060
WO/2010/105110
21/81/1828
514150
DEVICE FOR ADMINISTERING AN AT
LEAST TWO-COMPONENT
SUBSTANCE
OMRIX BIOPHARMACEUTICALS
LTD.
US
61/154135
20/02/2009
PCT/IL/2010/000137
WO/2010/095128
22/81/1828
116111 ‫צירופים רוקחיים המכילים‬
‫ לטיפול בסוגי סרטן‬BAY/119 RDEA
‫מסויימים‬
‫התקן נתינה של חומר בעל שני מרכיבים‬
‫לפחות‬
‫אומריקס ביופארמאצבטיקה בע"מ‬
514155
METHODS AND SYSTEMS FOR
DIAGNOSIS AND TREATMENT OF A
DEFINED CONDITION, AND
METHODS FOR OPERATING SUCH
SYSTEMS
S.M BALANCE HOLDINGS
US
61/202335
19/02/2009
PCT/IL/2010/000143
WO/2010/095134
22/81/1828
48
A61B )5010.01(
‫שיטות ומערכות לזיהוי וטיפול בתופעה‬
‫מוגדרת ושיטות להפעלת מערכות אלה‬
514152
METHOD FOR IDENTIFYING A
SUBPOPULATION OF MAMMALIAN
CELLS WITH DISTINCTIVE
RIBOSOME TRANSLATION PROFILES
WAYNE STATE UNIVERSITY
US
61/153642
18/02/2009
A61B )5010.01(
C12Q )5010.01(
‫שיטה לזיהוי אוכלוסיה משנית של תאי‬
‫יונקים עם פרופילי תרגום ריבוזום ייחודיים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PCT/US/2010/024634
WO/2010/096594
1//81/1828
514154
COMPOSITIONS , SYNTHESIS, AND
METHODS OF UTILIZING
ARYLPIPERAZINE DERIVATIVES
REVIVA PHARMACEUTICALS, INC
US
61/155791
26/02/2009
PCT/US/2010/025687
WO/2010/099502
8//81/1828
514155
ANTI-RHESUS D MONOCLONAL
ANTIBODY
LFB-BIOTECHNOLOGIES
FR
0951412
06/03/2009
PCT/FR/2010/050376
WO/2010/100383
18/81/1828
514151
MULTISPECIFIC ANTIBODIES
COMPRISING FULL LENGTH
ANTIBODIES AND SINGLE CHAIN
FAB FRAGMENTS
ROCHE GLYCART AG
EP
090074909.9 02/04/2009
PCT/EP/2010/002004
WO/2010/112193
11/81/1828
49
514151
A61K )5010.01(
‫ סינתיזה ושיטות לשימוש‬,‫תכשירים‬
‫בתולדות של ארילפיפראזין‬
A61K )5010.01(
D ‫נוגדן חד–שבטי נגד רזוס‬
C07K )5010.01(
‫נוגדנים רב–ספיציפיים המכילים נוגדנים‬
‫ בודדים‬FAB ‫באורך מלא וקטעי שרשרת‬
A61K )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
COMPOSITIONS AND METHODS TO
PREVENT AND/OR TREAT CANCER
WITH PA-CARD
CDG THERAPEUTICS, INC.
US
61/154236
20/02/2009
/2/21/11/
2//8//188/
US
PCT/US/2010/024904
WO/2010/096754
1//81/1828
514110
COMBINATION OF A NUCLEOSIDE
POLYMERASE INHIBITOR WITH A
MACROCYCLIC PROTEASE
INHIBITOR AND USE THEREOF IN
THE TREATMENT OF HEPATITIS C,
LIVER FIBRPSIS AND IMPAIRED
LIVER FUNCTION
ROCHE PALO ALTO LLC
US
61/156414
27/02/2009
/2/1/11/1
81/22/188/
US
PCT/US/2010/025611
WO/2010/099458
2//81/1828
‫או טיפול‬/‫תכשירים ושיטות למניעת ו‬
CARD–PA ‫בסרטן‬
‫שילוב של מעכב נוקליאוזיד פולימראז עם‬
‫מעכב פרוטיאז מקרוציקלי ושימוש בו‬
‫ לייפת כבד ותפקוד לקוי‬,C ‫בטיפול בצהבת‬
‫של הכבד‬
514115
MODIFICATIONS OF CUPREDOXIN
DERIVES PEPTIDES AND METHODS
OF USE THEREOF
CDG THERAPEUTICS, INC.
US
12/389120
19/02/2009
PCT/US/2010/024778
WO/2010/096681
2//81/1828
METHODS AND DEVICES FOR
VENOUS OCCLUSION FOR THE
TREATMENT OF VENOUS
INSUFFICIENCY
50
A61K )5010.01(
514112
C07K )5010.01(
‫פפטידים הנגזרים משינויים של‬
‫קופרדוקסין ושיטות לשימוש בהם‬
A61B )5010.01(
‫שיטות ומכשירים עבור חסימה ורידית‬
‫לטיפול באי–ספיקת ורידית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
SAPHEON, INC.
US
61/154322
/2/12//1/
US
PCT/US/2010/024820
WO/2010/096717
21/81/1828
20/02/2009
22/21/188/
514114
PROCESS FOR THE PREPARATION
OF PYRAZOLE DERIVATIVES
BASF SE
EP
09155198.6 16/03/2009
PCT/EP/2010/053146
WO/2010/105969
1//81/1828
514115
USE OF SYNTHETIC AND
BIOLOGICAL FUNGICIDES IN
COMBINATION FOR CONTROLLING
HARMFUL FUNGI
BASF SE
EP
09156360.1 26/03/2009
8/2//21201
8//8//188/
EP
PCT/EP/2010/053867
WO/2010/108973
2//81/1828
514111
CONTENT ACCESS PLATFORM AND
METHODS AND APPARATUS
PROVIDING ACCESS TO INTERNET
CONTENT FOR HETEROGENEOUS
DEVICES
HOI SHUEN CHAU
GB
0902834.1
19/02/2009
PCT/GB/2010/000295
WO/2010/094927
51
C07D )5010.01(
‫תהליך להכנת תולדות פיראזול‬
A01N )5010.01(
‫שימוש בצירוף של קוטלי פטריות‬
‫סינתטיים וביולוגיים לשליטה בפטריות‬
‫מזיקות‬
G06F )5010.01(
‫תוכנית גישה לתוכן ושיטות ומערכות‬
‫לאספקת גישה לתוכן אינטרנט עבור‬
‫מכשירים הטרוגנים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514111
11/81/188/
PORTABLE CONNECTING DEVICE OF
PIPELINE TYPE, WATER PURIFIER AND
PURIFIED WATER PREPARING
MACHINE, PURIFIED WATER
PREPARING MACHINE
QIDI ZHOU
CN
200920009837.7 23/02/2009
PCT/CN/2009/070512
WO/2010/094179
1//81/1828
514111
JAK KINASE MODULATING
QUINAZOLINE DERIVATIVES AND
METHODS OF USE THEREOF
AMBIT BIOSCIENCES CORPORATION
US
61/156447
27/02/2009
/2/1/1821
22/82/1828
US
/2/1/11/8
21/82/1828
US
PCT/US/2010/025500
WO/2010/099379
81/81/1828
514110
A BUSBAR CONNECTOR
RAYTHEON COMPANY
US
12/409639
24/03/2009
PCT/US/2010/026014
WO/2010/111004
28/81/1828
PANEL ARRAY
514111
B01D )5010.01(
‫התקן התחברות נייד של צינור מסוג‬
‫מטהר מים ומכונה להכנת מים‬
‫ ומכונה להכנת מים‬,‫מטוהרים‬
‫ ומכונה להכנת מים מטוהרים‬,‫מטוהרים‬
C07D )5010.01(
‫נגזרות קינזולין כמודולטורים של קינאז‬
‫ ושיטות שימוש בהן‬JAK
H01R )5010.01(
‫מחבר פס צבירה‬
H01Q )5010.01(
‫מערך פנל‬
RAYTHEON COMPANY
52
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/163002
21/121/1/
US
PCT/US/2010/026861
WO/2010/111038
81/81/1828
24/03/2009
2//8//188/
514112
APPARATUS AND METHOD FOR
CONTROLLING A SOLID STATE DISK
IBM CORPORATION
EP
09158373.2 21/04/2009
PCT/EP/2010/054600
WO/2010/121902
2//81/1828
82/81/1828
‫מערכת ושיטה לשליטה על אמצעי אחסון‬
‫מידע‬
514114
COPY CIRCUMVENTION IN A
VIRTUAL NETWORK ENVIRONMENT
IBM CORPORATION
US
12/396257
02/03/2009
PCT/EP/2010/051930
WO/2010/100027
53
G06F )5010.01(
‫הקשיית העתקה בסביבת רשת וירטואלית‬
514115
A01N )5010.01(
C ‫מעכבי וירוס צהבת‬
HEPATITIS C VIRUS INHIBITORS
ENANTA PHARMACEUTICALS, INC.
US
61/156131
27/02/2009
/2/2/2812
8//81/188/
US
PCT/US/2010/025741
WO/2010/099527
22/81/1828
G06F )5010.01(
514111
A61Q )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫שיטה לטיפול קוסמטי בקמטים‬
‫המבוסס על מיצוי של זנטוקסילום‬
‫בונגאנום‬
COSMETIC WRINKLE TREATMENT
METHOD BASED ON A ZANTHOXYLUM
BUNGEANUM EXTRACT
INDENA S.P.A.
IT
MI2009A000247
PCT/EP/2010/001010
WO/2010/094477
8//81/1828
23/02/2009
514116
–‫נוגדנים הומאניים שלמים ספציפיים ל‬
CADM1
FULLY HUMAN ANTIBODIES
SPECIFIC TO CADM1
OXFORD BIOTHERAPEUTICS LTD
US
61/209471
05/03/2009
/2/18/1/8
8//81/188/
US
PCT/US/2010/026315
WO/2010/102175
11/81/1828
514110
NITROGEN-CONTAINING FUSED
HETEROCYCLIC COMPOUNDS AND
THEIR USE AS BETA AMYLOID
PRODUCTION INHIBITORS
C07K )5010.01(
C07D )5010.01(
‫תרכובות הטרוציקליות מאוחות המכילות‬
‫חנקן ושימושן כמעכבי ייצור בטא אמילואיד‬
EISAI R&D MANAGEMENT CO., LTD.
2009JP
26/02/2009
043337
/2/2////1
1//81/188/
US
PCT/JP/2010/053368
WO/2010/098487
1//81/1828
514112
METHODS OF REPROGRAMMING
RENAL CELLS
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD.
54
C12N )5010.01(
‫שיטות לתכנות מחדש של תאי כליה‬
‫תשתית ושירותים‬, ‫מחקרים‬-‫תל השומר‬
‫רפואיים בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/202426
/2/18111/
US
PCT/IL/2010/000159
WO/2010/097794
82/81/1828
26/02/2009
1//81/188/
514114
METHODS OF USING SNS-595 FOR
TREATMENT OF CANCER SUBJECTS
WITH REDUCED BRCA2 ACTIVITY
SUNESIS PHARMACEUTICALS, INC.
US
61/156449
27/02/2009
/2/218821
2//81/188/
US
PCT/US/2010/025737
WO/2010/099526
2//81/1828
A61K )5010.01(
‫ לטיפול בחולי‬SNS–565–‫שיטות לשימוש ב‬
‫ מופחתת‬BRCA5 ‫סרטן עם פעילות‬
514115
DIHYDROLIPOIC ACID
DERIVATIVES COMPRISING NITRIC
OXIDE AND THERAPEUTIC USES
THEREOF
INVASC THERAPEUTICS INC.
C07C )5010.01(
‫נגזרות של חומצה דיהידרוליפואית‬
‫המכילות תחמוצת החנקן ושימושים‬
‫טיפוליים שלהן‬
PCT/US/2010/024772
WO/2010/096677
21/28/1881
514111
CELL BINDING AGENT
MAYTANSINOID CONJUGATES AND
METHODS FOR USING THE SAME
IMMUNOGEN, INC.
US
60/509901
10/10/2003
28///8/81
82/28/1881
US
PCT/US/2004/030917
WO/2005/037992
55
C07D )5010.01(
‫תצמידי גורם המחבר לתא‬
‫ומאיטאנסינואיד ושיטות לשימוש בהם‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//81/1828
514116
‫מכלול מתאם למיכל במערכת ערבוב‬
‫תרופה‬
‫טבע מדיקל בע"מ‬
VIAL ADAPTER ASSEMBLY IN DRUG
MIXING SYSTEM
TEVA MEDICAL LTD.
US
61/154793
24/02/2009
PCT/US/2010/024246
WO/2010/099000
22/8//1828
514165
CONTENT PROVISIONING AND
REVENUE DISBURSEMENT
CATCH MEDIA INC.
US
12/495766
30/06/2009
PCT/US/2010/039273
WO/2011/008418
21/81/1828
21/81/1828
56
G01N )5010.01(
‫אימונובדיקות לפעילות אנדופפטידאז מיועד‬
‫מחדש‬
514164
CELLS USEFUL FOR IMMUNOBASED BOTULINUM TOXIN
SEROTYPE A ACTIVITY ASSAYS
ALLERGAN, INC.
US
61/160199
13/03/2009
PCT/US/2010/027242
WO/2010/105234
G06F )5010.01(
‫אספקת תוכן וחלוקת הכנסות‬
514162
IMMUNO-BASED RETARGETED
ENDOPEPTIDES ACITIVITY ASSAYS
ALLERGAN, INC.
US
61/160217
13/03/2009
PCT/US/2010/027244
WO/2010/105236
A61J )5010.01(
C12N )5010.01(
‫תאים שימושיים לאינומובדיקות של‬
A ‫פעילות רעלן בוטולינום מסוג‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/81/1828
514161
LACRIMAL IMPLANTS AND
RELATED METHODS
QLT INC.
US
61/154693
23/02/2009
/2/18/81/
81/81/188/
US
/2/18//18
8//81/188/
US
/2/1122/1
11/81/188/
US
/2/1/18/1
2//28/188/
US
PCT/US/2010/025089
WO/2010/096822
21/81/1828
514161
METHODS AND COMPOSITIONS FOR
STEM CELL CULTURES
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/168679
13/04/2009
PCT/US/2010/030899
WO/2010/120785
82/81/1828
514166
P38MAP KINASE INHIBITOR
RESPIVERT LIMITED
US
61/166594
03/04/2009
8/8////02
8//81/188/
GB
PCT/GB/2010/050575
WO/2010/112936
11/81/1828
514100
SPECIFIC DIARYLHYDANTOIN AND
DIARYLTHIOHYDANTION
COMPOUNDS
57
A61F )5010.01(
‫שתלים דמעתיים ושיטות קשורות‬
C12N )5010.01(
‫שיטות ותכשירים עבור תרביות של תאי‬
‫גזע‬
C07D )5010.01(
‫ קינאז‬MAP38P ‫מעכב‬
A01N )5010.01(
‫תרכובות ספיציפיות דיארילהידנתואין‬
‫ודיארילתיאוהידנתואין‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
MEDIVATION PROSTATE
THERAPEUTICS, INC.
US
61/155119
24/02/2009
/2/2//1/2
11/81/188/
US
PCT/US/2010/025283
WO/2010/099238
81/81/1828
514101
ARRANGEMENT FOR STORAGE,
WAREHOUSE RACK AND HANDLING
MACHINE PARTICULARLY FOR
SUCH ARRANGEMENT
ANTAL ZOMBORI
HU
P0900128
02/03/2009
PCT/HU/2010/000024
WO/2010/100513
22/81/1828
514105
NOISE ERROR AMPLITUDE
REDUCTION
HARRIS CORPORATION
US
12/403646
13/03/2009
PCT/US/2010/026886
WO/2010/104995
1//81/1828
514104
CHROMELESS USER INTERFACE
MICROSOFT CORPORATION
US
12/414455
30/03/2009
PCT/US/2010/028699
WO/2010/117661
11/81/1828
58
514105
B65G )5010.01(
‫ אצטבה למחסן ומכונה‬,‫סידור לאחסון‬
‫ עבור סידור כזה‬,‫לטיפול בפרט‬
G10K )5010.01(
‫הפחתת אמפליטודת שגיאת רעש‬
G06F )5010.01(
‫ממשק משתמש חסר צבע‬
A01N )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫ליגנדות לרצפטור האסטרוגן ושיטות‬
‫לשימושם‬
ESTROGEN RECEPTOR LIGANDS
AND METHODS OF USE THEREOF
GTx, INC.
US
61/154707
23/02/2009
/2/2/2/21
21/81/188/
US
/2/1/2///
2//22/188/
US
PCT/US/2010/025032
WO/2010/096801
2//81/1828
514101
PREBIOTIC FORMULATIONS AND
METHODS OF USE
RITTER PHARMACEUTICALS, INC.
US
61/155150
24/02/2009
/2/111/11
21/28/188/
US
PCT/US/2010/000447
WO/2010/098822
8//81/1828
8//82/1828
A61K )5010.01(
‫צורות מתן פומיות עם העמסה גבוהה של‬
‫פרודראג גאבאפנטין‬
514101
VISFATIN THERAPEUTIC AGENTS
FOR THE TREATMENT OF ACNE AND
OTHER CONDITIONS
HEALOR LTD
US
61/208386
24/02/2009
/2/1/21/1
2//22/188/
US
PCT/IL/2010/000011
WO/2010/097788
59
‫פורמולציות פרהביוטיות ושיטות לשימוש‬
‫בהן‬
514101
ORAL DOSAGE FORMS HAVING A
HIGH LOADING OF A GABAPENTIN
PRODRUG
XENOPORT INC.
US
61/158065
06/03/2009
PCT/US/2010/026427
WO/2010/102252
A01N )5010.01(
C07K )5010.01(
‫חומרים רפואיים הכוללים ויספטין לטיפול‬
‫באקנה ובמצבים אחרים‬
‫הילעור בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
82/81/188/
514106
BIOMARKERS FOR THE PREDICTION
OF RENAL INJURY
COMPUGEN LTD.
C12Q )5010.01(
‫סמנים ביולוגים לחיזוי של נזק לכליות‬
‫קומפיוג'ן בע"מ‬
PCT/IL/2009/000235
WO/2010/100633
22/81/1828
514115
SUPPORT UNIT FOR PHYSICALLY
HANDICAPPED PATIENTS
PIRLI, ASLAN ALI
TR
2009/01453 26/02/2009
PCT/TR/2010/000032
WO/2010/098731
2//81/1828
11/81/1828
B65D )5010.01(
‫מילוי מחדש של מחסניות של מוצר טישו‬
‫מקופל‬
514115
SYSTEM FOR DISTRIBUTING A
PLURALITY OF UNIQUE
VIDEO/AUDIO STREAMS
MANUFACTURING RESOURCES
INTERNATIONAL INC.
US
61/154951
24/02/2009
60
‫יחידת תמיכה לחולים נכים‬
514114
REFILL CARTRIDGES OF A FOLDED
TISSUE PRODUCT
KIMBERLY-CLARK WORLDWIDE,
INC.
US
61/165200
31/03/2009
PCT/IB/2010/051113
WO/2010/113058
A61F )5010.01(
H04N )5010.01(
‫מערכת להפצה של מחרוזות מגוונות‬
‫אודיו‬/‫ומיוחדות של וידאו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PCT/US/2010/025222
WO/2010/099194
11/81/1828
514111
SYSTEM AND METHOD FOR
CONTROLLING THE OPRATION
PARAMETERS OF A DISPLAY IN
RESPONSE TO CURRENT DRAW
MANUFACTURING RESOURCES
INTERNATIONAL INC.
US
61/154936
24/02/2009
PCT/US/2010/025213
WO/2010/099187
11/81/1828
‫מערכת ושיטה לבקרת גורמי הפעלה של‬
‫צג כתגובה לתצרוכת זרם‬
514111
SYSTEM AND METHOD FOR
DISPLAYING MULTIPLE
IMAGES/VIDEOS ON A SINGLE
DISPLAY
MANUFACTURING RESOURCES
INTERNATIONAL INC.
US
61/155100
24/02/2009
PCT/US/2010/025202
WO/2010/099178
82/81/1828
514111
DIFFERENTIATION OF PLURIPOTENT
CELLS
CELLULAR DYNAMICS
INTERNATIONAL, INC.
US
61/156304
27/02/2009
PCT/US/2010/025776
WO/2010/099539
61
G09G )5010.01(
G09G )5010.01(
‫מערכת ושיטה לתצוגת דמויות‬
‫וידאו בצג יחיד‬/‫מרובות‬
C12N )5010.01(
‫דיפרנצאציה של תאים רב–פוטנטיים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
8//82/1822
514116
SENSOR ASSEMBLY FOR A FLUID
FLOWMETER
MCCROMETER, INC.
US
12/683266
06/01/2010
PCT/US/2011/020241
WO/2011/085016
11/81/1828
514151
TOILET PAPER ROLL HAVING
ANGLED SIDES
KIMBERLY-CLARK WORLDWIDE,
INC.
US
61/164016
27/03/2009
21//1111/
12/21/188/
US
PCT/IB/2010/051237
WO/2010/109404
18/81/1828
514155
SUBSTITUTED AZOANTHRACENE
DERIVATIVES, PHARMACEUTICAL
COMPOSITIONS, AND METHODS OF
USE THEREOF
TRANSTECH PHARMA, INC.
US
61/164523
30/03/2009
/2/18/112
82/81/1828
US
PCT/US/2010/029172
WO/2010/114824
1//81/1828
514152
FIBER OPTICAL ASSEMBLY FOR
FLUORESCENCE SPECTROMETRY
THE RESEARCH FOUNDATION OF
STATE UNIVERSITY OF NEW YORK
US
61/211264
25/03/2009
PCT/US/2010/028692
62
G01F )5010.01(
‫מכלול חישן עבור מד זרימת ניגרים‬
A47K )5010.01(
‫גליל נייר טואלט בעל צדדים בזווית‬
A01N )5010.01(
‫ תכשירי‬,‫תולדות אזואנטרצן מותמרות‬
‫רוקחות ושיטות לשימוש בהן‬
A01N )5010.01(
‫הרכב סיב אופטי עבור ספקטרומטריה‬
‫פלואורסנטית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/111508
22/81/1828
514154
SELECTION OF DOWNLINK
INTERFACE IN AN ASYMMETRIC
BROADBAND DATA RADIO
NETWORK
HARRIS CORPORATION
US
12/403594
13/03/2009
PCT/US/2010/026892
WO/2010/104999
11/81/1828
‫בחירה של ממשק שידור מלוויין ברשת‬
‫נתוני רדיו רחבת פס אסימטרית‬
514155
THIENOPYRIDINE DERIV ATIVES
FOR THE TREATMENT AND
PREVENTION OF DENGUE VIRUS
INFECTIONS
SIGA TECHNOLOGIES, INC.
US
61/156132
27/02/2009
PCT/US/2010/025183
WO/2010/099166
1//81/1828
2//81/1828
63
A01N )5010.01(
‫תולדות תיאנופירידין לטיפול ומניעה של‬
‫זיהום וירוס דנגה‬
514151
CUTTING TOOL, CUTTING TOOL
HOLDER AND CUTTING INSERT
THEREFOR
NO SCREW LTD
US
61/2024445 27/02/2009
/2/181112
81/81/188/
US
PCT/IL/2010/000162
WO/2010/097797
H04W )5010.01(
B23C )5010.01(
‫ מחזיק לשימה ושימה לשימוש‬,‫כלי חיתוך‬
‫בו‬
514151
‫בלי בורג בע"מ‬
C07K )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
BISPECIFIC ANTI-HER ANTIBODIES
GENENTECH, INC.
US
61/210562
20/03/2009
PCT/US/2010/028023
WO/2010/108127
8//81/1828
514151
METHODS FOR CLONING AND
MANIPULATING GENOMES
SYNTHETIC GENOMICS, INC.
US
61/158320
06/03/2009
PCT/US/2010/026434
WO/2010/102257
11/81/1828
514156
DEVICE AND METHOD FOR
INSPECTING SEMICONDUCTOR
WAFERS
ALTATECH SEMICONDUCTOR,
FR
0900862
25/02/2009
PCT/FR/2010/000165
WO/2010/097523
2//81/1828
514122
NOVEL NUCLEAR
REPROGRAMMING SUBSTANCE
NATIONAL INSTITUTE OF
ADVANCED INDUSTRIAL SCIENCE
AND TECHNOLOGY
US
61/208853
27/02/2009
/2/11/211
82/8//188/
US
PCT/JP/2010/053024
WO/2010/098419
64
HER – ‫נוגדנים ביספציפים אנטי‬
C12N )5010.01(
‫שיטות לשיבוט והשפעה על גנום‬
G01B )5010.01(
‫מכשיר ושיטה לבדיקת פרוסות מוליכות‬
‫למחצה‬
C12N )5010.01(
‫חומר מתכנת מחדש גרעיני חדש‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514125
82/81/1828
FUSARIUM RESISTANT CUCUMBER
PLANTS
MONSANTO INVEST N.V.
EP
09153969.2 27/02/2009
PCT/NL/2010/050101
WO/2010/098670
1//81/1828
25/02/2009
514121
ISOLATED POPULATIONS OF RENAL
STEM CELLS AND METHODS OF
ISOLATING AND USING SAME
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD.
US
61/202425
26/02/2009
/2/18111/
1//81/188/
US
PCT/IL/2010/000158
WO/2010/097793
22/81/1828
C12N )5010.01(
‫אוכלוסיות מבודדות של תאי נבט כיליתיים‬
‫ושיטות לבידוד ושימוש בהם‬
514121
PRESSURE MANAGEMENT
HYDRAULIC CONTROL VALVE
BERMAD CS LTD.
IL
197320
26/02/2009
PCT/IB/2010/050718
65
C07K )5010.01(
mX (EPSILON) C – ANTI ‫נוגדנים כנגד‬
‫ של אדם על‬mIgE ‫המסוגלים להקשר ל‬
B ‫לימפוציטים מסוג‬
ANTI-C(EPSILON) mX ANTIBODIES
CAPABLE OF BINDING TO HUMAN
mIgE ON B LYMPHOCYTES
ACADEMIA SINICA
US
61/155224
PCT/CN/2010/000232
WO/2010/097012
‫צמחי מלפפון עמידים לפוסריום‬
514121
1//81/1828
C12N )5010.01(
‫ תשתית ושירותים‬,‫תל השומר מחקרים‬
‫רפואיים בע"מ‬
F16K )5010.01(
‫שסתום בקרה הידראולי לשליטה בלחץ‬
‫אגודה שיתופית חקלאית בע"מ‬-‫ברמד‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/097734
11/81/1828
514126
DEVICES, SYSTEMS AND METHODS
FOR MAGNETIC - ASSISTED
THERAPEUTIC AGENT DELIVERY
UNIVERSITY OF OKLAHOMA
US
61/155223
25/02/2009
21/121221
11/81/1828
US
PCT/US/2010/032238
WO/2010/099552
2//81/1828
81/81/1828
514141
METHOD FOR PRODUCING
HALOGEN-SUBSTITUTED BENZENE
DIMETHANOL
SUMITOMO CHEMICAL COMPANY,
LIMITED
2009JP
05/03/2009
051677
PCT/JP/2010/054070
WO/2010/101299
66
‫ מערכות ושיטות למתן טיפול‬,‫התקנים‬
‫בעזרת מגנט‬
514140
HUMANISED ANTIBODIES WITH
ANTI-TUMOUR ACTIVITY
CEPHALON AUSTRALIA PTY LTD
AT
2009901129 16/03/2009
/2/2/8/21
2//81/188/
US
/2/1/2/21
8//22/188/
US
PCT/AU/2010/000298
WO/2010/105290
A61M )5010.01(
C07K )5010.01(
‫נוגדנים אנושים עם פעילות אנטי גידולית‬
C07C )5010.01(
‫שיטה לייצור של להחלפת הלוגן בנזאן‬
‫דימאת'נול‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
1//81/1828
514145
‫השמה של מתכת נטולת מטען במבנים‬
‫מיקרוניים‬
ELECTROLESS METAL DEPOSITION
FOR MICRON SCALE STRUCTURES
BAE SYSTEMS PLC
GB
0903642.7
27/02/2009
PCT/GB/2010/050317
WO/2010/097620
22/81/1828
514144
OMEGA-3 ENRICHED FISH OIL - INWATER PARENTERAL NUTRITION
EMULSIONS
STABLE SOLUTIONS LLC
US
12/382196
11/03/2009
PCT/US/2010/000723
WO/2010/104575
8//81/1828
514145
67
C07K )5010.01(
DKK –1–‫נוגדני‬
514141
BISPECIFIC ANTI-ERBB-2/ANTI-CMET ANTIBODIES
ROCHE GLYCART AG
EP
09005109.5 07/04/2009
PCT/EP/2010/002006
WO/2010/115553
A61K )5010.01(
‫אמולסיות תזונתיות של שמן דגים מועשר‬
‫ בתוך מים למתן פרנטלי‬2– ‫באומגה‬
DKK-1 ANTIBODIES
ELI LILLY AND COMPANY
US
61/168411
10/04/2009
PCT/US/2010/030039
WO/2010/117980
18/81/1828
C23C )5010.01(
C07K )5010.01(
ERBB–2/ANTI–‫נוגדנים דו–ספציפיים כנגד‬
C–MET
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/81/1828
514141
SYSTEMS AND METHODS FOR
FACET JOINT TREATMENT
ZYGA TECHNOLOGY, INC.
US
12/509,260
24/07/2009
PCT/US/2010/042931
WO/2011/011621
2//81/1828
514146
PROCESS FOR THE PREPARATION
OF PROPIONIC ACID DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09156074.8 24/03/2009
8/21211802
81/21/188/
EP
PCT/EP/2010/053598
WO/2010/108861
1//81/1828
514150
LOW-MAINTENANCE LAWN SEED
MIXTURES AND USE THEREOF
PEARL'S PREMIUM, INC.
US
61/208773
27/02/2009
PCT/US/2010/000582
WO/2010/098870
8//81/1828
514151
IL -17 BINDING PROTEINS
ABBOTT LABORATORIES
US
61/209272
05/03/2009
PCT/US/2010/026424
WO/2010/102251
68
A61F )5010.01(
‫מערכת ושיטה לטיפול בדיסקיות עמוד‬
‫השידרה‬
C07D )5010.01(
‫תהליך להכנת תולדות של חומצה‬
‫פרופיונית‬
A01G )5010.01(
‫תערובות זרעים למדשאות הדורשות‬
‫תחזוקה מועטה ושימושים בהן‬
A61K )5010.01(
IL – 11 ‫חלבונים הקושרים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1828
514151
SYSTEM AND METHOD FOR
DEPLOYING AN ENDOLUMINAL
PROSTHESIS AT A SURGICAL SITE
BOLTON MEDICAL, INC.
US
61/160052
13/03/2009
/2/1//11/
11/28/188/
US
PCT/US/2010/027191
WO/2010/105195
11/81/1828
‫מערכת ושיטה לפרישת תותב בעל חלל‬
‫פנימי במקום הניתוח‬
514151
PROCESS FOR PREPARING
ANTIVIRAL COMPOUND
ABBOTT LABORATORIES
US
61/162705
24/03/2009
/2/12/121
11/81/1828
US
PCT/US/2010/028433
WO/2010/111348
12/82/188/
A61F )5010.01(
C07D )5010.01(
‫תהליך להכנת תרכובת אנטי – ויראלית‬
514110
B24D )5010.01(
ABRASIVE TOOLS HAVING A
PERMEABLE STRUCTURE
SAINT GOBAIN ABRASIVES, INC.
US
11/240809
30/09/2005
PCT/US/2006/033438
WO/2007/040865
81/81/1828
‫כלי השחזה בעל מבנה בר–חלחול‬
514111
METHOD FOR DISPLAY OFFLINE,
TARGETED, INDIVIDUALLY
SCHEDULED ADVERTISEMENTS IN
ANY DESKTOP DISPLAY
MANDARR PATIL
IN
463/MUM/2009 04/03/2009
PCT/IB/2010/050903
WO/2010/100608
69
G06F )5010.01(
‫שיטה לתצוגה לא מקוונת של פרסומות‬
‫ על כל‬,‫מיועדות ומתוכננות אישית‬
‫תצוגה שולחנית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
514115
22/8//1828
PROCESS FOR SYNTHESIS OF
DIARYLPYRIMIDINE NON-NUCLEOSIDE
REVERSE TRANSCRIPTASE INHIBITOR
C07D )5010.01(
‫תהליך לסינתזה של מעכב‬
‫דיארילפירימידיני לא – נוקליאוזידי של‬
‫רברס טראנסקריפתאז‬
EMCURE PHARMACEUTICALS LIMITED
IN
1479/MUM/2009 22/06/2009
PCT/IN/2010/000422
WO/2010/150279
21/81/1828
514112
POLYMER FIBER, ITS USE AND
PROCESS FOR ITS MANUFACTURE
BAUMHUETER EXTRUSION GMBH
EP
09003912.4 18/03/2009
PCT/EP/2010/053182
WO/2010/105980
22/81/1828
514114
ARTICLE HAVING A SEAL AND
PROCESS FOR FORMING THE SAME
THE PROCTER & GAMBLE
COMPANY
US
61/159906
13/03/2009
PCT/US/2010/026887
WO/2010/104996
2//81/1828
514115
CLAMPED GAS BLOCK FOR BARREL
RA BRANDS, LLC
US
61/162099
20/03/2009
21/1118/1
22/81/1828
US
PCT/US/2010/027916
70
D01F )5010.01(
‫ שימושו ותהליך לייצורו‬,‫סיב פולימרי‬
B29C )5010.01(
‫פריט בעל חותם ותהליך ליצירתו‬
F41A )5010.01(
‫חוסם גז עבור קנה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/108068
2//81/1828
514111
‫נוגדן אנטגוניסט ספיציפי הטרודימרי‬
1–‫–בתא‬4–‫אלפא‬
ALPHA-4-BETA-7 HETERODIMER
SPECIFIC ANTAGONIST ANTIBODY
AMGEN INC.
US
61/162154
20/03/2009
/2/18/21/
11/81/1828
US
PCT/US/2010/027422
WO/2010/107752
1//81/1828
514116
514110
MULTI-FIELD CHARGED PARTICLE
CANCER THERAPY METHOD AND
APPARATUS
ZAKRYTOE AKTSIONERNOE
OBSHCHESTVO PROTOM
G01S )5010.01(
‫מערכת איתור אלחוטית של רשת‬
‫אוטונומית‬
NETWORK AUTONOMOUS
WIRELESS LOCATION SYSTEM
TRUEPOSITION, INC.
US
12/428325
22/04/2009
PCT/US/2010/028951
WO/2010/123655
81/81/188/
C07K )5010.01(
A61N )5010.01(
‫שיטה ומערכת לטיפול בסרטן באמצעות‬
‫חלקיק טעון רב–תחומי‬
PCT/RU/2009/000105
WO/2010/101489
81/81/1828
DEVICE FOR PRODUCING MILK
FROTH
71
514111
A47J )5010.01(
‫מכשיר לייצור קצף חלב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
DELICA AG
EP
09154238.1
PCT/EP/2010/052649
WO/2010/100170
1//81/1828
03/03/2009
514115
METHODS FOR TREATING AND
PREVENTING PNEUMONIA AND
VENTILATOR-ASSOCIATED
TRACHEOBRONCHITIS
PULMATRIX, INC
US
61/163767
26/03/2009
/2/1/28/1
1//82/1828
US
PCT/US/2010/028901
WO/2010/111641
12/81/1828
81/81/1828
E21B )5010.01(
–‫המרת חומר אורגני מהיווצרות תת‬
‫קרקעית לפחמימנים הניתנים לייצור‬
‫באמצעות שליטה על פעולות הייצור על‬
‫בסיס זמינות של משאב ייצור אחד או יותר‬
514111
AN ELECTRICAL CONNECTOR TO
CONNECT CIRCUIT CARDS
RAYTHEON COMPANY
US
61/162769
24/03/2009
21/1121/1
8//81/188/
US
PCT/US/2010/025860
72
‫שיטות לטיפול ומניעה של דלקת ריאות‬
‫ודלקת סמפונות וקנה הקשורה לאוורור‬
514112
CONVERTING ORGANIC MATTER
FROM A SUBTERRANEAN
FORMATION INTO PRODUCIBLE
HYDROCARBONS BY CONTROLLING
PRODUCTION OPERATIONS BASED
ON AVAILABILITY OF ONE OR
MORE PRODUCTION RESOURCES
EXXONMOBIL UPSTREAM
RESEARCH COMPANY
US
61/175547
05/05/2009
PCT/US/2010/031910
WO/2010/129174
A61K )5010.01(
H01R )5010.01(
‫מחבר חשמלי לחבר כרטיסי מעגל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/111097
8//81/1828
TRANSLATING HINGE
RAYTHEON COMPANY
US
61/162748
21/1//218
US
PCT/US/2010/026324
WO/2010/111012
81/81/1828
514111
‫ציר מזיז‬
24/03/2009
21/8//188/
514110
NANOPARTICLE MEDIATED
DELIVERY OF SEQUENCE SPECIFIC
NUCLEASES
DOW AGROSCIENCES LLC
US
61/167389
07/04/2009
PCT/US/2010/030155
WO/2010/118077
21/81/1828
514111
514115
BONE CEMENT DELIVERY SYSTEMS
AND RELATED KITS AND METHODS
WYETH LLC
73
C12N )5010.01(
‫מתן נוקליאזים לרצפים ספציפיים בתיווך‬
‫ננוחלקיקים‬
A PKN3/RHOC MACROMOLECULAR
COMPLEX AND METHODS OF USE
THEREFOR
WYETH LLC
US
61/159739
12/03/2009
/2/11/812
2//81/188/
US
PCT/US/2010/027095
WO/2010/105128
22/81/1828
E05D )5010.01(
G01N )5010.01(
‫ מקרומולקולרי‬RHOC/3PKN ‫תצמיד‬
‫ושיטות לשימושים בו‬
A61B )5010.01(
‫מערכות שילוח מלט עצמות וערכות‬
‫ושיטות הקשורות בהן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/160063
PCT/US/2010/026919
WO/2010/105018
82/81/1828
13/03/2009
514114
TRIVALENT, BISPECIFIC
ANTIBODIES
ROCHE GLYCART AG
EP
09005108.7 07/04/2009
PCT/EP/2010/002122
WO/2010/115589
18/81/1828
514115
BISPECIFIC ANTI-ERBB-1/ANTI-CMET ANTIBODIES
ROCHE GLYCART AG
EP
09005109.5 07/04/2009
PCT/EP/2010/002003
WO/2010/115551
2//81/1828
514111
FATTY ACID MONOGLYCERIDE
COMPOSITIONS
STIEFEL RESEARCH AUSTRALIA
PTY LTD.
US
61/202635
20/03/2009
/2/121121
12/8//188/
US
PCT/US/2010/027905
WO/2010/108060
21/81/1828
74
514111
C07K )5010.01(
‫ תלת–ערכיים‬,‫נוגדנים דו–ספציפיים‬
C07K )5010.01(
MET –C/1– ‫נוגדנים דו–ספציפיים כנגד‬
ERBB
A01N )5010.01(
‫תכשירי חומצה שומנית של מונוגליצריד‬
G06F )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
SYSTEM AND METHOD OF
MANAGING POWER AT A PORTABLE
COMPUTING DEVICE AND A
PORTABLE COMPUTING DEVICE
DOCKING STATION
QUALCOMM INCORPORATED
US
61/164084
27/03/2009
21//1/811
11/21/188/
US
PCT/US/2010/024424
WO/2010/110958
81/8//188/
‫מערכת ושיטה לניהול כח בהתקן חישוב‬
‫נייד ובתחנת עגינה ניידת להתקן חישוב‬
514116
PRODUCT MULTI-PACK AND A
SYSTEM FOR ORIENTING AND
PACKAGING SUCH MULTI-PACKS
BIO CLINICAL DEVELOPMENT, INC
US
12/424139
15/04/2009
PCT/US/2009/045970
WO/2010/120319
21/81/1828
‫רב–חבילות מוצר ומערכת לכיוון ואריזת‬
‫כאלה רב–חבילות‬
514160
A PORTABLE DOCKING STATION
FOR A PORTABLE COMPUTER
DEVICE
QUALCOMM INCORPORATED
US
61/164024
27/03/2009
21//11121
11/21/188/
US
PCT/US/2010/024379
WO/2010/110954
1//81/1828
75
G06F )5010.01(
‫תחנת עגינה ניידת להתקן חישוב נייד‬
514162
MILKING SYSTEM FOR MAMMALS,
PREFERABLY CATTLE, WHICH
DISTINGUISHES WHEN THE MILK
STOPS, INCLUDING A COLLECTOR,
TEAT CUPS, AND TUBES
B65B )5010.01(
A01J )5010.01(
,‫ במיוחד פרות‬,‫מערכת חליבה ליונקים‬
,‫ הכוללת קולט‬,‫המבחינה בהפסקת החלב‬
‫ וצינוריות‬,‫כוסיות פטמה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WILLIAM RONNIE USLAR
VALENZUELA
CL
437-2009
26/02/2009
PCT/CL/2010/000011
WO/2010/096945
81/81/1828
514165
METHOD FOR DETECTING
SUBSTANCE IN BIOLOGICAL
SAMPLE
VIRUS IKAGAKU KENKYUSHO INC
2009JP
02/03/2009
048661
PCT/JP/2010/053359
WO/2010/101157
8//81/1828
SYNOVIAL SHUNTS
JOINTECH MED. LTD
US
61/164580
PCT/IL/2010/000265
WO/2010/113153
21/81/1828
‫שיטת מעקב אחר חומר בדגימה ביולוגית‬
514161
A61M )5010.01(
‫מעקף סינוביאלי‬
30/03/2009
514166
SYSTEM AND METHOD OF
MANAGING DATA
COMMUNICATION AT A PORTABLE
COMPUTING DEVICE AND A
PORTABLE COMPUTING DEVICE
DOCKING STATION
QUALCOMM INCORPORATED
US
61/164097
27/03/2009
21//1/11/
11/21/188/
US
PCT/US/2010/024429
WO/2010/110959
76
G01N )5010.01(
G06F )5010.01(
‫מערכת ושיטה לניהול תקשורת נתונים‬
‫בהתקן חישוב נייד ובתחנת עגינה ניידת‬
‫להתקן חשיוב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1828
514600
SYSTEM AND METHOD OF
MANAGING SECURITY BETWEEN A
PORTABLE COMPUTING DEVICE
AND A PORTABLE COMPUTING
DEVICE DOCKING STATION
QUALCOMM INCORPORATED
US
61/164058
27/03/2009
21//111/1
11/21/188/
US
PCT/US/2010/024400
WO/2010/110956
81/81/1828
‫מערכת ושיטה לניהול אבטחה בין התקן‬
‫חישוב נייד ובתחנת עגינה ניידת להתקן‬
‫חישוב‬
514601
ULTRASONIC TREATMENT OF
ADIPOSE TISSUE AT MULTIPLE
DEPTHS
MEDICIS TECHNOLOGIES
CORPORATION
US
61/157534
04/03/2009
PCT/US/2010/026240
WO/2010/102128
21/81/1828
77
A61N )5010.01(
‫טיפול על–קולי של רקמה שומנית‬
‫בעומקים מרובים‬
514605
SYSTEM AND METHOD OF
PROVIDING WIRELESS
CONNECTIVITY BETWEEN A
PORTABLE COMPUTING DEVICE
AND A PORTABLE COMPUTING
DEVICE DOCKING STATION
QUALCOMM INCORPORATED
US
61/164139
27/03/2009
21//1/111
11/21/188/
US
PCT/US/2010/024439
WO/2010/110961
G06F )5010.01(
G06F )5010.01(
‫מערכת ושיטה לאספקת קישוריות‬
‫אלחוטית בין התקן חישוב נייד לבין תחנת‬
‫עגינה ניידת להתקן חישוב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1828
514602
SYSTEM AND METHOD OF
PROVIDING SCALABLE COMPUTING
BETWEEN A PORTABLE COMPUTING
DEVICE AND A PORTABLE
COMPUTING DEVICE DOCKING
STATION
QUALCOMM INCORPORATED
US
61/164115
27/03/2009
21//1/181
11/21/188/
US
PCT/US/2010/024434
WO/2010/110960
81/81/1828
514605
MAGNETIC CONFIGURATION AND
TIMING SCHEME FOR
TRANSCRANIAL MAGNETIC
STIMULATION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/156835
02/03/2009
PCT/IL/2010/000171
WO/2010/100643
81/81/1828
514601
PROCESS FOR THE PREPARTION OF
AJOENE
NEEM BIOTECH LIMITED
GB
0903869.6
05/03/2009
PCT/GB/2010/050367
WO/2010/100486
81/81/1828
78
514601
G06F )5010.01(
‫מערכת ושיטה לאספקת מחשוב שניתן‬
‫להתאים את מימדיו בין התקן חישוב נייד‬
‫לבין תחת עגינה ניידת להתקן חישוב‬
A61N )5010.01(
‫תצורה מגנטית ומערכת זמנים לגרייה‬
‫מגנטית למוח‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C07C )5010.01(
‫תהליך להכנת איואן‬
C07D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
DERIVATIVES OF BENZOTHIAZINES,
PREPARATION THEREOF AND
APPLICATION THEREOF AS DRUGS
PIERRE FABRE MEDICAMENT
FR
0951336
03/03/2009
PCT/EP/2010/052609
WO/2010/100139
82/81/1828
514601
IMAGE TRANSFORMATION
SYSTEMS AND METHODS
FACECAKE MARKETING
TECHNOLOGIES, INC.
US
61/156537
01/03/2009
21/121/22
12/81/1828
US
PCT/US/2010/025814
WO/2010/101850
82/81/1828
514606
MICROENCAPSULATED
INSECTICIDE FORMULATIONS
DOW AGROSCIENCES LLC
US
61/157339
04/03/2009
PCT/US/2010/025755
WO/2010/101821
81/81/1828
514611
SOLFONYLATED
TETRAHYDROAZOLOPYRAZINES
AND THEIR USE AS MEDICINAL
PRODUCTS
GRUNENTHAL GMBH
EP
09003075.0 04/03/2009
PCT/EP/2010/001299
WO/2010/099938
79
‫ הכנתן ושימוש‬,‫נגזרות של בנזותיאזינים‬
‫בהן כתרופות‬
G06T )5010.01(
‫מערכות ושיטות להמרת תמונות‬
A01N )5010.01(
‫פורמולציות קוטלי חרקים במעטפות‬
‫מיקרו–קפסולריות‬
C07D )5010.01(
‫טטראהידרואזולופיראזינים מותמרים‬
‫בסולפוניל ושימוש בהם כמוצרים‬
‫תרופתיים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/81/1828
514615
PEPTIDES DERIVED FROM FICOLIN
AS SURFACTANTS
METAMOREFIX
US
61/202483
03/03/2009
PCT/IL/2010/000179
WO/2010/100646
81/81/1828
514612
STABILIZED REVERSE
TRANSCRIPTASE FUSION PROTEINS
C07K )5010.01(
‫פפטידים שמקורם בפיקולים כחמרים‬
‫פעילי שטח‬
‫מטמורפיקס‬
C07K )5010.01(
‫חלבוני איחוי מיוצבים של רברס‬
‫טרנסקריפטאז‬
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM
US
61/157332
04/03/2009
PCT/US/2010/026165
WO/2010/102085
81/82/1828
514614
TANTALUM SPUTTERING TARGET
JX NIPPON MINING & METALS
CORPORATION
2009JP
11/08/2009
186237
PCT/JP/2010/063193
WO/2011/018970
81/82/1828
514615
TANTALUM SPUTTERING TARGET
JX NIPPON MINING & METALS
CORPORATION
2009JP
11/08/2009
186256
80
C23C )5010.01(
‫מטרת התזה עם טנטלום‬
C23C )5010.01(
‫מטרת התזה עם טנטלום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PCT/JP/2010/063194
WO/2011/018971
82/81/1828
514611
PROCESS FOR PREPARAING 2,2
DIFLUOROETHYLAMINE
DERIVATIVES BY IMINE
HYDROGENATION
BAYER CROPSCIENCE AG
EP
09155209.1 16/03/2009
PCT/EP/2010/001419
WO/2010/105747
21/81/1828
–5,5 ‫תהליך להכנת תולדות‬
‫דיפלואורואתילאמין באמצעות הידרוגנציה‬
‫של אימין‬
514611
BIOMARKER FOR MONITORING
PATIENTS
TRANSGENE S.A.
EP
09305328.8 17/04/2009
PCT/EP/2010/054743
WO/2010/119003
81/81/1828
514611
QUINOXALINE COMPOUND
ASTELLAS PHARMA INC.
2009JP
05/03/2009
052577
PCT/JP/2010/053586
WO/2010/101230
22/81/1828
514616
METHOD FOR THERAPEUTIC USE
AC IMMUNE S.A.
US
61/161165
18/03/2009
81
C07D )5010.01(
G01N )5010.01(
‫סמן ביולוגי לניטור חולים‬
C07D )5010.01(
‫תרכובת קווינוקסלין‬
A61K )5010.01(
‫שיטה עבור שימוש טיפולי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
/2/1//812
US
PCT/EP/2010/053519
WO/2010/106127
82/81/1828
1//28/188/
514650
METHOD FOR PRODUCING NONPUTRESCIBLE SLUDGE AND
ENERGY AND CORRESPONDING
PLANT
VEOLIA WATER SOLUTIONS &
TECHNOLOGIES SUPPORT
FR
0951443
06/03/2009
PCT/EP/2010/052900
WO/2010/100281
1//81/1828
‫שיטה לייצור בוצה שאינה נרקבת ואנרגיה‬
‫ומפעל מתאים‬
514651
CALCIUM CITRATE AND CALCIUM
LACTATE FORMULATIONS FOR
ALTERTION OF BIOPHYSICAL
PROPERTIES OF MUCOSAL LINING
PULMATRIX, INC
US
61/163772
26/03/2009
/2/1/1111
82/21/188/
US
PCT/US/2010/028914
WO/2010/111650
81/81/1828
514655
THERAPEUTIC USES OF MASTIC
GUM FRACTIONS
REGENERA PHARMA LTD
US
1/157215
04/03/2009
PCT/IL/2010/000183
WO/2010/100650
82
C02F )5010.01(
A61K )5010.01(
‫הרכבים של סידן ציטראט וסידן לקטאט‬
‫לשינוי תכונות ביופיזיקליות של דופן‬
‫הרירית‬
A61K )5010.01(
‫שימושים רפואיים לפרקציות של שרף‬
‫מסטיק‬
‫רג'נרה פארמה בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/81/1828
514652
COMPOSITIONS OF POLYMERIC
MYRCENE
REGENERA PHARMA LTD
US
61/157216
04/03/2009
PCT/IL/2010/000184
WO/2010/100651
82/81/1828
‫תרכובות של מירסן פולימרי‬
‫רג'נרה פארמה בע"מ‬
514655
514651
VIBRATING MICRO-MECHANICAL
SENSOR OF ANGULAR VELOCITY
VTI TECHNOLOGIES OY
FI
20095201
02/03/2009
188///81
81/8//188/
FI
PCT/FI/2010/050160
WO/2010/100334
11/81/1828
83
G01C )5010.01(
‫חיישן מהירות זוויתית מיקרו מכני רוטט‬
514651
SELECTIVE HYDROGENATION
CATALYST COMPOSITIONS AND
METHODS OF MAKING AND USING
THE SAME
CHEVRON PHILLIPS CHEMICAL
COMPANY LP
US
61/157491
04/03/2009
PCT/US/2010/025038
WO/2010/101736
G01C )5010.01(
‫התקן תהודה מיקרו מכני‬
MICRO-MECHANICAL RESONATOR
VTI TECHNOLOGIES OY
FI
20095201
02/03/2009
188///81
81/8//188/
FI
PCT/FI/2010/050159
WO/2010/100333
82/81/1828
A61K )5010.01(
B01J )5010.01(
‫תכשירי זרז הידרוגנציה סלקטיבית ושיטות‬
‫להכנתו ושימוש בו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
1//81/1828
514651
‫אריזת ממחטות נייד‬
TISSUE PACKAGE
DR. SCHUMACHER GMBH
PL
P-387389
02/03/2009
PCT/EP/2010/001162
WO/2010/099894
514656
8//81/1828
B65D )5010.01(
PROCESS FOR PRODUCING 3-(2-CYANO-1PROPENYL)-2,2DIMETHYLCYCLOPROPANECARBOXYLIC
ACID OR SALT THEREOF
C07C )5010.01(
–5(–2 ‫אריזת לייצור חומצה או מלח‬
–5,5–)‫–פרופאניל‬1–‫ציאנו‬
‫דימאת'ילציקלופרופאנקרבוקסילית‬
‫או המלח שלו‬
SUMITOMO CHEMICAL COMPANY,
LIMITED
JP
2009-091874
06/04/2009
PCT/JP/2010/056487
WO/2010/117072
81/81/188/
514620
STRETCHABLE CHEMICAL
PROTECTIVE MATERIAL
GORE ENTERPRISE HOLDINGS, INC.
A62D )5010.01(
‫חומר מתיח המגן מפני כימיקלים‬
PCT/US/2009/001398
WO/2010/101544
22/81/1828
514621
DRIVE MECHANISM FOR A SOLAR
CONCENTRATOR ASSEMBLY
GOSSAMER SPACE FRAMES
US
61/209970
11/03/2009
21/1111/2
22/81/1828
US
PCT/US/2010/027061
84
F24J )5010.01(
‫מנגנון הנעה להרכבת מרכז סולארי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/105111
82/81/1828
514625
METHODS AND SYSTEMS FOR
GENERATING AN INSPECTION
PROCESS FOR A WAFER
KLA-TENCOR CORPORATION
US
12/403905
13/03/2009
PCT/US/2010/026559
WO/2010/104800
81/8//188/
514622
MULTIPLEXING OF W-CDMA AND
OFDM SIGNALS IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/577083
04/07/2004
PCT/US/2005/019544
WO/2005/122425
81/81/1828
514624
CELL-ALLOCATION IN LOCATIONSELECTIVE INFORMATION
PROVISION SYSTEMS
MOASIS GLOBAL INC
US
61/157224
04/03/2009
/2/2111/1
12/81/188/
US
PCT/US/2010/026017
WO/2010/101979
82/81/1828
85
514625
H01L )5010.01(
‫שיטות ומערכות לייצור תהליך בדיקה‬
‫עבור שבב‬
H04L )5010.01(
OFDM–‫ ו‬CDME–W ‫ריבוב של אותות‬
‫במערכת תקשורת אלחוטית‬
H04W )5010.01(
‫הקצאת תאים במערכות להספקת מידע‬
‫מיקום סלקטיבי‬
A01N )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
MICROENCAPSULATED
INSECTICIDE WITH ENHANCED
RESIDUAL ACTIVITY
DOW AGROSCIENCES LLC
US
61/157297
04/03/2009
PCT/US/2010/025754
WO/2010/101820
‫קוטל חרקים במעטפת מיקרו–קפסולרית‬
‫בעל פעילות שיורית מוגברת‬
514621
81/81/1828
METHOD FOR TEXTURIZING SILICON
WAFERS, TREATMENT LIQUID
THEREFOR AND USE THEREOF
GEBR. SCHMID GMBH & CO.
DE
102009012827.1 03/03/2009
PCT/EP/2010/052677
WO/2010/100185
PLATELET-DERIVED GROWTH
FACTOR COMPOSITIONS AND
METHODS FOR THE TREATMENT OF
OSTEOCHONDRAL DEFECTS
BIOMIMETIC THERAPEUTICS, INC.
US
61/209520
05/03/2009
/2/2/11//
11/81/188/
US
PCT/US/2010/026450
WO/2010/102266
WAVEFRONT ANALYSIS
INSPECTION APPARATUS AND
METHOD
86
A61K )5010.01(
‫תכשירי פקטור גדילה הנגזרים מטסיות דם‬
‫ושיטות לטיפול בפציעות עצם וסחוס‬
514621
81/81/1828
MEIMOUN, ELIE
US
61/202496
/2/1/12/2
US
PCT/IL/2010/000177
‫ נוזל‬,‫שיטה לאריגת מצעי סיליקון‬
‫טיפולי המיועד לכך והשימוש בו‬
514621
8//81/1828
H01L )5010.01(
A61B )5010.01(
‫מתקן ושיטה לבדיקת אבחונית לצורה‬
‫קדמית של גל‬
‫מימון אלי‬
04/03/2009
8//82/1828
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/100644
1//81/1828
514626
HEPATITIS C VIRUS INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
61/164579
30/03/2009
PCT/US/2010/028999
WO/2010/117704
1//81/1828
514640
METHOD AND DEVICE FOR
PRODUCING A POLYMER TAPE
DSM IP ASSETS B.V.
EP
09156932.7 31/03/2009
/2/2//18/
12/81/188/
US
PCT/EP/2010/053987
WO/2010/112418
12/81/1828
514641
ISOXAZOLE-PYRAZOLE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09159364.0 05/05/2009
PCT/EP/2010/055694
WO/2010/127975
81/81/1828
514645
BENZOFURANYL DERIVATIVES
USED AS GLUCOKINASE
INHIBITORS
PFIZER INC.
US
61/159099
11/03/2009
PCT/IB/2010/050943
87
C07D )5010.01(
C ‫מעכבי וירוס הפטיטיס‬
B29C )5010.01(
‫שיטה והתקן לייצור סרט פולימר‬
C07D )5010.01(
‫תולדות איזוקסאזול–פיראזול‬
C07D )5010.01(
‫תולדות בנזופורניל המשמשות כמעכבי‬
‫גלוקוקינאז‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/103437
81/81/1828
514642
8-SUBSTITUTED QUINOLINES AND
RELATED ANALOGS AS SIRTUIN
MODULATORS
SIRTRIS PHARMACEUTICALS, INC.
US
61/156749
02/03/2009
PCT/US/2010/025963
WO/2010/101949
8//81/1828
22/81/1828
‫ ואנלוגים‬1 ‫קווינולינים מותמרים בעמדה‬
‫קרובים כמאפננים של סירטואין‬
514644
SUBSTITUTED 3-AMINO-2MERCAPTOQUINOLINES AS
KCNQ2/3 MODULATORS
GRUNENTHAL GMBH
EP
09003431.5 10/03/2009
PCT/EP/2010/001449
WO/2010/102779
514645
514641
SUBSTITUTED NICOTINAMIDES AS
KCNQ2/3 MODULATORS
88
G01S )5010.01(
‫–מרקפטוקווינולינים מותמרים‬5–‫–אמינו‬2
KCNQ5/2 ‫כמאפנני‬
SUBSTITUTED 2MERCAPTOQUNIOLINE-3CARBOXAMIDES AS KCNQ2/3
MODULATORS
GRUNENTHAL GMBH
EP
09003597.3 12/03/2009
PCT/EP/2010/001509
WO/2010/102811
22/81/1828
C07D )5010.01(
C07D )5010.01(
‫–קרבוקסאמידים‬2–‫–מרקפטוקווינולין‬5
KNCQ5/2 ‫מותמרים כמאפנני‬
C07D )5010.01(
‫ניקוטינאמידים מותמרים כמאפנני‬
KCNQ5/2
November 30, 2011-‫ד' בכסלו התשע"ב‬
GRUNENTHAL GMBH
EP
09003598.1
PCT/EP/2010/001507
WO/2010/102809
22/81/1828
12/03/2009
514641
SUBSTITUTED 2-MERCAPTO-3AMINOPYRIDINES AS KCNQ2/3
MODULATORS
GRUNENTHAL GMBH
EP
09003604.7 12/03/2009
PCT/EP/2010/001508
WO/2010/102810
11/81/1828
514641
CAPPED TUFTED LAMINATE WEB
THE PROCTER & GAMBLE
COMPANY
US
12/415140
31/03/2009
PCT/US/2010/028458
WO/2010/117636
21/81/1828
514646
COLORED WEB MATERIAL
COMPRISING A PLURALITY OF
DISCRETE EXTENDED ELEMENTS
THE PROCTER & GAMBLE
COMPANY
US
61/159906
13/03/2009
PCT/US/2010/027078
WO/2010/105122
21/81/1828
89
514650
C07D )5010.01(
‫–אמינופירידינים מותמרים‬2–‫–מרקפטו‬5
KCNQ5/2 ‫כמאפנני‬
A61F )5010.01(
‫רשת שעברה למינציה מכוסה‬
B32B )5010.01(
‫חומר רשתי צבוע המכיל מספר רב של‬
‫אלמנטים בדידים מוארכים‬
B32B )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
WEB MATERIAL EXHIBITING
VIEWING-ANGLE DEPENDENT
COLOR AND COMPRISING A
PLURALITY OF DISCRETE
EXTENDED ELEMENTS
THE PROCTER & GAMBLE
COMPANY
US
61/159906
13/03/2009
PCT/US/2010/027080
WO/2010/105124
82/81/1828
‫חומר רשתי המציג צבע תלוי זווית–ראייה‬
‫והמכיל מספר רב של אלמנטים בדידים‬
‫מוארכים‬
514651
METHOD AND MATERIAL FOR SITE
ACTIVATED COMPLEXING OF
BIOLOGIC MOLECULES
METAACTIV, INC.
US
61/209260
04/03/2009
PCT/US/2010/025805
WO/2010/101844
2//82/188/
514655
FICIAL TISSUE PACK WITH MIRROR
KIMBERLY-CLARK WORLDWIDE,
INC.
US
61/166914
06/04/2009
PCT/IB/2009/053667
WO/2010/116212
8//81/1828
514652
ACTIVATED LEUKOCYTE
COMPOSITION
MACROCURE LTD.
US
61/209298
05/03/2009
/2/122/21
82/81/188/
US
PCT/IB/2010/000882
WO/2010/100570
90
C12N )5010.01(
‫שיטה וחומר ליצירת קומפלקסים באתר‬
‫פעיל של מוליקולות ביולוגיות‬
A47K )5010.01(
‫אריזת טישו לטיפול פנים עם מראה‬
A61K )5010.01(
‫תכשיר לוקוציט משופעל‬
‫מקורוקיור בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/81/1828
514655
HIGH MOISTURE BARRIER AND
SELF-DESICCATING CONTAINER
WITH LIVING HINGE
MULTISORB TECHNOLOGIES, INC.
US
12/398751
05/03/2009
PCT/US/2010/025917
WO/2010/101915
8//81/1828
514651
ANTIBODY FORMULATION
GENENTECH, INC.
US
61/158331
06/03/2009
PCT/US/2010/026410
WO/2010/102241
28/81/1828
514651
PYRROLO [2,3-B] PYRIDINE
DERIVATIVES FOR THE INHIBITION
OF RAF KINASES
PLEXXIKON, INC.
US
61/159390
11/03/2009
/2/2//1/1
22/81/188/
US
/2/2//1//
22/81/188/
US
/2/2//1//
22/81/188/
US
/2/2//188
22/81/188/
US
/2/2//181
22/81/188/
US
/2/2//18/
22/81/188/
US
PCT/US/2010/026816
WO/2010/104945
8//81/1828
NOVEL USES OF FIBRINOGEN
91
514651
B65D )5010.01(
‫מחסום לחות גבוהה ומיכל ייבוש עצמי‬
‫בעל ציר חיבור‬
C07K )5010.01(
‫הרכב נוגדן‬
C07D )5010.01(
‫]פירידין לעיכוב של‬B–2,5[ ‫תולדות פירולו‬
‫ קינאזות‬RAF
A61K )5010.01(
‫שימושים חדשים של פיברינוגן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0951440
06/03/2009
PCT/FR/2010/050380
WO/2010/100385
8//81/1828
514656
HUMANIZED PCRV ANTIBODY
HAVING ANTI-PSEUDOMONAL
ACTIVITY
SHIONOGI & CO. LTD.
2009JP
11/03/2009
057929
PCT/JP/2010/053828
WO/2010/104052
81/81/1828
514610
DETECTION OF SURFACE AND
BURIED OBJECTS
L-3 COMMUNICATIONS CYTERRA
CORPORATION
US
61/157098
03/03/2009
/2/111221
22/8//188/
US
PCT/US/2010/000641
WO/2010/101630
81/81/1828
514611
PYRIDINE DERIVATIVE
COMPOUNDS, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
05/03/2009
051820
PCT/JP/2010/053384
92
C12N )5010.01(
‫ מתורבתים בעלי פעילות‬PCRV ‫נוגדני‬
‫אנטי פסאודומונאלית‬
G01S )5010.01(
‫חשיפת פני שטח ועצמים קבורים‬
C07D )5010.01(
‫ תכשירים המכילים אותן‬,‫תולדות פירידין‬
‫ושימושים בהן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/101164
8//81/1828
514615
MUSCARINIC AGONIST
COMPOUNDS, COMPOSITIONS
COMPRISING THE SAME, METHODS
OF PREPARING THE SAME AND
USES THEREOF
MITHRIDION, INC.
US
61/157789
05/03/2009
/2/181/82
8//81/188/
US
/2/2/2828
8//81/188/
US
/2/112/1/
8//28/188/
US
PCT/US/2010/026380
WO/2010/102218
82/81/1828
‫ תכשירים‬,‫תרכובות אגוניסט מוסקריניות‬
‫ שיטות להכנתן ושימושים‬,‫המכילים אותן‬
‫בהן‬
514615
GAMMA RESISTANT NONWOVEN
WEB LAMINATE
INTERNATIONAL ENVIROGUARD
SYSTEMS, INC.
US
61/158146
06/03/2009
PCT/US/2010/026554
WO/2010/102298
21/81/1828
D04H )5010.01(
‫חומר מרובד לא ארוג עמיד לקרנית גמה‬
514611
PROCESS AND DEVICE FOR CASCADE
INJECTION MOLDING
INCOE CORPORATION
DE
102009012082.3 06/03/2009
PCT/US/2010/024084
WO/2010/101709
93
A01N )5010.01(
B29C )5010.01(
‫תהליך והתקן לעיצוב הזרקה בדירוג‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
82/81/1828
514611
PROTEIN-CONTAINING EMULSIONS
AND ADHESIVES, AND
MAUFACTURE AND USE THEREOF
BIOPOLYMER TECHNOLOGIES, LTD
US
61/157944
06/03/2009
/2/11/182
12/8//188/
US
PCT/US/2010/026526
WO/2010/102284
82/81/1828
,‫חומרים מתחבלים ודבקים המכילים חלבון‬
‫וייצור ושימוש שלהם‬
514611
PROTEIN-CONTAINING FOAMS,
MANUFACTURE AND USE THEREOF
BIOPOLYMER TECHNOLOGIES, LTD
US
61/157944
06/03/2009
/2/11/12/
12/8//188/
US
/2/11/182
12/8//188/
US
PCT/US/2010/026553
WO/2010/102297
81/81/1828
514615
METHOD FOR STEREOSELECTIVELY
AND ENZYMATICALLY REDUCING
KETO COMPOUNDS
IEP GMBH
EP
09450050.1 05/03/2009
PCT/EP/2010/052701
WO/2010/100195
81/81/1828
514612
METHODS AND SYSTEMS FOR
MONITORING INTRABODY TISSUES
SENSIBLE MEDICAL INNOVATIONS
LTD
US
61/157261
04/03/2009
PCT/IL/2010/000182
94
C08G )5010.01(
‫ביופולימר טכנולוג'יס בע"מ‬
C08G )5010.01(
‫ ייצור ושימושים שלו‬,‫קצף המכיל חלבון‬
‫ביופולימר טכנולוג'יס בע"מ‬
C12P )5010.01(
‫תהליך לחיזור סטריאוסלקטיבי ואנזימטי‬
‫של קטונים‬
A61B )5010.01(
‫שיטות ומערכות לניטור רקמות פנימיות‬
‫סנסיבל מדיקל אינוביישנס בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/100649
21/81/1828
514616
COMPOSITIONS AND METHODS FOR
ELIMINATION OF GRAM-NEGATIVE
BACTERIA
UNIVERSITE PARIS DIBEROT PARIS
7
US
61/160162
13/03/2009
PCT/EP/2010/053231
WO/2010/103119
2//81/1828
21/81/1828
A61J )5010.01(
‫שיטת ייצור לנוזל הכולל מימן שהינו בר‬
‫יישום עבור יצורים חיים והתקן ייצור עבורו‬
514611
FORMULATION COMPRISING
AVERMECTIN PARTICLES COATED
WITH A PHOTO-PROTECTING AGENT
SYNGENTA PARTICIPATIONS AG
GB
0904659.0
18/03/2009
PCT/GB/2010/000464
WO/2010/106314
95
–‫תכשירים ושיטות לחיסול בקטריה גרם‬
‫שלילית‬
514610
PRODUCING METHOD FOR LIVING
ORGANISM-APPLICABLE
HYDROGEN-CONTAINED FLUID
AND PRODUCING APPARATUS FOR
THE SAME
MIZ CO, LTD
2009JP
13/03/2009
061785
188/-8/2111 2//81/188/
JP
188/-112//1 1//8//188/
JP
PCT/JP/2010/052201
WO/2010/103894
A61K )5010.01(
A01N )5010.01(
‫הרכב הכולל חלקיקי אוורמקטין מצופים‬
‫בחומר מגן אור‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
82/81/1828
514615
NOVEL DERIVATIVES OF
STEROIDAL[3,2-C]PYRAZOLE
COMPOUNDS WITH
GLUCOCORTICOID ACTIVITY
ASTRAZENECA AB
US
61/166325
03/04/2009
PCT/SE/2010/050367
WO/2010/114476
8//81/1828
8//81/1828
‫תולדות חדשות של תרכובות‬
‫]פיראזול בעלות פעילות‬C–5,2[‫סטרואידל‬
‫של גלוקוקורטיקואיד‬
514612
ANTIBODY DRUG CONJUGATED
THAT BIND MONOMETHYL
AURISTATIN E (MMAE),
COMPOSITIONS COMPRISIMG THE
SAME AND USES THEREOF
SEATTLE GENETICS, INC.
US
61/158143
06/03/2009
PCT/US/2010/026429
WO/2010/111018
96
A61K )5010.01(
–‫תצמידי נוגדן–תרופה שנקשרים ל‬
,)E, (MMAE ‫מונומטיל אוריסטאטין‬
‫תכשירים המכילים אותם ושימושים בהם‬
514615
VEHICLE-MOUNTABLE IMAGING
SYSTEMS AND METHODS
BAE SYSTEMS INFORMATION AND
ELECTRONIC SYSTEMS
INTEGRATION, INC.
US
12/404177
13/03/2009
PCT/US/2010/026592
WO/2010/104813
8//81/1828
C07J )5010.01(
514611
B60R )5010.01(
‫מערכת הדמיה הניתנות להצבה על גבי‬
‫ ושיטות‬,‫כלי–רכב‬
H03M )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
IR DETECTOR SYSTEM AND
METHOD
SELEX GALILEO LTD
GB
0903864.7
06/03/2009
PCT/EP/2010/052837
WO/2010/100260
21/81/1828
514611
TRIGGER MECHANISM FOR A DRUG
DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09003805.0 17/03/2009
PCT/EP/2010/053433
WO/2010/106090
28/81/1828
COUNTER
EURO-CELTIQUE S.A.
GB
0904040.3
PCT/GB/2010/050404
WO/2010/103315
1//81/1828
514616
A61M )5010.01(
‫מנגנון הפעלה והתקן לשחרור תרופה‬
A61M )5010.01(
‫מונה‬
10/03/2009
514661
METHODS FOR PREVENTING MAJOR
ADVERSE CARDIOVASCULAR
EVENTS WITH DPP-IV INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
61/164153
27/03/2009
/2/2//1//
12/81/188/
US
PCT/US/2010/028933
WO/2010/111665
97
‫מערכת גלאי איפרה–אדום ושיטה‬
A61K )5010.01(
–‫שיטות למניעת תופעות לוואי קרדיו‬
IV– ‫ואסקולריות עיקריות בעזרת מעכבי‬
DPP
November 30, 2011-‫ד' בכסלו התשע"ב‬
8//81/1828
514665
APPARATUS FOR THE DISCHARGE
OF A FILLER MATERIAL
SULZER MIXPAC AG
EP
09154942.8 11/03/2009
PCT/EP/2010/052827
WO/2010/102955
28/81/1828
‫מערכת לפריקת חומר מילוי‬
514661
514661
ARRANGEMENT OF BATTERY POLES
OF AN ELECTRIC ENERGY
ACCUMULATOR
ALEXANDER SITTE
AT
A376/2009
09/03/2009
PCT/AT/2010/000064
WO/2010/102314
18/28/1828
98
H01M )5010.01(
‫סידור של קטבי סוללה של מצבר אנרגיה‬
‫חשמלית‬
515001
COMPOSITE CONCRETE FOR FLOOR
SLABS AND RAFTS
PRIMETEH A/S
LV
P-09-186
26/10/2009
PCT/LV/2010/000014
WO/2011/053103
C07K )5010.01(
BCMA ‫נוגדנים אנטי‬
ANTI-BCMA ANTIBODIES
BIOGEN IDEC MA INC.
US
61/158942
10/03/2009
/2/2/1/11
11/81/188/
US
PCT/US/2010/026825
WO/2010/104949
81/81/1828
B05C )5010.01(
C04B )5010.01(
‫בטון מרוכב המיועד ליציקת משטחי רצפה‬
‫ויסודות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//81/1828
515004
DYNAMIC VERTEBRAL COLUMN
PLATE SYSTEM
HAROLD HESS
US
61/160154
13/03/2009
PCT/US/2010/027368
WO/2010/105279
22/81/1828
515005
OX40/TRAIL FUSION PROTEINS
THE TRUSTEES OF THE UNIVERSITY
OF PENNSYLVANIA
US
61/159941
13/03/2009
PCT/US/2010/027000
WO/2010/105068
18/21/188/
515001
INTERSPINOUS PROCESS IMPLANT
AND FUSION CAGE SPACER
HAROLD HESS
US
61/209997
13/03/2009
21///1/11
81/8//188/
US
PCT/US/2009/006742
WO/2010/104496
21/28/1828
515001
POWER SUPPLY FOR LIGHT-BASED
DERMATOLOGIC TREATMENT
DEVICE
SHASER, INC.
US
61/252369
16/10/2009
PCT/US/2010/052664
WO/2011/047149
99
A61B )5010.01(
‫מערכת פלטה דינאמית לעמוד השדרה‬
C12P )5010.01(
TRAIL/40OX ‫חלבונים כימריים‬
A61B )5010.01(
‫שתל תהליך תוך–שדרתי ומפרד כלוב‬
‫התכה‬
A61N )5010.01(
‫ספק כח למכשיר טיפול דרמטולוגי‬
‫המבוסס על אור‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/81/1828
515012
METHOD FOR ASSIGNING AND
UTILIZING FORWARD ERROR
CORRECTING (FEC)
MOTOROLA, INC.
US
12/415596
31/03/2009
PCT/US/2010/026951
WO/2010/117544
28/81/1828
‫שיטה להקצאה ושימוש בתיקון שגיאה‬
‫מתמשך‬
515014
ANTIBODY MOLECULES HAVING
BINDING SPECIFICITY FOR HUMAN
IL-13
UCB PHARMA S.A.
GB
0904214.4
11/03/2009
PCT/GB/2010/000432
WO/2010/103274
2//8//188/
100
C07K )5010.01(
‫מולקולות נוגדן בעלות יחודיות קישור עבור‬
‫ אנושי‬IL–12
515015
CRYSTALLINE STRUCTURE OF
PYRACLOSTROBIN, PROCESS FOR ITS
PREPARATION AND A COMPOSITION
FOR CROP PROTRCTION COMPRISING
IT
BASF SE
DE
102005028493.0 20/06/2005
PCT/EP/2006/005869
WO/2006/136357
22/81/1828
H04L )5010.01(
515011
A01N )5010.01(
,‫מבנה גבישי של פיראכלוסטרובין‬
‫תהליך להכנתו ותכשיר להגנת הצומח‬
‫המכיל אותו‬
C07D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
NEW BENZOTHIADIAZEPINE
COMPOUNDS, A PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LES LABORATOIRES SERVIER
FR
09/01300
20/03/2009
PCT/FR/2010/000227
WO/2010/106249
1//81/1828
515011
COMPOSITION FOR METAL PLATING
COMPRISING SUPPERSSING AGENT
FOR VOID FREE SUBMICRON
FEATURE FIILING
BASF SE
EP
09157542.3 07/04/2009
/2/1//11/
18/28/188/
US
PCT/EP/2010/054108
WO/2010/115756
1//81/1828
101
C25D )5010.01(
‫הרכב לציפוי מתכתי המכיל גורם הסתרה‬
‫עבור מילוי של חלל חופשי תת–מיקרוני‬
515016
TRICYCLIC INDOLE DERIVATES AS
PBR LIGANDS
GE HEALTHCARE LIMITED
C25D )5010.01(
‫הרכב לציפוי מתכתי המכיל גורם הסתרה‬
‫עבור מילוי של חלל חופשי תת–מיקרוני‬
515011
COMPOSITION FOR METAL PLATING
COMPRISING SUPPRESSING AGENT
FOR VOID FREE SUBMICRON
FEATURE FILLING
BASF SE
EP
09005106.1 07/04/2009
/2/1//111
18/28/188/
US
PCT/EP/2010/053881
WO/2010/115717
1//81/1828
‫ תהליך‬,‫תרכובות בנזותיאדיאזפין חדשות‬
‫להכנתן ותכשירי רוקחות המכילים אותן‬
C07D )5010.01(
‫תולדות אינדול טריציקליות כליגנדים של‬
PBR
November 30, 2011-‫ד' בכסלו התשע"ב‬
GB
0905328.1
/2/2/1212
US
PCT/EP/2010/053998
WO/2010/109007
21/81/1828
27/03/2009
11/81/188/
515055
NOVEL PROCESS FOR THE
PREPARATION OF
ENAMINOCARBONYL COMPOUNDS
BAYER CROPSCIENCE AG
EP
09155202.6 16/03/2009
PCT/EP/2010/001577
WO/2010/105779
21/81/1828
515052
NOVEL PROCESS FOR PREPARING
ENAMINOCARBONYL COMPOUNDS
BAYER CROPSCIENCE AG
EP
09155199.4 16/03/2009
PCT/EP/2010/001568
WO/2010/105772
1//81/1828
515054
PROCESS FOR PREPARING PYRIDYLSUBSTITUTED PYRAZOLES
BAYER CROPSCIENCE AG
EP
09157317.0 03/04/2009
PCT/EP/2010/001926
WO/2010/112178
1//81/1828
102
515055
C07D )5010.01(
‫תהליך חדש להכנת תרכובות‬
‫אנאמינוקרבוניל‬
C07D )5010.01(
‫תהליך חדש להכנת תרכובות‬
‫אנאמינוקרבוניל‬
C07D )5010.01(
‫תהליך להכנת פיראזולים מותמרים‬
‫בפירידיל‬
C07D )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
QUINOXALINE DERIVATIVES AND
THEIR USE FOR TREATING BENIGN
AND MALIGNANT TUMOUR
DISORDERS
AETERNA ZENTARIS GMBH
EP
09157141.4 02/04/2009
/2/2////1
81/81/188/
US
PCT/EP/2010/053891
WO/2010/115719
21/8//188/
ANTAGONIST OF zB7R1
ZYMOGENETICS INC.
US
60/680374
/8/1/2/1/
US
/8/1//88/
US
PCT/US/2006/018537
WO/2006/124667
28/81/1828
‫תולדות קווינוקסאלין והשימוש בהן לטיפול‬
‫באי–סדרים בגידולים שפירים וממאירים‬
515051
R7zB1 ‫אנטגוניסט של‬
12/05/2005
21/81/188/
1//81/188/
515051
515056
COMPACT DEVICE FOR RAPIDLY
MIXING AND DELIVERING
SUBSTANCES TO A PATIENT
PURDUE RESEARCH FOUNDATION
US
61/158435
09/03/2009
/2/22121/
82/8//188/
US
/2/1121/1
22/8//188/
US
PCT/US/2010/026670
103
C05F )5010.01(
‫שיטה ומערכת מופעלת סולרית לטיפול‬
‫בבוצה‬
‫צדיק בועז‬
SOLAR POWERED METHOD AND
SYSTEM FOR SLUDGE TREATMENT
ZADIK BOAZ
US
61/202532
10/03/2009
PCT/IL/2010/000203
WO/2010/103520
8//81/1828
C07K )5010.01(
A61M )5010.01(
‫מכשיר קומפקטי לערבוב ואספקה מהיר‬
‫של חומרים לחולה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/104858
21/81/1828
515020
ANTI-CORROSION AND LOW
FRICTION COATING
HI-SHEAR CORPORATION
US
61/160176
13/03/2009
PCT/US/2010/027251
WO/2010/105241
‫ציפוי למניעת קורוזיה וחיכוך נמוך‬
515021
21/81/1828
IMPROVED MICROCAPSULES AND
PRODUCTION OF THE SAME
FOLLMAN & CO. GESELLSCHAFT FUR
CHEMIE-WERKSTOFFE UND
VERFAHRENSTECHNIK MBH & CO. KG
DE
102009012455.1 12/03/2009
PCT/EP/2010/001572
WO/2010/102830
28/81/1828
515025
REINFORCED POLYESTER RESIN
COMPOSITION
ADEKA CORPORATION
2009JP
12/03/2009
060262
PCT/JP/2010/053959
WO/2010/104103
22/81/1828
SYSTEM AND METHOD FOR
CONTROLLING INDUCIVE POWER
TO MULTIPLE MODULES
104
C09D )5010.01(
515022
B01J )5010.01(
‫מיקרוקפסולות משופרות וייצורן‬
C08L )5010.01(
‫תכשיר שרף פוליאסטר מזוין‬
H02J )5010.01(
‫מערכת ושיטה לבקרת כוח השראתי‬
‫למספר רב של מודולים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
POWERMAT LTD
US
61/202554
/2/181///
US
/2/181//1
US
PCT/IL/2010/000209
WO/2010/103525
28/81/1828
‫פאוורמאט בע"מ‬
12/03/2009
21/81/188/
21/81/188/
515025
ALGAE BIOMASS FRACTIONATION
SRS ENERGY
US
61/158935
10/03/2009
/2/1/2182
1//82/1828
US
PCT/US/2010/026780
WO/2010/104922
18/8//188/
515021
APPARATUS FOR CONDUCTING
THERMOLYSIS OF PLASTIC WASTE
AND METHOD OF THERMOLYSIS IN
CONTINUOUS MANNER
CLARITER POLAND SPOLKA Z
ORGANICZONA
ODPOWIEDZIALNOSCIA
PL
387499
14/03/2009
PCT/IB/2009/052830
WO/2010/106399
22/81/1828
515021
TREATMENT OF PANCREATIC
CANCER
ARDEA BIOSCIENCES, INC.
US
61/159397
11/03/2009
PCT/US/2010/027021
WO/2010/105082
105
C12N )5010.01(
‫חלוקה ביומסה אצתית לחלקים‬
C10G )5010.01(
‫מערכות לביצוע תרמוליזה של פסולת‬
‫פלסטית ושיטות לתרמוליזה רציפה‬
A61K )5010.01(
‫טיפול בסרטן הלבלב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
28/81/1828
515021
USE OF ATORVASTATIN LACTOLS
AS MEDICAMENTS
BRADFORD PHARMA LIMITED
GB
0904102.1
10/03/2009
PCT/GB/2010/050408
WO/2010/103319
28/81/1828
‫שימוש באטורווסטטין לקטולים כתרופות‬
515026
USE OF ROSUVASTATIN LACTOLS
AS MEDICAMENTS
BRADFORD PHARMA LIMITED
GB
0904100.5
10/03/2009
PCT/GB/2010/050409
WO/2010/103320
28/81/1828
515040
ROSUVASTATIN AND
ATORVASTATIN DERIVATIVES
BRADFORD PHARMA LIMITED
GB
0904104.7
10/03/2009
PCT/GB/2010/050407
WO/2010/103318
2//81/1828
515041
OPTIMIZED FC VARIANTS
LFB-BIOTECHNOLOGIES
EP
09305250.4 20/03/2009
PCT/EP/2010/053644
WO/2010/106180
106
A61K )5010.01(
A61P )5010.01(
‫שימוש ברוזווסטטין לקטולים כתרופות‬
A61K )5010.01(
‫תולדות רוזווסטטין ואטורווסטטין‬
C07K )5010.01(
‫ יעילים‬FC ‫משתני‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/81/1828
515045
FAST CHARGING DEVICE FOR AN
ELECTRIC VEHICLE
RENAULT S.A.S.
FR
0951529
11/03/2009
PCT/EP/2010/053078
WO/2010/103063
8//81/1828
515042
COMPOSITIONS COMPRISING A
FATTY ACID OIL MIXTURE AND A
SURFACTANT, AND METHODS AND
USES THEREOF
PRONOVA BIOPHARMA NORGE AS
US
61/158613
09/03/2009
/2/111/18
2//8//188/
US
/2/1/11/2
11/28/188/
US
/2/1/11/1
11/28/188/
US
PCT/IB/2010/000824
WO/2010/103404
22/81/1828
515045
SYSTEM AND METHOD FOR SALES
AND DISTRIBUTION OF TICKETS TO
FUTURE EVENTS
REISNER DANIEL
US
61/160103
13/03/2009
PCT/IL/2010/000207
WO/2010/103523
22/81/1828
515041
MODULAR STORAGE SYSTEM
MONASTYRSKY YAKOV
US
61/159098
11/03/2009
PCT/IL/2010/000208
107
B60L )5010.01(
‫מכשיר לטעינה מהירה עבור כלי רכב‬
‫חשמלי‬
A61K )5010.01(
‫תכשירים המכילים תערובת של שמן‬
‫וחומצת שומן וחומר פעיל שטח ושיטות‬
‫ושימושים בהם‬
G06Q )5010.01(
‫מערכת ושיטה למכירות והפצה של‬
‫כרטיסי לאירועים עתידיים‬
‫שי בושינסקי‬
E04H )5010.01(
‫מערכת אחסון מודולרית‬
‫יעקב מונסטירסקי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/103524
21/81/1828
515046
GPR119 AGONIST COMPOUND,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
PROSIDION LIMITED
GB
0904284.7
12/03/2009
PCT/GB/2010/050440
WO/2010/103333
21/81/1828
515050
GPR119 AGONIST COMPOUND,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
PROSIDION LIMITED
GB
0904285.4
12/03/2009
PCT/GB/2010/050441
WO/2010/103334
21/81/1828
515051
GPR119 AGONIST COMPOUND,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
PROSIDION LIMITED
GB
0904287.0
12/03/2009
PCT/GB/2010/050442
WO/2010/103335
8//81/1828
515054
COMPOSITIONS AND METHODS FOR
PREVENTION AND TREATMENT OF
NEURODEGENERATIVE DISEASES
108
C07D )5010.01(
‫ תכשירים‬,PGR116 ‫תרכובות אגוניסטי‬
‫המכילים אותן ושימושים בהן‬
C07D )5010.01(
‫ תכשירים‬,GPR116 ‫תרכובות אגוניסטי‬
‫המכילים אותן ושימושים בהן‬
C07D )5010.01(
‫ תכשירים‬,GPR116 ‫תרכובות אגוניסטי‬
‫המכילים אותן ושימושים בהן‬
C07K )5010.01(
‫תכשירים ושיטות לטיפול ומניעה של‬
‫מחלות נוירודגנרטיביות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
61/202523
09/03/2009
PCT/IL/2010/000193
WO/2010/103515
11/81/1828
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
515055
C ‫מעכבי וירוס הפטיטיס‬
HEPATITIS C VIRUS INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
61/164531
30/03/2009
21/11//18
11/81/1828
US
PCT/US/2010/028456
WO/2010/117635
22/81/1828
515051
COMPOSITIONS AND METHODS FOR
CHARACTERIZING ARTHRITIC
CONDITIONS
AUGUREX LIFE SCIENCES
CORPORATION
US
61/159386
11/03/2009
PCT/CA/2010/000368
WO/2010/102412
28/81/1828
109
G01N )5010.01(
‫הרכבים ושיטות לאיפיון מצבים שגרוניים‬
515051
IMMEDIATE RELEASE
PHARMACEUTICAL COMPOSITIONS
COMPRISING OXYCODONE AND
NALOXONE
EURO-CELTIQUE S.A
EP
09154805.7 10/03/2009
PCT/EP/2010/053028
WO/2010/103039
C07D )5010.01(
A61K )5010.01(
‫תרכובות רוקחיות לשחרור מיידי המכילות‬
‫אוקסיקודון ונלוקסן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
18/81/1828
515056
‫תכשיר ליפוזום‬
LIPOSOME COMPOSITION
EISAI R&D MANAGEMENT CO., LTD.
2009JP
30/03/2009
082521
/2/2/1//1
18/81/188/
US
PCT/JP/2010/055770
WO/2010/113984
82/8//1822
515010
515011
COMPOUNDS, COMPOSITIONS AND
METHODS OF TREATING CANCER
AND FIBROTIC DISEASES
QUARK PHARMACEUTICALS, INC.
US
61/162348
23/03/2009
PCT/US/2010/028200
WO/2010/111198
18/81/1828
C07K )5010.01(
‫ תכשירי רוקחות ושיטות לטיפול‬,‫תרכובות‬
‫בסרטן ובמחלות פיברוטיות‬
515015
BISPECIFIC ANTI-ERBB-3/ANTI-CMET ANTIBODIES
ROCHE GLYCART AG
EP
09005110.3 07/04/2009
PCT/EP/2010/002005
WO/2010/115552
110
G08B )5010.01(
‫בקר טמפרטורה לתינוק‬
‫יאסין ברנרד‬
TEMP-CONTROL
11/81/1828
A61K )5010.01(
C07K )5010.01(
MET–C/3– ‫נוגדנים בי–ספציפיים נגד‬
ERBB
November 30, 2011-‫ד' בכסלו התשע"ב‬
8//81/1828
515012
SINGLE PROTEIN NANOCAPSULES
FOR PROTEIN DELIVERY WITH
LONG-TERM EFFECT
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/158588
09/03/2009
/2/1/1212
11/28/188/
US
PCT/US/2010/026678
WO/2010/104865
‫ננוקפסולות של חלבון בודד לשם משלוח‬
‫חלבון בעל השפעה ארוכת טווח‬
515014
82/81/1828
METHOD AND DEVICE FOR
DISSOLVING SOLID SUBSTANCES IN
WATER
MARCHI & BREVETTI INTEPRISE S.R.L.
CON UNICO SOCIO
IT
BO2009A000142 09/03/2009
PCT/IB/2010/000474
WO/2010/103368
21/81/1828
515015
PROLINE DERIVATIVES AS
CATHEPSIN INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
09158212.2 20/04/2009
PCT/EP/2010/054792
WO/2010/121918
11/81/1828
515011
LIQUID CLEANING COMPOSITION
WITH FILMS
COLGATE-PALMOLIVE COMPANY
US
US61/174684 01/05/2009
PCT/US/2010/032189
WO/2010/126789
111
B82B )5010.01(
C02F )5010.01(
‫שיטה והתקן להמסת חומרים מוצקים‬
‫במים‬
C07D )5010.01(
‫תולדות פרולין כמעכבי קתפסין‬
C11D )5010.01(
‫הרכב נוזלי עם שכבות לניקוי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
1//81/1828
515016
WIRELESS TWO-WAY
TRANSMISSION OF SERIAL DATA
SIGNALS BETWEEN AN
ELECTRONIC DEVICE AND A POWER
METER
ITRON FRANCE
EP
09305314.8 14/04/2009
PCT/EP/2010/053884
WO/2010/118940
‫שידור דו–סיטרי אלחוטי של אותות נתונים‬
‫סדרתיים בין מכשיר אלקטרוני למד כח‬
515010
12/81/1828
TRANSPARENT, WEATHER-RESISTANT
BARRIER FOIL, PRODUCTION THEREOF
BY MEANS OF LAMINATION,
EXTRUSION LAMINATION OR
EXTRUSION COATING
EVONIK ROHM GMBH
DE
102009003225.8 19/05/2009
PCT/EP/2010/055660
WO/2010/133427
8//81/1828
515011
POLYAMIDE MANUFACTURING
PROCESS
RHODIA OPERATIONS
FR
0951779
20/03/2009
PCT/EP/2010/052957
WO/2010/105939
8//81/1828
112
H04L )5010.01(
515015
B32B )5010.01(
,‫רדיד חוסם שקוף העמיד במזג האוויר‬
‫ למינצית‬,‫ייצורו באמצעות למינציה‬
‫שיחול או ציפוי שיחול‬
C08G )5010.01(
‫תהליך להכנת פוליאמיד‬
C07K )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
CONTROL OF COPOLYMER
COMPOSITIONS
MOMENTA PHARMACEUTICALS,
INC.
US
61/166608
03/04/2009
/2/111112
18/8//188/
US
PCT/US/2010/029896
WO/2010/115175
1//81/1828
‫בקרה של תכשירי קו–פולימר‬
515012
‫תרכובת פירימידין‬
PYRIMIDINE COMPOUND
ASTELLAS PHARMA INC.
2009JP
30/03/2009
082282
PCT/JP/2010/055506
WO/2010/113834
18/81/1828
515014
SUBSTITUTED IMIDAZO[1,2A]PYRIDINE DERIVATIVES,
PHARMACEUTICAL COMPOSITIONS,
AND METHODS OF USE AS ?SECRETASE INHIBITORS
HIGH POINT PHARMACEUTICALS,
LLC
US
61/173180
27/04/2009
PCT/US/2010/031781
WO/2010/126745
21/82/188/
113
C07D )5010.01(
,‫]פירידין מותמרות‬A–5,1[ ‫תולדות אימידאזו‬
‫תכשירי רוקחות ושיטות לשימוש כמעכבי‬
‫בתא–סקרטאז‬
515011
LEAD-FREE BRASS ALLOY
NATIONAL BRONZE & METALS, INC.
US
12/400283
09/03/2009
PCT/US/2009/053505
WO/2010/104527
C07D )5010.01(
C22C )5010.01(
‫סגסוגת נחושת ואבץ ללא עופרת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/81/1828
515016
COMBINATION THERAPY WITH
THIOCOLCHICINE DERIVATIVES
ABRAXIS BIOSCIENCE, LLC
US
61/210074
13/03/2009
PCT/US/2010/027159
WO/2010/105172
28/81/188/
515010
TRI-ACETYL-3-HYDROXYLPHENYL
ADENOSINE AND ITS USE AS A
HYPOLIPIDEMIC AGENT
INSTITUTE OF MATARIA MEDICA,
CHINESE ACADEMY OF MEDICAL
SCIENCES
A01N )5010.01(
‫טיפול משולב עם תולדות תיאוקולציסין‬
C07H )5010.01(
‫טרי–אצטיל–הידרוקסילפניל אדנוסין‬
‫והשימוש בה כסוכן‬
PCT/CN/2009/070725
WO/2010/040286
22/81/1828
515011
METHODS AND SYSTEMS OF
IMAGING CUT STONES
DSEE IMAGING LTD
US
61/202537
11/03/2009
PCT/IL/2010/000211
WO/2010/103526
22/81/1828
METHODS OF PURIFYING SMALL
MODULAR
IMMUNOPHARMACEUTICAL
PROTEINS
WYETH LLC
114
515015
G01N )5010.01(
‫שיטה ומערכת להדמיית אבנים חתוכות‬
‫דיסי אימג'ינג בע"מ‬
C07K )5010.01(
‫שיטות לניקוי חלבונים מודולריים קצרים‬
‫בעלי פעילות אימונופרמאצבטית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
US
61/159347
PCT/US/2010/026931
WO/2010/147686
18/81/188/
11/03/2009
515014
IMPROVED FABRIC FOR
PREVENTING AND REDUCING SKIN
WOUNDS
PRECISION FABRICS GROUP, INC
US
12/501875
13/07/2009
21//82/2/
21/81/188/
US
21//82111
21/81/188/
US
PCT/US/2009/052285
WO/2011/008220
21/81/1828
‫בד מושבח למניעת והפחתת פגיעות בעור‬
515015
TABLET AND GRANULATED
POWDER CONTAINING 6-FLUORO-3HYDROXY-2PYRAZINECARBOXAMIDE
TOYAMA CHEMICAL CO., LTD.
2009JP
13/03/2009
061837
PCT/JP/2010/054191
WO/2010/104170
21/81/1828
115
A61K )5010.01(
–1 ‫גלולה ואבקה מגורענת המכילים‬
5––‫–הידרוקסי‬2–‫פלואורו‬
‫פיראזינקארבוקסאמיד‬
515011
METHOD FOR OBTAINING COPPER
POWDERS AND NANOPOWDERS
FROM INDUSTRIAL ELECTROLYTES
INCLUDING WASTE INDUSTRIAL
ELECTROLYTES
NANO-TECH SP. Z O.O.
PL
P-387565
20/03/2009
PCT/PL/2010/000022
WO/2010/107328
D03D )5010.01(
C25C )5010.01(
‫שיטה לקבלת אבקות נחושת ואבקות ננו‬
‫מאלקטרוליטים תעשייתיים כולל פסולת‬
‫של אלקטרוליטים תעשייתיים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/81/1828
515016
SPARC ANGIOGENIC DOMAIN
POLYPEPTIDES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
ABRAXIS BIOSCIENCE, LLC
US
61/159322
11/03/2009
PCT/US/2010/027041
WO/2010/105097
28/81/1828
COUNTER
EURO-CELTIQUE S.A.
GB
0904059.3
PCT/GB/2010/050405
WO/2010/103316
21/81/188/
C07K )5010.01(
,SPARC ‫פוליפפטידי התחום האנגיוגני של‬
‫תכשירים המכילים אותם ושימושים בהם‬
515060
A61M )5010.01(
‫מונה‬
10/03/2009
515061
LARGE-ANGLE UNIFORM RADIANCE
SOURCE
RAYTHEON COMPANY
G01J )5010.01(
‫מקור קרינה אחידה בעלת זוית גדולה‬
PCT/US/2009/036920
WO/2010/104512
82/81/1828
515065
USE OF SNMP FOR MANAGEMENT
OF SMALL FOOTPRINT DEVICES
ASSA ABLOY AB
US
61/160177
13/03/2009
21/128/8/
82/8//188/
US
PCT/US/2010/026477
WO/2010/104771
116
H04L )5010.01(
‫ לניהול מכשירי‬SNMP ‫שימוש בפרוטוקול‬
‫ קטנים‬FOOTPRINT
November 30, 2011-‫ד' בכסלו התשע"ב‬
2//81/1828
515062
VACCINE COMPOSITIONS AND
METHODS FOR TREATMENT OF
MUCORMYCOSIS AND OTHER
FUNGAL DISEASES
LOS ANGELES BIOMEDICAL
RESEARCH INSTITUTE AT HARBORUCLA MEDICAL CENTER
US
61/161614
19/03/2009
PCT/US/2010/000820
WO/2010/107500
1//81/1828
515064
INHIBITORS OF HEPATITIS C VIRUS
REPLICATION
MERCK SHARP & DOHME CORP
US
61/163958
27/03/2009
/2/111122
18/8//188/
US
PCT/US/2010/028653
WO/2010/111483
8//81/1828
515065
HEPATITIS C VIRUS INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
61/167989
09/04/2009
PCT/US/2010/030032
WO/2010/117977
21/8//1822
SYSTEM AND METHOD FOR
PRODUCING CLASS YEARBOOKS
AND CLASS PHOTOGRAPHS
117
515110
C07K )5010.01(
‫הרכבים חיסוניים ושיטות לטיפול‬
‫במוקורמיקוסיס ומחלות פטרייתיות‬
‫אחרות‬
A01N )5010.01(
C ‫מעכבי שכפול וירוס הפטיטיס‬
C07D )5010.01(
C ‫מעכבי וירוס הפטיטיס‬
B42D )5010.01(
‫מערכת ושיטה להפקת ספרי מחזור‬
‫ותמונות מחזור‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫רמי דותן‬
TAL PETEL
515111
21/8//1822
KEY AND LOCK ASSEMBLIES
RAV BARIACH (08) INDUSTRIES LTD
IL
211024
03/02/2011
WO
PCT/IL2011/000339 1//81/1822
‫חלקי מפתח ומנעול‬
‫ ) תעשיות בע"מ‬01( ‫רב בריח‬
515115
B08B )5010.01(
21/8//1822
‫רובוט לניקוי ברכות‬
‫מיטרוניקס בע"מ‬
POOL CLEANING ROBOT
MAYTRONICS LTD.
21/8//1822
515155
METHOD OF CONSTRUCTING
COMPLEX FUNCTIONS THAT HAVE
AN EXTERNAL AFFECT
A-ONLINE CAPITAL (A.O.C) LTD
IL
214222
20/07/2011
21/8//1822
A METHOD FOR MANUFACTURING
NANO ALUMINA
MENAHEM SKOP
118
E05B )5010.01(
515151
G06F )5010.01(
‫שיטה לבנות משבאות מורכבות‬
‫שמשביעות בעולם החיצוני‬
‫) בע"מ‬.‫סי‬.‫או‬.‫אונליין קפיטל (אי‬-‫אי‬
C01F )5010.01(
‫שיטה ליצור נאנו אלומינה‬
‫מנחם סקופ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/8//1822
515145
‫מקלט מתקפל‬
‫ישעיה גירפי‬
FOLDING SHELTER
YISHAI GIRAFE
2//8//1822
515155
515115
THE AVI HAYON TAXATION
SYSTEM
AVI HAYON
22/8//1822
G07B )5010.01(
‫שיטת המס‬
‫אבי חיון‬
515111
CALIBRATION SYSTEM FOR A
FORCE-SENSING CATHETER
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/899909
07/10/2010
119
F16H )5010.01(
‫תמסורת רבת יחסי העברה המבוססת על‬
‫רצועת זורם‬
'‫שרון איצקוביץ‬
MULTI RATIO FLUID -BELT
TRANSMISSION
SHARON ITSKOVICH
22/8//1822
E04B )5010.01(
A61B )5010.01(
‫מערכת כיול לצנתר עם חישת כוח‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/8//1822
515111
SIMULATION OF AN INVASIVE
PROCEDURE
BIOSENSE WEBSTER (ISRAEL) LTD
US
12/897828
05/10/2010
22/8//1822
515552
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
2//8//1822
515525
A METHOD FOR DETECTING DATA
MISUSE IN AN ORGANIZATION'S
NETWORK
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
2//8//1822
515522
A METHOD OF ESTIMATING THE
POTENTIAL DAMAGE OF DATA
LEAKAGE INCIDENT BY ASSIGNING
MISUSEBILITY WEIGHT
120
A61B )5010.01(
‫סימולציה של פרוצדורה חודרנית‬
G05F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
G06F )5010.01(
, ‫שיטה לגילוי של שימוש לרעה במידע‬
‫ברשתות אירגוניות‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
G06F )5010.01(
‫שיטה להערכת הנזק הפוטנציאלי של‬
‫מקרה זליגת מידע ע"י הקצאת משקל‬
‫לחוסר יכולת בשימוש‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
2//8//1822
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
515541
DELIVERY OF MEDICINE AND
MEDICATION OF THE CUSTOMER'S
(PATIENT'S) DOOR (HOME PHARM)
G07B )5010.01(
)‫אספקת תרופות לבית הלקוח (הום פארם‬
‫קלאתי ננה‬
2//8//1822
515541
‫שיטה למינון נפחי חומרים אי הומוגניים‬
‫בעזרת לחיצה‬
‫פאק ליין בע"מ‬
METHOD FOR VOLUMETRICALLY
PORTIONING NON-HOMOGEN
PACK LINE LTD.
18/8//1822
515551
AN APPARATUS AND METHOD FOR
TRANSFERRING TEST TUBES
AMIR ZILBERBERG
18/8//1822
121
G01R )5010.01(
515512
B01D )5010.01(
‫התקן ושיטה להעברת מבחנות‬
‫אמיר זילברברג‬
H01R )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
SECURITY PLUG FOR PREVENTING
ACCESS TO A USB SOCKET
PHOTAX MOLDS LTD
2//81/1828
515515
SYRINGE FOR SINGLE USE
SULZER MIXPAC AG
EP
09155936.9 23/03/2009
PCT/EP/2010/053625
WO/2010/108868
11/81/1828
515511
SUBSTITUTED SPIRO-AMIDE
COMPOUNDS
GRUNENTHAL GMBH
EP
09004235.9 25/03/2009
8/8221820/
21/8//188/
EP
PCT/EP/2010/001804
WO/2010/108651
12/81/1828
515511
C6ORF167 PEPTIDES AND VACCINES
CONTAINING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/211700
01/04/2009
PCT/JP/2010/002352
WO/2010/113495
21/81/1828
122
515516
USB ‫תקע ביטחון למנוע גישה לשקע‬
‫פוטקס תבניות בע"מ‬
A61C )5010.01(
‫מזרק לשימוש חד–פעמי‬
C07D )5010.01(
‫תרכובות ספירו–אמיד מותמרות‬
C07K )5010.01(
‫ וחיסונים המכילים‬ORF6O111 ‫פפטידי‬
‫אותם‬
C12N )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
METHOD FOR THE PRODUCTION OF
TRANSGENIC PLANTS HAVING HIGH
STARCH AND BIOMASS CONTENT
AND YEILD
IDEN BIOTECHNOLOGY
ES
P200930009 24/03/2009
PCT/ES/2010/070158
WO/2010/109045
81/81/1828
SYNTHESIS OF 2'-OFUCOSYLLACTOSE
GLYCOM A/S
DK
PA200900469
PCT/EP/2010/054608
WO/2010/115935
11/81/1828
515510
07/04/2009
515511
515515
MEDIA TIMELINE UNTERACTION
MICROSOFT CORPORATION
US
12/427919
22/04/2009
PCT/US/2010/031109
WO/2010/123738
12/81/1828
123
C07H )5010.01(
‫–פוקוזילאקטוז‬O–'5 ‫סינטזה של‬
USER-BASED AUTHENTICATION
FOR REALTIME COMMUNICATIONS
MICROSOFT CORPORATION
US
12/432773
30/04/2009
PCT/US/2010/032303
WO/2010/126800
21/81/1828
‫שיטה לייצור צמחים טרנסגנים בעלי‬
‫תכולה גבוהה של עמילן וביומסה ויבול‬
515512
H04W )5010.01(
‫אימות מבוסס–משתמש עבור תקשורת‬
‫בזמן אמת‬
G06F )5010.01(
‫אינטראקציה בין מדיה לציר–זמן‬
G06F )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
MAINTAINING UNDO AND REDO
CAPABILITY ACROSS METADATA
MERGES
MICROSOFT CORPORATION
US
12/431883
29/04/2009
PCT/US/2010/031951
WO/2010/126763
1//81/1828
‫שימור יכולת קיום וביטול באיחודי מטא‬
‫נתונים‬
515515
PHARMACEUTICAL FORMULATIONS
AND METHODS FOR TREATING
RESPIRATORY TRACT INFECTIONS
PULMATRIX, INC
US
61/163763
26/03/2009
/2/2/11/1
1//81/188/
US
/2/2/1111
1//81/188/
US
/2/1//1/1
12/28/188/
US
/2/1/28/1
1//82/1828
US
/2/18/22/
22/81/1828
US
PCT/US/2010/028906
WO/2010/111644
1//81/1828
124
‫הרכבי רוקחות ושיטות לטיפול בזיהומים‬
‫בדרכי הנשימה‬
515511
DRY POWDER FORMULATIONS AND
METHODS FOR TREATING
PULMONARY DISEASES
PULMATRIX, INC
US
61/163763
26/03/2009
/2/2/11/1
1//81/188/
US
/2/2/1111
1//81/188/
US
/2/1//1/1
12/28/188/
US
/2/1/1111
82/21/188/
US
/2/1/28/1
1//82/1828
US
/2/18/22/
22/81/1828
US
PCT/US/2010/028961
WO/2010/111680
A61K )5010.01(
A61K )5010.01(
‫הרכבים אבקתיים יבשים ושיטות לטיפול‬
‫במחלות ריאה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
515511
18/81/1828
VEHICLE HAVING PITCH
COMPENSATION
BOMBARDIER TRANSPORTATION
GMBH
DE
102009014866.3 30/03/2009
18188/82/11/0/
22/22/188/
DE
2//22/188/
AT
GM733/2009
IT
MI2009U000372 2//22/188/
PCT/IB/2010/001593
WO/2010/113045
11/81/1828
515511
PLATFORM EXTENSIBILTY
FRAMEWORK
MICROSOFT CORPORATION
US
12/433327
30/04/2009
PCT/US/2010/032308
WO/2010/126803
12/8//1822
515511
DECORATIVE
MICHELL BEN MOHA
125
‫רכב בעל מנטרל טלטול‬
G06F )5010.01(
‫תוכנית עם מסגרת הניתנת להרחבה‬
B63H )5010.01(
‫ציר זרם טורבינה רוח‬
‫מינוטין לאוניד‬
PIVOTAL JET WIND TURBINE
MINUTIN D. LEONID
12/8//1822
B61F )5010.01(
515515
G09B )5010.01(
‫אביזרי חשמל מעוצבים‬
‫מישל בן מוחה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
515512
11/81/1828
RESTORATIVE DEVICE
CHI2 GEL LTD
US
61/162367
PCT/IL/2010/000243
WO/2010/109460
‫התקן שיקום‬
‫ ג'ל בע"מ‬5‫כי‬
23/03/2009
12/8//1822
515514
MULTI FEATURES COMPUTERIZE
ELECTRONIC DEVISE INSTALL
AMONG OTHER APPARATUS IN
MINI-BAR
YECHIEL YOSHPE
11/81/1828
‫יחיאל ישפה‬
515515
C07D )5010.01(
‫ ושימוש רפואי‬,‫ הכנתן‬,‫נגזרות ניקוטינאמיד‬
‫שלהן כתרופות נגד סרטן‬
515511
9H-PYRROLO[2,3-B:5,4-C]DIPRIDINE
AZACARBOLINE DERIVATIVES,
PREPARATION THEREOF, AND
THERAPEUTIC USE THEREOF
SANOFI
126
G09G )5010.01(
‫מכשיר אלקטרוני ממוחשב מרובה‬
‫בתכונות המורכב בין השאר ב–מיני–בר‬
NICOTINAMIDE DERIVATIVES,
PREPARATION THEREOF, AND
THERAPEUTIC USE THEREOF AS
ANTICANCER DRUGS
SANOFI
FR
0901365
24/03/2009
PCT/FR/2010/050511
WO/2010/109122
18/22/188/
A61F )5010.01(
C07D )5010.01(
‫]דיפירידין‬B:4,5–C–2,5[‫–פירולו‬H6 ‫נגזרות‬
‫ הכנתן ושימוש רפואי שלהן‬,‫אזאקרבולין‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
FR
0901368
8////11
FR
PCT/FR/2009/052330
WO/2010/109084
18/8//1828
24/03/2009
8//28/188/
515511
VARIANTS OF C-TYPE NATRIURETIC
PEPTIDE
BIOMARIN PHARMACEUTICAL INC.
US
61/180112
20/05/2009
/2/1/1//1
11/28/188/
US
PCT/US/2010/035586
WO/2010/135541
1//81/1828
515511
COMPOSITIONS FOR STIMULATION
OF MAMMALIAN INNATE IMMUNE
RESISTANCE TO PATHOGENS
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM
US
61/163137
25/03/2009
/2/21/11/
22/8//188/
US
PCT/US/2010/028658
WO/2010/111485
18/81/1828
515516
IMPROVED METHOD FOR
PREPARING DIPEPTIDYL
PEPTIDASE-IV INHIBITOR AND
ITERMEDIATE
DONG-A PHARMACEUTICAL. CO.,
LTD.
10-2009KR
30/03/2009
0027106
PCT/KR/2010/001948
WO/2010/114292
127
A61K )5010.01(
C ‫וריאנטים של פפטיד משתן נתרן מסוג‬
C12N )5010.01(
‫תכשירים לגירוי התנגדות החיסונית‬
‫הטבעית של יונקים לפתוגניים‬
C07C )5010.01(
‫שיטה משופרת להכנת מעכב וחומר‬
4–‫ביניים של דיפפטידיל פפטידייס‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
18/81/1828
515560
IMPROVED METHOD FOR
PREPARAING DIPEPTIDYL
PEPTIDASE-IV INHIBITOR AND
INTERMEDIATE
DONG-A PHARMACEUTICAL. CO.,
LTD.
10-2009KR
30/03/2009
0027105
PCT/KR/2010/001947
WO/2010/114291
21/82/1882
515565
PUSH BUTTON FLIP TOP WITH
ATTACHED SECOND CONTAINER
KRAFT FOODS GLOBAL BRANDS
LLC
US
11/840651
17/08/2007
28/81/188/
515211
FUNGICIDAL COMPOSITION
COMPRISING N-{2-[3-CHLORO-5(TRIFLUOROMETHYL)-2PYRIDINYL]ETHYL}-2TRIFLUOROMETHYLBENZAMIDE
AND A COMPOUND CAPABLE OF
INHIBITING THE TRANSPORT OF
ELECTRONS OF THE RESPIRATORY
CHAIN IN PHYTOPATHOGENIC
FUNGAL ORGANISMS, AND A
METHOD FOR PREVENTIVELY OR
CURATIVELY CONTROLLING
PHYTOPATHOGENIC FUNGI OF
CROPS
BAYER S.A.S.
128
C07C )5010.01(
‫שיטה משופרת להכנת מעכב וחומר‬
4–‫ביניים של דיפפטידיל פפטידייס‬
B65D )5010.01(
‫הסרת מכסה בלחיצה ממיכל בעל מיכל‬
‫נוסף הקשור אליו‬
A01N )5010.01(
–N–{2–[3 ‫תכשיר קוטל פטריות המכיל‬
–5–)‫–(טריפלואורומתיל‬5–‫כלורו‬
–5–}‫פירידיניל]אתיל‬
‫טריפלואורומתילבנזאמיד ותרכובת‬
‫המסוגלת לעכב העברת אלקטרונים של‬
‫שרשרת נשימה באורגניזמים פטריתיים‬
‫פיטופתוגניים ושיטה למניעת או שליטה‬
‫בריפוי פטרייה פיטופטוגנית של גידולים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
EP
04356019.2
811//8//08
EP
/8//11218
US
PCT/EP/2005/002563
WO/2005/077901
1//8//1881
12/02/2004
22/8//1881
21/21/1881
515215
AUTOMATIC INJECTION DEVICE
ABBOTT BIOTECHNOLOGY LTD.
US
60/817849
30/06/2006
/8/222112
18/8//188/
US
/8/212/8/
22/82/188/
US
/8/21///1
8//28/188/
US
/8/2//1/1
81/81/1881
US
/8//81/1/
82/81/1881
US
/8//22211
21/81/1881
US
PCT/US/2007/015095
WO/2008/005315
11/8//1822
515252
DETACHABLE EDUCATIONAL
AUDIO PLAYER FOR BABY BOTTLE
SHARABY, ZVI
21/21/1881
515225
HLA-A*1101-RESTRICTED WT1
PEPTIDE AND PHARMACEUTICAL
COMPOSITION COMPRISING THE
SAME
INTERNATIONAL INSTITUTE OF
CANCER IMMUNOLOGY, INC.
2006JP
28/12/2006
355356
129
A61M )5010.01(
‫התקן הזרקה אוטומטי‬
A63H )5010.01(
‫נגן חינוכי לבקבוק תינוק הניתן להפרדה‬
‫ממנו‬
‫צבי שערבי‬
C07K )5010.01(
‫ מצומצם‬WT1 ‫ –פפטיד‬A– HILA * 1101
‫ותרכובת רוקחות המכילה אותו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PCT/JP/2007/074146
WO/2008/081701
21/21/1881
515222
HLA-A*1101-RESTRICTED WT1
PEPTIDE AND PHARMACEUTICAL
COMPOSITION COMPRISING THE
SAME
INTERNATIONAL INSTITUTE OF
CANCER IMMUNOLOGY, INC.
2006JP
28/12/2006
355356
PCT/JP/2007/074146
WO/2008/081701
21/21/1881
515224
HLA-A*1101-RESTRICTED WT1
PEPTIDE AND PHARMACEUTICAL
COMPOSITION COMPRISING THE
SAME
INTERNATIONAL INSTITUTE OF
CANCER IMMUNOLOGY, INC.
2006JP
28/12/2006
355356
PCT/JP/2007/074146
WO/2008/081701
11/8//1822
A METHOD FOR PERFORMING A
DECISION MAKING PROCESS
MY SINGLE POINT LTD
130
515240
C07K )5010.01(
‫ מצומצם‬WT1 ‫ –פפטיד‬A– HILA * 1101
‫ותרכובת רוקחות המכילה אותו‬
C07K )5010.01(
‫ מצומצם‬WT1 ‫ –פפטיד‬A– HILA * 1101
‫ותרכובת רוקחות המכילה אותו‬
G06F )5010.01(
‫שיטה לביצוע הליך לקבלת החלטות‬
‫מיי סינגל פוינט בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/81/188/
515252
‫שיטות מדיה וירטואלית‬
VIRTUAL MEDIA METHODS
AVOCENT CORPORATION
US
60/675842
29/04/2005
22/128821
1//81/188/
US
PCT/US/2006/015909
WO/2006/118921
82/22/1881
515212
SPINK1 AS A PROSTATE CANCER
MARKER AND USES THEREOF
THE REGENTS OF THE UNIVERSITY
OF MICHIGAN
US
60/857758
08/11/2006
/8//8/21/
21/81/1881
US
PCT/US/2007/084090
WO/2008/058239
1//8//1822
FINGER SAFETY DOOR
ABRAHAM SHAFER
131
C12Q )5010.01(
‫ כסמן סרטן הערמונית והשימוש‬1 ‫ספינק‬
‫בו‬
515214
CAPSULE OF SALTS FOR PEDICURE
BATH
VIKTOR DOBINCHUK
1//8//1822
G06F )5010.01(
515215
C07K )5010.01(
‫קפסולת מלחים לפדיקור‬
‫ויקטור דובינצ'וק‬
E05D )5010.01(
‫דלת בטיחותית לאצבעות‬
‫אברהם שפר‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/8//1822
515211
FULL CONTACT SPARRING
INSTRUMENT
VLADIMIR KUSHNIR
1//8//1822
‫כלי נשק קר לאימון לחימה‬
‫נח גרוס‬
515216
ADAPTION OF CORRUGATER STEEL
PIPES FOR UNDERGROUND
STORAGE OF OIL, SAFE AGAINST
BOMBINGS
YEHUDA LINDENBAUM
22/8//1881
ALGAL MEDIUM CHAIN LENGTH
FATTY ACIDS AND
HYDROCARBONS
132
E04B )5010.01(
‫התאמות מבנה פלדה גלי לאחסון דלקים‬
‫תת קרקעי מוגן מהפצצות‬
‫יהודה לינדנבאום‬
515215
ALGAL MEDIUM CHAIN LENGTH
FATTY ACIDS AND
HYDROCARBONS
THE ARIZONA BOARD OF REGENTS,
A BODY CORPORATE OF THE STATE
OF ARIZONA ACTING FOR AND ON
BEHALF OF ARIZONA STATE
UNIVERSITY
US
60/825946
18/09/2006
PCT/US/2007/078760
WO/2008/036654
22/8//1881
F41A )5010.01(
C12N )5010.01(
‫פחמימנים וחומצות שומן של אצות באורך‬
‫שרשרת בינוני‬
515211
C12N )5010.01(
‫פחמימנים וחומצות שומן של אצות באורך‬
‫שרשרת בינוני‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
THE ARIZONA BOARD OF REGENTS,
A BODY CORPORATE OF THE STATE
OF ARIZONA ACTING FOR AND ON
BEHALF OF ARIZONA STATE
UNIVERSITY
US
60/825946
18/09/2006
PCT/US/2007/078760
WO/2008/036654
11/8//1822
515265
‫שיטה‬
‫רוטוניב טכנולוגיות בע"מ‬
METHOD
ROTONIV TECHNOLOGIES LTD
21/28/188/
515406
SELF-PROPELLABLE ENDOSCOPIC
APPARATUS AND METHOD
SOFTSCOPE MEDICAL
TECHNOLOGIES, INC.
US
11/260342
27/10/2005
PCT/US/2006/040617
WO/2007/050370
1//22/188/
515410
APPARATUS AND METHOD FOR
GENERATING FRESH WATER
KOBELCO ECO-SOLUTIONS CO, LTD
2008JP
28/11/2008
304623
188/-81222/ 21/81/188/
JP
188/-8122/2 21/81/188/
JP
188/-811811 21/81/188/
JP
188/-81181/ 21/81/188/
JP
PCT/JP/2009/069932
133
F16L )5010.01(
A61B )5010.01(
‫התקן אנדוסקופי הנדחף מעצמו ושיטה‬
‫הקשורה לכך‬
B01D )5010.01(
‫שיטה והתקן לייצור מים מזוקקים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WO/2010/061879
1//22/188/
515411
APPARATUS AND METHOD FOR
GENERATING FRESH WATER
KOBELCO ECO-SOLUTIONS CO, LTD
2008JP
28/11/2008
304623
188/-81222/ 21/81/188/
JP
188/-8122/2 21/81/188/
JP
188/-811811 21/81/188/
JP
188/-81181/ 21/81/188/
JP
PCT/JP/2009/069932
WO/2010/061879
1//22/188/
515415
METHOD AND APPARATUS FOR
DESALINATING SEA WATER
KOBELCO ECO-SOLUTIONS CO, LTD
2008JP
28/11/2008
304623
188/-81222/ 21/81/188/
JP
188/-8122/2 21/81/188/
JP
188/-811811 21/81/188/
JP
188/-81181/ 21/81/188/
JP
PCT/JP/2009/069932
WO/2010/061879
1//22/188/
515412
METHOD AND APPARATUS FOR
DESALINATING SEA WATER
KOBELCO ECO-SOLUTIONS CO, LTD
2008JP
28/11/2008
304623
188/-81222/ 21/81/188/
JP
188/-8122/2 21/81/188/
JP
188/-811811 21/81/188/
JP
134
B01D )5010.01(
‫שיטה והתקן לייצור מים מזוקקים‬
B01D )5010.01(
‫שיטה והתקן להתפלת מי ים‬
B01D )5010.01(
‫שיטה והתקן להתפלת מי ים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
188/-81181/
JP
PCT/JP/2009/069932
WO/2010/061879
21/81/188/
21/81/1881
515452
METHODS AND COMPOSITIONS FOR
THE REPAIR AND/OR
REGENERATION OF DAMAGED
MYOCARDIUM
NEW YORK MEDICAL COLLEGE
US
10/162,796
05/06/2002
PCT/US/2003/007731
WO/2003/103611
11/8//1822
‫או יצור מחדש‬/‫שיטות ותכשירים לתיקון ו‬
‫של שרירית הלב‬
515451
515451
SPRAYING AND POURING OIL
DISPENSER
EREZ BARON
11/8//1822
ORTAL METHOD FOR PERFECT
BLOCKING, IN FRIDGES WITHOUT
CENTRAL DIVIDER
135
F04F )5010.01(
‫משאבת ואקום מורכבת‬
‫דן גבע‬
INSERT VACUUM PUMP
DAN GEVA
11/8//1822
A61K )5010.01(
B65D )5010.01(
‫מנפק שמן במזיגה והתזה‬
‫ארז בר און‬
515451
F25D )5010.01(
‫שיטת אורטל לאטימה מושלמת‬
‫במקררים ללא מחיצה מרכזית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫יוסף שמואל‬
YOSEF SHMUEL
11/8//1822
515456
DEVICE AND TOOL FOR REMOVING
FOOD FROM BARBECUE SKEWER
PAUL ASSENHEIM
US
US61/390207 06/10/2010
11/8//1822
‫התקן וכלי להסרת אוכל משיפוד ברביקיו‬
‫פול אסנהיים‬
515421
METHOD AND MODULE FOR
SWITCHING OPTICAL SIGNALS
HAVING DIFFERENT MODES OF
PROPAGATION
ECI TELECOM LTD.
81/82/1881
136
F24J )5010.01(
‫חבקים למיגון פנלים פוטו אלקטרים‬
‫אילן יר זנבר‬
SOLOR POINELING LOCK
ILAN YAR ZANBAR
11/8//1822
A47J )5010.01(
515425
H04L )5010.01(
‫שיטה ומודול למיתוג אותות אופטיים בעלי‬
‫אופני התפשטות שונים‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
515421
G11C )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
SYSTEM AND METHOD FOR LOW
POWER WORDLINE LOGIC FOR A
MEMORY
QUALCOMM INCORPORATED
US
60/756100
04/01/2006
/8/1//2//
8//82/188/
US
22/181121
22/81/188/
US
PCT/US/2007/060117
WO/2007/012093
11/8//1822
‫מערכת ושיטה ללוגיקת קו–מילולי בכוח‬
‫נמוך לזיכרון‬
515441
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
81/28/1822
515441
A PHONE ROUTER AND METHOD
THEREFOR
HABEEB FARAH
8//8//1881
H04J )5010.01(
‫נתב לטלפון ושיטה עבורו‬
‫חביב פרח‬
515450
PHARMACEUTICAL COMPOSITIONS
COMPRISING GLUTAMINYL AND
GLUTAMATE CYCLASE INHIBITORS
AND THEIR USE FOR PREPARATION
OF MEDICAMENTD FOR
TREATMENT OF ALZHEIMER'S
DISEASE AND DOWN SYNDROME
PROBIODRUG AG
US
60/468043
05/05/2003
/8/1/2821
8//8//1881
US
137
G06F )5010.01(
A61K )5010.01(
‫תכשירים רוקחיים הכוללים מעכבי‬
‫גלוטמיניל ציקלאז והשימוש בהם להכנת‬
‫תרופות לטיפול באלצהיימר ובדאון‬
‫סינדרום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
/8//21812
US
PCT/EP/2004/004778
WO/2004/098625
81/28/1822
2//28/188/
515411
CONVERTIBLE SINGLE AND MULTISEAT STROLLER
LAZAROVICH ORON
2//28/188/
‫עגלה מתכווננת בעלת מושב יחיד או ריבוי‬
‫מושבים‬
‫גבע כץ‬
515411
SUBMERSIBLE VEHICLE AND
METHOD OF OPERATION THEREOF
GO SCIENCE LIMITED
GB
0521292.3
19/10/2005
PCT/GB/2006/003901
WO/2007/045887
2//28/188/
515411
SUBMERSIBLE VEHICLE AND
METHOD OF OPERATION THEREOF
GO SCIENCE LIMITED
GB
0521292.3
19/10/2005
PCT/GB/2006/003901
WO/2007/045887
81/28/1822
515465
SYSTEM AND METHOD FOR UPLINK
INTERCEPTION BASED ON
DOWNLINK RECEPTION
VERINT SYSTEMS LTD.
138
B62B )5010.01(
B63G )5010.01(
‫כלי רכב בר צלילה ושיטה להפעלתו‬
B63G )5010.01(
‫כלי רכב בר צלילה ושיטה להפעלתו‬
H04L )5010.01(
‫מערכת ושיטה ליירוט ערוץ עולה על ידי‬
‫קליטת ערוץ יורד‬
‫ורינט מערכות בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
81/28/1822
515500
‫מערכת צמיג בטחון‬
‫איתמר ברזילי‬
SECURITY TAYER'S SYSTEM
ITAMAR BARZILAI
81/28/1822
515501
IRRIGATING PLANTS WITH SALTY
WATER
GIL SHANI
22/21/1881
‫גיל שני‬
515501
C07K )5010.01(
)TSLP( ‫חלבון טימיק סטרומל לימפופואטין‬
‫כלבי והשימושים בו‬
515551
IMPROVED IMMUNOASSAY
METHODS
ONCIMMUNE LIMITED
US
60/685422
27/05/2005
139
A01G )5010.01(
‫השקיית צמחים במיים מלוחים‬
CANINE THYMIC STROMAL
LYMPHOPOIETIN PROTEIN AND
USES THEREOF
SCHERING-PLOUGH LTD.
US
60/875135
14/12/2006
PCT/US/2007/025318
WO/2008/076255
1//8//188/
B60C )5010.01(
G01N )5010.01(
‫שיטות תבחין אימוני משופרות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
8/28/1101
GB
PCT/GB/2006/001944
WO/2006/126008
11/8//188/
1//8//188/
515551
IMPROVED IMMUNOASSAY
METHODS
ONCIMMUNE LIMITED
US
60/685422
27/05/2005
8/28/1101
11/8//188/
GB
PCT/GB/2006/001944
WO/2006/126008
81/28/1822
515556
DEVICE FOR AUTOMATICALLY
DISPENSING CHEMICALS IN TO A
TOILET WATER TANK
YAFIM GISSER
81/28/1822
140
‫שיטות תבחין אימוני משופרות‬
B67D )5010.01(
‫מכשיר להזנה אוטומטית של חומר ניקוי‬
‫למיכל–הדחה שלאסלה‬
‫יפים גיסר‬
515520
ROCKER SWITCH LOCKING
MECHANISM
NETANEL BAADANI
82/81/188/
G01N )5010.01(
H01H )5010.01(
‫מנגנון לנעילת מתג‬
‫נתנאל בעדני‬
515521
C12N )5010.01(
November 30, 2011-‫ד' בכסלו התשע"ב‬
METHODS FOR GENERATING
NEURONAL CELLS FROM HUMAN
EMBRYONIC STEM CELLS AND USES
THEREOF
REUBINOFF, BENJAMIN
US
60/561147
09/04/2004
/8///8//1
81/81/188/
US
PCT/US/2005/011857
WO/2005/118920
8//28/1822
‫שיטות להשראת התמיינות תאי גזע‬
‫עובריים לתאים נוירונליים והשימוש בהם‬
515544
515511
TAMPER-RESISTANT GAS VALVE
DEVICE AND THE LIKE
HYDRO LOCK LTD.
8//28/1822
BED WITH ACCESSIBLE AND
USABLE SPACE
WEIDER, THE EXPERTS IN BEDS
AND MATTRESSES LTD.
141
G03B )5010.01(
‫מצלמה פנורמית‬
‫רונית בצלאל‬
PANORAMIC CAMERA
RONIT BETZALEL
8//28/1822
‫אוניברסיטת בר אילן‬
F16K )5010.01(
‫התקן למניעת גישה לשסתום גז וכדומה‬
‫הידרו לוק בע"מ‬
515515
A47D )5010.01(
‫מיטה עם חלל נגיש ושמיש‬
‫וידר המומחים למיטות ומזרונים בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
8//28/1822
515511
C23C )5010.01(
PROCESS FOR SURFACE
TREATMENT
ACKTAR LTD.
8//81/188/
‫תהליך לטיפול שטח‬
‫אקטר בע"מ‬
515516
–2–‫–בנזיל‬1 ‫תולדות חדשות‬
‫הידרוקסימתילאינדאזול ושימוש בהן‬
‫בטיפול במחלות המבוססות על הביטוי‬
,MCP–1 ‫של‬
P40–‫ ו‬CX3CR1
NOVEL 1-BENZYL-3HYDROXYMETHYLINDAZOLE
DERIVATIVES AND USE THEREOF IN
THE TREATMENT OF DISEASES
BASED ON THE EXPRESSION OF
MCP-1, CX3CR1 AND P40
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A.
EP
08425139.6 07/03/2008
PCT/EP/2009/052590
WO/2009/109618
515516
21/81/188/
515561
ONE-HAND KEYBOARD FOR TYPING
ON A TABLET OR SIMILAR TOUCH
SCREEN COMPUTER
DAVID LEE HOFFMAN
142
A01N )5010.01(
‫הרכב המכיל לפחות קוטל פטריות‬
‫אחד ממשפחות הקונאזולים‬
PREPARATION CONTAINING AT LEAST
ONE OF FUNGICIDAL CONAZOLE
BASF SE
DE
102005017800.6 18/04/2005
PCT/EP/2006/003429
WO/2006/111327
8//28/1822
C07D )5010.01(
B41J )5010.01(
‫לוח מקשים ליד אחת עבור מחשב לוח או‬
‫מחשב דומה עם מסך מגע‬
‫דוד לי הופמן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
1//82/1882
515566
PAPILLOMAVIRUS E2 POLYPEPTIDE
USED FOR VACCINATION
TRANSGENE SA
EP
07360004.1 30/01/2007
811/882202
2//8//1881
EP
PCT/EP/2008/051032
WO/2008/092854
8//28/1822
515105
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
81/21/1881
515111
SUBSTITUTED PYRROLO-PYRAZOLE
DERIVATIVES AND PROCESS FOR
THEIR PREPARATION
PFIZER ITALIA S.R.L
US
60/434952
19/12/2002
PCT/EP/2003/050942
WO/2004/056827
8//28/1822
515155
A SLAT HOLDER AND METHOD FOR
INSERTION AND REMOVAL
THEREOF
143
A61K )5010.01(
‫ של וירוס הפאפילומה‬E5 ‫פוליפפטיד‬
‫המשמש לחיסון‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
C07D )5010.01(
‫נגזרות מותמרות של פירולו–פירזול‬
‫ותהליך להכנתן‬
E06B )5010.01(
‫תפס לתריס ושיטה להכנסתו ולהסרתו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫אסף אכדרי‬
ASAF ACHDARI
8//28/1822
515152
‫ערכת תקשורת אלחוטית‬
‫רן זר‬
A WIRELESS COMMUNICATION KIT
RAN ZAR
28/28/1822
515154
FOLDABLE APRON IN ELEVATOR
WITH MOVEABLE FLOOR IN
REDUCED PIT
YORAM MADAR
28/28/1822
ACCELEROMETER
144
B66B )5010.01(
‫סינר מתקפל למעלית עם רצפה נעה בבור‬
‫עם עומק מופחת‬
‫יורם מדר‬
515155
METHOD, SYSTEM, AND DEVICE
FOR RETRIEVING AND ANCHORING
A CORPUS
NOAM SHAUL SHAMAY
28/28/1822
H04W )5010.01(
515151
A61B )5010.01(
‫ מערכת והתקן להחזרה ולעגינה‬,‫שיטה‬
‫של גוף‬
‫נעם שאול שמאי‬
G01P )5010.01(
‫מד תאוצה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
ISRAEL AEROSPACE INDUSTRIES
LTD.
82/8//188/
‫התעשייה האוירית לישראל בע"מ‬
515111
DUAL STAGE ULTRAFILTER DEVICE
IN THE FORM OF PORTABLE FILTER
DEVICES, SHOWER DEVICES, AND
HYDRATION PACKS
NEPHROS, INC.
US
60/714058
02/09/2005
/8/1/1/11
18/82/188/
US
/8/28//12
18/8//188/
US
PCT/US/2006/034268
WO/2007/028044
82/81/1882
‫מתקני מסנן–על דו–שלבי בצורת מתקני‬
‫ מתקני התזה ומיכלי השקיה‬,‫סינון נישאים‬
515111
METHODS OF DIAGNOSING AND
PREDICTING AN ABNORMALITY IN
ENDOMETRIAL GLANDULAR
DEVELOPMENT
HARVEY J. KLIMAN
US
60/187682
08/03/2000
PCT/US/2001/007321
WO/2001/066786
81/81/188/
515116
SHARED VIRTUAL AREA
COMMUNICATION ENVIRONMENT
BASED APPARATUS AND METHODS
SOCIAL COMMUNICATIONS
COMPANY
US
61/042714
05/04/2008
PCT/US/2009/039470
WO/2009/146130
145
B01D )5010.01(
G01N )5010.01(
‫שיטות לאיבחון וניבוי של אבנורמליות‬
‫בהתפתחות בלוטות אנדומטריאליות‬
G06F )5010.01(
‫שיטות והתקנן המובססים על סביבת‬
‫תקשורת שיתופית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
21/21/188/
515111
PROCESSES FOR PREPARING
ANSAMITOCINS
IMMUNOGEN, INC.
US
11/037104
19/01/2005
PCT/US/2005/044783
WO/2006/078368
22/28/1822
22/28/1822
‫תהליך להכנת אנסמיטוסינים‬
515111
SYSTEM AND METHOD OF
DETECTING COMMERCIAL BREAKS
IN A TV PROGRAM FOR ALERTING A
SUBSCRIBED PERSON
TAL CHEMI
DRIVER AND METHOD
CORTEX DENTAL IMPLANTS
INDUSTRIES LTD.
146
G09F )5010.01(
‫מערכת ושיטה להתראה על התחלה וסיום‬
‫של פרסומות בטלוויזיה‬
515111
‫טל חמי‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DETE ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
22/28/1822
C12P )5010.01(
515121
A61B )5010.01(
‫מוביל ושיטה‬
‫קורטקס תעשיות שתלים דנטלים בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
22/28/1822
515121
METHOD FOR FAST-RE-ROUTING
(FRR) IN COMMUNICATION
NETWORKS
ECI TELECOM LTD.
22/28/1822
‫) ברשתות‬FRR( ‫שיטה לניתוב מחדש מהיר‬
‫תקשורת‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
515126
INNA BRAVERMAN
515140
DEVICE AND METHOD FOR
TRANSFERRING CONDUITS IN
CONSTRUCTION ELEMENTS
ARIE BERKOVICH
11/28/1822
E04B )5010.01(
‫התקן ושיטה להעברת צינורות בתוך‬
‫אלמנטי בניה‬
‫אריה ברקוביץ‬
515141
METHOD FOR RECOGNIZING INPUT
GESTURES
SERGEY POPOV
147
F03B )5010.01(
‫תחנת כוח לייצור חשמל מגלי הים שהיא‬
‫רב–כיוונית וניתנת להתאמה למיקום ולמזג‬
‫האוויר‬
‫יבגני ברוורמן‬
MULTI-DIRECTIONAL, LOCATIONAND WEATHER-ADJUSTABLE SEA
WAVE POWER PLANT
11/28/1822
H04L )5010.01(
G06F )5010.01(
‫שיטה לזיהוי מחוות קלט‬
‫סרגיי פופוב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
11/28/1822
A FOLDABLE PARASOL
TALI LEVI
148
515145
F04D )5010.01(
‫שמשיה מתקפלת‬
‫טלי לוי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
149
- ‫ לחוק הפטנטים תשכ"ז‬51 ‫הודעה לפי סעיף‬
1611
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬20 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬51 ‫הפטנטים בדרך הקבועה בתקנה‬
.1611 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
000111
‫אנלוגים של נוקלאוסידים נעולים ותרכובות‬
‫חומצה נוקלאיות המכילים אותם‬
]54[
LOCKED NUCLEOSIDE
ANALOGUES AND NUCLEIC
ACID COMPOUNDS COMPRISING
THEM
]11[
]32[
14.09.1998
1054/97
]31[ 12.09.1997
]33[ DK
2491997
2922122997
DK
1142991
2421222991
DK
1114991
1321322991
DK
1515991
1921422991
DK
419111319
1521422991
US
PA00750/98
1121422991
DK
PA00982/98
1121722991
DK
Int. Cl.(2010.01) C07H 01/00, 19/02, 21/00, C07K 02/00, C12N 09/00
EXIQON A/S, DENMARK
JESPER WENGEL, POUL NIELSEN
WO/1999/014226
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to novel bicyclic and tricyclic nucleoside and nucleotide
analogues of formula (I) as well as to oligonucleotides comprising such elements. The
nucleotide analogues, LNAs (Locked Nucleoside Analogues), are able to provide
valuable improvements to oligonucleotides with respect to affinity and specificity
towards complementary RNA and DNA oligomers. The novel type of LNA modified
oligonucleotides, as well as the LNAs as such, are useful in a wide range of diagnostic
applications as well as therapeutic applications. Among these can be mentionned
antisense applications, PCR applications, strand displacement oligomers, as substrates
for nucleic acid polymerases, as nucleotide based drugs, etc. The present invention
also relates to such applications.
]52[
]72[
]71[
]17[
]74[
]57[
The applications for division
150
,22//18,22////
‫בקשות חלוקה מבקשה זו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
0‫שטרם פורסמו‬
from this application have
not yet been published
__________________
]22[]12[
]54[
USE OF ETXB, CTXB OR VTXB IN
THE MANUFACTURE OF A
VACCINE AGAINST INFECTIOUS
DISEASES
]11[
]32[
10.05.1999
9809958.3
]31[ 08.05.1998
912295421
1321422991
912132429
1121422991
Int. Cl.(2010.01) A61K 39/39
TRIDENT PHARMACEUTICALS,
INC., U.S.A.
WO/1999/058145
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]72[
]17[
]74[
]57[
139467
‫ להכנת‬VtxB ‫ או‬EtxB, CtxB ‫השימוש ב‬
‫תרכיב חיסון נגד מחלות מידבקות‬
]33[
GB
GB
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
There is disclosed the use of: (i) EtxB, CtxB or VtxB free from whole toxin; (ii) an
agent other than EtxB or CtxB, having GM1-binding activity, or an agent other than
VtxB having Gb3-binding activity; or (iii) an agent having an effect on intracellular
signalling events mediated by GM1-binding or Gb3 binding; as an immunomodulator
for a vaccine against infectious diseases.
__________________
]22[]12[
]54[
151
FILM COATED EXTENDED
RELEASE ORAL DOSAGE
COMPOSITION COMPRISING
PSEUDOEPHEDRINE AND
DESLORATADINE AND USES
THEREOF
140450
‫תרכיב מינון יציב בשכבת פילם עם שיחרור‬
‫מתמשך למתן דרך הפה המכיל פסיאודואפדרין‬
‫ודסלוראתאדין ושימושו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]74[
]57[
20.12.2000
60/172836
]31[ 20.12.1999
]33[ US
Int. Cl.(2010.01) A61K 09/00, 09/20, 09/28
SCHERING CORPORATION, U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
An extended release solid oral dosage composition comprising: (a) a core comprising
an effective amount of pseudoephedrine or a pharmaceutically acceptable salt thereof,
(b) a first coating covering the core and comprising a water-swellable film-forming
neutral or cationic copolymeric ester, a film modifier and a lubricant and (c) a second
coating covering the first coating and comprising an effective amount of desloratadine
wherein the amounts of pseudoephedrine or said salt thereof and of desloratadine are
effective to produce desired geometric maximum plasma concentrations of the active
agents at the desired time after administration of a single dose of said composition.
__________________
]22[]12[
140451
‫תרכיב מינון עם שיחרור מתמשך למתן בפה‬
]54[
EXTENDED RELEASE ORAL
DOSAGE COMPOSITION
]11[
]32[
]52[
]72[
]74[
20.12.2000
60/172752
]31[ 20.12.1999
]33[ US
Int. Cl.(2010.01) A61K 09/00
SCHERING CORPORATION, U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A solid composition comprising an anti-allergic effective amount of desloratadine in a
free base form and desloratadine-protective amount of at least one pharmaceutically
acceptable antioxidant, wherein: the desloratadine does not form a pharmaceutically
acceptable salt with an antioxidant; about 0.1% to about 10% of the at least one
pharmaceutically acceptable antioxidant is present; at least 80% of the desloratadine
dissolves in a 0.1N HCl solution at 37o C. in about 45 minutes; and the total amount of
desloratadine degradation products in the solid composition is less than or equal to 2%
by weight.
]57[
152
__________________
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
143289
]54[
STREPTOCOCCAL C5A
PEPTIDASE VACCINE,
COMPOSITIONS COMPRISING IT
AND USES THEREOF
]11[
]32[
]52[
]72[
03.12.1999
09/206898
]31[ 07.12.1998
]33[ US
Int. Cl.(2010.01) A61K 38/48, 39/09, C12N 09/52, 15/57
REGENTS OF THE UNIVERSITY OF
MINNESOTA, U.S.A.
WO/2000/034487
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
,‫ של סטרפטוקוקוס‬a5C ‫חיסון נגד וריאנט‬
‫תכשירים רוקחיים המכילים אותו ושימושים בו‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Novel vaccines for use against beta-hemolytic Streptococcus colonization or infection
are disclosed. The vaccines contain an immunogenic amount of a variant of
streptococcal C5a peptidase (SCP). Also disclosed is a method of protecting a
susceptible mammal against beta-hemolytic Streptococcus colonization or infection by
administering such a vaccine. Enzymatically inactive SCP, and polynucleotides
encoding these SCP proteins are further disclosed.
__________________
]22[]12[
146127
‫אנלוגים של פוליאמינים בעלי קונפורמציה‬
‫מוגבלת ושמושים בהם‬
]54[
CONFORMATIONALLY
RESTRICTED POLYAMINE
ANALOGS AND USES THEREOF
]11[
]32[
]52[
]72[
27.04.2000
60/131779
]31[ 30.04.1999
]33[ US
Int. Cl.(2008.04) A61K 31//13, A61P 35//00, C07C 21/1/00, 21/1/13
PROGEN PHARMACEUTICALS,
INC., U.S.A.
153
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/2000/066587
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Novel conformationally restricted polyamine analogs are provided, as well as
compositions comprising these novel polyamine analogs. Methods of using the novel
polyamine analogs in treatment of diseases such as cancer are also provided. Also
provided is a method of delivering these analogs specifically to tumor cells by
covalently attaching polyamine analogs to porphyrin compounds, along with novel
polyamine-porphyrin covalent conjugates.
__________________
]22[]12[
148270
‫ זרעי‬,‫שיטה לביטוי חומצת גרעין בזרעי פשתן‬
‫ רצף חומצת‬,‫ רצף חומצת גרעין‬,‫פשתן טרנסגניים‬
‫גרעין מאוחה מבודדת וזרע ותא צמחיים‬
‫המכילים אותם‬
]54[
METHOD FOR EXPRESSION OF
NUCLEIC ACID SEQUENCE IN
FLAX SEEDS, TRANSGENIC
FLAX SEED, ISOLATED NUCLEIC
ACID SEQUENCE, ISOLATED
CHIMERIC NUCLEIC ACID
SEQUENCE AND PLANT SEED
AND CELL COMPRISING THEM
]11[
]32[
25.08.2000
60/151044
]31[ 27.08.1999
]33[ US
419242711
1722122999
US
1321314
3121521111
CA
Int. Cl.(2010.01) A01H 05/00, 05/10, C12N 15/11, 15/29, 15/82
SEMBIOSYS GENETICS INC.,
CANADA
COMMONWEALTH SCIENTIFIC
AND INDUSTRIAL RESEARCH
ORGANISATION, AUSTRALIA
WO/2001/016340
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
154
Novel methods for the expression of non-native genes in flax seeds and the seeds of
other plant species are provided. The methods involve the use of seed-specific
promoters obtained from flax. Additionally provided are novel flax seed-specific
November 30, 2011-‫ד' בכסלו התשע"ב‬
promoters, chimeric nucleic acid constructs comprising novel flax seed-specific
promoters, transgenic plant cells, transgenic plants and transgenic plant seeds
containing novel flax seed-specific promoters. The promoters and methods are useful,
for example, for altering the seed oil and protein composition in flax seed or other
plant seeds.
__________________
]22[]12[
149139
‫שימוש במטפורמין וגליבוריד להכנת תכשירי‬
‫רוקחות‬
]54[
USE OF METFORMIN AND
GLYBURIDE TO PREPARE
PHARMACEUTICAL
COMPOSITIONS
]11[
]32[
13.10.2000
09/432465
]31[ 03.11.1999
]33[ US
199441911
2422122999
US
Int. Cl.(2010.01) A61K 31/155, 31/64, 45/06, A61P 03/10, C07C 279/26, 311/54
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2001/032157
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
method is provided for first line treatment of type 2 diabetes employing a combination
of metformin and glyburide. A method for treating diabetes in drug naive human
patients is also provided employing the above formulation to reduce insulin resistance
and/or post-prandial glucose excursion and/or hemoglobin 1Ac, and/or increase postprandial insulin, thereby treating the diabetes.
]52[
]72[
]17[
]74[
]57[
__________________
]22[]12[
]54[
155
HAPTOTACTIC PEPTIDES
150458
‫פפטידים הפטוטקטים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
21.01.2001
09/487790
]31[ 20.01.2000
]33[ US
Int. Cl.(2010.01) A61K 38/08, 38/10, A61P 07/02, 07/04, 17/02, 19/00, C07K 07/00,
07/08, 14/75
HADASIT MEDICAL RESEARCH
,‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
SERVICES & DEVELOPMENT LTD.
‫ירושלים‬
RAPHAEL GORODETSKY, GERARD
‫ ג'רארד מרקס‬,‫רפאל גורודצקי‬
MARX
WO/2001/053324
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
2 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
Novel peptide sequences homologous to the known fibrinogen derived haptotactic
peptides, Cbeta and CalphaE, are disclosed. The novel peptides are derived from
proteins related or unrelated to fibrinogen including a peptide adjacent to fibrinogen
gamma-chain C terminus denoted pre-Cgamma as well as isotypes of angiopoietin,
human microfibril-associated glycoprotein (mfap) and tenascins. Novel peptides
having significant homology to the known fibrinogen derived haptotactic peptides are
now shown to possess cell attraction activities. Active fragments comprising shorter 810 mer peptides are also disclosed, and shown to elicit significant haptotactic activity
from a variety of cells, such as fibroblasts, endothelial and smooth muscle cells. The
homologous peptides disclosed permit delineation of consensus sequences for
haptotactic activity. The peptides are useful in pharmaceutical compositions alone or in
conjunction with a medical device or implant 2
__________________
]22[]12[
]54[
INTERSYSTEM BASE STATION
HANDOVER
]11[
]32[
]52[
]72[
07.03.2001
09/521359
]31[ 08.03.2000
Int. Cl.(2010.01) H04W 84/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/067788
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
156
151261
‫מסירה של תחנת בסיס בין–מערכתית‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A mobile wireless telecommunications system includes base stations of a first type
operating according to a first air interface, and base stations of a second type operating
according to a second air interface. Methods and apparatus are provided for handing
over a mobile station in the system from a first base station, which is of the first type,
to a second base station, which is of the second type. A communications link is
established over the first air interface between the mobile station and the first base
station. Data are received from the mobile station responsive to a signal received by
the mobile station over the second air interface from the second base station,
substantially without breaking the communications link with the first base station. The
mobile station is handed over form the first to the second base station responsive to the
data received therefrom. In particular, a method of conducting intersystem handover
from a multicarrier system to a direct spread system is provided. Timing
synchronization is also advantageously made available through the mobile station.
__________________
]22[]12[
151265
]54[
METHODS OF DIAGNOSING AND
PREDICTING AN
ABNORMALITY IN
ENDOMETRIAL GLANDULAR
DEVELOPMENT
]11[
]32[
]52[
]72[
]17[
]74[
08.03.2001
60/187682
]31[ 08.03.2000
]33[
Int. Cl.(2010.01) C12Q 01/00, G01N 33/68
HARVEY J. KLIMAN, U.S.A.
WO/2001/066786
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
157
‫שיטות לאיבחון וניבוי של אבנורמליות‬
‫בהתפתחות בלוטות אנדומטריאליות‬
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
Methods of diagnosing an abnormality in endometrial glandular development in a
woman suspected of being infertile are disclosed. Methods of predicting abnormal
endometrial glandular development are also disclosed. In addition, methods of
assessing the suitability of the endometrium for embryo implantation in a woman
undergoing ovulation induction are disclosed. Further, methods of evaluating the effect
of a hormonal protocol on endometrial glandular development in a woman undergoing
a hormonal protocol to produce a mock cycle are disclosed. Methods of evaluating a
hormone replacement therapy protocol in a woman undergoing hormone replacement
therapy are disclosed. Further, methods of diagnosing endometrial glandular mitotic
arrest in a woman suspected of having endometrial hyperplasia are disclosed.
,12//1/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
153619
‫פגז בר אנרגיה קינטית גבוהה עם סגמנטים תת‬
‫קליבריים רבים‬
]54[
HIGH KINETIC ENERGY
PROJECTILE WITH A
PLURALITY OF SUBCALIBRE
SEGMENTS
]11[
]32[
]52[
]72[
20.06.2001
0002481-0
]31[ 03.07.2000
]33[ SE
Int. Cl.(2010.01) F42B 12/58
BAE SYSTEMS BOFORS AB,
SWEDEN
TORSTEN RONN
WO/2002/003009
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to a segmented subcalibre projectile (1) subdivisible into
a number of separate segments contiguous with each other at least initially to form an
integral projectile of united segments or submunitions (5). The advantage with this
subcalibre projectile is that since the segments or submunitions (5) are arranged
sequentially after each other, each one comprises an explosive charge (7) initiatable by
a very powerful shock and encased in an outer casing (6) of hard material such that the
projectile in integral form can be used directly against heavy armour, and by means of
dispersion of the various segments can also be used against aircraft.
]71[
]17[
]74[
]57[
158
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
154273
‫תהליך לסימון שירותים ברשימה במערכת‬
‫טלויזיה וטרמינל הקשור לתהליך‬
]54[
PROCESS FOR MARKING
SERVICES IN A LIST IN A
TELEVISION SYSTEM AND
TERMINAL ASSOCIATED WITH
THE PROCESS
]11[
]32[
]52[
]72[
03.02.2003
02/01564
]31[ 04.02.2002
]33[ FR
Int. Cl.(2010.01) G09G 05/00, H04N 05/445, 07/08
THOMSON LICENSING S.A.,
FRANCE
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
159
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a process for selecting services in a television system using
graphical indications displayed on a screen. The invention comprises in particular the
steps of: (a) determining a first list (30) of services, the first list being a subset of a
second list; (b) displaying at least a part of the first list, ordered according to a
predetermined criterion; (c) selecting a service present in the second list, but not in the
first list; (d) displaying a visual indicator (39) marking the relative location, according
to the predetermined criterion, of the selected service in the first list (30). The
invention also relates to the terminal for the implementation of the process.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
154671
‫מעכבים של פרוטאז פפטידומימטיים‬
]54[
PEPTIDOMIMETIC PROTEASE
INHIBITORS
]11[
]32[
31.08.2001
60/229398
]31[ 31.08.2000
]33[ US
419177442
1221321112
US
Int. Cl.(2010.01) C07D 403/00
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
WO/2002/018369
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to peptidomimetic compounds useful as protease
inhibitors (1), particularly as serine protease inhibitors and more particularly as
hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including
novel steroselective processes to intermediates. The invention is also directed to
pharmaceutical compositions and to methods for using the compounds for inhibiting
HCV protease or treating a patient suffering from an HCV infection or physiological
condition related to the infection. Also provided are pharmaceutical combinations
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
160
comprising, in addition to one or more HCV serine protease inhibitors, one or more
interferons exhibiting anti-HCV activity and/or one or more compounds having anti
HCV activity and a pharmaceutically acceptable carrier, and methods for treating or
preventing a HCV infection in a patient using the compositions. The present invention
is also directed to a kit or pharmaceutical pack for treating or preventing HCV
infection in a patient.
The applications for division
from this application have
not yet been published
,12/2/1,12/2/2,12/2/8,22//11
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
155036
]54[
POLYMORPHIC FORMS OF 5-[4-[2-[N-METHYL-N-(2PYRIDYL)AMINO]ETHOXY]BENZYL]THIAZOLIDINE2,4-DIONE MALEATE AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE SAME
]11[
]32[
]52[
]72[
]17[
]74[
25.09.2001
805/MAS/00
]31[
26.09.2000
]33[ IN
Int. Cl.(2010.01) A61K 31/4439, A61P 03/04, 03/06, 03/10, 09/10, 09/12, 19/10, C07D 417/12
DR. REDDY'S LABORATORIES LTD., INDIA
WO/2002/026737
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
This invention relates to novel polymorphic/pseudopolymorphic forms of 5-[4-[2[N-methyl-N-(2pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate having formula (I). The invention also
relates to a pharmaceutical composition comprising the novel polymorphic form or their mixture and a
pharmaceutically acceptable carrier. The polymorphic forms of the present invention are more active, as
antidiabetic agent, than the hitherto known 5-[4-[2-[N-(2-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]
thiazolidine-2,4-dione maleate.
]57[
161
–N]–2]–4]–5 ‫צורות פולימורפיות של‬
–N –(2–‫מתיל‬
–‫פירידיל)אמינו]איתוקסי]בנזיל]תיאזולידין‬
‫–דיאון מליאט ותכשירי רוקחות‬4,2
‫במכילים אותן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
155189
]54[
CRYSTALLINE FORMS OF A
FACTOR XA INHIBITOR
]11[
]32[
04.10.2001
60/238316
]31[ 05.10.2000
]33[ US
121191324
2121421112
GB
Int. Cl.(2010.01) A61K 31/4412, A61P 07/02, C07D 213/89
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2002/028836
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Novel crystals of an inhibitor of Factor Xa or formula (I), processes for its preparation,
compositions containing the same and its therapeutic use.
]52[
]72[
]17[
]74[
]57[
Xa ‫צורות גבישיות של מעכב פקטור‬
__________________
162
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
155330
‫מערכת ושיטה ליצירת קרן אור עם קיטוב‬
‫משתנה במרחב‬
]54[
SYSTEM AND METHOD FOR
PRODUCING A LIGHT BEAM
WITH SPATIALLY VARYING
POLARIZATION
]11[
]52[
]72[
09.04.2003
Int. Cl.(2010.01) G02B 05/30
TECHNION RESEARCH AND
‫ חיפה‬,‫מוסד הטכניון למחקר ופיתוח בע"מ‬
DEVELOPMENT FOUNDATION
LTD.
STEPHEN GEOFFREY LIPSON,
‫ אמיר שוהם‬,‫סטפן גופרי ליפסון‬
AMIR SHOHAM
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An apparatus for providing a light beam with spatially varying polarization, the
apparatus comprising: two circumferentially curved reflectors positioned substantially
opposite each other; and a polarizer positioned in an optical path between the two
reflectors, for polarizing light reflected from one reflector and passing through the
polarizer before it reaches the other; whereby a non-polarized light beam incident
along a given axis on one of the reflectors is radially reflected off that reflector,
acquires predetermined polarization by passing through the polarizer and is then
reflected off the second reflector to produce an outgoing light beam of spatially
varying polarization.
]71[
]74[
]57[
163
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
156031
‫תולדות של תרכובות אימידאזול ואוקסאזול‬
‫מותכות ותכשירי רוקחות המכילים אותן כחומר‬
‫נגד חיידקים‬
]54[
FUSED IMIDAZOLE AND
OXAZOLE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME AS ANTI-BACTERIAL
AGENTS
]11[
]32[
12.12.2001
60/256094
]31[ 15.12.2000
]33[ US
419175191
2321321112
US
Int. Cl.(2010.01) A61K 31/4184, 31/423, 31/437, 31/4439, 31/4709, 31/506, 31/5377,
31/55, A61P 31/00, C07D 235/30, 263/58, 401/04, 401/14, 403/04, 403/12, 403/14,
405/04, 405/14, 413/04, 413/14, 471/04, 471/14
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
WO/2002/060879
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to compounds of the formula (I): or a pharmaceutically
acceptable derivative or prodrug thereof. The compounds are useful as inhibitors of
bacterial gyrase activity. The present invention also relates to methods for treating
bacterial infections in mammals. The present invention also relates to methods for
decreasing bacterial quantity in a biological sample.
]52[
]72[
]17[
]74[
]57[
__________________
]22[]12[
]54[
164
METHOD FOR PARTICLE SIZE
AND CONCENTRATION
MEASUREMENT
156856
‫שיטה למדידת גודל וריכוז של חלקיקים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]52[
]72[
]71[
]74[
]57[
09.07.2003
Int. Cl.(2010.01) G01N 15/14
P.M.L - PARTICLES MONITORING
TECHNOLOGIES LTD.
JOSEPH SHAMIR, NIR
KARASIKOV
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
‫ ניר קרסיקוב‬,‫יוסף שמיר‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
A method of particle size and concentration measurement comprising the following
steps: using one or more lasers to produce a Gaussian laser beam; using means for
converting said Gaussian laser beam into a focused, synthesized, non-Gaussian dark
beam; causing said particles to flow relative to a stationary dark beam or using a
scanning mechanism to cause said beam to interact with said particles; using a
detection system to measure the interaction signal and number of interactions per unit
time of said dark beam with said particles; and feeding an output of said detection
system into a computer comprising algorithms adapted to map said interaction signals
to said particle size and said number of interactions per unit time to said concentration.
__________________
]22[]12[
]54[
ATRIAL ABLATION CATHETER
]11[
]32[
]52[
]72[
]74[
18.07.2003
10/199525
]31[ 19.07.2002
Int. Cl.(2010.01) A61B 17/32
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330
]57[
165
157016
‫צנתר פרוזדורי להסרת ריקמה‬
]33[
US
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
A catheter for ablating tissue is provided. The catheter comprises an elongated
generally-tubular catheter body having proximal and distal ends and at least one lumen
extending therethrough. A non-retractable ablation assembly is attached to the distal
end of the catheter body. The ablation assembly comprises proximal and distal nonconductive tubings, each having a lumen extending therethrough and a generally
tubular electrode mounted between the proximal and distal non-conductive tubings.
The tubular electrode is formed of a material having shape-memory and has at least
one irrigation port through which fluid can pass from the inside to the outside of the
electrode. The ablation assembly further comprises a non-conductive protective tubing
November 30, 2011-‫ד' בכסלו התשע"ב‬
extending generally parallel to and along the outside of the tubular electrode.; The
protective tubing has proximal and distal ends extending into the proximal and distal
non-conductive tubings, respectively. The catheter further comprises at least one of an
electrode lead wire and a temperature sensor wire, and preferably both, extending
through the non-conductive protective tubing and catheter body, the electrode lead
wire having a distal end mounted to a ring electrode mounted on the distal nonconductive tubing, and the temperature sensor wire having a distal end mounted on or
under the distal non-conductive tubing. The catheter also comprises an infusion tube
extending through the catheter body and having a distal end in fluid communication
with the proximal end of the tubular electrode.
__________________
]22[]12[
]54[
166
METHOD FOR PROVIDING CELL
POPULATION FROM UMBILICAL
CORD BLOOD OR PLACENTA
157332
‫שיטה להשגת אוכלוסיית תאים מהדם בחבל‬
‫הטבור או משליה אשר מסוגלים להתמיין לסוגי‬
‫תאים של שורות תאים עובריים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
WHICH CAN DIFFERENTIATE
INTO CELL TYPES OF THE
EMBRYONIC LINEAGE
]11[
]32[
]52[
]72[
]17[
]74[
]57[
14.02.2002
60/268786
]31[ 14.02.2001
]33[ US
419149141
2521121112
US
419321415
1721121112
US
419343314
1522121112
US
Int. Cl.(2010.01) A01K 67/027, A61K 35/12, C12N 05/0789, G01N 33/49, 33/50
ABT HOLDING COMPANY, U.S.A.
WO/2002/064748
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates generally to mammalian multipotent adult stem cells
(MASC), and more specifically to methods for obtaining, maintaining and
differentiating MASC to cells of multiple tissue types. Uses of MASC in the
therapeutic treatment of disease are also provided.
The applications for division
from this application have
not yet been published
,121/11
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
167
GLUCOCORTICOID RECEPTOR
ANTAGONIST FOR
158744
‫אנטגוניסט של קולטן גלוקוקורטיקואיד לשיפור‬
‫סימטומים של הזיה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
AMELIORATION OF SYMPTOMS
OF DELIRIUM
]11[
]32[
]52[
]72[
]17[
]74[
]57[
06.05.2002
60/288619
]31[ 04.05.2001
]33[ US
219237111
1221521111
US
Int. Cl.(2010.01) A61K 31/56, A61P 05/46, 25/00
CORCEPT THERAPEUTICS, INC.,
U.S.A.
WO/2002/096433
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
This invention generally pertains to the field of psychiatry. In particular, this invention
pertains to the discovery that agents which inhibit the binding of cortisol to its
receptors can be used in methods for treating delirium. Mifepristone, a potent specific
glucocorticoid receptor antagonist, can be used in these methods. The invention also
provides a kit for treating delirium in a human including a glucocorticoid receptor
antagonist and instructional material teaching the indications, dosage and schedule of
administration of the glucocorticoid receptor antagonist.
__________________
]22[]12[
158860
]54[
101P3A11 PEPTIDES FOR USE IN
VACCINE PREPARATION
]11[
]32[
15.05.2002
60/291118
]31[ 15.05.2001
]33[ US
219112449
3222121112
US
219127144
2422121112
US
Int. Cl.(2010.01) A61K 38/08, 38/17, C07K 07/06, 14/705, G01N 33/53
AGENSYS, INC., U.S.A.
WO/2002/092842
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Novel gene (designated 101P3A11 or PHOR-1) and its encoded proteinv t avrav dn
]52[
]72[
]17[
]74[
]57[
‫ לשימוש בהכנת חיסונים‬P3A11111 ‫פפטידי‬
d frfcr, vrf tfnhraeft x frfa 212 3i22 fw aeadn dannef n,fharah
fw,rfnnac a cr vl vteld dannef, v t an vefrrv dla fw,rfnnft a d f
168
November 30, 2011-‫ד' בכסלו התשע"ב‬
3i22 ,rcaatfn v 212 ,hv hfrn landft a bvelf 2 tc nfsef dla
tavg cndah, ,rcg cndah, ,rc, alvhdah v t9cr d frv,fedah dvrgfd rcr hv hfr2
b f 212 3i22 gf f cr rrvg f d d frfcr, cr adn f hctft ,rcdfa , cr
avrav dn d frfcr, hv ef enft dc flahad v e crvl cr hfllelvr a
e f
hflln rfvhdaaf xad 212 3i22 hv ef enft a rfn,c nfd v daectafn cr b
2vhdaaf cr ,vnnaaf a
e aevdac
__________________
]22[]12[
159773
‫ תכשירים‬,]‫נגזרות ביס[תיו–הידרזיד אמידיות‬
‫רוקחים המכילים אותן ושימושים בהן להכנת‬
‫תרופות להגברת הפעילות נוגדת לסרטן של‬
‫פקליטקסל או אנלוג של פקליטקסל‬
]54[
BIS[THIO-HYDRAZIDE AMIDE]
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF FOR
THE MANUFACTURE OF
MEDICAMENTS TO ENHANCE
THE ANTI-CANCER ACTIVITY
OF PACLITAXEL OR OF A
PACLITAXEL ANALOG
]11[
]32[
10.07.2002
60/304252
]31[ 10.07.2001
]33[ US
419342944
1421321111
US
Int. Cl.(2010.01) A61K 31/16, 31/38, 31/395, A61P 35/00, C07C 327/56, C07D
209/42, 213/78, 261/18, 295/14, 307/54, 307/66, 307/68, 333/38, 333/68
SYNTA PHARMACEUTICALS
CORP., U.S.A.
WO/2003/006430
]52[
]72[
]17[
169
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Disclosed is a compound represented by the Structural Formula (I); Y is a covalent
bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl
group. In addition, Y, taken together with both -C=Z groups to which it is bonded, is a
substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or C(R7R8)-. R1 and R2 are independently an aryl group or a substituted aryl group, R3
and R4 are independently -H, an aliphatic group, a substituted aliphatic group, an aryl
group or a substituted aryl group. R5-R6 are independently -H, an aliphatic group, a
substituted aliphatic group, an aryl group or a substituted aryl group. R7 and R8 are
each independently -H, an aliphatic or substituted aliphatic group, or R7 is -H and R8
is a substituted or unsubstituted aryl group, or, R7 and R8, taken together, are a C2-C6
substituted or unsubstituted alkylene group. Z is =O or =S. Also disclosed are
pharmaceutical compositions comprising the compound of the present invention and a
pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a
subject with cancer by administering to the subject a compound of Structural Formula
(I) in combination with taxol or an analog of taxol.
__________________
]22[]12[
160442
‫ תכשירים רוקחיים‬,‫נגזרות אמינובנזופנון‬
‫המכילים אותן ושימוש בהן‬
]54[
AMINOBENZOPHENONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USES
]11[
]32[
26.08.2002
60/315025
]31[ 28.08.2001
]33[ US
PA200200189
1121121111
DK
Int. Cl.(2010.01) A61K 31/135, A61P 01/04, 11/06, 17/00, 19/06, C07C 225/22,
229/44, 233/25, 233/36, 233/43, 235/10, 235/20, 235/74, 271/20, 271/22, 271/28,
275/24, 275/26, 275/40, 309/73, 311/09, 311/15, 311/21, 317/48, 323/52, 33/40,
335/12, C07D 207/27, 207/404, 209/48, 211/22, 233/72, 233/74, 233/96, 295/12
LEO PHARMA A/S, DENMARK
WO/2003/018535
]52[
]72[
]17[
170
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to a novel class of aminobenzophenones derivatives, to
pharmaceutical preparations comprising said compounds, to dosage units of such
preparations, to methods of treating patients comprising administering said
compounds, and to the use of said compounds in the manufacture of pharmaceutical
preparations.
__________________
]22[]12[
160691
‫ תהליכים‬,‫נגזרות בנזותיאזפין ובנזותיאדיאזפין‬
‫ תכשירי רוקחות המכילים אותן‬,‫להכנתן‬
‫והשימוש בהן כתרופות לעכוב מעביר חומצה‬
‫) בחיה בעלת דם‬IBAT( ‫מרה המרה האיליאלי‬
‫חם‬
]54[
BENZOTHIAZEPINE AND
BENZOTHIADIAZEPINE
DERIVATIVES, PROCESSES FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USE AS
MEDICAMENTS FOR INHIBITING
ILEAL BILE ACID TRANSPORT
(IBAT) IN A WARM BLOODED
ANIMAL
]11[
]32[
05.09.2002
0121768.6
]31[ 08.09.2001
]33[ GB
111944329
1521421111
GB
Int. Cl.(2010.01) A61K 31/554, 31/66, 31/695, 38/05, 38/06, A61P 03/06, C07D
281/02, 285/36, 417/12, C07F 07/10, 09/547, C07K 05/06, 05/08
ALBIREO AB, SWEDEN
INGEMAR STARKE, MIKAEL ULF
JOHAN DAHLSTROM, DAVID
BLOMBERG, SUZANNE
ALENFALK, TORE SKJARET,
MALIN LEMURELL
WO/2003/022286
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.,
21 ‫רחוב אחד העם‬
P.O.B. 2499,
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
]52[
]72[
]71[
]17[
]74[
171
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
The present invention relates to compounds of formula (I) wherein Rv, R1, R2, Rx,
Ry, M, Rz, v, R3, R4, R5 and R4 are as defined herein, vr vhfedahvlla d
vhhf,dvelf nvldn, nclavdfn, nclavdfn cr neh nvldn v t ,rctregn d frfcr
v t d far enf vn alfvl ealf vhat drv n,crd l biba a aeadcrn rcr d f
t drfvd f d cr a,frla,atvf av2 rchfnnfn rcr d far v ervhderf v
2, vr vhfedahvl hc ,cnadac n hc dva a g d f vrf vlnc tfnhraeft
__________________
]22[]12[
161522
‫שימוש בתולדות של פרובוקול להכנת תרופות‬
‫לטיפול בדחיית שתל‬
]54[
USE OF PROBUCOL
DERIVATIVES IN
MANUFACTURE OF
MEDICAMENTS FOR TREATING
TRANSPLANT REJECTION
]11[
]32[
]52[
]72[
]17[
]74[
25.10.2002
60/339535
]31[ 25.10.2001
]33[ US
Int. Cl.(0) A61K 31/10, 31/19, 31/235, 31/24, 31/34, 31/351, A61P 37/06
ATHEROGENICS, INC., U.S.A.
WO/2003/039231
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
The use of compounds of the formula (I) and pharmaceutically acceptable salts
thereof, alone or in combination for the treatment of transplant rejection, wherein the
substituents are defined in the application.
__________________
172
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
161522
‫שימוש בתולדות של פרובוקול להכנת תרופות‬
‫לטיפול בדחיית שתל‬
]54[
USE OF PROBUCOL
DERIVATIVES IN
MANUFACTURE OF
MEDICAMENTS FOR TREATING
TRANSPLANT REJECTION
]11[
]32[
]52[
]72[
]17[
]74[
25.10.2002
60/339535
]31[ 25.10.2001
]33[ US
Int. Cl.(0) A61K 31/10, 31/19, 31/235, 31/24, 31/34, 31/351, A61P 37/06
ATHEROGENICS, INC., U.S.A.
WO/2003/039231
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
The use of compounds of the formula (I) and pharmaceutically acceptable salts
thereof, alone or in combination for the treatment of transplant rejection, wherein the
substituents are defined in the application.
__________________
]22[]12[
161851
‫תכשירים המכילים תרכובת של צפלוספורין‬
‫ושימושם בטיפול של זיהומים בקטריאליים‬
‫בחתולים וכלבים‬
]54[
FORMULATIONS COMPRISING A
CEPHALOSPORIN COMPOUND
AND THEIR USE FOR TREATING
BACTERIAL INFECTIONS IN
CATS AND DOGS
]11[
]32[
13.11.2002
60/338536
]31[ 30.11.2001
]33[ US
419391931
1421721111
US
Int. Cl.(2010.01) A61K 31/546, 47/00, C07D 501/00
PFIZER PRODUCTS, INC., U.S.A.
]52[
]72[
173
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/2003/045435
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Formulations containing an antibacterial alkali metal salt of a cephalosporin compound
and methods of treating or preventing bacterial infections in dogs and cats.
__________________
]22[]12[
161927
‫התקן תזכורת תפילות‬
]54[
PRAYER REMINDER DEVICE
]11[
]52[
]72[
11.05.2004
Int. Cl.(2010.01) G09B 19/00
RAEL CHEMICALS EXPORT (1981)
LTD.
]74[
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
A method of visually reminding a user of specific prayers , comprising the steps of
providing a prayer book, providing a device sized to be inserted within the confines
thereof, said device being provided with a plurality of individual tabs, said tabs being
individually extendable from said device to protrude beyond the confines of said book
and being provided with indicia comprising specific prayers, prayer segments and
words applicable to the prayers of a specific day, extending one or more individual
tabs and visually reminding oneself of said specific prayers, prayer segments and
words applicable to the prayers of a specific day by viewing said one or more
individual tabs.
]57[
,‫) בע"מ‬1611( ‫ראל כימיקלים אקספורט‬
‫ירושלים‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
__________________
]22[]12[
]54[
174
DEVICE FOR INSERTING START
CONNECTOR IN IRRIGATION
HOSE
162539
‫התקן לניעיצת מחבר ראשי בצינור השקייה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]52[
]72[
]74[
]57[
15.06.2004
Int. Cl.(2010.01) A01G 03/00
MORDECHAI ELDAR
‫ אור יהודה‬,‫מרדכי אלדר‬
MORDECHAI ELDAR,
,‫מרדכי אלדר‬
12 ODEM ST.,
‫נוה סביון‬, 15 ‫רח' האודם‬
NEVE SAVYON,
‫אור יהודה‬
OR YEHUDA 60406
A cutting tool assembly (20) for forming a hole in a main plastic pipe (10) and for
inserting a connector (36) into the hole so as to connect the main pipe with a
subsidiary pipe, said tool assembly comprising: elongated shaft means (22) defined by
an upper portion and a lower portion, said upper portion suitable for applying pressure
on the shaft means substantially along its central axis so as to bring the lower portion
towards the pipe or to pull it from the pipe, said upper portion being suitable for
applying a rotational moment to the shaft means and said lower portion carrying
thereon a cutting tool (38) and the connector, a collar member (28), connected to the
lower portion of the shaft means with possibility for relative linear and rotational
displacement there between, a bias member (32) capable upon relief of the pressure to
remove the lower portion of the shaft means from the hole, wherein said cutting tool
which is secured on the lower portion of the shaft means is suitable upon applying
pressure to penetrate into the main pipe and upon applying rotational moment to make
the hole thereinto and said connector is deployed on the cutting tool with possibility
for advancing simultaneously with the cutting tool towards the hole and penetration
into the hole, while said connector is capable of retention within the hole when the
lower portion of the shaft means is pulled from the pipe.
__________________
]22[]12[
]54[
175
WEST NILE VIRUS AND DENGUE
TYPE 4 VIRUS NUCLEIC ACID
CHIMERA FOR USE IN A VIRAL
VACCINE TO PREVENT DISEASE
162949
‫כימרה של חומצת גרעין המורכב מוירוס הנילוס‬
‫ לשימוש‬2 ‫המערבי ווירוס קדחת דנגה מסוג‬
‫בתרכיב נגיפי למניעת מחלה הנגרמת ע"י וירוס‬
‫הנילוס המערבי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
CAUSED BY WEST NILE VIRUS
CAUSED BY WEST NILE VIRUS
]11[
]32[
]52[
]72[
]17[
]74[
]57[
09.01.2003
60/347281
]31[ 10.01.2002
]33[ US
Int. Cl.(2010.01) A61K 39/12, 39/295, A61P 01/12, 31/14, C07K 14/18, C12N 15/09,
15/40, 15/62, 15/86
THE WALTER REED ARMY
INSTITUTE OF RESEARCH, U.S.A.
THE GOVERNMENT OF THE
UNITED STATES OF AMERICA, AS
REPRESENTED BY THE
SECRETARY OF HEALTH AND
HUMAN SERVICES, U.S.A.
WO/2003/059384
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The present invention relates to attenuated, immunogenic West Nile virus chimeras
built on a dengue virus backbone for the production of immunogenic, live, attenuated
West Nile virus vaccines.
,18/111
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
SUCROSE STABILIZED ANTIINTERLEUKIN-6 RECEPTOR
ANTIBODY HPM-1 SOLUTIONS
]11[
]32[
14.02.2003
2002-36244
176
]31[
14.02.2002
163354
‫תמיסות המיוצבות ע"י סוכרוז המכילות נוגדן‬
6–‫ לרצפטור אנטי–אינטרלויקין‬hPM–1
]33[
JP
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
Int. Cl.(2010.01) A61K 09/08, 39/395, 47/08, 47/10, 47/12, 47/26, 47/34
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN
WO/2003/068260
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
Antibody-containing solution pharmaceuticals comprising a saccharide as a stabilizer.
These solution pharmaceuticals can further comprise a surfactant as another stabilizer.
__________________
]22[]12[
163452
]54[
R-(-)-1-[2-(7-CHLOROBENZO [B]
THIOPHEN-3-YL-METHOXY)-2(2,4-DICHLOROPHENYL)ETHYL]-1H -IMIDAZOLE, ITS
PREPARATION AND
PHARMACEUTICAL AND
AGRICULTURAL
COMPOSITIONS COMPRISING
THE SAME
]11[
]32[
]52[
]72[
04.02.2003
200200328
]31[ 11.02.2002
]33[ ES
Int. Cl.(2010.01) C07D 409/00
FERRER INTERNACIONAL, S.A.,
SPAIN
WO/2003/068770
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to R− (−) −1− [2− (7−Chloro−benzo [b] thiophen−3 − yl −
methoxy) −2− (2,4−dichloro−phenyl) −ethyl] −1H− imidazole and the salts thereof.
The invention also relates to compositions thereof and their use either for treating
fungal infections in humans and animals or combating crop diseases. A process for
their preparation is also described.
]17[
]74[
]57[
177
– 3 –‫] תיופן‬b[ ‫ –כלורובנזו‬R – (–) –1 –[2 –(7
–]‫ –דיכלורופניל)–אתיל‬4, 2(– 4 – )‫איל–מתוקסי‬
‫ הכנתו ותכשירים פרמצבטיים‬, ‫ –אימדאזול‬H1
‫וחקלאיים המכילים אותו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
163529
‫סינתזות של פוליקטיד מייצר ספינוזין‬
]54[
SPINOSYN-PRODUCING
POLYKETIDE SYNTHASES
]11[
]32[
]52[
]72[
]71[
19.02.2003
60/358075
]31[ 19.02.2002
]33[ US
Int. Cl.(2010.01) A01N 43/22, A61K 31/7048, C07H 17/08, C12N 15/52, C12P 19/62
DOW AGROSCIENCES LLC, U.S.A.
PAUL LEWER, PAUL R.
GRAUPNER, CLIVE WALDRON,
LESLEY S. BURNS, CHRISTINE J.
MARTIN, WILLIAM A. VOUSDEN,
BARRIE WILKINSON
WO/2003/070908
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention provides, biologically active spinosyns, hybrid spinosyn polyketide
synthases capable of functioning in Saccharopolyspora spinosa to produce the
spinosyns, and methods of controlling insects using the spinosyns.
]17[
]74[
]57[
,188112
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
MILKING CUP LINER
]11[
]52[
]72[
17.08.2004
Int. Cl.(2010.01) A01K 01/12
P. & P. MILKER LTD.
178
163585
‫ביטנה לגביע לחליבה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]74[
]57[
179
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
An elongated teat cup liner ( 1 ) located inside said teat cup, which is having a
proximal portion in communication to the milking vacuum system and the milk pail
and a distal portion in communication with the animal teat; said teat cup liner
comprising: a plurality of segments ( 1 f- 1 h) barriered by a means of one or more
rings ( 1 a); and, a vacuum duct comprising a plurality of vacuum valves ( 3 b- 3 d);
each of said valve is in communication with one or more rings and is adapted to
provide a reversible inflation/deflation of elastomeric rubber-like sleeve.
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫__________________‬
‫‪163868‬‬
‫תולדות המיאסטרליניות ותכשירי רוקחות‬
‫המכילים אותן‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫[‪]22[]12‬‬
‫‪HEMIASTERLIN DERIVATIVES‬‬
‫‪AND PHARMACEUTICAL‬‬
‫[‪]54‬‬
‫‪180‬‬
COMPOSITIONS COMPRISING
THEM
]11[
]32[
]52[
]72[
]17[
]74[
]57[
21.03.2003
60/366592
]31[ 22.03.2002
]33[ US
Int. Cl.(2010.01) A61K 38/00, A61P 35/00, C07K 05/027, 05/04, 05/065, 05/078,
05/087, 05/097
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2003/082268
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The present invention provides compounds having formula (I): (I) and additionally
provides methods for the synthesis thereof and methods for the use thereof in the
treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
__________________
]22[]12[
163981
‫שימוש בתכשיר רוקחי המכיל טסטוסטרון‬
‫להכנת תרופה לטיפול או מניעה בסיכון של‬
‫התפתחות מחלה דיכאונית‬
]54[
USE OF A TESTOSTERONE
COMPRISING
PHARMACEUTICAL
COMPOSITION IN THE
PREPARATION OF
MEDICAMENT FOR TREATING
OR PREVENTING THE RISK OF
DEVELOPING A DEPRESSIVE
DISORDER
]11[
]32[
14.03.2003
]31[ 15.03.2002
]33[ US
10/098232
21.05.2002
US
10/153468
Int. Cl.(2010.01) A61K 31/56, 47/00, 47/10, 47/14, 47/32, C07J 01/00
UNIMED PHARMACEUTICALS,
LLC, U.S.A.
]52[
]72[
181
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
LABORATORIES BESINS
INTERNATIONAL, S.A., FRANCE
WO/2004/091631
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to methods, kits, combinations, and compositions for
treating, preventing or reducing the risk of developing a depressive disorder, or the
symptoms associated with, or related to a depressive disorder in a subject in need
thereof. The present invention also related to a method of administering a steroid in the
testosterone synthetic pathway, for example testosterone, to a subject in need thereof.
In addition, the methods, kits, combinations and compositions may be used in
conjunction with other pharmaceutical agents including agents effective at treating,
preventing, or reducing the risk of developing a depressive disorder in a subject.
The applications for division
from this application have
not yet been published
,12//11
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
164127
‫אנלוגים של סומטוסטטין בעלי ציקליזציית שלד‬
‫הפעילים באור לטיפול פוטודינמי ולהדמיה‬
]54[
PHOTO-ACTIVE BACKBONE
CYCLIZED SOMATOSTATIN
ANALOGS FOR PHOTODYNAMIC
THERAPY AND IMAGING
]11[
]32[
]52[
]72[
]71[
19.03.2003
148921
]31[ 26.03.2002
]33[ IL
Int. Cl.(2010.01) A61K 38/16, 41/00, 49/00, C07K 07/64, 14/655
DEVELOGEN ISRAEL LTD.
‫ רחובות‬,‫דבלוגן ישראל בע"מ‬
THOMAS A. BONASERA, NURIT
‫ תמר יחזקאל‬,‫ יוסף סאליטרה‬,‫נורית ליבנה‬
LIVNAH, YOSEPH SALITRA,
TAMAR YEHEZKEL
WO/2003/079966
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
2 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
Novel photo-active labeled diagnostic and therapeutic peptides which are
conformationally constrained backbone cyclized somatostatin analogs, having
]17[
]74[
]57[
182
November 30, 2011-‫ד' בכסלו התשע"ב‬
improved somatostatin receptor subtype affinity and selectivity are disclosed. The
backbone cyclized peptide analogs disclosed possess unique and superior properties
over other analogs, such as chemical and metabolic stability, selectivity, increased
bioavailability and improved pharmacokinetics. Furthermore, the unique patterns of
receptor subtype selectivity provide compounds having improved diagnostic and
therapeutic utilities. Pharmaceutical compositions comprising the photo-active
backbone cyclized somatostatin analogs, reagents for synthesizing same, and methods
of using such compositions for diagnostic and therapeutic purposes including optical
imaging and photodynamic therapy are also disclosed.
__________________
]22[]12[
164536
‫שימוש בנגזרות של הידרוקסיפירידון להכנת‬
‫תכשירים רוקחיים לריפוי פצעים‬
]54[
USE OF HYDROXYPYRIDONEDERIVATIVES IN THE
PREPARATION OF
PHARMACEUTICALS FOR
WOUND HEALING
]11[
]32[
]52[
08.04.2003
02008902.5
]31[ 20.04.2002
]33[ EP
Int. Cl.(2010.01) A61K 31/122, 31/16, 31/4166, 31/4412, 31/721, A61P 17/02, C07D
213/89
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2003/088966
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to the use of compounds of the formula (I), in which R 1;
R2; R3 and R4 have the meanings indicated in the claims, for the treatment of wound
healing.
]72[
]17[
]74[
]57[
183
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
GRADIENT STRUCTURES
INTERFACING MICROFLUIDICS
AND NANOFLUIDICS, METHODS
FOR FABRICATION AND USES
THEREOF
]11[
]32[
16.04.2003
60/373409
]31[ 16.04.2002
419429741
2122121111
Int. Cl.(2010.01) B82B 01/00
PRINCETON UNIVERSITY, U.S.A.
WO/2003/106693
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
184
164602
‫מבני גרדיאנט הבאים במגע עם מיקרו–וננו‬
‫ שיטת ייצור ושימוש בהם‬,‫נוזלים‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a device for interfacing nanofluidic and microfluidic
components suitable for use in performing high throughput macromolecular analysis.
Diffraction gradient lithography (DGL) is used to form a gradient interface between a
microfluidic area and a nanofluidic area. The gradient interface area reduces the local
entropic barrier to anochannels formed in the nanofluidic area. In one embodiment, the
gradient interface area is formed of lateral spatial gradient structures for narrowing the
cross section of a value from the micron to the nanometer length scale. In another
embodiment, the gradient interface area is formed of a vertical sloped gradient
structure. Additionally, the gradient structure can provide both a lateral and vertical
gradient.
November 30, 2011-‫ד' בכסלו התשע"ב‬
The applications for division
from this application have
not yet been published
,121/21
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
164643
‫ תכשירים אימונולוגיים המכילים‬,‫פפטידים‬
‫אותם ושימוש בהם להכנת תרופות לטיפול‬
‫במחלת האלצהיימר‬
]54[
PEPTIDES, IMMUNOGENIC
COMPOSITIONS CONTAINING
THEM AND USE THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF ALZHEIMER'S
DISEASE
]11[
]32[
]52[
]72[
07.04.2003
60/373914
]31[ 19.04.2002
]33[ US
Int. Cl.(2010.01) A61K 38/03, 39/00, C07K 14/47
THE GOVERNING COUNCIL OF
THE UNIVERSITY OF TORONTO,
CANADA
PETER ST. GEORGE-HYSLOP,
JOANNE MCLAURIN
WO/2003/089460
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]71[
]17[
]74[
]57[
185
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬5116 .‫ד‬.‫ ת‬,
The present invention relates to immunogenic compositions and peptides comprising
residues 4-10 (FRHDSGY) of the amyloid peptide Abeta42. The invention further
relates to antibodies that bind to the Abeta(4-10) antigenic determinant. The invention
provides methods for treating Alzheimer's disease and for reducing the amyloid load in
Alzheimer patients. The invention also relates to methods for designing small molecule
inhibitors of amyloid deposition.
November 30, 2011-‫ד' בכסלו התשע"ב‬
,2///11
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
165086
‫ תרכובות רוקחיות‬, ‫פירידיל ציאנוגואנידינים‬
‫המכילות אותם והשימוש בהם להכנת תרופות‬
]54[
PYRIDYL CYANOGUANIDINES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF FOR
THE PREPARATION OF
MEDICAMENTS
]11[
]32[
]52[
]72[
]17[
]74[
15.05.2003
60/380836
]31[ 17.05.2002
]33[ US
Int. Cl.(2010.01) A61K 31/4425, A61P 29/00, 35/00, C07D 213/00, 213/72
LEO PHARMA A/S, DENMARK
WO/2003/097601
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
Pyridyl cyanoguanidine compounds of the general formula I wherein A, X 1, X2, X3,
Y1, Y2, Y3, R1, R2, R5, R6 and n are as indicated in the description are suitable as
prodrugs in human and veterinary therapy of proliferative diseases such as cancers.
__________________
]22[]12[
]54[
186
COMPOSITIONS COMPRISING
FLORFENICOL AND FLUNIXIN
OR A DERIVATIVE THEREOF
FOR TREATING INFECTION IN
CATTLE AND SWINE
165252
‫תכשירים המכילים פלורפניקול ופלוניקסין או‬
‫נגזרת שלו לטיפול בזיהום בבקר ובחזירים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
19.05.2003
60/382015
]31[ 20.05.2002
]33[ US
Int. Cl.(2010.01) A61K 31/00, 31/165, 31/455, C01B 04/00, C07C 233/12, 235/42,
255/52, 311/15, 317/14, 323/18, C07D 213/79, C07F 09/142
SCHERING-PLOUGH LTD.,
SWITZERLAND
WO/2003/097054
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Novel formulations combining a non-steroidal anti-inflammatory drug (NSAID) such
as flunixin, with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic
such as florfenicol as disclosed. Methods for using such formulations in the treatment
and prevention of infectious diseases of bovines and swine, including bovine
respiratory disease and swine respiratory disease, are also disclosed.
__________________
]22[]12[
]54[
PROCESS FOR PRESERVING
FRESH PRODUCE
]11[
]32[
04.06.2003
60/386574
]31[ 07.06.2002
419441294
2521221113
Int. Cl.(2010.01) A23B 07/022
MANTROSE-HAEUSER CO. INC.,
U.S.A.
WO/2003/104730
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
187
165320
‫תהליך לשימור תוצר טרי‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention pertains to methods of preserving fresh produce with a produce
preservative which extends the shelf life of fresh produce, particularly cut fresh
produce. The produce preservative preserves the texture, flavor, appearance, crispness,
and color of the fresh produce, particularly the exposed surface of the fresh produce.
The method comprises the following steps: providing a solution of produce
preservative comprising: water, magnesium ions or zinc ions or tin ions; and ascorbate
November 30, 2011-‫ד' בכסלו התשע"ב‬
ions, or erythorbate ions; wherein the magnesium ion or zinc ions or tin ions and
ascorbate ions are present in a mole ratio of preferably from 0.2:1 to 8:1, more
preferably from 0.75:1 to 8:1, more preferably from 1:1 to 4:1, most preferably 1.5:1 to
3:1, applying said produce preservative to the produce; applying said produce
preservative to the produce.
__________________
]22[]12[
165755
‫תכשיר ותמיסה המכילים פרומונים של ציפורים‬
‫ חרדה ואגרסיביות‬,‫ותהליך להפחתת מתח‬
]54[
COMPOSITION AND SOLUTION
COMPRISING AVIAN APPEASING
PHEROMONES AND A PROCESS
TO DECREASE STRESS, ANXIETY
AND AGGRESSIVENESS
]11[
]32[
19.06.2003
60/389768
]31[ 19.06.2002
]33[
1119253324
2921421111
Int. Cl.(2010.01) A61K 35/00, 35/55, 35/56
FIDELINE, FRANCE
WO/2004/000336
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
US
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Compositions comprising a mixture of fatty acids or derivatives thereof derived from
secretions of the uropygial glands of birds are disclosed. This composition, named an
avian appeasing pheromone, can be used to decrease stress, anxiety and aggressiveness
in birds.
__________________
]22[]12[
]54[
188
PROCESS FOR THE
PREPARATION OF 4-
166304
–1–‫–אזאנדרוסט‬2 ‫תהליך להכנתן של תולדות‬
β17 ‫–ון המותמרות בעמדה‬3–‫אן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
AZAANDROST-1-ENE-3-ONE
17BETA-SUBSTITUTED
DERIVATIVES
]11[
]32[
]52[
]72[
]17[
]74[
]57[
02.07.2003
1242/02
]31[ 16.07.2002
2375911
1121121111
1125913
1121221113
Int. Cl.(2010.01) C07J 73/00
SIEGFRIED GENERICS
INTERNATIONAL AG,
SWITZERLAND
WO/2004/007523
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
CH
CH
CH
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing 17ß-substituted 4-aza-androst-1-ene3-one compounds of the general formula (I), or a pharmaceutically approved salt
thereof by (A) introducing protective groups into the 3-keto-4-aza group of the
corresponding 1,2-dihydro compound, thereby producing a compound of the general
formula (III), (B) reacting the compound so obtained in the presence (i) of a
dehydration catalyst, and in the presence of (ii) optionally substituted benzoquinone,
allylethylcarbonate and/or allylpropylcarbonate, and, (C) removing the protective
groups R3 and R4 and optionally converting the compound so obtained to a salt.
__________________
]22[]12[
]54[
189
CELLULAR METHOD FOR
166345
‫שיטה תאית לזיהוי חומרים היכולים להשפיע‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫על הפעילות של מולקולת מטרה‬
IDENTIFYING SUBSTANCES
CAPABLE OF INFLUENCING THE
ACTIVITY OF A TARGET
MOLECULE
]11[
]32[
]52[
]72[
]17[
]74[
]57[
14.07.2003
10233516.8
]31[ 23.07.2002
]33[ DE
Int. Cl.(2010.01) C12Q 01/00, G01N 33/68
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/019036
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention concerns a cellular method for identifying substances capable of
influencing the activity of a target molecule, the cells to be analyzed bearing at least
one reporter gene and the activity of said target molecule affecting cell propagation.
Said method consists in contacting at least one cell with the substance to be tested, to
detect cell propagation and to detect the activity of the reporter gene product.
__________________
]22[]12[
166780
]54[
USE OF IKAPPAB-KINASE
INHIBITORS FOR PRODUCING
PHARMACEUTICALS FOR
TREATING PAIN
]11[
]32[
]52[
05.08.2003
10237723.5
]31[ 17.08.2002
]33[ DE
Int. Cl.(2010.01) A61K 31/403, 31/4184, A61P 25/04, 29/00, C07D 209/14, 235/18,
401/04, 403/04, 413/12, 413/14
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/022057
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to the use of IκB kinase inhibitors that are suitable for producing
medicaments for the treatment of pain. Suitable inhibitors are produced from
]72[
]17[
]74[
]57[
190
‫ להכנת‬IKAPPAB ‫שימוש במעכבי קינאז‬
‫תכשירים רפואיים לטיפול בכאב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
compounds of formulas (I) and (Ia).
__________________
]22[]12[
167391
‫תכשיר לטיפול בסימפטומים של איידס המכיל‬
‫תערובת תמציות צמחים‬
]54[
COMPOSITION COMPRISING A
MIXTURE OF PLANT EXTRACTS
FOR TREATING SYMPTOMS OF
AIDS
]11[
]32[
]52[
]72[
]17[
]74[
11.09.2003
10/241973
]31[ 12.09.2002
]33[ US
Int. Cl.(2010.01) A61K 35/00, 36/00, 36/22, 36/24, 36/89, A61P 31/18
WILLFRED-RAMIX, INC., U.S.A.
WO/2004/024071
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
An Aids and associated conditions related to Aids treating compositions is disclosed.
The compositions comprises: a medicament selected from an extract of at lease one of
the following plant families: (1.) Apocynaceae (Pleioscarpa Bicarpellata); (2)
Annonaceae (Cleistopholis Patens); (3) Dichapetalaceae (Dichapetehan Madagasca
Riense); (4) Annoceae (Uvaristrum Pierreanum); (5) Cynocynaceae (Strophantus
Gratus); (6) Asclepiadaceae (Gongronema Latifolium); (7) Combretaceae (Combretum
Racemosum); (8) Apocynaceae (Alsotonia boonei); (9) Amaranthaceae (Alternanthera
Pungens); (10) Aroceae (Anchomanes Differmis); (11) Cyperaceae (Seleria Voivinil);
(12) Anacardiaceae (Lannea Acida); (13) Bignoniaceae (Kigelia Africana); (14)
Bombacaceae (Ceiba Pentanota); (15) Anarcardiaceae (Antrocaryon Micraster); (16)
Bombacaceae (Bombax Bounopozense); (17) Anarcardiaceae (Spondias Mombin);
(18) Caricaceae (Carica Papaya); (19) a glyceryl ester of any of the foregoing extracts;
(20) a saponin of any of the foregoing extracts; (21) an alkaloid of any of the foregoing
extracts; (22) a protein of any of the foregoing extracts; (23) a fat of any of the
foregoing extracts; (24) a sugar of any of the foregoing extracts; and (25) any mixture
of any of the foregoing.
191
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
167621
‫תכשירים המכילים אוליגונוקליוטידים להורדת‬
‫ לטפול בסרטן‬HSP27 ‫כמות‬
]54[
COMPOSITIONS COMPRISING
OLIGONUCLEOTIDES FOR
REDUCTION OF HSP27 IN THE
TREATMENT OF CANCER
]11[
]32[
02.10.2003
60/415859
]31[ 02.10.2002
]33[ US
419443951
2121421113
US
Int. Cl.(2010.01) A61K 31/7088, 31/7125, 31/713, 48/00, A61P 35/00
THE UNIVERSITY OF BRITISH
COLUMBIA, CANADA
WO/2004/030660
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention makes use of therapeutic agents which target heat shock protein
(hsp) 27 in vivo to provide treatment to individuals, particularly human individuals,
suffering from prostate cancer and other cancers that overexpress hsp 27. In
accordance with the invention, a therapeutic agent, for example an antisense
oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp 27
mRNA, for example human hsp 27 mRNA, is administered to an idvidivual suffering
from prostate cancer or some other cancer expressing elevated levels of hsp 27 in a
therapeutically effective amount. The therapeutic agent is suitably formulated into a
pharmaceutical composition which includes a pharmaceutically aceptable carrier, and
packaged in dosage unit form. A preferred dosage unit form is in injectable dosage unit
form.
]52[
]72[
]17[
]74[
]57[
__________________
192
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
167898
‫–תיאדיאזול ותכשירים קוטלי‬1 ,4 ,2 ‫תרכובות‬
‫פרוקי רגליים המכילים את הנ"ל‬
]54[
1,2,4-THIADIAZOLE
COMPOUNDS AND ARTHROPOD
CONTROLLING COMPOSITIONS
CONTAINING THE SAME
]11[
]32[
]52[
]72[
28.10.2003
2002-337884 ]31[ 21.11.2002
]33[ JP
Int. Cl.(2010.01) A01N 43/836, C07D 285/08
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2004/046125
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention relates to a novel 1,2,4-thiadiazole compound represented by the
formula (1): wherein, R1 represents C3-C7 alkynyl that may be substituted with
halogen atom; R2 represents C3-C8 cycloalkyl which may be substituted with C1-C4
alkyl, halogen atom and trifluoromethyl or the like; A1 represents a single bond, C1C2 alkylene or C2-C3 alkylidene. The 1,2,4-thiadiazole compound has an excellent
arthropod controlling activity, and can effectively control an arthropod pests such as
insect pests, acarine pests and the like.
]17[
]74[
]57[
__________________
]22[]12[
168028
‫תכשיר המכיל אימונוגלובלין או קטע הימנו‬
‫המתחבר לאנטיגן‬
]54[
COMPOSITION CONTAINING AN
IMMUNOGLOBULIN OR AN
ANTIGEN BINDING FRAGMENT
THEREOF
]11[
]32[
]52[
]41[
]72[
10.10.1996
08/544404
]31[ 10.10.1995
]33[ US
Int. Cl.(2010.01) C07K 16/00, 16/28, C12N 05/20, 15/85
DIVISION FROM 124043
GENPHARM INTERNATIONAL
INC., U.S.A.
193
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/1997/013852
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to transgenic non-human animals capable of producing
heterologous antibodies and methods for producing human sequence antibodies which
bind to human antigens with substantial affinity.
__________________
]22[]12[
168119
]54[
N-ALKYL-4-METHYLENEAMINO3-HYDROXY-2-PYRIDONES,
PHARMACEUTICAL
COMPOSITIONS AND METHODS
FOR PREPARING THEM
]11[
]32[
]52[
07.11.2003
60/425070
]31[ 09.11.2002
]33[ US
Int. Cl.(2010.01) A61K 31/4412, 31/4427, A61P 31/04, C07D 213/69, 401/06,
401/12, 401/14, 405/12, 413/06, 417/06, 491/10
WARNER CHILCOTT COMPANY,
LLC, PUERTO RICO
WO/2004/043927
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
–4–‫–הידרוקסי‬3–‫–מתילנאמינו‬2–‫–אלקיל‬N
‫ תכשירים רוקחיים המכילים אותם‬,‫פירידונים‬
‫ושיטה להכנתם‬
Compounds of Formula (I) are effective in the treatment of a microbial infection.
__________________
194
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
168184
‫שימוש בתצמיד של ליגנד ופוטוסנסיטייזר‬
‫בשילוב עם חומר כימולומינסנטי להכנת תרופה‬
‫לטיפול פוטודינאמי‬
]54[
USE OF A LIGANDPHOTOSENSITIZER
CONJUGATE IN COMBINATION
WITH A CHEMILUMINESCENT
AGENT IN THE MANUFACTURE
OF A MEDICAMENT FOR
PHOTODYNAMIC THERAPY
]11[
]52[
]72[
21.04.2005
Int. Cl.(2010.01) A61K 41/00, 47/48
ARIEL-UNIVERSITY RESEARCH
‫חברה אוניברסיטאית למחקר ופיתוח‬-‫אריאל‬
AND DEVELOPMENT COMPANY
‫ אריאל‬,‫בע"מ‬
LTD.
MICHAEL A. FIRER, RAISA
‫ ראיסה לפטב‬,‫ פירר‬.‫מיכאל א‬
LAPTEV
WO/2006/111971
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A method for destroying harmful cells is provided, applicable in treating proliferative
diseases. The cells are destroyed by a combined treatment with a chemiluminescent
agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits
light on reacting with oxygen species present in situ, the conjugate binds to the cell
through its ligand and is activated by the emitted light, thereby destroying the cell. The
method is demonstrated on a conjugate of transferrin-hematoporphyrin, which
destroys cancerous cells in the presence of luminol.
]71[
]17[
]74[
]57[
__________________
]22[]12[
]54[
LIQUID EJECTION DEVICE
]11[
]32[
]52[
]41[
]72[
20.04.2000
PP9930
]31[ 22.04.1999
Int. Cl.(2010.01) B41J 02/005, 02/045
DIVISION FROM 145973
SILVERBROOK RESEARCH PTY.
195
168247
‫התקן פליטה נוזלית‬
]33[
AU
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
LTD., AUSTRALIA
WO/2000/064678
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method is disclosed for controlling liquid movement to and from a liquid ejection
device (1) (such as an ink jet printing device). The device has a nozzle chamber (2), a
liquid ejection aperture (4) in the nozzle chamber and a movable element (60) located
within the chamber for displacing liquid through the ejection aperture. The method
comprises displacing the movable element (60) so that it moves from a quiescent first
position to a liquid ejecting second position with a first average velocity, then
returning it from the second position to the first position with a second average
velocity which is lower than the first average velocity.
__________________
]22[]12[
168461
]54[
METHOD OF COMPENSATION
FOR EDDY CURRENT
DISTORTION IN AN AC
MAGNETIC TRACKING SYSTEM
]11[
]32[
08.05.2005
60/567385
]31[ 30.04.2004
]33[ US
229221511
1121421115
US
Int. Cl.(2010.01) G01B 07/004, 07/04
ALKEN, INC. D/B/A POLHEMUS,
U.S.A.
HERBERT R. JONES JR, ROBERT F.
HIGGINS, HENRY E. HIMBERG
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Techniques for removing distortion in an AC magnetic tracker identify a characteristic
frequency in the distortion environment which is then utilized to extract distortion
]52[
]72[
]71[
]74[
]57[
196
AC ‫שיטה לפיצוי עיוותי זרם מערבולת במערכת‬
‫מגנטית למעקב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
components from the tracker receiver signals so that the corrected position and
orientation can be calculated. A multiplicity of alternative techniques for determining
this characteristic frequency are disclosed, several of which can be done during
operation without interrupting system operation while others can be done off-line. The
invention also allows the use of a tuned tracker transmitter since it does not need to
operate at multiple frequencies. The invention differs from the prior art by treating an
extended conductor characteristic as just another unknown. The position and
orientation algorithm solves the 6 unknown coordinates of position and orientation
plus the one more unknown-the extended conductor characteristic frequency. This
enables the tracker to operate full time in one mode of operation without ever
suspending normal operation and without additional hardware capabilities.
__________________
]22[]12[
168779
‫שיטה ומפעל להתפלת מים המכילים מלח‬
]54[
METHOD AND PLANT FOR
DESALINATING SALTCONTAINING WATER
]11[
]32[
]52[
]72[
]17[
]74[
26.11.2003
1022059
]31[ 28.11.2002
]33[
Int. Cl.(2010.01) C02F 01/02, 01/04, 01/14
HANS JOSEF VAN ELS, GERMANY
WO/2004/048273
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Method and plant for desalinating salt-containing water, wherein the salt-containing
water is passed through a heat exchanger (5) disposed in a basin (1) containing brine,
whereupon the salt-containing water that has been heated in the heat exchanger (5) is
passed through an evaporator (9) for evaporating at least part of the salt-containing
water, after which the vapor thus formed is introduced into a condenser (12) so as to
obtain water from which the salt has been removed. The plant for desalinating saltcontaining water comprises a basin (1) that contains brine, in which a heat exchanger
(5) is disposed, wherein means (6) for supplying the water to be desalinated are
connected to an inlet of the heat exchanger (5), whilst an outlet of the evaporator (9) is
connected to means for condensing the water vapour that has been formed in the
evaporator (13, 12).
197
NL
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
168822
]54[
METHOD AND APPARATUS FOR
PROTEIN SYNTHESIS
MONITORING BASED ON
ELECTROMAGNETIC
RADIATION
]11[
]32[
]52[
]72[
]71[
]17[
]74[
27.11.2003
60/429532
]31[ 29.11.2002
]33[
Int. Cl.(2010.01) C12Q 01/00, G01N 33/68
ANIMA CELL METROLOGY, U.S.A.
ZEEV SMILANSKY
WO/2004/050825
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]57[
198
‫שיטה ומתקן לבקרה של יצירת חלבונים‬
‫המבוססים על קרינה אלקטרומגנטית‬
US
‫אנימה סל מטרולוג'י‬
‫זאב סמילנסקי‬
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬5116 .‫ד‬.‫ ת‬,
A method and a device are disclosed for monitoring the synthesis of proteins by the
ribosome in real time, in-vivo as well as in in-vitro. The ribosome is engineered to
carry a donor fluorophore, and tRNA and/or amino acids and/or some other part of the
ribosome are either engineered to carry acceptor fluorophores or else their natural
fluorescent properties are utilized as acceptors. As the ribosome mechanism processed
the mRNA and tRNA molecules and synthesizes a polypeptide chain, a light source
illuminates the ribosome, exciting the donor fluorophores and thereby the acceptor
fluorophores whenever these are in sufficient proximity to a donor. The resulting
signals are detected and used as a key for real-time database searching and
identification of the protein being synthesized. The resulting data can be tabulated and
interpreted in different ways. Figure (1) describes the propertires of a FRET pair and
the dependence of FRET on pair distance.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
169019
‫נגזרות מותמרות של פירולו–פירזול כמעכבי‬
‫קינז‬
]54[
SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVES AS
KINASE INHIBITORS
]11[
]32[
]52[
]72[
04.12.2003
60/434952
]31[ 19.12.2002
]33[ US
Int. Cl.(2010.01) A61K 31/4162, A61P 31/00, 35/00, C07D 487/04
NERVIANO MEDICAL SCIENCES
S.R.L., ITALY
WO/2004/056827
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Compounds represented by formula (Ia) or (lb) and wherein R and R 1 are as defined in
the description, and pharmaceutically acceptable salts thereof, are disclosed; the said
compounds are useful in the treatment of cell cycle proliferative disorders, e.g. cancer,
associated with an altered cell cycle dependent kinase activity.
]17[
]74[
]57[
The applications for division
from this application have
not yet been published
,12//21
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
BENZO[D]AZEPINE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR USE IN THE
TREATMENT OF
NEUROLOGICAL DISEASE OR A
PSYCHIATRIC DISORDER
]11[
18.12.2003
199
169091
‫ תכשירים רוקחיים‬,‫תולדות של בנזו[ד]אזפין‬
‫הכוללים אותן ושימושן בייצור תרופות לטיפול‬
‫במחלה נוירולוגיות או הפרעה פסיכיאטרית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]32[
]52[
]72[
]17[
]74[
]57[
0229820.6
]31[ 20.12.2002
]33[ GB
132141725
1121421113
GB
Int. Cl.(2010.01) A61K 31/55, A61P 25/26, 25/28, C07D 401/12, 403/12
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2004/056369
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to benzazepine derivatives of formula ( I ) wherein: R 1
represents -C3-7 cycloalkyl optionally substituted by C1-3 alkyl; having pharmacological
activity, processes for their preparation, to compositions containing them and to their
use in the treatment of neurological and psychiatric disorders.
__________________
]22[]12[
169100
‫הנדסה תלת מימדית של מבני רקמה באמצעות‬
‫התמיינות של תאי גזע עובריים‬
]54[
ENGINEERING THREEDIMENSIONAL TISSUE
STRUCTURES USING
DIFFERENTIATING EMBRYONIC
STEM CELLS
]11[
]32[
10.12.2003
60/432228
]31[ 10.12.2002
]33[ US
419443914
3221221113
US
219732471
1922121113
US
Int. Cl.(2010.01) A61L 27/18, 27/22, 27/38, C12N 05/0735
TECHNION RESEARCH AND
‫ חיפה‬,‫מוסד הטכניון למחקר ופתוח בע"מ‬
DEVELOPMENT FOUNDATION
LTD.
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY, U.S.A.
WO/2004/053096
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
200
A method of producing a tissue engineering construct. The method includes providing
a population of embryonic stem cells, seeding the embryonic stem cells on a cell
support matrix, and exposing the embryonic stem cells to at least one agent selected to
November 30, 2011-‫ד' בכסלו התשע"ב‬
promote differentiation of the stem cells along a predetermined cell lineage or into a
specific cell type. The step of exposing may be performed before or after the step of
seeding2
__________________
]22[]12[
169183
‫–אמינו–פניל‬4–‫אריל‬/‫תולדות אריל–קווינאזולין‬
‫ תכשירים רוקחיים הכוללים אותן‬,‫מתאנון‬
‫ושימושן בייצור תרופות לטיפול ומניעה של‬
‫מחלות עצם הקשורות בעליה בהתדלדלות של‬
‫סידן‬
]54[
ARYL-QUINAZOLINE/ARYL-2AMINO-PHENYL METHANONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE THEREOF
FOR THE MANUFACTURE OF
MEDICAMENTS FOR
PREVENTING AND TREATING
BONE CONDITIONS ASSOCIATED
WITH INCREASED CALCIUM
DEPLETION
]11[
]32[
]52[
22.12.2003
0230015.0
]31[ 23.12.2002
]33[ GB
Int. Cl.(2010.01) A61K 31/498, A61P 05/18, C07D 239/78, 239/82, 401/06, 401/12,
403/06, 403/10, 405/06, 409/06, 413/06, 413/10, 417/06
NOVARTIS AG, SWITZERLAND
WO/2004/056365
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
]72[
]17[
]74[
201
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A compound of formula (I): wherein R1, R2, R3 and Y are as defined herein, or a
pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful
for promoting the release of parathyroid hormone, e.g. for preventing or treating bone
conditions which are associated with increased calcium depletion or resorption or in
which stimulation of bone formation and calcium fixation in the bone is desirable.
__________________
]22[]12[
169189
]54[
ANALOG HPNA HUB AND
NETWORK INCLUDING ANALOG
HPNA HUB
]11[
]32[
]52[
]72[
18.12.2003
10/330703
]31[ 27.12.2002
]33[ US
Int. Cl.(2010.01) G06F 01/00, 01/06
COPPERGATE COMMUNICATIONS
‫ תל אביב‬,‫קופרגייט תקשורת בע"מ‬
LTD.
WO/2004/059896
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
Analog HPNA hub (404) including at least one group of coils (442, 452 (1), 452 (2),
]17[
]74[
]57[
202
‫ אנאלוגית ומערכת תקשורת‬HPNA ‫מרכזת‬
‫ אנאלוגית‬HPNA ‫הכוללת מרכזת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
452 (N), the coils inducing HPNA signals there between, a plurality of filters (454 (1),
454 (2), 454 (N), each of the filters coupled with a respective one of the coils and
further coupled, via respective telephone wiring (508 (1), 508 (2), 508 (N), with at
least a respective HPNA node, wherein each of the filters enables transmission of
HPNA data signals there through, and wherein each of the filters prevents transmission
of conventional telephony signals there through.
,18/18/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
169401
‫חיישן גופי בלתי יביל‬
]54[
IMMOBILIZABLE IN VIVO
SENSING DEVICE
]11[
]32[
]52[
]72[
]71[
]17[
]74[
25.12.2003
60/436003
]31[ 26.12.2002
]33[ US
Int. Cl.(2010.01) A61B 01/00
GIVEN IMAGING LTD.
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
GAVRIEL J. IDDAN, ZVIKA GILAD
‫ צביקה גלעד‬,‫גבריאל יוסף עידן‬
WO/2004/058041
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An in vivo sensing device (10) including an immobilizer (30) that may immobilize the
device in an in vivo location. The immobilizer may be activated by for example a
processor (20) or in response to an in vivo condition or in response to a signal (42)
from an outside operator.
]57[
203
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
169481
‫מוביל למשגר טילים‬
]54[
MOBILE CARRIER FOR A
PROJECTILE LAUNCHER
]11[
]52[
]72[
30.06.2005
Int. Cl.(2010.01) F41A 23/36
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]71[
]74[
EHUD DEKEL
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
A mobile projectile launcher (5), comprising: (a) a plurality of canisters (12) in each of
which projectiles to be launched are stored and fired; (b) a horizontal cargo bed (15);
(c) a front wall, rear wall, and side walls extending vertically from said cargo bed and
delimiting a volume in which said plurality of canisters are disposed; (d) at least one
tiltable launching platform (22) for supporting said plurality of canisters; (e) at least
one support plate (20) selected from the group of said front wall, rear wall and side
walls which is pivotally connected to said cargo bed, said at least one support plate
being made of a material which is resistant to projectile plume following launching
and sufficiently sturdy to support a person standing thereon; and (f) at least one linear
actuator for said at least one support plate by which said at least one support plate is
swingable from a closed position, wherein said at least one support plate is
substantially perpendicular to said cargo bed to an open horizontal position wherein
said at least one support plate is substantially parallel to said cargo bed, wherein said
at least one support plate is adapted to protect, shield and conceal loaded canisters
when set in a closed position, and is adapted to support a person during loading or
unloading of canisters, and when accessing a control system of said launcher and to
deflect projectile plume when set in an open position.
]57[
204
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫אהוד דקל‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
169769
‫תצמידים של אנטראציקלין–נוגדן‬
]54[
ANTHRACYCLINE-ANTIBODY
CONJUGATES
]11[
]32[
]52[
]72[
]17[
]74[
20.01.2004
60/442125
]31[ 24.01.2003
Int. Cl.(2010.01) A61K 39/395, 47/48
IMMUNOMEDICS, INC., U.S.A.
WO/2004/067038
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to therapeutic conjugates with the ability to target various
antigens. The conjugates contain a targeting antibody or antigen binding fragment
thereof and an anthracycline chemotherapeutic drug. The targeting antibody and the
chemotherapeutic drug are linked via a linker comprising a hydrazide moiety.
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
205
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
170461
–‫–פירידניל–דיהידרוספירו‬8' ‫נגזרות של‬
–6–‫]פירימידין‬a–4,1[–‫[ציקלואלקיל]–פירימידו‬
–‫'–פירימידניל–דיהידרוספירו‬8–‫ ו‬, ‫און‬
–6–‫] פירימידין‬a–1,4[‫]ציקלואלקיל[–פירימידו‬
‫און מותמרות ושימושיהן לטיפול בסוכרת בלתי‬
‫תלויה באינסולין‬
]54[
SUBSTITUTED 8'-PYRIDINYLDIHYDROSPIRO[CYCLOALKYL]-PYRIMIDO[1,2A]PYRIMIDIN-6-ONE AND 8'PYRIMIDINYL-DIHYDROSPIRO[CYCLOALKYL]-PYRIMIDO[1,2A]PYRIMIDIN-6-ONE
DERIVATIVES AND THEIR USE
FOR TREATING NON-INSULIN
DEPENDENT DIABETES
]11[
]32[
]52[
]72[
05.03.2004
03290569.7
]31[ 07.03.2003
]33[ EP
Int. Cl.(2010.01) A61K 31/519, A61P 03/00, 25/28, 35/00, C07D 487/04
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
SANOFI, FRANCE
WO/2004/078760
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a dihydrospiro-[cycloalkyl]-pyrimidone derivative represented
by formula (I) or a salt thereof: wherein: X represents two hydrogen atoms, a sulfur
atom, an oxygen atom or a C1-2 alkyl group and a hydrogen atom; Y represents a bond,
a carbonyl group, a methylene group optionally substituted; R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the ring being optionally substituted; R2
represents a benzene ring or a naphthalene ring; the rings being optionally substituted;
R3 represents a hydrogen atom, a C1-6 alkyl group or a halogen atom; m represents 1 to
4 n represent 0 to 3 p represents 0 to 2 q represents 0 to 2, p+ q being inferior to 4. The
invention relates also to a medicament comprising the said derivative or a salt thereof
as an active ingredient which is used for preventive and/or therapeutic treatment of a
neurodegenerative disease caused by abnormal activity of GSK3beta, such as
Alzheimer's disease.
]17[
]74[
]57[
__________________
]22[]12[
206
170507
November 30, 2011-‫ד' בכסלו התשע"ב‬
]54[
METHOD FOR PRODUCTION OF
A PHARMACEUTICAL
COMPOSITION IN THE FORM OF
FIBRATE-CONTAINING TABLETS
AND TABLETS PRODUCED BY
SAID METHOD
]11[
]32[
]52[
]72[
27.02.2004
03/02520
]31[ 28.02.2003
Int. Cl.(2010.01) A61K 31/216
SARL GALENIX INNOVATIONS,
FRANCE
WO/2004/078108
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
‫שיטה לייצור תכשירי רוקחות בצורת טבליות‬
‫המכילות פיבראט וטבליות המיוצרות בשיטה זו‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing a pharmaceutical composition
containing a fenofibrate active substance or one of the derivatives thereof, possibly
associated to a second active substance, in the form of tablets. The inventive method is
characterised in that it consists of a stage for compacting said active substance and
excipients by dry granulation.
__________________
]22[]12[
170527
‫ ותכשירי רוקחות‬5 ‫אינדזולים מותמרים בעמדה‬
‫המכילים אותם‬
]54[
INDAZOLES SUBSTITUTED AT 5POSITION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAME
]11[
]32[
25.02.2004
10/378164
]31[ 03.03.2003
]33[ US
219411149
2522121113
US
Int. Cl.(2010.01) A61K 31/416, 31/4162, 31/4745, A61P 35/00, C07D 231/56,
261/20, 401/14, 403/04, 413/12, 471/04
ARRAY BIOPHARMA, INC, U.S.A.
DEVAN BALACHARI, U.S.A.
]52[
]72[
]71[
207
MARK MUNSON, DAVID A.
MARESKA, YOUNGBOO KIM,
ROBERT GRONEBERG, JAMES
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
RIZZI, MARTHA RODRIGUEZ, GUY
VIGERS, CHANG RAO, DEVAN
BALACHARI, DARREN HARVEY,
GANHYEOK KIM
WO/2004/078116
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
1
7 JABOTINSKY ST.,
‫גן‬
‫רמת‬
RAMAT GAN 52520
This invention relates to inhibitors of p38, and methods for producing these inhibitors.
The invention also provides pharmaceutical compositions comprising the inhibitors of
the invention and methods of utilizing the inhibitors and pharmaceutical compositions
in the treatment and prevention of various disorders mediated by p38.
The applications for division
from this application have
not yet been published
,12//21,2//211
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
170590
‫ תכשיר רוקחי הכולל‬,‫אוטואנטיגן‬/‫מבנה נוגדן‬
‫אותו ושימושו בהכנת תרופה לטיפול במחלות‬
‫אוטואימוניות‬
]54[
ANTIBODY/AUTOANTIGEN
CONSTRUCT, COMPOSITION
COMPRISING THE SAME AND
USE THEREOF IN THE
PREPARATION OF A
MEDICAMENT FOR TREATING
AUTOIMMUNE DISEASES
]11[
]32[
04.03.2004
60/451816
]31[ 04.03.2003
]33[ US
419519511
2522121113
US
419541315
1121121114
US
Int. Cl.(2010.01) A61K 39/395, C07K 16/10, 16/28
ALEXION PHARMACEUTICALS,
INC., U.S.A.
WO/2004/091543
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Antibodies to antigen presenting cells may be utilized to interfere with the interaction
]52[
]72[
]17[
]74[
]57[
208
November 30, 2011-‫ד' בכסלו התשע"ב‬
of the antigen presenting cell and immune cells, including T cells. Peptides my be
linked to said antibodies thereby generating an immune response to such peptides.
Preferably peptides linked to the antibodies are associated with autoimmunity.
,12/2/1
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
SYSTEM FOR DELIVERING A
MEDICAL DEVICE TO A BODY
LOCATION
]11[
]52[
]72[
]74[
06.09.2005
Int. Cl.(2010.01) A61F 02/84
ALLIUM LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
170698
‫מערכת להובלת התקן רפואי לאתר בגוף‬
‫ קסריה פארק תעשיה‬,‫אליום בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]57[
i nandf rcr tflaafra g v ftahvl tfaahf dc v ecta
lchvdac hc ,rana g v n fvd , c f cr crf elvtfn v t v vhdevda g fh v an hv,velf
v t cr hvena g d f n fvd dc nlatf ,rcwa vllla v t ef nlad lc gadeta vlla ea d f elvtfn
2dc fw,cnf d f ftahvl tfaahf
209
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
170743
‫–ילמתיל אמיניות‬4–‫שימוש בתולדות פירידין‬
‫לייצור תרופה לטיפול בסימפטומים לכאב כרוני‬
‫ממקור ניורופתולוגי או פסיכוגני‬
]54[
USE OF PYRIDIN-2YLMETHYLAMINE
DERIVATIVES FOR THE
PRODUCTION OF A
MEDICAMENT FOR THE
TREATMENT OF CHRONIC PAIN
SYMPTOMS OF
NEUROPATHOLOGICAL OR
PSYCHOGENIC ORIGIN
]11[
]32[
]52[
15.03.2004
03/03099
]31[ 13.03.2003
]33[ FR
Int. Cl.(2010.01) A61K 31/445, A61P 25/04, C07D 401/12, 401/14, 405/14, 409/14,
413/14, 417/14
PIERRE FABRE MEDICAMENT,
FRANCE
WO/2004/083171
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
The invention relates to the use of a compound of formula (I) and the therapeuticallyacceptable salts thereof, more particularly where u = methyl, v and w = H, x = F, y =
Cl, z = F, A = H or aminomethyl and the pharmaceutically-acceptable addition salts
with mineral or organic acids, for the production of a medicament for the treatment of
chronic pain symptoms of neuropathological or psychogenic origin.
__________________
]22[]12[
]54[
210
SAMPLE MOUNTS FOR
MICROCRYSTAL
CRYSTALLOGRAPHY AND
METHOD OF MOUNTING A
CRYSTAL ON A SAMPLE MOUNT
170954
‫מעמדי דוגמיות לקריסטלוגרפיית‬
‫מיקרוקריסטלים ושיטת הצבת קריסטל על‬
‫מעמדי דוגמיות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
22.03.2004
60/455853
]31[ 20.03.2003
]33[ US
Int. Cl.(2010.01) G01N 23/20
CORNELL RESEARCH
FOUNDATION, INC., U.S.A.
WO/2004/094993
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Sample mounts (10) for mounting microcrystals of biological macromolecules for Xray crystallography are prepared by using patterned thin polyimide films (12) that have
curvature imparted thereto, for example, by being attached to a curved outer surface of
a small metal rod (16). The patterned film (12) preferably includes a tapered tip end
(24) for holding a crystal. Preferably, a small sample aperture is disposed in the film
for reception of the crystal. A second, larger aperture can also be provided that is
connected to the sample aperture by a drainage channel, allowing removal of excess
liquid and easier manipulation in viscous solutions. The curvature imparted to the film
(12) increases the film's rigidity and allows a convenient scoop-like action for
retrieving crystals. The polyimide contributes minimally to background and
absorption, and can be treated to obtain desired hydrophobicity or hydrophilicity.
__________________
]22[]12[
171067
]54[
OPTIMIZED EXPRESSION OF
HPV 31 L1 IN YEAST
]11[
]32[
]52[
]72[
19.03.2004
60/457172
]31[ 24.03.2003
]33[ US
Int. Cl.(2010.01) A61K 39/12, C07K 14/025, C12N 15/37, 15/81
MERCK SHARP & DOHME CORP.,
211
‫ בשמרים‬L1 31 HPV ‫ביטוי אופטימלי של‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
U.S.A.
WO/2004/084831
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically,
the present invention provides polynucleotides encoding HPV31 L1 protein, wherein
said polynucleotides are free from internal transcription termination signals that are
recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1
wherein the polynucleotides have been codon-optimized for high level expression in a
yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles
(VLPs), and to produce vaccines and pharmaceutical compositions comprising the
HPV31 VLPs. The vaccines of the present invention provide effective
immunoprophylaxis against papillomavirus infection through neutralizing antibody
and cell-mediated immunity2
__________________
]22[]12[
171133
‫וירוסים סטומטיטיס שלפוחיתיים מוטנטיים‬
‫ושימושם‬
]54[
MUTANT VESICULAR
STOMATITIS VIRUSES AND USE
THEREOF
]11[
]32[
]52[
]72[
29.03.2004
60/457591
]31[ 27.03.2003
]33[ US
Int. Cl.(2010.01) A61K 39/205, C07K 14/145, C12N 07/04, 15/47, 15/86
WELLSTAT BIOLOGICS
CORPORATION, U.S.A.
OTTAWA HOSPITAL RESEARCH
INSTITUTE, CANADA
JOHN C. BELL, BRIAN D. LICHTY,
DAVID F. STOJDL
WO/2004/085658
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
The present invention provides mutant viruses with a decreased ability to block nuclear
transport of mRNA or protein in an infected cell which are attenuated in vivo. The
mutant viruses of the present invention may also be capable of triggering the anti-viral
systems of normal host cells while remaining sensitive to the effects of these systems.
The present invention further provides for the use of the mutant viruses in a range of
applications including, but not limited to, as therapeutics for the treatment of cancer
November 30, 2011-‫ד' בכסלו התשע"ב‬
]71[
]17[
]74[
]57[
212
and infections, as vaccines and adjuvants, as viral vectors, and as oncolytic and
cytolytic agents for the selective lysis of malignant or infected cells.
__________________
]22[]12[
171339
‫תכשירים רוקחיים הכוללים מעכבי גלוטמיניל‬
‫ציקלאז והשימוש בהם להכנת תרופות לטיפול‬
‫באלצהיימר ובדאון סינדרום‬
]54[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
GLUTAMINYL CYCLASE
INHIBITORS AND THEIR USE
FOR PREPARATION OF
MEDICAMENTS FOR
TREATMENT OF ALZHEIMER'S
DISEASE AND DOWN SYNDROME
]11[
]32[
05.05.2004
60/468043
]31[ 05.05.2003
]33[ US
419441124
1521521113
US
419521131
2522121115
US
Int. Cl.(2010.01) A61K 31/4178, 31/4184, 31/4192, 31/4745, 38/00, A61P 25/28,
C12N 09/00
PROBIODRUG AG, GERMANY
WO/2004/098625
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
The present invention provides novel physiological substrates of mammalian
glutaminyl cyclase (QC, EC 2.3.2.5), new effectors of QC, methods for screeing for
such effectors, and the use of such effectors and pharmaceutical compositions
comprising such effectors for the treatment of conditions that can be treated by
modulation of QC-activity. Preferred compositions additionally comprise inhibitors of
DP IV or DP IV-like enzymes for the treatment or alleviation of conditions that can be
treated by modulation of QC- and DP IV-activity.
The applications for division
from this application have
not yet been published
,12/1/8,18/88/
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
213
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
171513
‫דיהידרוצינאזולינים מותמרים בעלי תכונות‬
‫ תכשירי רוקחות המכילים אותם‬,‫אנטי ויראליות‬
‫והכנתם‬
]54[
SUBSTITUTED
DIHYDROCHINAZOLINES
HAVING ANTIVIRAL
PEROPERTIES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR
PREPARATION
]11[
]32[
]52[
]72[
17.04.2004
10319612.9
]31[ 02.05.2003
]33[ DE
Int. Cl.(2010.01) A61K 31/517, A61P 31/22, C07D 239/84, 403/04
AICURIS GMBH & CO.KG,
GERMANY
WO/2004/096778
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]17[
]74[
]57[
The invention relates to substituted dihydrochinazolines of formula (I), methods for the
production thereof, and the use thereof for producing medicaments used for treating
and/or preventing diseases, particularly as antiviral agents, especially against
cytomegaloviruses.
__________________
]22[]12[
]54[
METHOD AND SYSTEM FOR
MOTION IMPROVEMENT
]11[
]32[
]52[
]72[
]17[
]74[
02.05.2004
60/466464
]31[ 30.04.2003
Int. Cl.(2010.01) A24C 05/47
BIOXTREME LTD.
WO/2004/096501
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
214
171514
‫שיטה ומערכת לשיפור תנועה‬
]33[
US
‫ אשקלון‬,‫ביואקסטרים בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
‫רמת החייל‬
A method and system are presented for improving the object's motion. Data indicative
of a measured motion of the object is processed, and a relation between the measured
motion and a predetermined correct motion is determined. This relation is indicative of
an error in the measured motion. Based on the determined error, an operating signal
may be generated to be used to apply an effecting force to the object. The operating
signal is such that the effecting force, when applied to the object, will increase a value
of the error in the object's motion.
__________________
]22[]12[
171651
‫שימוש בפפטיד עבור הייצור של‬
‫נוגדנים עבור טיפול במחלת אלצהיימר‬
]54[
USE OF A PEPTIDE FOR THE
PRODUCTION OF ANTIBODIES FOR THE
TREATMENT OF ALZHEIMER'S DISEASE
]11[
]32[
]52[
]72[
]17[
]74[
03.05.2004
P200301054 ]31[ 08.05.2003
]33[
ES
Int. Cl.(2010.01) A61K 38/17, 39/00, 39/385, A61P 25/28
ARACLON BIOTECH, S.L., SPAIN
WO/2004/098631
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The invention relates to antibodies which are used in the preparation of a medicament
for the treatment of Alzheimer's disease. More specifically, the invention relates to the
use of an antibody specifically recognising any one of the predominant variants of the
amyloid beta peptide, Ab40 and Ab42, in the preparation of a medicament that is used to
prevent and/or treat Alzheimer's disease 2
]57[
215
November 30, 2011-‫ד' בכסלו התשע"ב‬
The applications for
division from this
application have not yet
been published
,181222,181228,18121/,181212,181211,18121/,18121/
‫בקשות‬
‫חלוקה‬
‫מבקשה זו‬
‫שטרם‬
0‫פורסמו‬
__________________
]22[]12[
171686
‫ תהליך להכנתן ושימושן‬,‫נגזרת בנזותיאזול‬
‫בהכנת תרופות לטיפול במחלות הקשורות‬
‫לקולטן אדנוזין‬
]54[
BENZOTHIAZOLE DERIVATIVES,
PROCESSES FOR THEIR
PREPARATION AND USES
THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF ADENOSINE
RECEPTOR RELATED DISEASES
]11[
]32[
]52[
]72[
14.05.2004
03011039.9
]31[ 19.05.2003
]33[ EP
Int. Cl.(2010.01) A61K 31/428, A61P 25/28, C07D 417/14, 419/10
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/000842
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to compounds of the general formula (I) wherein R 1 is 1,4dioxepanyl or tetrahydropyran-4-yl; R 2 is -N(R)-(CH2)n,-5-or 6 membered non
aromatic heterocycle, optionally substituted by one or more substituents, selected from
the group consisting of lower alkyl or -NR2, or is - (CH2)n-5-or 6 membered non
aromatic heterocycle, optionally substituted by -(CH2)n-OH, lower alkyl, lower alkoxy,
or is -CH2)n-5-or 6 membered aromatic heterocycle, optionally substituted by lower
alkyl, lower alkoxy, halogen, halogen-lower alkyl, -CH2N(R)(CH2)20CH3, N(R)(CH2)20CH3, -CH2-morpholinyl or -CH2-pyrrolidinyl or is (CH2)n-cycloalkyl,
optionally substituted by hydroxy, or is -N(R)-cycloalkyl, optionally substituted by
hydroxy or lower alkyl, or is phenyl, optionally substituted by lower alkoxy, halogen,
halogen-lower alkyl, lower alkyl, -CH2-pyrrolidin-1-yl, -CH2-morpholinyl, CH2N(R)(CH2)20CH3 or -CH2-N(R)C(O)-lower alkyl, or is 1,4-dioxa-8-azaspiro[4,5]decane, or is 2-oxa-5-aza-bicyclo[2.2.1]heptane, or is I-oxa-8-azaspiro[4,5]decane, or is -N(R)-7-oxa-bicyclo [2.2. 11 hept-2-yl, or is 2-azabicyclo[2.2.2]decane; R is hydrogen or lower alkyl; n is 0 or 1; and pharmaceutically
acceptable acid addition salts thereof for the treatment of diseases, which relate to the
A2A receptor.
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
216
__________________
]22[]12[
171913
‫שיטה לאנליזה כרומטוגרפית של תמיסת חלבון‬
]54[
METHOD OF
CHROMATOGRAPHIC ANALYSIS
OF A PROTEIN SOLUTION
]11[
]32[
]52[
]72[
18.05.2004
03101458.2
]31[ 21.05.2003
]33[ EP
Int. Cl.(2010.01) C07K 01/16, 01/20, 09/00, 14/555, 14/59
ARES TRADING S.A.,
SWITZERLAND
CARLO EMMANUELE GIARTOSIO,
REINOUD DRIEBERGEN, PIERRE
LEPAGE, GIUSEPPE ARPAIA,
MARCO BERARDI, ENRICO
CHAVEZ
WO/2004/104025
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
An improved method of chromatographic analysis of protein samples is disclosed in
which a Pluronic surfactant is used.
]71[
]17[
]74[
]57[
__________________
]22[]12[
]54[
217
FROZEN CONFECTION AND
172322
‫רקיחה מוקפאת ותהליך ליצורה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PROCESS FOR
MANUFACTURING SUCH
]11[
]32[
]52[
]72[
]74[
]57[
01.12.2005
04258086.0
]31[ 23.12.2004
Int. Cl.(2010.01) A23G 09/00
UNILEVER PLC, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A low-calorie frozen confection is provided which is substantially free from nonsaccharide sweeteners. The frozen confection comprises total sugar in an amount of
less than 14.5% by weight and digestible complex saccharides in an amount of from 7
to 30% by weight. The total sugar comprises at least 4% fructose by weight of the
frozen confection. Also provided is a process for manufacturing the frozen confection.
__________________
]22[]12[
172451
‫מרכיבים מבור קרביד עם צפיפות גבוה‬
]54[
HIGH DENSITY BORON CARBIDE
COMPONENTS
]11[
]32[
]52[
]72[
14.06.2004
60/478045
]31[ 12.06.2003
]33[ US
Int. Cl.(2010.01) C04B 35/563, 35/64
GEORGIA TECH RESEARCH
CORPORATION, U.S.A.
WO/2004/110685
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
High-density components and products as well as processes for making high-density
components and products are disclosed. One exemplary component, among others,
includes a boron carbide component comprised of a homogeneous boron carbide
powder. The component has at least a 93% relative density (RD) and a Vickers
hardness of at least 2000kg/mm2.
]17[
]74[
]57[
__________________
218
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
172466
‫הרכב רוקחי למניעת היריון וטיפול חלופי‬
‫הורמונאלי‬
]54[
PHARMACEUTICAL
FORMULATION FOR
CONTRACEPTION AND
HORMONE-REPLACEMENT
THERAPY
]11[
]32[
]52[
]72[
]17[
]74[
10.06.2004
60/477939
]31[ 13.06.2003
Int. Cl.(2010.01) A61K 09/16
JOHN CLAUDE SAVOIR, MEXICO
WO/2004/110408
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention provides slow release estradiol-progesterone formulations that
can be used in either contraception or hormone replacement therapies. The
formulations comprise shaped particles of estradiol that is in a hemicrystalline form
that exhibits especially low dissolution rates. The shaped particles comprise estradiol
compounded in a 1:1 molar ratio with cholesterol, and are administered in combination
with progesterone. The slow release formulations of the present invention afford the
dual advantages of a low dose estradiol formulation with a low frequency
administration regimen. The formulations can be parenterally administered once a
month or less often.
The applications for division
from this application have
not yet been published
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
,1282/2
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
219
172480
November 30, 2011-‫ד' בכסלו התשע"ב‬
]54[
METHOD FOR AUTOMATIC
DETECTION AND
CLASSIFICATION OF OBJECTS
AND PATTERNS IN LOW
RESOLUTION ENVIRONMENTS
]11[
]52[
]72[
08.12.2005
Int. Cl.(2010.01) G06K 09/46
AMIR ZAHAVI
SHAI NISSIM
]74[
]57[
‫שיטה לגילוי וסיווג אוטומטיים של אובייקטים‬
‫ודוגמאות בתוך סביבה של רזולוציה נמוכה‬
‫ פתח תקוה‬,‫אמיר זהבי‬
‫ אביב‬-‫ תל‬,‫שי ניסים‬
SIMON KAHN,
,‫סיימון קאהן‬
P.O.B. 34598, JERUSALEM
‫ירושלים‬24561 .‫ד‬.‫ ת‬,
A method of automatically detecting and classifying objects, the method comprising:
(a) providing an original image comprising one or more objects; (b) creating a new
image of each of said objects isolated from all other objects of said original image by
performing a process of image separation; (c) extracting geometrical characteristics of
the object from the new image, and storing them in a feature vector; (d) transforming
at least one of said new images of said isolated object into a vector using at least one
of erasing and shifting, wherein said transforming comprises reading the pixels of the
new image vector by vector, where said vector contains information of said isolated
object, and said vector comprises at least one consecutive background pixel for each
vector of the at least one new image; (e) applying a one Dimensional Continuous
Wavelet Transform to said vector; (f) extracting from said one Dimensional
Continuous Wavelet Transform, both the scale, and coefficient values of said isolated
object and storing said extracted values in said feature vector; (g) comparing said
feature vector to at least one other feature vector from a data base; and (h) classifying
each of said one or more objects responsive to said comparing of said feature vector.
__________________
]22[]12[
]54[
]11[
]32[
]52[
220
INTRODUCING VOIDS INTO
POLYMERIC MATERIAL FOR
BUFFERING ONE OR MORE
STRESS SENSITIVE
COMPONENTS FROM ONE OR
MORE STRESSES
17.06.2004
10/600984
]31[ 20.06.2003
Int. Cl.(2010.01) G02B 06/04
172640
‫הכנסת חללים לתוך חומר פולימרי לבלימת‬
‫זעזועים באחד או יותר רכיבים הרגישים ללחץ‬
‫מאחד או יותר לחצים‬
]33[
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
NORTHROP GRUMMAN
GUIDANCE AND ELECTRONICS
COMPANY, INC., U.S.A.
WO/2004/113840
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A plurality of voids are introduced into a polymeric material. One or more stress
sensitive components in abutment with a portion of the polymeric material are buffered
from one or more stresses through employment of the portion of the polymeric
material that comprises one or more voids of the plurality of voids. A movement of the
portion of the polymeric material is accommodated through compression of one or
more of the one or more voids.
__________________
]22[]12[
172844
‫תהליך לייצור חלבונים השוקעים בקור הכולל‬
‫שלב השבתה של וירוס‬
]54[
PROCESS FOR OBTAINING
CRYOPRECIPITABLE PROTEINS
INCLUDING A VIRUS
INACTIVATION STEP
]11[
]32[
]52[
]72[
08.07.2004
03/08403
]31[ 09.07.2003
]33[ FR
Int. Cl.(2010.01) A61K 09/19, 38/36, 47/12, 47/18, C07K 01/30, 14/745
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES, FRANCE
WO/2005/004901
]17[
221
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to a method for obtaining cryoprecipitatable proteins, comprising
a viral inactivation step by thermally treating a lyophilisate of these proteins,
comprising, before rendering the proteins in the form of a lyophilisate, an initial
addition step, to these proteins, of a stabilizing and solubilizing formulation containing
a mixture consisting of arginine, at least one hydrophobic amino acid and of tribasic
sodium citrate. The invention also relates to a concentrate consisting of at least one
cryoprecipitable protein containing the stabilizing and solubilizing formulation
introduced according to the method and being suited for therapeutic use2
__________________
]22[]12[
]54[
WIRELESS COMMUNICATION
METHOD AND APPARATUS
COORDINATING NODE-BS AND
SUPPORTING ENHANCED
UPLINK TRANSMISSIONS
DURING HANDOVER
]11[
]32[
29.10.2004
60/517656
]31[ 05.11.2003
419529991
2422221113
419511491
2722221113
419571474
2121421114
219941711
2122121114
Int. Cl.(2010.01) H04W 36/08, 36/12
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2005/048503
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
222
173216
‫שיטה ומתקן לתקשורת אלחוטית המתאמים‬
‫ ותומכים בתשדורות משופרות‬B ‫צמתים מסוג‬
‫מסוג אפלינק במהלך העברה‬
]33[
US
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A wireless communication method and apparatus for coordinating Node-Bs during
handover for enhanced uplink (EU) transmission. In one embodiment, a radio network
controller (RNC) initiates an inter-Node-B soft handover. A wireless transmit/receive
unit (WTRU) establishes communication connections with a plurality of Node-Bs. A
particular one of the Node-Bs is designated as being a primary Node-B, and each of
other Node-Bs are designated as being a non-primary Node-B. The RNC informs all
November 30, 2011-‫ד' בכסלו התשע"ב‬
of the Node-Bs that the particular Node-B is a primary Node-B. The primary Node-B
schedules EU transmission and performs ACK/NACK during soft handover. In
another embodiment, the RNC initiates a hard handover for a WTRU connected to a
source Node-B. The RNC sends an activation timer to the source Node-B to set the
time for handover. As many previously negatively acknowledged (NACKed) data
packets as possible are prioritized for retransmission in the source Node-B before the
activation timer expires.
__________________
]22[]12[
173276
‫מקלט בעל תפקוד שחזור תזמון ספרתי‬
]54[
RECEIVER HAVING DIGITAL
TIMING RECOVERY FUNCTION
]11[
]32[
22.01.2006
10-2005]31[ 29.03.2005
]33[ KR
26146
Int. Cl.(2010.01) H04L 07/033
SAMSUNG ELECTRO-MECHANICS
CO. LTD., REPUBLIC OF KOREA
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a receiver having a digital timing recovery function. The
receiver of the invention detects frequency offset of a received signal by using symbol
correlation between the received signal and a reference signal, and increases/decreases
the number of data samples according to the detected frequency offset, thereby
recovering symbol timing of the received signal.
]52[
]72[
]74[
]57[
__________________
223
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
173288
‫שיטה והתקן לגילוי וזיהוי של ריקמה‬
‫ביאולוגית‬
]54[
METHOD AND DEVICE FOR THE
DETECTION AND
CHARACTERIZATION OF
BIOLOGICAL TISSUE
]11[
]32[
]52[
]72[
]71[
]17[
]74[
28.07.2004
0309256
]31[ 28.07.2003
]33[ FR
Int. Cl.(2010.01) A61B 05/00
SOPRO, FRANCE
ALAIN MAZUIR, FRANCIS DIERAS
WO/2005/011486
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method for detection and location of a difference in density
and/or structure and/or chemical composition of a biological tissue (7) which is
subjected to continuous illumination in a first determined band of frequencies, causing
the former to generate a phenomenon of fluorescence, autofluorescence or
luminescence in a second band of frequencies. Said method is characterized in that it
comprises the following stages: the biological tissue thus illuminated is visually
captured by colour video means provided with image sensors with a mosaic of pixels
provided with additional colour filters; for each image point thus obtained 1)
information relating to the energy received by each pixel is collected in order to
reconstitute an image of the biological tissue (7), b) amplification occurs for the signal
corresponding to the energy received in the second frequency band in order to
characterize the biological tissue (7) difference or to cause the image thus obtained to
appear.
]57[
__________________
]22[]12[
]54[
224
SYSTEM FOR PERFORMING FLUID
ADMINISTRATION
173444
‫מערכת להחדרת נוזלים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
02.08.2004
PCT/CH03/000528 ]31[ 31.07.2003
Int. Cl.(2010.01) A61M 01/28, F04B 43/08
DEBIOTECH S.A., SWITZERLAND
FREDERIC NEFTEL, FLORENT JUNOD,
DIDIER VECTEN
WO/2005/009512
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]33[
CH
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11
‫רמת גן‬
The invention concerns a system and a method of use of said system for performing
fluid administration on a patient, the system comprising : a liquid pump (1), a liquid
distribution system (2) connected to said pump (1) in such a way that liquid can flow
from the liquid distribution system (2) to the pump (1) and vice versa, liquid supply
means (3) for supplying liquid to a patient (4) via said liquid distribution system (2)
and said pump (1), a patient conduit (5) adapted for connecting said liquid distribution
system (2) to a patient (4), the system being characterized by the fact that said liquid
pump (1) is unidirectional and that said liquid distribution system (2) comprises
switching means designed to alternatively connect the pump enter line (56) with the
supply means (3) or with the patient conduit (5).
__________________
]22[]12[
]54[
225
CAPSICUM ANNUUM PLANT
173566
‫צמח קפסיקום אנום המייצר פירות המציגים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מסוגלות לאחסון ממושך‬
PRODUCING FRUITS
EXHIBITING EXTENDED
STORABILITY
]11[
]32[
]52[
]72[
]17[
]74[
]57[
13.08.2004
60/495774
]31[ 15.08.2003
]33[ US
Int. Cl.(2010.01) A01H 05/08
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2005/015984
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to novel plants, in particular to Capsicum annuum plants
capable of producing fruits with extended storability after full coloring of the fruit, and
to seeds and fruits of said plants. The present invention also relates to methods of
making and using such plants and their fruits. In particular, fruits of plants of the
present invention retain marketability over extended periods of time compared to
presently available peppers.
__________________
]22[]12[
173593
‫נגזרות קווינזולין כמעכבי הקולטן לתירוזין‬
‫קינאז‬
]54[
QUINAZOLINE ANALOGS AS
RECEPTOR TYROSINE KINASE
INHIBITORS
]11[
]32[
10.08.2004
10/642440
]31[ 14.08.2003
]33[ US
419552721
2121321114
US
Int. Cl.(2010.01) A61K 31/517, A61P 35/00, C07D 413/14, 417/14, 498/04, 498/10
ARRAY BIOPHARMA, INC., U.S.A.
WO/2005/016346
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
This invention provides quinazoline analogs of Formula (I): where A is bonded to at
least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is
substituted by up to two independent R3 groups. The invention also includes methods
of using compounds of Formula (I) as type I receptor tyrosine kinase inhibitors and for
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
226
the treatment of hyperproliferative diseases such as cancer.
__________________
]22[]12[
]54[
IN VITRO ENRICHED
POPULATION OF GABAERGIC
NEURONS FOR USE IN CELL
THERAPY
]11[
]32[
02.09.2004
901/MUM/2003 ]31[ 03.09.2003
419557195
3221321114
Int. Cl.(2010.01) C12N 15/06
RELIANCE LIFE SCIENCES PVT.
LTD., INDIA
WO/2005/021704
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
173889
‫אוכלוסיה חוץ גופית מועשרת של תאי עתב‬
‫ לשימוש בטיפול תאי‬GABAergic
]33[
IN
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present disclosure is directed to improved methods for efficiently producing
neuroprogenitor cells and differentiated neural cells such as GABAergic neurons from
pluripotent stem cells, for example embryonic stem cells. Using the disclosed methods,
cell populations containing a high proportion of GABAergic neurons have been
isolated. The neuroprogenitor cells and terminally differentiated cells of the present
disclosure can be generated in large quantities, and therefore may serve as an excellent
source for cell replacement therapy in neurodegenerative disorders and neuronal
diseases such as stroke, ischemia, epilepsy, and Huntington's disease.
__________________
]22[]12[
227
173993
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מערכת רבב וידיאו מתקדמת ומסתגלת‬
]54[
ADVANCED, ADAPTIVE VIDEO
MULTIPLEXER SYSTEM
]11[
]32[
]52[
]72[
]17[
]74[
27.08.2004
60/449043
]31[ 29.08.2003
]33[ US
Int. Cl.(2010.01) H04N 01/193
RGB NETWORKS, INC., U.S.A.
WO/2005/022796
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An advanced multiplexer designed and optimized for next generation on-demand video
distribution is described. Features and capabilities include auto-discovery, channelstaggering and compatibility with static Virtual Channel Tables (VCTs). The
multiplexer system facilitates auto-discovery by inserting identifiers into MPTSs
(Multi-Program Transport Streams). These identifiers are echoed back to the
multiplexer by the client set-top (570’x’) thereby indicating correspondence between
modulators (552), service groups, and clients (570’x’). When modulating multiple
channels, FEC frames (Forward Error Correction frames) are staggered across
channels to reduce correlation and clipping in the IFFT processor (770).
]57[
__________________
]22[]12[
]54[
HANDOVER METHOD AND
APPARATUS
]11[
]32[
]52[
]72[
]17[
]74[
11.08.2004
10/674254
]31[ 29.09.2003
Int. Cl.(2010.01) H04W 36/14
MOTOROLA, INC., U.S.A.
WO/2005/036797
REINHOLD COHN AND PARTNERS,
228
174173
‫שיטה והתקן למסירה והעברה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A method (FIG. 11) and corresponding wireless communication unit (102, FIG. 5) and
mobility manager (116, FIG. 6) for facilitating a handover from one communication
network (106) to another communication network (108) of an ongoing communication
(120, 122) between a wireless communication unit (102) and a peer communication
unit (114, 714). The method including obtaining call information (1103) corresponding
to the ongoing communication where the ongoing communication uses the first
communication network; and ascertaining a handover number (1105) for use by the
wireless communication unit to originate a handover call (1107) via the second
network (108), the handover number terminating within the first communication
network for use in facilitating the handover of the ongoing communication to the
second communication network.
__________________
]22[]12[
]54[
MESSAGE SECURITY
]11[
]32[
13.09.2004
0302456-9
]31[ 12.09.2003
419511154
2121921113
1411131-1
1421121114
Int. Cl.(2010.01) H04L 09/12
SECURED EMAIL GOTEBORG AB,
SWEDEN
WO/2005/027404
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
229
174176
‫אבטחת הודעה‬
]33[
SE
US
SE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a method of transmitting an electrical message,
preferably an email from a first user having a first terminal to a second user having a
November 30, 2011-‫ד' בכסלו התשע"ב‬
second terminal, comprising the steps of: transmitting said email in an encrypted form
by said first terminal, said encrypted e-mail being encrypted by means of a key
generated by a first key generator using a seed, providing once said second user with
said seed for generating a key with a second key generator provided in said second
terminal, providing to and storing said seed in said second terminal, using said seed by
said second terminal for generating a key each time an encrypted email from said first
user to said second user is received, synchronising a counting value in each terminal;
and generating said key on the basis of said seed and a counting value in each terminal,
independently of other terminal.
__________________
]22[]12[
174331
‫שיטה ומערכת למתן התראות על התנגשות‬
‫קרובה בין כלי רכב‬
]54[
METHOD AND SYSTEM FOR
PROVIDING WARNINGS
CONCERNING AN IMMINENT
VEHICULAR COLLISION
]11[
]32[
]52[
]72[
]17[
]74[
15.09.2004
60/502942
]31[ 16.09.2003
]33[ US
Int. Cl.(2010.01) G06K 01/00, G08G 01/16
ZVI SHILLER
‫ קריית אונו‬,‫צבי שילר‬
WO/2005/027076
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Method for transmitting a warning signal to a driver of a driven vehicle regarding an
impending collision with a moving and/or stationary object in the vicinity of the driven
vehicle. The method comprises the following steps of providing the driven vehicle
with means for obtaining updated data regarding, position, velocity vector and
predicted moving path of the objects; selecting a series of one or more time horizons
having decreasing or increasing duration; for the longest of the selected time horizons:
]57[
230
November 30, 2011-‫ד' בכסלו התשע"ב‬
generating a linear velocity object (LVO) and/or non-linear velocity object (NLVO) of
each of the objects; selecting a sampling time interval dt, during which an LVO and/or
NLVO is generated; determining a range of feasible velocity vector changes for the
driven vehicle that are attainable within a performance time interval dT; repeatedly
providing the driver, after each dt, with information regarding feasible velocity vector
changes for the performance time interval; sensing, estimating or assuming dynamic
changes parameters representing the movement of the driven vehicle within the
performance time interval, and whenever required, generating a warning signal with an
escalating severity level that reflects the relative imminence of collision with the
objects and that corresponds to the longest time horizon; repeating the steps above,
while each time generating an updated LVO and/or NLVO for a subsequent sampling
time interval, until reaching another selected time horizon which is shorter than a
previously selected time horizon and another selected time horizon, until collision is
unavoidable.
__________________
]22[]12[
174552
‫מיתקן הדמיה תוך גופי ושיטה לייצורו‬
]54[
IN VIVO IMAGING DEVICE AND
METHOD OF MANUFACTURE
THEREOF
]11[
]32[
26.03.2006
60/436004
]31[ 26.12.2002
]33[ US
PCT/IL03/001105
1522121113
WO
229194153
3221321115
US
Int. Cl.(2010.01) A61B 05/05
GIVEN IMAGING LTD.
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
ZVIKA GILAD, SEMION KHAIT
‫ חאיט סמיון‬,‫צביקה גלעד‬
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A cylindrical swallowable in vivo imaging device comprising: a first dome-shaped end
and a second dome-shaped end, each dome-shaped end at an opposite end of the
]52[
]72[
]71[
]74[
]57[
231
November 30, 2011-‫ד' בכסלו התשע"ב‬
device; a first imager imaging via the first dome-shaped end; a first power contact and
a second power contact for a power source to provide power to device components; a
first illumination source illuminating via the first dome-shaped end; a second imager
imaging via the second dome-shaped end; a second illumination source illuminating
via the second dome-shaped end; a circuit board comprising a plurality of rigid circuit
board sections connected by a plurality of flexible circuit board sections, the first
imager and first power contact disposed on opposite sides of a first of the plurality of
rigid circuit board sections and the second imager and second power contact disposed
on opposite sides of a second of the plurality of rigid circuit board sections.
__________________
]22[]12[
174794
‫נוגדן ביספציפי מחליף עבור חלבונים‬
‫פונקציונאלים‬
]54[
BISPECIFIC ANTIBODY
SUBSTITUTING FOR FUNCTIONAL
PROTEINS
]11[
]32[
08.10.2004
PCT/JP03/13062 ]31[ 10.10.2003
]33[ WO
PCT/JP03/13123
2422121113
WO
Int. Cl.(2010.01) A61K 39/395, A61P 07/04, C07K 16/46, C12N 15/09
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN
WO/2005/035756
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
232
]57[
‫רמת החייל‬
A bispecific antibody functionally substituting for blood coagulation factor
VIII/activated blood coagulation factor VIII , which binds to both of blood coagulation
factor IX/activated blood coagulation factor IX and blood coagulation factor X and
enhances an enzymatic reaction, is successfully constructed.
__________________
]22[]12[
174893
‫אמצעי מניעה תלת שלבי המכיל רמה ראשונית‬
‫נמוכה של אסטרוגן ומנות עוקבות עולות של‬
‫אסטרוגן‬
]54[
TRIPHASIC ESTROGEN
CONTRACEPTIVE WITH LOW
LEVEL INITIAL ESTROGEN
PHASE FOLLOWED BY STEPPED
INCREASES IN ESTROGEN
]11[
]32[
]52[
]72[
12.11.2004
60/520182
]31[ 14.11.2003
]33[ US
Int. Cl.(2010.01) A61K 31/565, 31/567, A61P 15/18
WARNER CHILCOTT COMPANY,
LLC, PUERTO RICO
WO/2005/049142
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the
reduction or elimination of estrogen in the initial phase is disclosed. Also described is
a contraceptive kit that may be used to practice the method of the invention 2
__________________
]22[]12[
]54[
HIGH SPEED MEDIA ACCESS
CONTROL WITH LEGACY
SYSTEM INTEROPERABILITY
]11[
]32[
15.10.2004
60/511750
419522914
233
]31[
15.10.2003
2522121113
174944
‫בקרת גישה למדיה במהירות גבוהה עם מערכת‬
‫הנחלה בעלת יכולת פעולה הדדית‬
]33[
US
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
419523139
1222121113
US
419514354
1222121113
US
419514347
1222121113
US
419531792
1322121113
US
419545943
2121121114
US
419574545
1121421114
US
419514142
1121721114
US
419411941
2221121114
US
219944331
2322121114
US
Int. Cl.(2010.01) H04B 07/005, H04L 12/66, 29/06, H04W 52/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/039133
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Techniques for MAC processing for efficient use of high throughput systems that is
backward compatible with various types of legacy systems are disclosed. In one aspect
a first signal is transmitted according to a legacy transmission format to reserve a
portion of a shared medium, and communication according to a second transmission
format transpires during the reserved portion. In another aspect, a communication
device may contend for access on a legacy system, and then communicate according to
a new class communication protocol with one or more remote communication devices
during the access period. In another aspect, a device may request access to a shared
medium according to a legacy protocol, and, upon grant of access, the device may
communicate with or facilitate communication between one or more remote stations
according to a new protocol.
__________________
]22[]12[
]54[
234
COMPOSITIONS, ENZYMES,
VECTORS AND CELLS FOR THE
SITE-SPECIFIC INCORPORATION
174947
‫ וקטורים ותאים לשילוב‬,‫ אנזימים‬,‫תכשירים‬
‫ספציפי למיקום של חומצות אמינו מחמזרות‬
‫פעילות לתוך חלבונים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
OF REDOX ACTIVE AMINO
ACIDS INTO PROTEINS
]11[
]32[
]52[
]72[
]17[
]74[
]57[
13.10.2004
60/511532
]31[ 14.10.2003
Int. Cl.(2010.01) C12N 15/00, 15/11
THE SCRIPPS RESEARCH
INSTITUTE, U.S.A.
WO/2005/038002
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Compositions and methods of producing components of protein biosynthetic
machinery that include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases,
and orthogonal pairs of tRNAs/synthetases, which incorporate redox active amino
acids into proteins are provided. Methods for identifying these orthogonal pairs are
also provided along with methods of producing proteins with redox active amino acids
using these orthogonal pairs.
,18218/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
175105
‫מתקן לאחסון פסולת‬
]54[
WASTE STORAGE DEVICE
]11[
]32[
]52[
]72[
21.10.2004
0324764.0
]31[ 23.10.2003
]33[ GB
Int. Cl.(2010.01) B65F 01/04, 01/06
SANGENIC INTERNATIONAL
LIMITED, UNITED KINGDOM
MARK ARMSTRONG, JAN A. WEBB
WO/2005/042381
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
1
7 JABOTINSKY ST.,
‫גן‬
‫רמת‬
RAMAT GAN 52520
A waste storage device includes a container (21) in which a cassette (1) is mounted.
Tubing (2) is pulled through the centre of the cassette (1) to store packages (35)
]71[
]17[
]74[
]57[
235
November 30, 2011-‫ד' בכסלו התשע"ב‬
separated by twists. The cassette (1) is rotated relative to the container (21) to provide
the twists between packages (35) by virtue of a rotatable disk (100) and user grip
portion (102). The package is gripped against rotation by a gripper diaphragm (120)
and is guided towards a wall of the container by a guide diaphragm (122) to prevent
untwisting between packages.
__________________
]22[]12[
175156
‫תהליך להכנת גאבאפנטין‬
]54[
PROCESS FOR THE PREPARATION
OF GABAPENTIN
]11[
]32[
]52[
]72[
]17[
]74[
09.11.2004
MI2003A002165 ]31[ 11.11.2003
]33[
Int. Cl.(2010.01) C07C 229/28, 231/02, 231/24
ZAMBON GROUP S.P.A., ITALY
WO/2005/044779
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to an improved process for the preparation of gabapentin
and, more particularly, to an improvement of the preparation reaction of 1,1cyclohexanediacetic acid monoamide, intermediate utilized in the preparation of
gabapentin.
IT
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
236
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
175188
‫תצוגת מניפה של אולטרא סאונד דו–מימדי‬
DISPLAY OF TWODIMENSIONAL ULTRASOUND
FAN
]11[
]32[
]52[
]72[
]74[
25.04.2006
11/114680
]31[ 26.04.2005
]33[
Int. Cl.(2010.01) A61B 08/00, 08/12
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330
]57[ Abstract
Image
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
The parent application from which
this application has been divided has
not yet been published
The applications for division
from this application have
not yet been published
US
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
‫ לתקנות‬1/ ‫פירוט זה נבחן בהתאם לתקנה‬
2//2 – ‫ תשכ"ח‬,‫הפטנטים‬
‫בקשת הורה לבקשה זו שטרם פורסמה‬
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
ROSUVASTATIN DEGRADATION
PRODUCTS
]11[
]32[
]52[
]72[
02.12.2004
60/526449
]31[ 02.12.2003
Int. Cl.(2010.01) C07D 239/70
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
]71[
]17[
]74[
NINA FINKELSTEIN
WO/2005/056534
TEVA PHARMACEUTICAL
INDUSTRIES LTD.,
5 BASEL ST.,
P.O.B. 3190,
237
175511
‫תוצרי דגרדציה של רוזובסטטין‬
]33[
US
‫ פתח‬,‫טבע תעשיות פרמצבטיות בע"מ‬
‫תקוה‬
‫נינה פינקלשטיין‬
,‫טבע תעשיות פרמצבטיות בע"מ‬
‫ מחלקת פטנטים‬5 ‫בזל‬
‫פתח תקוה‬2160 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
PETAH TIQVA 49131
Provided are rosuvastatin degradation products and their use as a reference standard
(including reference marker) for analysis of rosuvastatin.
__________________
]22[]12[
175550
,‫תרכובות חומצה בורונית המכילות הטרוציקלים‬
‫תערובות שלהן ותכשירים פרמצבטיים המכילים‬
‫אותן‬
]54[
HETEROCYCLIC BORONIC ACID
COMPOUNDS, MIXTURES
THEREOF AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]32[
12.11.2004
60/519566
]31[ 12.11.2003
]33[ US
419557122
1521321114
US
419591971
3121721114
US
Int. Cl.(2010.01) A61K 31/69, A61P 03/10, C07F 05/02
PHENOMIX CORPORATION, U.S.A.
DAVID ALAN CAMPBELL, DAVID
T. WINN, JUAN M. BETANCORT
WO/2005/047297
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]71[
]17[
]74[
]57[
238
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Dipeptidyl peptidase IV (DPP-IV)-inhibiting compounds are provided that have
formula I: wherein n is 1 to 3; X is CH2; S; O; CF2 or C (CH3)2; Z is H; halogen;
hydroxyl; (C1-6)alkoxy; (C1-12)alkyl; (C3-12)cycloalkyl; phenyl; or heteroaryl; where the
phenyl and heteroaryl groups are optionally mono- or independently plurisubstituted
with R7; optionally, X together with an adjacent ring carbon and Z form a fused
cyclopropyl; and optionally, one of the bonds in the ring containing X is a double
bond; and CriRii, R1, R1, R3, R4 and R5 are as described herein. Methods for preparing
these compounds, and methods for treating diabetes, especially Type II diabetes, and
other related diseases are described using the compounds of formula I in
pharmaceutical compositions which contain these compounds. Pharmaceutical
compositions which contain combinations of these compounds with other antidiabetic
agents are also described herein.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
175755
‫–קווינולינונים‬4 ‫ –פנילאלקיל‬6–‫–אלקניל ו‬6
‫ תכשירים‬,‫–קווינוקסאלינונים מותמרים‬4–‫ו‬
‫ תהליכים להכנתם‬,‫רוקחיים המכילים אותם‬
‫והשימוש בהם להכנת תרופות‬
]54[
6-ALKENYL AND 6-PHENYLALKYL
SUBSTITUTED 2-QUINOLINONES
AND 2-QUINOXALINONES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM, PROCESSES FOR THEIR
PREPARATION AND USES
THEREOF FOR THE PREPARATION
OF MEDICAMENTS
]11[
]32[
18.11.2004
PCT/EP03/13028 ]31[ 20.11.2003
]33[ WO
1317114121
1522121113
EP
Int. Cl.(2010.01) A61K 31/4704, A61P 43/00, C07D 215/227, 241/44, 401/06, 401/14,
403/06, 405/06, 405/14, 407/06, 409/12
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2005/054201
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
239
The present invention provides compounds of formula (I) and compounds of formula
(I), (VII-a), as well as pharmaceutical compositions comprising said compounds and
their use as PARP inhibitors wherein n, R1, R2, R3, R4, R5, R6, R7, Re, Rd and X have
defined meanings.
__________________
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
175901
‫שיוך אוגרים לעיבוד נתונים‬
]54[
ALIASING DATA PROCESSING
REGISTERS
]11[
]32[
]52[
]72[
]17[
]74[
01.07.2004
0328513.7
]31[ 09.12.2003
]33[ GB
Int. Cl.(2010.01) G06F 09/30, 09/38, 12/08, 15/76, 15/80, 15/82
ARM LIMITED, UNITED KINGDOM
WO/2005/057417
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A register data store (20) is provided within a data processing system (2). The register
data store (20) may be accessed via registers for which a data processing instruction
specifies a register size Q, D and a data element size S16, S8 for the multiple SIMD
data elements to be manipulated by that data processing instruction. A given data
processing element may be accessed via different registers depending upon the
mapping between the register specifier, the register size and the data element size to a
particular location within the register data store (20).
]57[
__________________
]22[]12[
175962
‫מודל לתקשורת בין רמות ייצור וניהול‬
]54[
MODEL FOR COMMUNICATION
BETWEEN MANUFACTURING
AND ENTERPRISE LEVELS
]11[
]32[
]52[
]72[
28.05.2006
11/142200
]31[ 01.06.2005
]33[ US
Int. Cl.(2010.01) G06F 17/30, 17/40, H04L 12/58
ILS TECHNOLOGY LLC, U.S.A.
240
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A system for communicating data to and from a control and monitoring device, said
system comprising: a controller coupled to and in communication with said control and
monitoring device, said controller having a network connection; and software installed
on said controller; wherein said software can read data from said control and
monitoring device and receive messages from said control and monitoring device and
further wherein said software can configure and send said data and messages to an
application at a destination, in a format required by the application, via said network
connection for automatic, direct connectivity between the controller and the
application at the destination without manual intervention, wherein said software
comprises a logic server for tracking changes in said data read from said control and
monitoring device and for applying logical manipulations to said data read from said
control and monitoring device, and an expression server for evaluating mathematical
and/or logic expressions and using data read from said control and monitoring device,
wherein said data is sent via said network connection upon occurrence of one or more
configurable trigger conditions, wherein said configuring of said trigger conditions
includes selecting information regarding the data to be sent, an event upon which the
data is sent, a destination of said data, and the format in which said data is to be sent
upon satisfaction of said trigger condition, and wherein the system further comprises
one or more configuration files contained in non-volatile storage on said controller,
said configuration files containing a record of all defined projects, transports and
general settings, and further wherein said software can restore itself to a previous state
using said configuration files upon recovery from a power fail condition.
__________________
]22[]12[
176022
]54[
WINGS FOR AIRCRAFT
]11[
]52[
]72[
30.05.2006
Int. Cl.(2010.01) B64C 03/14, 03/50, 09/18
ISRAEL AEROSPACE
INDUSTRIES LTD.
MICHAEL SHEPSHELOVICH,
ALEX NAGEL
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]74[
]57[
241
‫כנפיים עבור מטוס‬
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
‫ אלכס נגל‬,‫מיכאל שפשלוביץ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A wing for an aircraft, comprising at least a first wing portion configured for
November 30, 2011-‫ד' בכסלו התשע"ב‬
providing high-lift mild stall characteristics at least at Reynolds numbers in the range
between about 0.3x10^6 and about 2.0x10^6, said first wing portion having a first
sectional f limit, and at least a second wing portion comprising a substantially
permanently slotted aerofoil arrangement, said second wing portion having a second
sectional limit, wherein said second sectional limit is higher than said first sectional
limit.
__________________
]22[]12[
176250
]54[
A-BETA IMMUNOGENIC
PEPTIDE CARRIER
CONJUGATES AND
COMPOSITIONS COMPRISING
THE SAME
]11[
]32[
]52[
]72[
17.12.2004
60/530481
]31[ 17.12.2003
]33[ US
Int. Cl.(2010.01) A61K 39/00, 39/385, C07K 01/00, 17/00, G01N 33/53
WYETH LLC, U.S.A.
ELAN PHARMA INTERNATIONAL
LIMITED, IRELAND
WO/2005/058941
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]17[
]74[
]57[
242
‫ עם נשא‬β A ‫צמדים של אימונוגן פפטיד‬
‫ותכשירים המכילים אותם‬
The present invention is directed to methods of producing conjugates of A-beta
peptide immunogens with protein/polypeptide carrier molecules, which are useful as
immunogens, wherein peptide immunogens are conjugated to protein carriers via
activated functional groups on amino acid residues of the carrier or of the optionally
attached linker molecule, and wherein any unconjugated reactive functional groups on
amino acid residues are inactivated via capping, thus retaining the immunological
functionality of the carrier molecule, but reducing the propensity for undesirable
reactions that could render the conjugate less safe or effective. Furthermore, the
invention also relates to such immunogenic products and immunogenic compositions
containing such immunogenic products made by such methods2
November 30, 2011-‫ד' בכסלו התשע"ב‬
The applications for division
from this application have
not yet been published
,1212//
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
176255
‫תכשירים מוצקים יציבים המכילים מלחים של‬
‫ תהליכים‬,‫– קווינולין קרבוקסאמיד‬3 ‫נגזרות‬
‫ וצורה גבישית של מלחים כאלה‬,‫לייצובם‬
]54[
STABLE SOLID
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SALTS OF 3QUINOLINECARBOXAMIDE
DERIVATIVES, PROCESS FOR
THEIR STABILIZATION AND
CRYSTALLINE FORM OF SUCH
SALTS
]11[
]32[
]52[
]72[
]17[
]74[
04.02.2005
0400235-8
]31[ 06.02.2004
]33[ SE
Int. Cl.(2010.01) A61K 31/4704, A61P 37/04, C07D 215/56
ACTIVE BIOTECH AB, SWEDEN
WO/2005/074899
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A stable solid pharmaceutical composition consisting essentially of an effective
amount of a salt of formula (II) together with an alkaline-reacting component
maintaining the pH preferably above 8, or a salt with a divalent metal cation; and at
least one pharmaceutical excipient; said salt of formula (II) being essentially stable
during storage at room temperature for a period of at least 3 years. A process for
stabilizing the salt of formula (II). A crystalline salt of formula (II) and a process for
preparing said salt.
243
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
176349
‫תולדות של טריאזול פיפירידיניל כאנטגוניסטים‬
V1A ‫לרצפטור של וסופרסין‬
]54[
PIPERIDINYL TRIAZOLE
DERIVATIVES AS V1A
VASOPRESSIN RECEPTOR
ANTAGONISTS
]11[
]32[
09.12.2004
0329693.6
]31[ 22.12.2003
]33[ GB
141171924
1121421114
GB
Int. Cl.(2010.01) A61K 31/454, A61P 25/00, C07D 401/04, 401/14, 403/04, 403/14,
405/04, 405/14, 409/04, 409/14, 413/04, 413/14, 417/04, 417/14, 495/04
PFIZER INC., U.S.A.
WO/2005/063754
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,
wherein: V represents a direct link or -O-; Ring A represents an optionally substituted
5- to 7-membered saturated heterocyclic ring, or a phenylene group.
]52[
]72[
]17[
]74[
]57[
__________________
]22[]12[
]54[
244
METHOD FOR ANALYZING A
GLYCOMOLECULE
176376
‫שיטה לאנליזת גליקומולקולה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
20.12.2004
60/531578
]31[ 18.12.2003
]33[ US
Int. Cl.(2010.01) G01N 33/48, 33/68
PROCOGNIA (ISRAEL) LTD.
‫ אשדוד‬,‫פרוקוגניה (ישראל) בע"מ‬
OFER MARKMAN, RAKEFET
,‫ יהודית עמור‬,‫ רקפת רוזנפלד‬,‫עופר מרקמן‬
ROSENFELD, YEHUDIT AMOR,
,‫ אלבנה סמוקובליצקי‬,‫גולקו‬-‫מירית קולוג‬
MIRIT KOLOG-GULKO, ALBENA
‫ אידיל‬,‫ רות מאיה‬,‫ טל אלרגנד‬,‫פרדי קליינמן‬
SAMOKOVLISTKY, FREDI
‫ חיים בנג'ו‬,‫ סבינה רבה‬,‫קלסון‬-‫קסוטו‬
KLEINMAN, TAL ALERGAND,
RUTH MAYA, IDIL KASUTOKELSON, SABINA REBE, HAIM
BANGIO
WO/2005/059563
DR. D. GRAESER LTD.,
,‫ גרייזר בע"מ‬.‫ד"ר ד‬
P.O.B. 2496,
12 ‫הסדנא‬
RAANANA
‫רעננה‬5461 .‫ד‬.‫ ת‬,
43650
The invention relates generally the structural analysis of glycomolecule-containing
macromolecules, such as those that occur either attached to proteins (proteoglycans,
glycoproteins), lipids, or as free saccharides.
__________________
]22[]12[
]54[
METHOD FOR ACTIVATION OF
AN ACCESS TO A COMPUTER
SYSTEM OR TO A PROGRAM
]11[
]32[
]52[
]72[
14.12.2004
103 59 680.1 ]31[ 18.12.2003
Int. Cl.(2010.01) G06F 21/20, 21/22
GIESECKE & DEVRIENT GMBH,
GERMANY
245
176378
‫שיטה למתן גישה למערכת מחשב או לתכנה‬
]33[
DE
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/2005/059722
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to a method for activation of an access to a computer system or
to a programme for a user, by means of a terminal (2) without specific software
installed for the above purpose on said terminal (2). A data connection between a
portable data support (1) of the user and the terminal (2) is thus generated. An
authentication of the user is carried out by the portable data support (1). On successful
authentication, an access code, for activation of the access to the computer system, or
the programme, for a transmission by means of the data connection, is generated by
the portable data support (1).
__________________
]22[]12[
176564
,‫ תהליך להכנתן‬,‫תולדות של סולפונאמיד‬
‫תכשירים רפואיים המכילים אותן ושימושן‬
4‫לייצור תרופה בעלת פעילות של אגוניסט–בטא‬
]54[
SULFONAMIDE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE MANUFACTURE OF A
MEDICAMENT HAVING BETA2
AGONIST ACTIVITY
]11[
]32[
12.01.2005
04290169.4
]31[ 22.01.2004
]33[ EP
141431722
1121321114
GB
419411141
1921121114
US
Int. Cl.(2010.01) A61K 31/18, 31/472, A61P 11/06, 11/08, C07C 311/08, C07D
]52[
246
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
217/06
PFIZER INC., U.S.A.
WO/2005/080313
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to compounds of formula (1) and to processes for the preparation
of compositions containing and the uses of such derivatives. The compounds according
to the present invention are useful in numerous diseases, disorders and conditions, in
particular inflammatory, allergic and respiratory diseases, disorders and conditions.
__________________
]22[]12[
]54[
USE OF INSULIN IN THE
PREPARATION OF A
MEDICAMENT FOR MIMICKING
A PHYSIOLOGICAL MEALRELATED FIRST PHASE INSULIN
RESPONSE AND REDUCING A
RISK FACTOR FOR
ATHEROSCLEROSIS IN TYPE 2
DIABETICS
]11[
]32[
]52[
]72[
]17[
]74[
10.01.2005
60/535945
]31[ 12.01.2004
Int. Cl.(2010.01) A61K 38/28
MANNKIND CORPORATION, U.S.A.
WO/2005/067964
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
247
176699
‫שימוש באינסולין להכנת תרופה לחיקוי תגובת‬
‫אינסולין פאזה ראשונה קשורת–ארוחה‬
‫פיזיולוגית והפחתת פקטור סיכון לטרשת‬
4 ‫עורקים בחולי סכרת מסוג‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Methods are provided for reducing serum proinsulin levels, lessening post-prandial
pancreatic stress, and reducing risk factors for atherosclerosis in subjects with diabetes
mellitus, type 2. The method includes administration of insulin in a manner that
mimics the meal-related first phase insulin response, using a dose sufficient to reduce
November 30, 2011-‫ד' בכסלו התשע"ב‬
serum levels of proinsulin. In some embodiments of the method insulin administration
is commenced early in the course of the disease. Mimicking first phase kinetics, peak
serum insulin levels can be reached within about 18 minutes of administration. In
increasingly preferred embodiments peak serum insulin levels can be reached within
about 15, 12, or 10 minutes of administration. Serum insulin levels return to baseline
within about two hours of administration.
__________________
]22[]12[
177087
‫ ושיטה‬,‫הרכב פרמצבטי המשוחרר באופן מבוקר‬
‫להכנתו‬
]54[
CONTROLLED-RELEASE
PHARMACEUTICAL
COMPOSITION AND METHOD
FOR PRODUCING THE SAME
]11[
]32[
]52[
]72[
23.03.2005
2004-093506 ]31[ 26.03.2004
]33[ JP
Int. Cl.(2010.01) A61K 09/00, 31/4439, 47/06, A61P 01/00, C07D 401/12
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2005/092336
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Controlled-leaching preparations containing a physiologically active substance
unstable in acids, in particular, pulsed-leaching preparations being slight in lag time
fluctuation and enhanced in reliability of leaching performance. There are disclosed
controlled-leaching preparations comprising core (1) containing a physiologically
active substance unstable in acids and a disintegrant and controlled-leaching coating
(2) covering the core and containing a water-insoluble polymer, an enteric polymer
and a fat-soluble wax.
]17[
]74[
]57[
248
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
SHORT PULSE/STEPPED
FREQUENCY RADAR SYSTEM
AND METHOD OF SENSING
USING THE SAME
]11[
]32[
]52[
]72[
]17[
]74[
06.06.2005
10/863623
]31[ 08.06.2004
Int. Cl.(2010.01) G01S 13/32
RAYTHEON COMPANY, U.S.A.
WO/2005/124390
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
249
177147
‫תדירות‬/‫מערכת מכ"ם בעלת פעימה קצרה‬
‫מדורגת ושיטת חישה המשתמשת בה‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A unique hardware architecture that combines short pulse, stepped frequency and
centerline processing. The inventive architecture implements a radar system having a
transmitter for transmitting short pulses, each pulse being stepped in frequency and a
receiver receiving the pulses and providing an output signal in response thereto. In the
illustrative embodiment, the transmitter includes a frequency source, an RF switch
coupled to the source and a controller for controlling the RF switch. The receiver
includes a signal processor implemented with a center line roughing filter. The signal
processor has multiple channels each of which has a range gate and a digital filter. The
digital filter includes a Fast Fourier Transform adapted to output a range Doppler
matrix.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
177236
‫התקן ושיטה לקביעת פרמטר של חיישן‬
‫אינרציאלי של כלי רכב‬
]54[
DEVICE AND METHOD FOR
DETERMINING A PARAMETER
OF AN INERTIAL SENSOR OF A
VEHICLE
]11[
]52[
]72[
02.08.2006
Int. Cl.(2010.01) G01C 01/00, 19/50, 21/06, 21/10, 25/00
ISRAEL AEROSPACE
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
INDUSTRIES LTD.
JOSEPH HASSON
‫יוסף חסון‬
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]71[
]74[
]57[
A method for measuring at least one parameter of at least one inertial sensor of a
vehicle, the method comprising: moving a testing device connected to the vehicle, and
receiving inertial sensor information provided by the at least one inertial sensor;
wherein the vehicle comprises the at least one inertial sensor and wherein the stage of
moving the testing device comprises positioning the vehicle at multiple positions that
differ from each other and receiving inertial sensor information provided when at least
substantial portion of the vehicle is poisoned in at least two different positions; and
determining at least parameter of the at least one inertial sensor in response to the
received inertial sensor information, wherein at least one of the parameters is usable
for calibrating said at said at least one inertial sensor2
__________________
250
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
177254
‫כרסום ריסוק כדורי‬
]54[
BALLNOSE END MILL
]11[
]52[
]72[
]71[
]74[
02.08.2006
Int. Cl.(2010.01) B23C 05/10
HANITA METAL WORKS LTD.
‫חניתה מפעלי מתכת בע"מ‬
MOTI BARON, RONI ABED
‫ רוני עבד‬,‫מוטי בראון‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A ballnose end mill having a centerline of rotation, comprising: a cutting body, a
hemispherical cutting head adjacent the cutting body and extending to one endof the
ball and mill and a plurality of serrations disposed on the hemispherical cutting head.
]57[
__________________
]22[]12[
177513
‫ תכשירים‬,‫תולדות הטרוציקליות דחוסות‬
‫רפואיים המכילים אותם ושימושם הרפואי‬
]54[
FUSED HETEROCYCLIC
DERIVATIVE, MEDICINAL
COMPOSITION CONTAINING
THE SAME AND MEDICINAL USE
THEREOF
]11[
]32[
]52[
03.03.2005
2004-061429 ]31[ 04.03.2004
]33[ JP
Int. Cl.(2010.01) A61K 31/7042, A61P 03/04, 03/06, 03/10, 07/10, 09/10, 09/12,
19/00, 19/06, C07H 17/00
KISSEI PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2005/085265
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]72[
]17[
]74[
]57[
251
A nitrogenous fused-ring derivative represented by the following general formula (I), a
pharmacologically acceptable salt thereof, or a prodrug of either. They have human
SGLT inhibitory activity and are useful as a preventive or therapeutic agent for
diseases attributable to hyperglycemia, such as diabetes, postprandial hyperglycemia,
impaired glucose tolerance, complications of diabetes, and obesity. [In the formula (I),
one of R1 and R4 represents a group represented by the following general formula (S)
(wherein R5 and R6 each represents H, OH, halogeno, etc.; Q represents alkylene, etc.;
November 30, 2011-‫ד' בכסלו התשע"ב‬
and ring A represents aryl, etc.) and the other represents H, OH, amino, etc.; R 2 and R3
each represents H, OH, amino, halogeno, optionally substituted alkyl, etc.; A1
represents O, S, etc.; A2 represents CH or N; and G represents a group represented by
the following general formula (G-1) (wherein E1 is H, F, or OH and E2 represents H, F,
methyl, etc.) or the group represented by the following general formula (G-2).]
__________________
]22[]12[
177643
‫ תכשירים רפואיים‬,‫לקטמים כמעכבי פרוטאז‬
‫המכילים אותם ושימוש בהם להכנת תכשירים‬
‫רפואיים‬
]54[
LACTAMS AS PROTEASE
INHIBITORS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USE IN THE
MANUFACTURE OF
MEDICAMENTS
]11[
]32[
]52[
23.02.2005
60/547226
]31[ 23.02.2004
]33[ US
Int. Cl.(2010.01) A61K 31/4015, 31/435, 31/55, A61P 03/00, C07D 207/273, 487/10,
C07K 05/06, 05/08
TRUSTEES OF TUFTS COLLEGE,
U.S.A.
WO/2005/082849
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
252
The present invention relates to inhibitors of post-proline cleaving enzyme, such as
November 30, 2011-‫ד' בכסלו התשע"ב‬
inhibitors of dipeptidyl peptidase IV, as well as pharmaceutical compositions thereof,
and methods for using such inhibitors. In particular, the inhibitors of the present
invention incorporate a lactam ring in the backbone of the inhibitors. The compounds
of the present invention can have a better therapeutic index, owing in part to reduced
toxicity and/or improved specificity for the targeted protease.
__________________
]22[]12[
177662
‫ שיטות‬,‫– דיקרבוקסאמיד‬3 ,2–‫נגזרות פירולידין‬
‫להכנתן ושימושים בהן‬
]54[
PYRROLIDINE-3,4DICARBOXAMIDE
DERIVATIVES, METHODS FOR
THEIR MANUFACTURE AND
USES THEREOF
]11[
]32[
]52[
17.03.2005
04101265.9
]31[ 26.03.2004
]33[ EP
Int. Cl.(2010.01) A61K 31/541, A61P 07/00, C07D 207/16, 401/12, 401/14, 403/12,
417/12
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/092881
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
253
The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of
Formula (I) ; wherein Rl to R9 and X are as defined in the description and in the
claims, as well as physiologically acceptable salts thereof. These compounds inhibit
the coagulation factor Xa and can be used as medicaments.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
177832
‫מתאם למתמר מומנט‬
]54[
ADAPTOR FOR A TORQUE
TRANSDUCER
]11[
]52[
]72[
31.08.2006
Int. Cl.(2010.01) G01L 25/00
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]74[
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
The present invention is an adaptor for a torque transducer operable in conjunction
with a torque tester. The adaptor of the invention comprises an outer sleeve member
coupleable with a torque tool, an inner sleeve member coupleable with a torque
transducer, and a breakable locking element secured to both the outer sleeve member
and the inner sleeve member. When the tool applies a torque greater than an allowable
limit the locking element is adapted to break whereby to decouple the tool from the
transducer.
]57[
254
,‫רפא"ל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
177931
‫מערכת גישה אלחוטית רחבת–פס ניידת עבור‬
‫העברת מידע שירות בשעת העברה‬
]54[
MOBILE BROADBAND
WIRELESS ACCESS SYSTEM FOR
TRANSFERRING SERVICE
INFORMATION DURING
HANDOVER
]11[
]32[
04.03.2005
10-2004]31[ 05.03.2004
]33[ KR
0015128
Int. Cl.(2010.01) H04B 07/26, H04L 12/56, H04W 36/00, 36/26
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2005/084146
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention is related to transmitting quality of service (QoS) information of
a target base station (13) for admitted service flows during a handover operation. The
invention comprises providing a service to a mobile station (11) from a serving base
station (12) and receiving at the serving base station (12) a handover request (S107)
from the mobile station (11). The serving base station (12) then provides a handover
notification (S108) to a target base station (13), wherein the handover notification
comprises a QoS parameter associated with the service. The serving base station (12)
then receives from the target base station (13) a handover notification response (S109),
wherein the handover notification response comprises service level prediction
information that is determined in response to the QoS parameter associated with the
service. Finally, the serving base station (12) provides a handover response (S110) to
the mobile station (11), the handover response comprising the service level prediction
information.
]52[
]72[
]17[
]74[
]57[
255
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
APPARATUS FOR
ELECTRICALLY MEDIATED
DELIVERY OF THERAPEUTIC
AGENTS
]11[
]32[
]52[
]72[
08.03.2005
60/551679
]31[ 08.03.2004
Int. Cl.(2010.01) A61N 01/30
ICHOR MEDICAL SYSTEMS , INC,
U.S.A.
STEVEN P. MASTERSON, ANDREW
W. HANNAMAN, ROBERT M.
BERNARD
WO/2005/087311
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]17[
]74[
]57[
256
177942
‫מכשיר להולכה של חומרים רפואיים באמצעות‬
‫חשמל‬
]33[
US
,‫פישר וילר ג'ונס‬
51 ‫הברזל‬
‫רמת החייל‬
Apparatus for the delivery of an electrical field which facilitates the intracellular
delivery of a therapeutic agent to a predetermined site within the tissue of a patient.
The apparatus will comprise a plurality of penetrating electrodes arranged in a
predetermined spatial relationship, each electrode with a cross sectional area
contributing to the total cross sectional area of all electrodes, and structural means
incorporating an inanimate source of energy operatively connected to the plurality of
electrodes for deploying the electrodes, wherein the source of energy is sufficient to
impart a force of at least 1000 pounds per square inch (0.7 kilogram per square
millimeter) of total cross sectional area of all electrodes at the initiation of the
deployment of the electrodes. The apparatus will also comprise means for generating
an electrical field which facilitates the intracellular delivery of a therapeutic agent,
which means is operatively connected to said electrodes at least in their deployed state.
November 30, 2011-‫ד' בכסלו התשע"ב‬
,1811//
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
178001
‫–פרפוראל‬4–‫–מתיל‬5 ‫תהליך להכנת‬
]54[
PROCESS FOR PREPARING 5METHYL-2-FURFURAL
]11[
]32[
11.09.2006
P2005]31[ 30.09.2005
]33[ JP
286834
Int. Cl.(2010.01) C07D 307/00, 307/48
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A process for preparing 5-methyl-2-furfural in a high yield by reacting 2-methylfuran,
phosgene and N,N-dimethylformamide in a reaction medium comprising a
hydrocarbon at a temperature of at least 45OC and hydrolyzing a reaction mixture2
]52[
]72[
]74[
]57[
__________________
]22[]12[
]54[
257
PHARMACEUTICAL
COMPOSITION FOR USE IN
SOLID FORMULATION
178249
‫תכשירי רוקחות לשימוש בהרכב מוצק של‬
‫סוליפנאצין גבישי או מלח שלו ותהליך להכנתו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
CRYSTALLINE SOLIFENACIN OR
SALT THEREOF AND A PROCESS
FOR ITS PREPARATION
]11[
]32[
]52[
]72[
]17[
]74[
]57[
24.03.2005
60/556025
]31[ 25.03.2004
]33[ US
419431311
1722121114
US
Int. Cl.(2010.01) A61K 09/20, 31/439, 47/34, A61P 01/12, 13/02, 27/08, C07D
453/02
ASTELLAS PHARMA INC., JAPAN
WO/2005/092889
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation
being stable and inhibited from decomposing with time when supplied to clinical
fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the
compound in an amorphous form was revealed to be causative of cardinal-drug
decomposition with time. The composition for a solid pharmaceutical preparation of
solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline form,
and the content of the compound in an amorphous form in the composition is within
the range which exerts no influence on product stability. Also provided are: a process
for producing the composition; and a medicinal composition for solid pharmaceutical
preparations which contains solifenacin and an amorphization inhibitor.
__________________
]22[]12[
]54[
TANTALUM FILM HAVING A
SINGLE CRYSTAL
MICROSTRUCTURE AND A
MICROELECTRONIC DEVICE
CONTAINING IT
]11[
]32[
]52[
]72[
24.03.2005
60/555759
]31[ 24.03.2004
Int. Cl.(2010.01) B81C 01/00
H.C. STARCK INC., U.S.A.
NORTH CAROLINA STATE
UNIVERSITY, U.S.A.
WO/2005/095263
]17[
258
178252
‫קרום טנטלום בעל מבנה זעיר חד גבישי והתקן‬
‫אלקטרוני זעיר המכיל אותו‬
]33[
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Thin tantalum films having novel microstructures are provided. The films have
microstructures such as nanocrystalline, single crystal and amorphous. These films
provide excellent diffusion barrier properties and are useful in microelectronic devices.
Methods of forming the films using pulsed laser deposition (PLD) and molecular beam
epitaxy (MBE) deposition methods are also provided, as are microelectronic devices
incorporating these films.
__________________
]22[]12[
178508
‫מרקרים לביטוי גני לחיזוי תגובה לכימותרפיה‬
]54[
GENE EXPRESSION MARKERS
FOR PREDICTING RESPONSE TO
CHEMOTHERAPY
]11[
]32[
]52[
]72[
07.04.2005
60/561035
]31[ 09.04.2004
]33[
Int. Cl.(2010.01) C12Q 01/68, G01N 33/574
GENOMIC HEALTH, INC., U.S.A.
FONDAZIONE IRCCS ISTITUTO
NAZIONALE DEI TUMORI, ITALY
WO/2005/100606
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
259
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides sets of genes the expression of which is important in
the prognosis of cancer. In particular, the invention provides gene expression
information useful for predicting whether cancer patients are likely to have a beneficial
treatment response to chemotherapy.
November 30, 2011-‫ד' בכסלו התשע"ב‬
,121///,121//1
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
178527
‫מעבד מחשב מותאם עם יעדים מתואמים‬
]54[
MODIFIED COMPUTER
ARCHITECTURE WITH
COORDINATED OBJECTS
]11[
]32[
]52[
]72[
22.04.2005
2004902146
]31[ 22.04.2004
]33[ AU
Int. Cl.(2010.01) G06F 15/16
WARATEK PTY LIMITED,
AUSTRALIA
WO/2005/103926
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention discloses a modified computer architecture (50, 71, 72) which
enables an applications program (50) to be run simultaneously on a plurality of
computers (M1, ...Mn). Shared memory at each computer is updated with amendments
and/or overwrites so that all memory read requests are satisfied locally. During initial
program loading (75), or similar, instructions which result in memory being re-written
or manipulated are identified (92). Additional instructions are inserted (103) to cause
the equivalent memory locations at all computers to be updated. In addition, the
initialization of JAVA language classes and objects is disclosed (162, 163) so all
memory locations for all computers are initialized in the same manner. The finalization
of JAVA language classes and objects is also disclosed (162, 163) so finalization only
occurs when the last class or object present on all machines is no longer required.
During initial program loading (75), or similar, instructions which result in the
application program (50) acquiring (or releasing) a lock on a particular asset (50A,
50X-50Y) (synchronization) are identified. Additional instructions are inserted (162,
163) to result in a modified synchronization routine with which all computers are
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
260
updated.
__________________
]22[]12[
178614
‫שיטת לזיהוי רצפי חומצות גרעין בעלי גן‬
‫ בדוגמיות‬PKS PUFA ‫ספציפי‬
]54[
METHOD FOR IDENTIFYING PUFA
PKS GENE-SPECIFIC NUCLEIC
ACIDS SEQUENCES IN SAMPLES
]11[
]32[
]52[
]72[
08.04.2005
102004017369.9 ]31[ 08.04.2004
]33[ DE
Int. Cl.(2010.01) C12Q 01/68
NUTRINOVA NUTRITION
SPECIALTIES & FOOD
INGREDIENTS GMBH, GERMANY
WO/2005/098033
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method for the rapid and simple identification of PUFA PKS
in microorganisms. Said method is characterized by the fact that DNA sections
representing PKS that produce specifically for PUFA (polyunsaturated fatty acids) are
reproduced in vitro. The PUFA PKS-specific amino acid sequence LGIDSIKRVEIL
makes it possible to derive oligonucleotides which are used for the efficient PCR
screening for PUFA PKS genes or PUFA-producing microorganisms. The inventive
method is particularly suitable for the high throughput screening of microorganisms for
PUFA PKS genes.
]17[
]74[
]57[
261
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
178842
‫פרוטזת דיסק בין–חולייתית‬
]54[
INTERVERTEBRAL DISC
PROSTHESIS
]11[
]32[
]52[
]72[
]71[
]17[
]74[
28.04.2005
04/04501
]31[ 28.04.2004
]33[ FR
Int. Cl.(2010.01) A61F 02/44
LDR MEDICAL, FRANCE
WILLEM ZEEGERS
WO/2005/104996
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
1
7 JABOTINSKY ST.,
‫גן‬
‫רמת‬
RAMAT GAN 52520
The present invention relates to an intervertebral disc prosthesis preferably comprising
at least three pieces including an upper plate (1), a lower plate (2) and a mobile core
(3) at least in relation to the lower plate (2), co-operation means (23, 33) allowing to
limit or eliminate the movements of the core (3) in relation to the lower plate (2), in
translation and in rotation, respectively, about an axis substantially parallel to the
lower plate (2) and about an axis substantially perpendicular to the lower plate (2), at
least one part of the surface of at least one plate being curved and complementary with
a curved surface (30) of the core (3), with which it is in contact, wherein the top (31)
of the curved surface (30) of the core (3) is off centre, in at least one direction, in
relation to the centre (32) of this curved surface (30).
]57[
__________________
]22[]12[
]54[
262
PYRAZOLE SULFONYLUREA
COMPOUND AND HERBICIDE
178854
‫תרכובת פיראזול סולפונילאוריאה וקוטל–עשבים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
27.04.2005
2004-130933 ]31[ 27.04.2004
]33[ JP
Int. Cl.(2010.01) A01N 47/36, C07D 413/14
NISSAN CHEMICAL INDUSTRIES
LTD., JAPAN
WO/2005/103044
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM ST.,
21 ‫רחוב אחד העם‬
P.O.B. 2499,
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
Disclosed is a novel herbicide. Specifically disclosed are a pyrazole sulfonylurea
compound represented by the following formula (1) (wherein R 1 represents a C1-3 alkyl
group; R2 represents a hydrogen atom, C1-3 alkyl group, C1-3 haloalkyl group or the
like; R3, R4, R5 and R6 independently represent a hydrogen atom, C1-3 alkyl group or
the like and at least one of R3, R4, R5 and R6 represents a C1-3 alkyl group or C1-3
haloalkyl group; X and Y independently represent a C1-3 alkyl group or the like; and Z
represents a nitrogen atom or a methine group) and a salt of such a pyrazole
sulfonylurea compound acceptable as an agricultural chemical. Also disclosed are an
agricultural chemical composition containing one or more substances selected from
such pyrazole sulfonylurea compounds and salts thereof as active constituents, and a
herbicide containing one or more substances selected from such pyrazole sulfonylurea
compounds and salts thereof as active constituents.
__________________
]22[]12[
178885
‫חלבוני פנאומוליזין מוטנטים‬
]54[
MUTANT PNEUMOLYSIN
PROTEINS
]11[
]32[
09.05.2005
0410220.8
]31[ 07.05.2004
]33[ GB
419549425
1721521114
US
Int. Cl.(2010.01) A61K 39/00, A61P 31/04, C07K 14/315, C12N 15/31
THE UNIVERSITY COURT OF THE
]52[
]72[
263
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
UNIVERSITY OF GLASGOW,
UNITED KINGDOM
WO/2005/108580
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to immunogenic compositions comprising mutant Streptococcus
pneumoniae pneumolysin proteins. The invention further relates to such proteins and
nucleic acids encoding these proteins. In particular embodiments, the invention is
directed to an isolated mutant pneumolysin (PLY) protein, wherein the mutant PLY
protein differs from the wild type PLY protein by the presence of a mutation within the
region of amino acids 144 to 161 of the wild type sequence, such that the toxicity of
the mutant is reduced relative to that of the wild-type protein. In particular
embodiments, the mutant PLY protein differs from the wild type protein by the
substitution or deletion of amino acids within this region, including the deletion of two
adjacent amino acids within the region of amino acids 144 to 151 of the wild type
sequence.
,18111/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
178962
‫שיטה להכנת חומר נוגד חמצון‬
]54[
METHOD FOR PREPARING AN
ANTIOXIDANT MATERIAL
]11[
]32[
]52[
]72[
27.12.2005
2004-377302 ]31[ 27.12.2004
]33[ JP
Int. Cl.(2010.01) A23L 01/302, 02/44, 02/52, A61K 31/375, 36/752, C09K 15/06
POKKA CORPORATION, JAPAN
AMANO ENZYME INC., JAPAN
]71[
SYUICHI FUKUMOTO, KAZUTAKA
TSURUHAMI, SHIGEHARU MORI
WO/2006/070810
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An antioxidant material comprising a flavonoid aglycone and vitamin C. The
flavonoid aglycone refers to eriodictyol and/or diosmetin obtained by treating a raw
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
264
material containing flavonoid glycosides derived from lemon, lime or sudachi (Citrus
sudachi Hort) into aglycone. This antioxidant material is preferably produced through
the step of mixing the flavonoid aglycone after the treatment into aglycone with
vitamin C. The treatment into aglycone refers to a glucosidase treatment using &bgr;glucosidase derived from Penicillium multicolor or a microbe of the genus
Aspergillus, or refers to a microbial fermentation treatment using a microbe of the
genus Aspergillus. Further, there are provided an anti-deterioration agent and food or
beverage comprising the above antioxidant material.
__________________
]22[]12[
179029
,‫תולדות פיפראזיניות של דיאלקיל אוקסינדולים‬
‫ תהליך‬,‫תכשירים רוקחיים המכילים אותם‬
‫ייצורן והשימוש בהן‬
]54[
PIPERAZINE DERIVATIVES OF
DIALKYL OXINDOLES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME, PROCESS FOR THEIR
MANUFACTURE AND USES
THEREOF
]11[
]32[
11.05.2005
P0400957
]31[ 11.05.2004
]33[ HU
P0500464
1521521115
HU
Int. Cl.(2010.01) A61K 31/404, 31/4465, A61P 25/24, 25/28, C07D 209/34, 401/08,
403/06
EGIS GYOGYSZERGYAR NYRT,
HUNGARY
WO/2005/109987
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
265
The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives
of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7
carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes
hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or
aryl optionally carrying one or two halogen substituent(s); R 4 stands for alkyl having
1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b),
wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for
hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6
and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple
bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which
November 30, 2011-‫ד' בכסלו התשע"ב‬
are useful in the treatment or prophylaxis of diseases of the central nervous system, the
gastrointestinal system and the cardiovascular system.
__________________
]22[]12[
179292
‫חיישן אופטי עם מבנה שכבתי פלסמוני להגברת‬
SERS ‫איתור של קבוצות כימיות באמצעות‬
]54[
OPTICAL SENSOR WITH
LAYERED PLASMON
STRUCTURE FOR ENHANCED
DETECTION OF CHEMICAL
GROUPS BY SERS
]11[
]32[
]52[
]72[
]17[
]74[
19.05.2005
60/572959
]31[ 19.05.2004
Int. Cl.(2010.01) G02B 27/10
VP HOLDING, LLC, U.S.A.
WO/2005/114298
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An optical sensor and method are disclosed for use with a visible-light laser excitation
beam (60) and a Raman spectroscopy detector, for detecting the presence chemical
groups in an analyte (80) applied to the sensor. The sensor includes a substrate (10), a
plasmon resonance mirror (20) formed on a sensor surface of the substrate (10), a
plasmon resonance particle layer (40) disposed over the mirror (20), and an optically
transparent dielectric layer (30) about 2-40 nm thick separating the mirror (20) and
particle layer (40). The particle layer (40) has a periodic array of plasmon resonance
particles with (i) a coating to binding analyte molecules (80), (ii) substantially uniform
particle sizes and shapes in a range between 50-200 nm (ii) a particle-to-particle
spacing less than the wavelength of the laser excitation beam. The device is capable of
detecting single analyte molecules (80) with an amplification factor of up to 10 12- 1014.
266
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
179316
‫משרן לצנתר‬
]54[
INDUCTOR FOR CATHETER
]11[
]32[
]52[
]72[
]17[
]74[
02.06.2005
10/873409
]31[ 21.06.2004
]33[ US
Int. Cl.(2010.01) A61B 19/00
MEDIGUIDE LTD.
‫ חיפה‬,‫מדיגייד בע"מ‬
WO/2005/122884
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
Electromagnetic field detector (100) located within a catheter (102), for determining
the position and orientation of the catheter. The electromagnetic field detector
including a ferromagnetic core (106) having a perforation (116) and at least one
winding (104) wound around the ferrous core, the perforation providing
communication between a first side (118) and a second side (120) of the ferrous core.
]57[
__________________
]22[]12[
]54[
PROCESS FOR PRODUCING LOW
MOLECULAR WEIGHT
ETHYLCELLULOSE AND USE
THEREOF
]11[
07.03.2005
267
179426
‫תהליך לייצור אתילצלולוז בעל משקל מולקולרי‬
‫נמוך והשימוש בו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]32[
]52[
]72[
]71[
]17[
]74[
]57[
60/574599
]31[ 26.05.2004
]33[ US
Int. Cl.(2010.01) C08B 11/00, 11/02, 11/20
DOW GLOBAL TECHNOLOGIES
INC., U.S.A.
MICHAEL V. SPENCER
WO/2005/118649
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Ethylcellulose having an ethoxyl content of from 40 to 55 percent and a viscosity of
from 1 to 100 mPas, measured as a 5 weight percent solution in toluene and ethanol at
a volume ratio of 80:20 at 25°C, is produced by depolymerization of an ethylcellulose
having an ethoxyl content of from 40 to 55 percent and a viscosity of from 4 to 400
mPas in the presence of gaseous hydrogen halide to achieve a reduction in viscosity of
the ethylcellulose of at least 10 percent.
__________________
]22[]12[
179437
– 3,1–‫–אילידן–פרופאן‬4–‫תולדות בנזאימידאזול‬
‫דיאון ותכשירי רוקחות שלהן‬
]54[
BENZIMIDAZOL-2-YLIDENE
PROPANE-1,3-DIONE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS THEREOF
]11[
]32[
02.06.2005
2004-166486 ]31[ 04.06.2004
]33[ JP
1115-199125
3121321115
JP
Int. Cl.(2010.01) A61K 31/4184, 31/4439, A61P 05/04, 13/08, 35/00, 43/00, C07D
235/04, 235/12, 401/06, 401/10, 401/14, 405/10, 405/14, 409/06
ASTELLAS PHARMA INC., JAPAN
WO/2005/118556
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
268
It is intended to provide a compound which is useful as a GnRH receptor antagonist.
As the results of studies on propane-1,3-dione derivatives, it is confirmed that, among
propane-1,3-dione compounds having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), a
compound having a benzene or thiophene ring substituted by a group derived from 1hydroxyalkyl has excellent blood transfer properties in addition to an excellent GnRH
November 30, 2011-‫ד' בכסלו התשע"ב‬
receptor antagonism. Because of having excellent blood transfer properties in addition
to a potent GnRH receptor antagonism, the above compound is expected as exhibiting
excellent drug effects in vivo and being useful in treating sex hormone-dependent
diseases such as prostatic cancer, breast cancer, uterine endometrium, uterine myoma
and prostate hypertrophy. Moreover, this compound is excellent in metabolic stability
in humans and shows little interactions among drugs. Namely, it has further preferred
properties as drugs to be used for the above diseases.
__________________
]22[]12[
179505
–3–‫–פאניל‬1–‫–אוקסו‬4 ‫תהליך ליצור של‬
‫] הקסאן‬3 .1 .1[‫אוקסאביציקלו‬
]54[
PROCESS FOR PRODUCING 2OXO-1-PHENYL-3OXABICYCLO[3.1.0]HEXANE
]11[
]32[
]52[
]72[
14.06.2005
2004-178957
]31[ 16.06.2004
]33[ JP
Int. Cl.(2010.01) C07D 307/93, 309/30
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2005/123709
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Disclosed is a method for producing 2-oxo-1-phenyl-3-oxabicyclo[3.1.0]hexane
comprising a step for reacting phenyl acetonitrile with epichlorohydrin in the presence
of sodium hydride. With this method, 2-oxo-1-phenyl-3-oxabicyclo[3.1.0]hexane can
be produced safely, simply and commercially advantageously.
]17[
]74[
]57[
__________________
]22[]12[
]54[
269
INJECTION MOLDING METHOD
AND SYSTEM AND MOLDED
PRODUCTS MANUFACTURED
THEREBY
179588
‫מערכת ושיטה ליציקה בהזרקה ומוצרים‬
‫מיוצקים המיוצרים דרכן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]52[
]72[
]74[
26.11.2006
Int. Cl.(2010.01) B29C 45/14
KETER PLASTIC LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A method of manufacture comprising:
(I) providing a substrate, comprising at least one electrically conducting layer overlaid
with at least one dielectric outer facing layer, and further comprising an inner facing
surface,
(II) applying an electrostatic charge to said outer facing layer,
(III) electrostatically holding said substrate in a desired position within a mold cavity,
(IV) injecting a suitable molten material into said mold cavity in a manner such that at
least a layer of said molten material possesses said substrate via said inner facing
surface, and allowing the molten material to solidify , the substrate being effectively
integrally set with respect to the solidified material to produce an item of manufacture,
wherein step (II) comprises holding the substrate in a configuration generally
corresponding to the form to be adopted by the substrate in step (IV) providing a
ground reference surface facing said inner facing surface, and establishing a suitable
electric field between an electric charger and said ground reference surface, wherein
the substrate in electrically charged outside of said mold cavity.
‫ הרצליה‬,‫כתר פלסטיק בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
179599
‫ תכשירים‬,‫אנטגוניסטים של רצפטור גלוקגון‬
‫רפואיים המכילים אותם ושימושם בהכנת‬
‫תרופות לטיפול בסוכרת או בהפרעות מטבוליות‬
‫אחרות הקשורות לגלוקגונים‬
]54[
GLUCAGON RECEPTOR
ANTAGONISTS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR TREATING
DIABETIC OR OTHER
GLUCAGON RELATED
METABOLIC DISORDERS
]11[
]32[
]52[
08.06.2005
60/579362
]31[ 14.06.2004
]33[ US
Int. Cl.(2010.01) A61K 31/19, 31/275, 31/335, 31/395, A61P 03/08, 03/10, C07C
235/52, 255/54, 323/62, C07D 213/63, 213/89, 295/096, 319/04
270
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
ELI LILLY AND COMPANY, U.S.A.
WO/2005/123668
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention discloses novel compounds of Formula I, or pharmaceutically
acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist
activity, as well as methods for preparing such compounds. In another embodiment,
the invention discloses pharmaceutical compositions comprising compounds of
Formula I as well as methods of using them to treat diabetic and other glucagon related
metabolic disorders, and the like.
__________________
]22[]12[
179600
‫הכנה אנאנטיוסלקטיבית של נגזרת של קוינולין‬
]54[
ENANTIOSELECTIVE
PREPARATION OF QUINOLINE
DERIVATIVE
]11[
]32[
]52[
]72[
]17[
]74[
21.06.2005
0413960.6
]31[ 22.06.2004
]33[ GB
Int. Cl.(2010.01) C07D 215/00, 215/26, 251/26
NOVARTIS AG, SWITZERLAND
WO/2005/123684
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A process for preparing 8-substituted oxy-5-((R)-2-halo-l-hydroxy-ethyl)-(1 H)quinolin-2-ones or acceptable solvates thereof. The process involves reacting a 5(alpha-haloacetyl)-8-substituted oxy-(1H)-quinolin-2-one with a reducing agent in the
presence of a chiral agent and a base to form a 8-(substituted oxy)-5-((R)-2-halo-lhydroxy-ethyl)-(1H)-quinolin-2-one, said chiral agent having a formula (I) or (II),
wherein M, L, X, R1, R2 and R3 have the meanings as indicated in the specification.
]57[
271
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
179684
‫צירופים המכילים גורמים אנטי–מוסקרינים‬
‫וקורטיקוסטירואידים‬
]54[
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
CORTICOSTEROIDS
]11[
]32[
]52[
]72[
]17[
]74[
31.05.2005
P200401312
]31[ 31.05.2004
]33[ ES
Int. Cl.(2010.01) A61K 31/137, 31/167, 31/439, 31/58, 31/655, 45/00, A61P 11/00
ALMIRALL, S.A., SPAIN
WO/2005/115466
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
A combination which comprises (a) a corticosteroid and (b) an antagonist of M3
muscarinic receptors which is 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3phenoxypropyl)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X,
which is a pharmaceutically acceptable anion of a mono or polyvalent acid
__________________
]22[]12[
179687
‫צירופים המכילים גורמים אנטי מוסקרינים‬
‫ואגוניסטים בתא–אדרנרגים‬
]54[
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
BETA-ADRENERGIC AGONISTS
]11[
]32[
]52[
]72[
31.05.2005
P200401312
]31[ 31.05.2004
]33[ ES
Int. Cl.(2010.01) A61K 31/137, 31/167, 31/439, 31/58, 45/00, 45/06
ALMIRALL, S.A., SPAIN
272
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
WO/2005/115467
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A combination which comprises (a) a beta2 agonist and (b) an antagonist of M3
muscarinic receptors which is 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3phenoxypropyl)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X,
which is a pharmaceutically acceptable anion of a mono or polyvalent acid.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
179726
]54[
METHOD FOR ENHANCING
DIFFERENTIATION OF HES
CELLS INTO
CARDIOMYOCYTES
]11[
]52[
]72[
01.06.2004
Int. Cl.(2010.01) C12N 05/16
ES CELL INTERNATIONAL PTE
LTD., SINGAPORE
WO/2005/118784
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides a method of enhancing the efficiency of differentiation
of hES cells into cardiomyocytes which method comprises incubating the cells under
serem free conditions. The method typically includes providing cells that induce
cardiomyocyte differentiation by cell to cell contact. Differentiation to cardiomyocytes
can occur via two routes, namely by spontaneous differentiation and by induced
differentiation. Without wishing to be bound by theory, the present inventors
hypthesise that, in the case of induced differentiation, END-2 cells, for instance, are
needed for aggregation to cause local high cell densities and in inducing differentation
of nascent mesodern. This second step could be enhanced in any human embryonic
stem cell line leading to the prediction that it will work in lines other than hES. In cell
lines that undergo sponantaneous differentiation, it is hypothesised that local induction
of embryoid bodies in edoderm occurs. Typically for induced differentiation this
method will also comprise culturing the hES cell with a cell excreting at least one
cardiomyocyte differentiation inducing factor or with an extracellular medium
therefrom, under conditions that induce differentiation.
]17[
]74[
]57[
273
hES ‫שיטה לשיפור התמיינותם של תאי‬
‫לקרדיומיוציטים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
IMAGE-AUGMENTED INERTIAL
NAVIGATION SYSTEM (IAINS)
AND METHOD
]11[
]32[
]52[
]72[
02.06.2005
60/576037
]31[ 02.06.2004
Int. Cl.(2010.01) G01C 21/00, 22/00
ROCKWELL COLLINS CONTROL
TECHNOLOGIES, INC., U.S.A.
WO/2005/119178
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
179775
) IAINS( ‫מערכת ניווט עם תמונה מוגדלת‬
‫ושיטה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An image-augmented inertial navigation system (LAWS) mounted on a vehicle (10)
includes an inertial navigation system (INS) configured to estimate a navigation state
vector and an imager (12) configured to output pixel signals associated with terrain
features passing through a field of view (x, y, z) of the imager. The system (IAINS)
further includes a processing unit operatively connected to the inertial navigation
system (INS) and the imager (12). The processing unit is configured to sense a
distance from the imager to a centroid of one or more of the terrain features passing
though a field of view of the imager for a given image frame associated with the
feature pixel signals. The processing unit is also configured to track each terrain
feature as the terrain features pass through the field of view of the imager. The
processing unit is further configured to update the navigation state vector of the inertial
navigation system (INS) based on calculated NED (North, East, Down) coordinates
position information of the inertial navigation system (INS) relative to the tracked
terrain features.
__________________
274
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
179871
‫תהליך להכנה של גבאפנטין‬
]54[
PROCESS FOR THE PREPARATION
OF GABAPENTIN
]11[
]32[
]52[
]72[
]17[
]74[
22.06.2005
MI2004A001271 ]31[ 24.06.2004
]33[ IT
Int. Cl.(2010.01) C07C 231/10, 233/08, C07D 221/20
ZAMBON GROUP S.P.A., ITALY
WO/2006/000562
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to a process for the preparation of gabapentin and, more
in particular, to a method of synthesis of 1,1-cyclohexane acetic acid monoamide, an
intermediate used in the preparation of gabapentin, comprising the basic hydrolysis
reaction of alpha ,alpha'-diaminocarbonyl-beta,beta'-pentamethylene glutarimide2
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
179904
‫תולדות איזוקסאזול ותכשירים המכילים אותן‬
BCL ‫לטיפול במחלות המתווכות על ידי חלבון‬
]54[
ISOXAZOLE DERIVATIVES AND
COMPOSITIONS COMPRISING
THEM FOR TREATING BCLMEDIATED DISORDERS
]11[
]32[
17.06.2005
60/580616
]31[ 17.06.2004
]33[ US
419459312
1721321115
US
Int. Cl.(2010.01) A61K 31/42, A61P 35/00, C07D 261/00, 261/02
INFINITY DISCOVERY, INC., U.S.A.
WO/2006/009869
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
275
One aspect of the present invention relates to isoxazoline derivatives that bind to bcl
proteins and inhibit Bcl function. Another aspect of the present invention relates to
November 30, 2011-‫ד' בכסלו התשע"ב‬
compositions comprising an isoxazoline derivative of the invention. The present
invention provides methods for treating and modulating disorders associated with
hyperproliferation, such as cancer.
__________________
]22[]12[
179906
‫ תכשירים‬,‫ תהליך להכנתן‬,‫תולדות הידנטואין‬
‫רוקחיים הכוללים אותן ושימושן בהכנת תרופות‬
‫לטיפול במחלה חסימתית של דרכי נשימה‬
]54[
HYDANTOIN DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF OBSTRUCTIVE
AIRWAY DISEASES
]11[
]32[
]52[
]72[
]71[
04.07.2005
0401762-0
]31[ 05.07.2004
]33[ SE
Int. Cl.(2010.01) A61K 31/506, A61P 11/00, C07D 401/14
ASTRAZENECA AB, SWEDEN
BALINT GABOS, LENA RIPA,
KRISTINA STENVALL
WO/2006/004532
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention provides compounds of formula (I), wherein R 1 and R2 are as defined in
the specification; processes for their preparation; pharmaceutical compositions
containing them; a process for preparing the pharmaceutical compositions; and their
use in therapy.
]17[
]74[
]57[
276
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
180026
‫נגזרי פיפראזין ותכשירים המכילים אותם‬
]54[
PIPERAZINE DERIVATIVES AND
PREPARATIONS CONTAINING
THEM
]11[
]32[
]52[
16.06.2005
60/581197
]31[ 17.06.2004
]33[ US
Int. Cl.(2010.01) A61K 31/42, 31/4245, 31/433, 31/44, 31/4545, 31/496, 31/506,
A61P 09/00, C07D 213/72, 295/26, 401/02, 403/02, 413/12, 513/04
CYTOKINETICS, INC., U.S.A.
BRADLEY P. MORGAN, ALEX
MUCI, PU-PING LU, ERICA
KRAYNACK, TODD TOCHIMOTO,
DAVID MORGANS
WO/2006/009726
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for
example by potentiating cardiac myosin, and are useful in the treatment of systolic
heart failure including congestive heart failure.
]72[
]71[
]17[
]74[
]57[
__________________
]22[]12[
]54[
SHIELD AND A PROJECTILE,
SUCH AS A SHELL, WHICH IS
EQUIPPED WITH ONE SUCH
SHIELD
]11[
]32[
]52[
]72[
]17[
24.06.2005
0407009
]31[ 25.06.2004
Int. Cl.(2010.01) F42B 15/36
TDA ARMEMENTS S.A.S., FRANCE
WO/2006/000575
277
180186
‫ המצויד עם מגן אחד‬,‫ כדוגמת פגז‬,‫מגן וקליע‬
‫מסוג זה‬
]33[
FR
November 30, 2011-‫ד' בכסלו התשע"ב‬
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a shield, such as the shield of a projectile comprising a
pyrotechnic charge, which is positioned between the pyrotechnic part and the
command and control part. The inventive shield comprises at least: one wall (21)
which is pierced with a conduit (22); and an end cap (23) consisting of a support part
(232) and a part (231) which is engaged in the conduit, such as to leave a space (25)
between same and the wall of the conduit, said two parts being connected by a
mechanically-brittle area (26). According to the invention, the support part (232) rests
on the wall (21) at the front, such that the engaged part (231) separates from the
support part under the effect of an external pressure in order to come into contact with
the inner wall of the conduit (22) and close the space (25). The invention is particularly
suitable for shells which detonate following a programmed delay after impact with the
target.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
__________________
]22[]12[
]54[
METHOD AND INTERMEDIATE FOR
PRODUCING 4(BENZIMIDAZOLYLMETHYLAMINO)BENZAMIDINES
]11[
]32[
]52[
]72[
18.06.2005
04014917.1
]31[
25.06.2004
Int. Cl.(2010.01) C07D 271/07
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH, GERMANY
278
180247
–2 ‫שיטה וחומר ביניים לייצור‬
–)‫(בנזימידאזולילמתיל אמינו‬
‫בנזאמידינים‬
]33[
EP
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
WO/2006/000353
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to a method for producing an optionally substituted 4benzimidazol-2-ylmethylamino-benzamidine. Said method is characterised in that (a)
an optionally correspondingly substituted diaminobenzol is condensed with 2-[4-(1,2,4oxadiazol-5-on-3-yl)-phenylamino]-ethanoic acid, (b) the thus obtained product is
hydrogenated, and (c) optionally the amidino group is carbonylated.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
,1221/2
The applications for division from this
application have not yet been published
‫בקשות חלוקה‬
‫מבקשה זו שטרם‬
0‫פורסמו‬
__________________
]22[]12[
]54[
POLYURETHANE COATINGS
WITH IMPROVED INTERLAYER
ADHESION
]11[
]32[
]52[
]72[
23.06.2005
10/882884
]31[ 30.06.2004
Int. Cl.(2010.01) C09D 175/04
PRC-DESOTO INTERNATIONAL,
INC., U.S.A.
WO/2006/025925
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
180279
‫ציפויי פוליאוריתן בעלי הידבקות בין שכבות‬
‫משופרת‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Compositions for refinishing aged surfaces, and methods of refinishing aged surfaces
by applying compositions comprising at least one chlorinated polyolefin are disclosed.
__________________
]22[]12[
]54[
279
CANNULA FOR IN UTERO
180332
‫קנולה לניתוח תוך רחמי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
SURGERY
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
15.07.2005
10/891937
]31[ 15.07.2004
]33[
Int. Cl.(2010.01) A61B 17/34, A61M 27/00
CHILDREN'S MEDICAL CENTER
CORPORATION, U.S.A.
JAMES LOCK, PAUL C. KIERCE,
AUDREY C. MARSHALL
WO/2006/020055
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
US
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
A cannula, a straightener, and a cannula and straightener combination for insertion into
tissue, the cannula including an elongated rigid hollow tube having a proximal end, a
distal end, and a passageway extending therebetween. The distal end includes a
memory of directionality to bend about a radius. The cannula straightener straightens
the distal end of the cannula when inserted through the passageway of the cannula. The
present invention also includes methods of inserting a cannula, removing a cannula,
and performing surgery with a cannula in tissue or in fetal tissue. The present
invention further includes methods of performing biliary cannulation in a transhepatic
approach, performing fetal aortic valvuloplasty, placing catheters into the brachial
plexus for pain management, placing catheters into the epidural space for anesthesia,
thoracic dissection treatment, laparoscopic dissection, and hydro dissection of tissue.
__________________
]22[]12[
]54[
SUBSTITUTED 2-ALKYL
QUINAZOLINONE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM, A PROCESS FOR THE
PREPARATION THEREOF AND
USES THEREOF
]11[
28.06.2005
280
180382
,‫–אלקיל קווינאזולינון מותמרות‬4 ‫תולדות‬
‫ תהליך‬,‫תכשירים רוקחיים המכילים אותן‬
‫להכנתם והשימוש בהם‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]32[
]52[
]72[
]17[
]74[
]57[
04076887.1
]31[ 30.06.2004
]33[ EP
Int. Cl.(2010.01) A61K 31/517, 31/5375, A61P 35/00, 43/00, C07D 401/06, 401/14,
413/14
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2006/003150
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The present invention provides compounds of formula (I), their use as PARP inhibitors
as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein R1, R3, L, X, Y and Z have defined meanings.
__________________
]22[]12[
180599
6 ‫ או‬2 ‫תרכובות אמינואלקיל גלוקוסאמיניד‬
‫פוספט ותכשירים רפואיים המכילים אותן‬
‫להגברת התגובה החיסונית‬
]54[
AMINOALKYL GLUCOSAMINIDE
4- OR 6-PHOSPHATE
COMPOUNDS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME FOR ENHANCING
THE IMMUNE RESPONSE
]11[
]32[
]52[
]72[
]17[
]74[
24.06.2005
10/888683
]31[ 08.07.2004
]33[ US
Int. Cl.(2010.01) C07H 15/04
CORIXA CORPORATION, U.S.A.
WO/2006/016997
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Compounds that are adjuvants and immunoeffectors are described and claimed. The
compounds augment antibody production in immunized animals as well as stimulate
cytokine production and activate macrophages. Compositions and methods for using
the compounds as adjuvants and immunoeffectors are also disclosed.
]57[
281
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
180628
‫תהליכים להכנת פוספוליפידים מחומצנים‬
]54[
PROCESS FOR THE
PREPARATION OF OXIDIZED
PHOSPHOLIPIDS
]11[
]32[
]52[
]72[
]71[
10.07.2005
60/586219
]31[ 09.07.2004
]33[ US
Int. Cl.(2010.01) A61K 31/66, C07F 09/02
VASCULAR BIOGENICS LTD.
‫ אור יהודה‬,‫וסקולר ביוג'ניק בע"מ‬
GIDEON HALPERIN, ETI
‫ אתי קובלבסקי ישי‬,‫גדעון הלפרין‬
KOVALEVSKI-ISHAI
WO/2006/006161
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Novel synthetic routes, which are highly applicable for industrial preparation of
therapeutically beneficial oxidized phospholipids are disclosed. Particularly, novel
methods for efficiently preparing compounds having a glycerolic backbone and one or
more oxidized moieties attached to the glycerolic backbone, which are devoid of
column chromatography are disclosed. Further disclosed are novel methods of
introducing phosphorous-containing moieties such as phosphate moieties to
compounds having glycerolic backbone and intermediates formed thereby.
]17[
]74[
]57[
The applications for division
from this application have
not yet been published
,1221//,1221//
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
282
N-HYDROXYAMIDE
DERIVATIVES, THEIR
PREPARATION AND USE FOR
THE PREPARATION OF A
MEDICAMENT
180682
‫ הכנתן והשימוש‬,‫–הידרוקסיאמיד‬N ‫תולדות‬
‫בהן לייצור תרופות‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
25.07.2005
04103574.2
]31[ 26.07.2004
]33[ EP
419592222
1421721114
US
1521144229
3221221115
EP
419441914
1221121115
US
Int. Cl.(2010.01) A61K 31/496, 31/5355, A61P 09/10, 11/06, 19/02, 25/28, 29/00,
35/00, 37/00, 43/00, C07D 211/46, 211/58, 213/74, 241/34, 295/18, 401/04, 401/12,
403/04, 405/06, 405/14, 413/04, 413/14, 417/04, 487/04
MERCK SERONO S.A.,
SWITZERLAND
CATHERINE JORAND-LEBRUN,
DOMINIQUE SWINNEN, PATRICK
GERBER, AGNES BOMBRUN,
JEROME GONZALEZ, STEFANO
CROSIGNANI
WO/2006/010751
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The present invention is related to N-hydroxyamide derivatives of Formula (I) and use
thereof, in particular for the treatment and/or prophylaxis of autoimmune disorders,
inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer,
respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema,
chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
__________________
]22[]12[
]54[
SYSTEM AND METHOD FOR
MANAGING TRANSMISSION IN
A SENSITIVE INFORMATION
ENVIRONMENT
]11[
14.01.2007
283
180693
‫מערכת ושיטה לניהול תשדורת בסביבת מידע‬
‫רגיש‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]74[
Int. Cl.(2010.01) G08B 03/10, H04L 09/00, 09/12
ISRAEL AEROSPACE
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
INDUSTRIES LTD.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]57[
System for preventing leaks in a communication platform, the communication
platform including at least one transmitter and at least one sensitive-signal processor,
coupled therebetween, the system comprising: a controller coupled with said at least
one transmitter and with said sensitive-signal processors, said at least one transmitter
and said sensitive-signal processors defining at least one leak prone set, said at least
one leak prone set including a group of said at least one transmitter and another group
of at least one of said sensitive-signal processors, such that sensitive signals can leak
from said at least one sensitive-signal processor to said at least one transmitter, in each
of said at least one leak prone set, said controller identifying said at least one
sensitive-signal processor, and at least one transmitter, which are about to operate
simultaneously, said controller determining a highest priority sensitive-signal
processor among said at least one sensitive-signal processor , which is about to operate
simultaneously, said controller determining a highest priority transmitter among said
at least one transmitter, which is about to operate simultaneously, said controller
determining a lower priority element, and a higher priority element, among said
highest priority sensitive-signal processor and said highest priority transmitter, said
controller disabling an entire group which includes said lower priority element, while
said higher priority element operates.
__________________
]22[]12[
]54[
]11[
284
METHOD OF CONVERTING
ALKANES
180804
‫שיטה להמרת אלקנים‬
02.02.2005
November 30, 2011-‫ד' בכסלו התשע"ב‬
]32[
]52[
]72[
]17[
]74[
]57[
10/894165
]31[ 19.07.2004
Int. Cl.(2010.01) C07C 01/26, 05/327
GRT, INC., U.S.A.
WO/2006/019399
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
In a method of converting alkanes to their corresponding alcohols, ethers, olefins, and
other hydrocarbons, a vessel comprises a hollow, unsegregated interior defined first,
second, and third zones. In a first embodiment of the invention oxygen reacts with
metal halide in the first zone to provide gaseous halide; halide reacts with the alkane in
the second zone to form alkyl halide; and the alkyl halide reacts with metal oxide in
the third zone to form a hydrocarbon corresponding to the original alkane. Metal halide
from the third zone is transported through the vessel to the first zone and metal oxide
from the first zone is recycled to the third zone. A second embodiment of the invention
differs from the first embodiment in that metal oxide is transported through the vessel
from the first zone to the third zone and metal halide is recycled from the third zone to
the first zone. In a third embodiment of the invention the flow of gases through the
vessel is reversed to convert the metal oxide back to metal halide and to convert the
metal halide back to the metal oxide.
The applications for division
from this application have
not yet been published
,1818//
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
285
APPARATUS AND METHOD FOR
INTERACTIVE CONTENT
REQUESTS IN A NETWORKED
COMPUTER JUKEBOX
180876
‫מכשיר ושיטה לבקשות תוכן אינטראקטיביות‬
‫ברשת מחשוב ג'וקבוקס‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
21.07.2005
60/590120
]31[ 22.07.2004
]33[ US
Int. Cl.(2010.01) G11B 07/085
AKOO INTERNATIONAL, INC.,
U.S.A.
WO/2006/014739
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Communication link to a control which is coupled to a digital audio-visual playback
device for selecting and playing a stored digital media by the playback device. The
control receives the digital media request and transmits digital media selection and/or
the selected digital media content directly to a selected playback device or indirectly to
the selected playback device through a playback device server. The communication
between the control and the playback device can be through a global communication
network.
__________________
]22[]12[
181053
‫מערכת עירוי בעלת פרופיל נמוך‬
]54[
LOW PROFILE INFUSION SET
]11[
]32[
]52[
]72[
]74[
30.01.2007
11/355780
]31[ 16.02.2006
]33[ US
Int. Cl.(2010.01) A61M 05/00, 05/14, 05/158, 05/32, 25/06
ANIMAS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An infusion set (10) comprising :a cannula housing portion (12) having a base surface
286
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
(13)da septum housing portion (16) adapted to be pivotally attached to said cannula
housing portion, said septum housing portion having an axis and being pivotable
between a first position wherein said axis is substantially perpendicular to said base
surface and a second position wherein said axis is substantially parallel to said base
surfacedcharacterized in that a cannula (18) is supported in and extends from said
septum housing portion, through said cannula housing portion and from the base
surface, such that said cannula is substantially parallel to said axis when said septum
housing portion is in the first position; and said septum housing portion is pivotally
attached to said cannula housing at a selected pivot point and further wherein the pivot
point is selected so that pivoting of said septum housing portion relative to said
cannula housing does not affect the position of that portion of the cannula below the
base surface2
__________________
]22[]12[
]54[
287
DEVICE FOR RELEASABLY
FASTENINIG A DUST FILTER BAG
IN A VACUUM-CLEANING
APPLIANCE
181130
‫מתקן להתקנה מתפרקת של שקית סינון אבק‬
‫במכשיר ואקום לניקוי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]74[
01.02.2007
202006006268.8 ]31[ 12.04.2006
]33[
Int. Cl.(2010.01) A47L 09/14, B01D 46/00
BRANOFILTER GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Device has flange part (5) which is pluggable to adaptor plate (7) radially outside of
annular seal (14) and is pivotally connected to adaptor plate so that flange part is
pivotable for adaptor plate in stored position, arranged coaxial to adaptor plate and
interlocked with adaptor plate. In stored position sealing surface (17) of flange part is
held against adaptor plate and/or annular seal of adaptor plate arranged on adaptor
plate. Independent claims are also included for the following: (A) adaptor plate for the
device; and (B) dust filter bag with flange part.
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
PERMUTATION DATA
TRANSFORM TO ENHANCE
SECURITY
]11[
]32[
09.08.2005
10/918717
]31[ 12.08.2004
219921213
2121121114
219921721
2121121114
Int. Cl.(2010.01) H04K 01/04
CMLA, LLC, U.S.A.
WO/2006/023334
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]72[
]17[
]74[
]57[
288
181206
‫פרמוטציות של העברת מידע להגברת בטיחות‬
]33[
US
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
One data transformation permutes certain bits in a data input (1005) based on other bits
in the data input (1030). Another data transformation raises one segment of a data
input (1120) to a power of a function of another segment, the power being relatively
prime to a function of a predefined modulus (1115). The modulus is then applied to the
result (1125), and the transformed data assembled (113). In one key derivation
application, a segment of the master key is hashed (1415). Two numbers are derived
from another segment of the master key (1420). A universal hash function is applied to
the result (1430) of the hash, from which bits are selected as the derived key (1435). In
November 30, 2011-‫ד' בכסלו התשע"ב‬
another embodiment, an encoded counter is combined with segments (1510) of the
master key. The result is then hashed (1520), from which bits are selected as the
derived key (1525).
The applications for division
from this application have
not yet been published
,12211/,12211/,122111,122111
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
METHOD AND SYSTEM FOR
CONTROLLING ACCESS TO A
WIRELESS COMMUNICATION
MEDIUM
]11[
]32[
]52[
]72[
05.08.2005
60/601323
]31[ 12.08.2004
Int. Cl.(2010.01) H04L 12/28
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/020520
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
289
181221
‫שיטה ומערכת לבקרת גישה לאמצעי תקשורת‬
‫אלחוטי‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system for controlling access to a medium in a wireless communication
system. A superframe structure is defined in time domain to include a contention free
period (CFP) which has at least one scheduled resource allocation (SRA) (3712), at
least one management SRA (MSRA) (3718) and a contention period. An extended
beacon (EB) (3746) including information about the SRA and MSRA is transmitted
for. The architecture reduces station battery consumption, supports higher throughput
for non-real time (NRT) traffic and is more efficient for real time (RT) traffic while
maintaining full compatibility.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
METHOD FOR ASSEMBLING A
THERMAL TYMPANIC
THERMOMETER
]11[
]32[
]52[
]41[
]72[
15.04.2003
60/432904
]31[ 12.12.2002
Int. Cl.(2010.01) G01K 13/00
DIVISION FROM 168913
SHERWOOD SERVICES AG,
SWITZERLAND
WO/2004/055488
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
290
181374
‫שיטת הרכבה של מדחום להכנסה לתוף‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present disclosure provides a tympanic thermometer including a heat sensing
probe defining a longitudinal axis and an outer surface extending from a distal end of
the tympanic thermometer. The heat sensing probe includes a sensor housing
extending to a distal end thereof. A sensor can is mounted with the sensor housing and
a nozzle is mounted onto the sensor housing. The sensor can includes temperature
sensing electronics for sensing temperature via the heat sensing probe. The nozzle
includes a base disposed with the sensor housing and an elongated cylindrical nose
portion disposed about the sensor housing. The nozzle is configured to direct heat flux
to the distal end of the heat sensing probe. A probe cover is mountable to the distal end
of the tympanic thermometer. The probe cover has an inner surface configured to
engage an outer surface of the nozzle. The sensor can preferably include a lip
extending radially therefrom and contacting the nozzle at at least one contact point to
provide heat flux to the sensor can.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
MEDIUM AND METHOD FOR
CULTURING
UNDIFFERENTIATED STEM
CELLS
]11[
]32[
]52[
]72[
08.09.2005
60/608040
]31[ 08.09.2004
Int. Cl.(2010.01) C12N 05/00
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2006/029197
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
291
181437
‫מצע ושיטה לגידול תרבית של תאי גזע בלתי‬
‫ממויינים‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Previous methods for culturing human embryonic stem cells have required either
fibroblast feeder cells or a medium which has been exposed to fibroblast feeder cells in
order to maintain the stem cells in an undifferentiated state. It has now been found that
if high levels of fibroblast growth factor, gamma amino butyric acid, pipecholic acid,
lithium and transforming growth factor beta are added to the medium in which the
stem cells are cultured, the stem cells will remain undifferentiated indefinitely through
multiple passages, even without feeder cells or conditioned medium.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
181624
‫שיטה ומכשיר לייצור מוצרי נייר מפסאודו–גזע‬
‫של צמח בננה‬
]54[
METHOD AND APPARATUS FOR
PRODUCING PAPER PRODUCTS
FROM THE PSEUDOSTEMS OF
BANANA PLANTS
]11[
]32[
]52[
]72[
15.09.2005
2004905315
]31[ 16.09.2004
]33[
Int. Cl.(2010.01) D21B 01/00, D21H 11/12
PAPYRUS AUSTRALIA LIMITED,
AUSTRALIA
WO/2006/029469
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
292
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and apparatus for producing sheets from the pseudostems of banana plants
in the family Musaceae, each pseudostem having a longitudinal axis. The method
includes the steps of feeding a pseudostem (14) into a workstation, supporting (62, 34)
the pseudostem for rotation thereof about its longitudinal axis within the workstation,
and contacting the rotating pseudostem along substantially its entire length with a
fibre-separating device (38), whereby a continuous sheet of fibre (60) is removed from
the pseudostem by the fibre-separating device during rotation. Raw paper may also be
made by laminating two or more of these sheets together such that the direction of the
generally parallel fibres in at least two adjacent sheets is not aligned and then curing
the sheets to form raw paper.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
181631
‫תיאום מסר הנשלח במערכת תקשורת אקראית‬
]54[
MESSAGE SYNCHRONIZATION
OVER A STOCHASTIC NETWORK
]11[
]32[
]52[
]72[
]17[
]74[
29.08.2005
10/931178
]31[ 30.08.2004
]33[
Int. Cl.(2010.01) H04J 03/06, H04L 07/00
HARMONIC INC., U.S.A.
WO/2006/026683
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Methods and apparatus to communicate between a local component (210) and a remote
component (230), where the local component (210) is connected to the remote
component (230) using a non-deterministic communication link (220). A local clock
(216) is synchronized with a remote clock (236) to within a maximum offset. A rate
message (226) from the remote component (230) is received at the local component
(210), where the rate message (226) includes a first time stamp. A data rate is adjusted
using the rate message (226) when the time of the local clock (216) substantially
matches a time determined using the first time stamp. A data message (222) is sent to
the remote component (230) using the adjusted data rate, where the data message (222)
includes a second time stamp for use in processing data in the data message (222). In
some implementations, the time determined using the first time stamp is also
determined using information about a communication link delay and/or a clock offset.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
293
PREFORMED COMPOSITIONS IN
181646
‫הרכבים מעוצבים מראש בצורה נגזרת המכילים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫תערובות פולימרים‬
SHAPED FORM COMPRISING
POLYMER BLENDS
]11[
]32[
]52[
]72[
]17[
]74[
]57[
02.09.2005
10/935857
]31[ 08.09.2004
Int. Cl.(2010.01) C08L 81/02, 81/04
PRC-DESOTO INTERNATIONAL,
INC., U.S.A.
WO/2006/029145
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Preformed compositions in shaped form comprising polymer blends, and the use of
these preformed compositions in shaped form to seal apertures are disclosed. In certain
embodiments, the preformed compositions are electrically conductive and are capable
of shielding EMI/RFI radiation. The polymer blend includes a polysulfide component
and a polythioether component.
__________________
]22[]12[
181737
‫ רכיב המיוצר‬,‫שיטה לחיבור רכיבים קרמיים‬
‫מקרמיים לא מחומצנים עם חיבור ללא תפרים‬
]54[
METHOD FOR JOINING CERAMIC
COMPONENTS, AND COMPONENT
MADE FOR UNOXIDISED
CERAMIC WITH A SEAMLESS
JOIN
]11[
]32[
]52[
]72[
06.09.2005
102004044942.2 ]31[ 16.09.2004
]33[
Int. Cl.(2010.01) B23K 20/02, F01D 25/28
ESK CERAMICS GMBH & CO, KG,
GERMANY
WO/2006/029741
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
294
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for joining ceramic components, said method being
characterised in that the components to be joined consist of sintered unoxidised
ceramic. The components are brought into contact by means of a diffusion-welding
method in the presence of a protective gas atmosphere, and are joined in a lowdeformation manner to form a monolith, at a temperature of at least 1600 °C,
November 30, 2011-‫ד' בכסלו התשע"ב‬
preferably above 1800 °C, especially preferably above 2000 °C, optionally with the
application of a load, the components to be joined undergoing a plastic deformation of
less than 5 %, preferably less than 1 %, in the direction of the application of force. The
invention also relates to a structure consisting of unoxidised ceramic with a seamless
join.
__________________
]22[]12[
181747
‫–((פנוקסיאלקיל)תיו)–של חומצות‬2
‫פנוקסיאצטיות ואנלוגים‬
]54[
4-((PHENOXYALKYL)THIO)PHENOXYACETIC ACIDS AND
ANALOGS
]11[
]32[
]52[
14.09.2005
60/609942
]31[ 15.09.2004
]33[ US
Int. Cl.(2010.01) A61K 31/192, 31/277, A61P 31/06, 31/10, C07C 323/20, 323/62,
59/68
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2006/032023
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs,
compositions containing them, and methods of using them as PPAR modulators to
treat or inhibit the progression of, for example, dyslipidemia.
__________________
295
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
181750
‫תערובות של קוטלי פטריות המכילות תולדת‬
‫תיופן‬
]54[
FUNGICIDAL MIXTURES
COMPRISING A THIOPHENE
DERIVATIVE
]11[
]32[
]52[
]72[
27.09.2005
60/613430
]31[ 27.09.2004
]33[ US
Int. Cl.(2010.01) A01N 43/56, 43/64, A01P 03/00, C07D 251/50, 405/06, 409/12
E.I. DU PONT DE NEMOURS AND
COMPANY, U.S.A.
WO/2006/036827
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Disclosed are fungicidal mixtures, compositions and methods for controlling plant
diseases relating to combinations comprising (a) N-[2-(1,3-dimethylbutyl)-3-thienyl]1-methyl-3-(trifluoromethyl)-1H-pyrazole-4 carboxamide (including all stereoisomers)
or an agriculturally suitable salt thereof; and (b) at least one compound selected from
the group consisting of compounds of Formula III or Formula IV which act at the bc1
complex of the fungal mitochondrial respiratory electron transfer site wherein W, A,
B, D and R5 are disclosed in this specification, and agriculturally suitable salts
thereof; and optionally (c) at least one compound selected from the group of
compounds acting at the demethylase enzyme of the sterol biosynthesis pathway and
agriculturally suitable salts thereof.
]17[
]74[
]57[
__________________
]22[]12[
]54[
METHODS FOR SCREENING A
LIBRARY OF MOLECULES
]11[
]32[
07.10.2005
0422433.3
296
]31[
08.10.2004
181928
‫שיטות לסריקה של ספרייה של מולקולות‬
]33[
GB
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
141143227
1122121114
Int. Cl.(2010.01) C40B 30/04, G01N 33/68
AFFITECH RESEARCH AS,
NORWAY
WO/2006/038021
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides a method of screening a library of molecules to identify
and/or select one or more members thereof which are candidate binding partners for
one or more ligands comprising: a) contacting an expression library in solution with
one or more ligands; b) capturing ligands which have become bound to one or more
members of the expression library onto a solid phase; and c) detecting the presence of
a ligand, thereby detecting the presence of one or more members of the expression
library which are candidate binding partners for the ligand.
__________________
]22[]12[
181989
‫מחבר כדורי זויתי‬
]54[
ANGULATED BALL ABUTMENT
]11[
]52[
]72[
]71[
18.03.2007
Int. Cl.(2010.01) A61C 08/00, 13/12
ALPHA BIO TEC. LTD.
‫ פתח תקוה‬,‫אלפא ביו טק בע"מ‬
OPHIR FROMOVICH, BENI
‫ בני כרמון‬,‫אופיר פרומוביץ‬
KARMON
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A device for positioning a dental prosthesis-support-structure in a dental implant (45)
comprising: (a) an abutment element (13); (b) an anti-rotational collar (14) connected
]74[
]57[
297
November 30, 2011-‫ד' בכסלו התשע"ב‬
to a first end of said abutment element, said anti-rotational collar having a plurality of
circumferentially-disposed engagement surfaces so as to engage corresponding bore
surfaces in a dental implant when said collar is seated at least partially inside said
bore; and (c) a prosthesis-support-structure (16) permanently fixed to a second end of
said abutment element at a point offset from a center point of said abutment element,
wherein a user defines a position of said prosthesis-support-structure by aligning said
engagement surfaces with said bore surfaces.
,18/111
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
298
ROTATABLE FROZEN
CONFECTION AND SUPPORT
182016
‫רקיחת ממתק קפואה מסתובבת ותמיכה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
04.10.2005
26012004
]31[ 08.10.2004
]33[ CL
Int. Cl.(2010.01) A23G 09/00
NESTEC S.A., SWITZERLAND
WO/2006/037601
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A packaged frozen confection product comprising: a frozen confection item; a holderstick for supporting the frozen confection item fixed to the frozen confection item; in
combination with: a handle element rotatably attachable to the holder-stick for holding
the frozen confection with one hand and a crank fixedly attachable to the holder-stick
for rotating the holder-stick with the other hand.
__________________
]22[]12[
182031
‫שיטה לתמיכת הפעלה של מצב רדום במערכת‬
‫גישת רדיו פס–רחב‬
]54[
METHOD OF SUPPORTING
OPERATION OF SLEEP MODE IN
A WIDEBAND RADIO ACCESS
SYSTEM
]11[
]32[
12.09.2005
10-2004]31[ 30.09.2004
]33[
0078044
21-11141422221114
1119151
Int. Cl.(2010.01) H04B 01/16, H04W 52/02
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/036047
WOLFF, BREGMAN AND GOLLER,
]52[
]72[
]17[
]74[
299
KR
KR
,‫ ברגמן וגולר‬,‫וולף‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of supporting operation of sleep mode in a wideband radio access system is
disclosed. More specifically, a mobile subscriber station (MSS) which determines a
frame offset information for synchronizing listening windows of at least one MSS that
is in sleep mode, and transmits the determined framed offset information to at least one
MSS.
__________________
]22[]12[
182132
‫מקטע מפרקי לאנדוסקופ‬
]54[
ARTICULATION SECTION FOR
AN ENDOSCOPE
]11[
]32[
]52[
]72[
]71[
22.09.2005
164260
]31[ 23.09.2004
]33[ IL
Int. Cl.(2010.01) A61B 01/008
MEDIGUS LTD.
‫ עומר‬,‫מדיגוס בע"מ‬
ELAZAR SONNENSCHEIN, AMIR
‫ מינלו זוננשיין‬,‫ אמיר גוברין‬,‫אלעזר זוננשיין‬
GOVRIN, MINELU SONNENSCHEIN
WO/2006/033109
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention is an articulation section for an endoscope (10). The articulation section
(50) is characterized in that each one of its vertebrae (52) is comprised of several
pieces that can be easily assembled or disassembled. This arrangement allows the
replacement of individual ones of the vertebrae and/or the replacement of individual
ones of the wires, cables, fibers, and tubes that pass through the vertebrae section
without having to disassemble and reassemble the entire articulation section.
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
300
__________________
]22[]12[
]54[
CULTIVATION OF CULTURED
PRIMATE EMBRYONIC STEM
CELLS EXPRESSING OCT4,
SSEA4 OR TRA1-60
]11[
]32[
27.09.2005
10/952096
]31[ 28.09.2004
229171737
2221321115
Int. Cl.(2010.01) C12N 05/074
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WICELL RESEARCH INSTITUTE,
INC.
WO/2006/036925
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]72[
]17[
]74[
]57[
182143
‫גידול בתרבית של תאי גזע עובריים של יונק‬
1 – 61 ‫ או‬OCT4, SSEA4 ‫עליון המבטאים‬
TRA
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to methods for culturing human embryonic stem cells by
culturing the stem cells in an environment essentially free of mammalian fetal serum
and in a stem cell culture medium including amino acids, vitamins, salts, minerals,
transferring, insulin, albumin, and a fibroblast growth factor that is supplied from a
source other than just a feeder layer the medium. Also disclosed are compositions
capable of supporting the culture and proliferation of human embryonic stem cells
without the need for feeder cells or for exposure of the medium to feeder cells.
__________________
]22[]12[
]54[
301
PARASITICICIDAL
COMPOSITION COMPRISING
AMITRAZ IN A NON-HYDROXYLGROUP-CONTAINING SOLVENT
MIXTURE, PROCESS FOR ITS
182312
‫תכשירים קותלי פרזיטים המכילים אמיטראז‬
‫ תהליך‬,‫בממיס שלא מכיל קבוצות הידרוקסיל‬
‫להכנתם ושיטה לטיפול בחיות בעלות דם–חם‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PREPARATION AND METHOD
FOR TREATING
HOMEOTHERMIC ANIMALS
]11[
]32[
]52[
]72[
]17[
]74[
]57[
07.10.2005
60/616995
]31[ 08.10.2004
]33[ US
419413444
1321521115
US
Int. Cl.(2010.01) A01N 37/18, 37/52, C07C 233/00
WYETH LLC, U.S.A.
WO/2006/042099
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention provides a stable composition which comprises a non-hydroxylgroup-containing solvent mixture comprising N,N-diethyl-m-toluamide and gammahexalactone, optionally with dimethyl sulfoxide, eucalyptol and 1-methoxy-2-propyl
acetate; and an effective amount of each of amitraz and at least one additional
parasiticidal compound, such as R-28153. Said composition allows for high
concentrations of a mixture of parasiticidal agents in a single application and is useful
for treating and controlling parasiticidal infection and infestation in a homeothermic
animal.
__________________
]22[]12[
182377
‫מערכת ושיטה לסימון חלקים‬
]54[
PARTS MARKING SYSTEM AND
METHOD
]11[
]32[
]52[
]72[
]17[
]74[
17.10.2005
60/727003
]31[ 15.10.2005
Int. Cl.(2010.01) G06F 19/00
THE FORCE, INC., U.S.A.
WO/2007/046801
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A parts marking system (100) has a memory (202) for storing data (230) indicative of
at least one algorithm associated with at least one object material and logic (214)
configured to display the at least one algorithm to a display device (210) and receive a
user input for at least one part in response to the displayed algorithm.
November 30, 2011-‫ד' בכסלו התשע"ב‬
302
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
182397
‫תולדות‬
,‫תיאזולילדיהידרואינדאזולים‬
‫תכשירי רוקחות המכילים אותן‬
‫וטטראהידרובנזתיאזול‬
‫אצטאמידים כתרכובות ביניים‬
‫להכנתן‬
]54[
THIAZOLYLDIHYDROINDAZOLE
DERIVATIVES, PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM AND
TETRAHYDROBENZTHIAZOLEACETAMIDE
INTERMEDIATES FOR THEIR PREPARATION
]11[
]32[
05.10.2005
102004048877.0
]31[
07.10.2004 ]33[ DE
21111511512321
1921121115
DE
1521713124
1521121115
EP
Int. Cl.(2010.01) A61K 31/429, A61P 35/00, C07D 277/62, 417/06, 513/04
BOEHRINGER INGELHEIM INTERNATIONAL
GMBH, GERMANY
WO/2006/040281
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
The invention relates to the compounds of general formula (1), wherein R 1 to R3 are
defined as in claim 1, which are suitable for use in the treatment of diseases that are
characterized by excessive or abnormal cell proliferation. The invention also relates to
the use of said compounds for producing a drug having the aforementioned properties.
__________________
]22[]12[
]54[
303
CHARGING NETWORK, CHARGING
182475
‫ התקן שגורם לחיוב ושיטה‬,‫רשת חיוב‬
‫לחיוב‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
AGENT APPARATUS AND CHARGING
METHOD THEREOF
]11[
]32[
]52[
]72[
]17[
]74[
]57[
20.04.2006
200510066099.6204 ]31[ 20.04.2005
Int. Cl.(2010.01) H04L 12/14
HUAWEI TECHNOLOGIES CO, LTD.,
CHINA
WO/2006/111095
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]33[
CN
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A charging network includes: traffic service component, for creating the charging event
during the services; charging agent apparatus, for connecting the traffic service
component with charging system, receiving the charging event sent by traffic service
component, determining the corresponding charging system according to the
information in charging event, and creating the charging request according to the
information in charging event, and then sending the created charging request to the
corresponding charging system. A charging system for charging according to the
received charging request. There are a charging agent apparatus and a charging
method. In the invention, charging agent apparatus is interactive with charging system
by adding the charging agent apparatus in the charging network, thereby it is not
necessary that the traffic service component connects directly with each required
interactive charging system, which decreases the complexity of the traffic service
component, also decreases the complexity of network.
__________________
]22[]12[
]54[
304
METHOD AND APPARATUS FOR
TRANSMITTING AND
182719
‫שיטה ומכשיר לשידור וקליטת אותות בקרה‬
)DOWNLINK( ‫בערוץ המסורת לוויני יורד‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
RECEIVING DOWNLINK
CONTROL INFORMATION IN A
MOBILE COMMUNICATION
SYSTEM SUPPORTING UPLINK
PACKET DATA SERVICE
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
‫במערכת קשר ניידת התומכים בשירות חבילות‬
)UPLINK( ‫מידע בתמסורת לווינית עולה‬
15.11.2005
10-2004]31[ 15.11.2004
]33[ KR
0093283
21-11142422221114
KR
1193743
Int. Cl.(2010.01) H04B 07/26, H04W 28/16, 72/14
SAMSUNG ELECTRONICS CO.,
LTD., REPUBLIC OF KOREA
YOUNG-BUM KIM, YONG-JUN
KWAK, JU-HO LEE, YOUNHYOUNG HEO, JOON-YOUNG CHO
WO/2006/052118
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A method and apparatus for transmitting and receiving downlink control information
in a mobile communication system supporting an uplink packet data service are
provided. To transmit packet data in an HARQ mobile communication system, a
second transceiver receives an RG as rate control information from a first transceiver.
The second transceiver sets the allowed maximum data rate of an HARQ process to
which the RG is applied to the allowed maximum data rate of an HARQ process
previous to the HARQ process, if the RG indicates hold. The second transceiver
transmits packet data within the set allowed maximum data rate to the first transceiver.
__________________
305
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
GLASS-DARKENING SYSTEM
WHICH IS SUITABLE FOR
WINDOWS AND SIMILAR
]11[
]32[
]52[
]72[
24.10.2005
P200402544
]31[ 25.10.2004
Int. Cl.(2010.01) E06B 03/677, 07/12
DANIEL MATOSES VERCHER,
SPAIN
DAVID MUNOZ MUNOZ, SPAIN
WO/2006/045871
PATENT4U LIMITED,
P.O.B. 2162, PETACH TIKVA
]17[
]74[
]57[
182784
‫מערכת להחשכת זכוכית אשר מתאימה לחלונות‬
‫ולדומיהם‬
]33[
ES
,‫פטנט פור יו לימיטד‬
‫פתח תקוה‬5115 .‫ד‬.‫ ת‬,
The invention relates to a glass-darkening system comprising a fluid-pumping device
which can fill and empty an internal chamber between two transparent glass panes or
pane segments belonging to a glazed structure. According to the invention, when the
chamber fills with fluid, the glazed structure darkens and, when the chamber empties,
the structure becomes transparent once again.
__________________
]22[]12[
182929
‫חזוי תגובה לכמותרפיה תוך שמוש בסמני בטוי‬
‫גנים‬
]54[
PREDICTING RESPONSE TO
CHEMOTHERAPY USING GENE
EXPRESSION MARKERS
]11[
]32[
]52[
]72[
04.11.2005
60/625485
]31[ 05.11.2004
]33[
Int. Cl.(2010.01) C12Q 01/68, G01N 33/574
GENOMIC HEALTH, INC., U.S.A.
NSABP FOUNDATION, INC., U.S.A.
]17[
WO/2006/052862
306
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention provides gene expression information useful for predicting
whether cancer patients are likely to have a beneficial response to treatment response
with chemotherapy.
__________________
]22[]12[
182973
‫שיטה ומכשיר להפחתת ריכוזי מתכת במים‬
]54[
METHOD AND APPARATUS FOR
REDUCING METAL
CONCENTRATION IN WATER
]11[
]52[
]72[
03.05.2007
Int. Cl.(2010.01) A61K 35/00, C02F 05/00, C25B 01/04
PH2O WATER TECHNOLOGIES
‫ או טכנולוגיות מים בע"מ‬.‫ טו‬.‫ אייץ‬.‫פי‬
LTD.
ALEXANDER MELAMUD, MOSHE
‫ גרגורי רוד‬,‫ משה קין‬,‫אלכסנדר מלמוד‬
KAIN, GREGORY RUD
SHILON ZUCKERSTEIN & CO.,
,'‫שילון צוקרשטיין ושות‬
AZRIELI CENTER 1, ROUND
16 ‫ קומה‬,‫ המגדל העגול‬1 ‫מרכז עזריאלי‬
TOWER, 19TH FLOOR,
‫תל אביב‬
TEL AVIV 67021
A device for decreasing the concentration of metallic components in water contained
]71[
]74[
]57[
in a reservoir, comprising (i) at least one electrolytic cell with water inlets,
comprising three electrodes (two cathodes and one anode or two anodes and one
cathode) and two ion selective membranes placed between said electrodes, providing a
divided cell containing four units; (ii) an aqueous fluid stream forming closed flow307
November 30, 2011-‫ד' בכסלו התשע"ב‬
circuits in which the mass of the fluid is essentially conserved; (iii) opened flowbranches through which the mass enters and exits the system; (iv) a vacuum cleaning
unit, for cleaning said electrolytic cell; and (v) a sedimentation tank connected to said
vacuum unit and said electrolytic cell and a collecting tank for collecting and
removing the sediment.
__________________
]22[]12[
183092
‫תאי גזע אנושיים לשימוש בטיפול במצבי ניוון‬
‫עצבי‬
]54[
HUMAN NEURAL STEM CELLS
FOR USE IN TREATING
NEURODEGENERATIVE
CONDITIONS
]11[
]32[
]52[
]72[
]17[
]74[
17.11.2005
62/629220
]31[ 17.11.2004
]33[ US
Int. Cl.(2010.01) A61K 35/30, A61P 25/28, C12N 05/0797
NEURALSTEM, INC., U.S.A.
WO/2006/055685
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method of treating neurodegenerative conditions is provided. Neural stem cells may
be implanted at and/or remote from a region of neuron degeneration. The methods can
include isolating neural stem cells from regions where specific types of neurons
corresponding to the neurons to be replaced are generated. The methods can include
isolating neural stem cells secreting growth factors affecting the growth and/or
regeneration of specific types of neuron. In this invention, we disclose a method of
treating such disorders, including several neurodegenerative disorders arising from the
lack of cells that produce particular neurotransmitters in neural circuitry by
transplanting exogenously cultured and expanded neural progenitors which, upon
transplantation into a neural tissue, differentiate into neurons capable of integrating
and producing neurotransmitters in sufficient quantities and in a sufficient manner to
overcome the symptoms associated with the neurodegeneration.
__________________
308
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
183106
‫ייצור חלבונים‬
]54[
PRODUCTION OF PROTEINS
]11[
]32[
]52[
]72[
28.11.2005
165484
]31[ 30.11.2004
]33[ IL
Int. Cl.(2010.01) C07K 01/00, C12N 05/10, 15/64, 15/79
MERCK SERONO S.A.,
SWITZERLAND
YEHUDA ASSARAF, LILAH
ROTHEM
WO/2006/059323
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
]71[
]17[
]74[
]57[
The present invention is of a method of producing proteins in mammalian cells using a
permanent selection in the absence of cytotoxic drugs. Specifically, the present
invention can be used to produce large quantities of highly pure human proteins which
are suitable for pharmaceutical applications.
__________________
]22[]12[
]54[
HEAT SINK WITH
MICROCHANNEL COOLING FOR
POWER DEVICES
]11[
]32[
]52[
14.11.2005
10/998707
]31[ 24.11.2004
Int. Cl.(2010.01) H05K 07/20
309
183311
‫מפזר חום עם קירור ע"י מיקרו–ערוצים עבור‬
‫התקני כח‬
]33[
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
GENERAL ELECTRIC COMPANY,
U.S.A.
WO/2007/001456
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An apparatus for cooling at least one heated surface includes a base plate defining a
number of inlet and outlet manifolds. The inlet manifolds are configured to receive a
coolant, and the outlet manifolds exhaust the coolant. The inlet and outlet manifolds
are interleaved. The apparatus also includes at least one substrate having inner and
outer surfaces. The inner surface is coupled to the base plate and defines a number of
microchannels that receive the coolant from the inlet manifolds and deliver the coolant
to the outlet manifolds. The microchannels are oriented substantially perpendicular to
the inlet and outlet manifolds. The outer surface is in thermal contact with the heated
surface. The apparatus also includes an inlet plenum that supplies the coolant to the
inlet manifolds, and an outlet plenum that exhausts the coolant from the outlet
manifolds. The inlet plenum and outlet plenum are oriented in a plane of the base
plate.
__________________
]22[]12[
183317
‫מערכות לטיוב מים‬
]54[
WATER RECLAMATION
SYSTEMS
]11[
]32[
]52[
]72[
05.12.2005
2004120501
]31[ 08.12.2004
]33[ EG
Int. Cl.(2010.01) B01D 05/00, E03B 03/28, F24J 03/06
MAGD AHMED KOTB ABDALLA
310
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/2006/061030
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Water reclamation system including a dome (C), on top of which is connected a
vertically arranged translucent cylinder (B), probably holding a water pump. A single
or multiple air entry structure (D) is connected over an underground placed
condensator pipe (F) to a container (G) for the water precipitated from the air sucked
in through the entry structure (D); the container (G) is connected over a pipe with the
bottom of the dome (C).
__________________
]22[]12[
183488
‫שיטה לבדיקת מהירות דליפה ממתקנים‬
‫אטומים בריק‬
]54[
METHOD FOR TESTING THE
LEAKAGE RATE OF VACUUM
ENCAPSULATED DEVICES
]11[
]32[
]52[
]72[
10.11.2005
04028993.6
]31[ 07.12.2004
]33[ EP
Int. Cl.(2010.01) G01M 03/18
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
WO/2006/061302
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention is directed to a method for testing the leakage rate of an
encapsulated device, comprising the step: bombing the device with a Neon and/or
Argon atmosphere using a bombing pressure of at least more than environmental
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
311
pressure and measuring the quality factor before and after bombing. Preferably, the
bombing time is about 10 to 100 hours, and the bombing pressure is 1,5 to 100 bar,
more preferably 1,5 to 5 bar and most preferably about 4 bar. With this test, the
leakage rate of fine leaks of the device may be determined. This test is helpful in
determining statistical surface contaminations or defects caused by wafer processing
that affect the seal integrity just enough to cause shorter lifetimes. Further, dicing, die
assembly and transfer molding may also introduce physical defects which may be
detected with the present method. Finally, the inventive test method may be useful for
process optimization: Hermeticity tests are a great help to optimize sealing processes.
__________________
]22[]12[
‫חתך כנף עם חריץ‬
]54[
SLOTTED AEROFOILS
]11[
]32[
]52[
]72[
29.05.2007
60/808957
]31[ 30.05.2006
Int. Cl.(2010.01) B64C 09/16
ISRAEL AEROSPACE INDUSTRIES
LTD.
MICHAEL SHEPSHELOVICH, ALEX
NAGEL
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]74[
]57[
183499
]33[
US
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
‫ אלכס נגל‬,‫מיכאל שפשלוביץ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A mild stall slotted aerofoil, comprising a leading element, a trailing element and a slot
therebetween, wherein said leading element is contoured to provide mild stall
characteristics for the aerofoil, wherein said aerofoil maintains a stall plateau for an
angle of attack range of at least 7 degrees where the lift coefficient associated with said
aerofoil is within up to about 5% of a maximum lift coefficient associated with said
aerofoil.
__________________
312
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
183556
‫שיטה לעיצוב מחט זעירה‬
]54[
METHOD OF MOLDING A
MICRONEEDLE
]11[
]32[
]52[
]72[
07.12.2005
60/634319
]31[ 07.12.2004
]33[
Int. Cl.(2010.01) A61M 37/00, B29C 45/56
3M INNOVATIVE PROPERTIES
COMPANY, U.S.A.
WO/2006/062974
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method of molding a microneedle using a mold apparatus that comprises a mold
insert (210) having the negative image of at least one microneedle (12), a compression
core (240), and a mold housing configured to allow a reciprocal motion between the
mold insert and the compression core. The mold apparatus has an open position and a
closed position. The mold apparatus is placed in the closed position and polymeric
material is injected into the closed mold apparatus. The injected polymeric material is
compressed between the mold insert and the compression core by a reciprocal motion
between the compression core and the mold insert. Also, molding methods wherein the
mold apparatus has sidewalls having an injection gate (270). Also, molding methods
comprising a heated mold insert. Also, molding methods comprising the application of
high frequency acoustic energy, such as ultrasonic energy, to the mold apparatus.
__________________
]22[]12[
]54[
313
PROCESS FOR THE PURIFICATION
OF GALANTHAMINE AND USE OF
183933
‫תהליך טיהור גאלאנתאמין ושימוש בתוצר‬
‫להכנת גאלאנתאמין הידרוברומיד‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
ITS PRODUCT FOR THE
PREPARATION OF
GALANTHAMINE
HYDROBROMIDE
]11[
]32[
]52[
]72[
]17[
]74[
23.11.2005
MI2004A002413 ]31[ 17.12.2004
Int. Cl.(2010.01) C07D 491/10
INDENA S.P.A., ITALY
WO/2006/063666
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
process for the purification of galanthamine (I) comprising precipitation of
galanthamine hydrobromide from a mixture of alkaloids obtained from a plant of the
Amaryllidaceae family containing galanthamine, treatment of the hydrobromide with
alkali, extraction and crystallization of galanthamine with a solvent of general formula
(II), in which R1 is hydrogen or methyl and R2 is selected from n-butyl, isobutyl, secbutyl and t-butyl. The resulting pure galanthamine can be conveniently used for the
preparation of galanthamine hydrobromide.
]33[
IT
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
METHOD FOR PROCESSING
IMAGES USING AUTOMATIC
GEOREFERENCING OF IMAGES
DERIVED FROM A PAIR OF
IMAGES CAPTURED IN THE
SAME FOCAL PLANE
]11[
]32[
16.12.2005
0413420
314
]31[
16.12.2004
183991
‫שיטה לעיבוד דמויות תוך שימוש בייחוס קרקעי‬
‫אוטומטי של דמויות נגזרות מזוג דמויות לכודות‬
‫באותו מישור מוקדי‬
]33[
FR
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
Int. Cl.(2010.01) G06T 17/50
CENTRE NATIONAL D'ETUDES
SPATIALES, FRANCE
WO/2006/064051
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention concerns a method for processing images using automatic
georeferencing of images derived from a pair of images acquired by two sensors
arranged in a single focal plane which consists in geometrically registering images
based on the generation of a digital terrain model in low stereoscopic base and on the
calculation of position offsets between the points of the digital terrain model taken as
reference and their counterparts identified in the generated digital terrain model. Said
method is applicable in automatic georeferencing of airborne and satellite images.
__________________
]22[]12[
184110
‫ירוט חוקי של רשת פרטית וירטואלית מבוססת‬
DSS1
]54[
LAWFUL INTERCEPTION OF
DSS1 BASED VIRTUAL PRIVATE
NETWORK
]11[
]52[
]72[
29.12.2004
Int. Cl.(2010.01) H04L 29/06, H04M 03/22, 07/00
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2006/071158
]17[
315
November 30, 2011-‫ד' בכסלו התשע"ב‬
]74[
]57[
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to methods and arrangements in a telecommunication
system to generate Interception Related Information IRI related to Virtual Private
Network VPN calls, which telecommunication system provides Virtual Private
Network services to at least one integrated exchange LE-C; in the system. The
exchange LE-C is associated with an Intercept Configuration Unit ICU. The method
comprises the following steps: - Sending from the Intercept Configuration Unit ICU to
the exchange LE-C, a request REQ to monitor Virtual Private Network calls involving
a defined Corporate Network CN-A. - Receiving by the exchange LE-C, a call
message SETUP; IAM in Virtual Private Network context comprising an
identification field identifying the defined Corporate Network CN-A. - Sending from
the exchange LE-C to the Intercept Configuration Unit ICU, Interception Related
Information IRI related to the call.
__________________
]22[]12[
184150
]54[
SURGICAL SYSTEM
]11[
]32[
]52[
]72[
]74[
21.06.2007
11/479668
]31[ 30.06.2006
]33[
Int. Cl.(2010.01) A61B 19/00, A61F 09/007
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
316
‫מערכת ניתוחית‬
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
A surgical system comprising: a touch screen display (115); a surgical console (100);
and a controller (200) coupled to the touch screen display and the surgical console, the
controller configured to: provide a GUI on the touch screen display, said GUI
comprising a representation of the surgical procedure and representations of one or
more surgical steps, wherein the GUI allows a user to perform one or more of addition,
removal and rearrangement of representations of surgical steps to the surgical
procedure representation by dragging and dropping representations of surgical steps
using the touch screen display, so as to modify the representation of the surgical
procedure; detect that the representation of the surgical procedure has been modified;
and modify the surgical procedure implemented by the surgical console to correspond
to the modified representation of the surgical procedure.
__________________
]22[]12[
]54[
REMOTELY COUPLED HYBRID
HUD BACKLIGHT
]11[
]32[
]52[
]72[
14.12.2005
11/027558
]31[ 30.12.2004
Int. Cl.(2010.01) G02B 27/01
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2006/073709
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
317
184287
‫עירוב תאורה אחורית בתצוגה עילית הנשלטת‬
‫מרחוק‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A head-up display assembly includes a liquid crystal display element (510), a first
backlight light source (514), and a remote backlight light source (518). The first light
source is physically mounted in proximity to the liquid crystal display element, and is
operable to directly backlight illuminate the liquid crystal display element. The remote
light source mounted physically remote from the liquid crystal display element, and is
operable to backlight illuminate the liquid crystal display element via a light guide
(520).
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
184298
‫ מכשירים ושיטות אלחוטיים להזרמת‬,‫מערכות‬
‫מדיה‬
]54[
WIRELESS STREAMING MEDIA
SYSTEMS, DEVICES AND
METHODS
]11[
]32[
04.03.2005
60/641076
]31[ 04.01.2005
]33[ US
229145211
1521121115
US
Int. Cl.(2010.01) H04N 07/00
AVOCENT HUNTSVILLE
CORPORATION, U.S.A.
KEVIN M. MCCAFFERTY,
RICHARD L. MOORE, IAIN
HUNTLY-PLAYLE, SHENG LI,
RICHARD A. SMITH, RUDOLPH J.
TIMMERMAN, DAVID C.
COVINGTON
WO/2006/073414
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A system (100) includes one or more transmitter devices (102-1) constructed and
adapted to transmit wireless streaming media, the transmitter device (102-1) connected
to at least one video source (104, 106, 108, 110) wherein the transmitter device (102-1)
is further constructed and adapted to automatically detect a type of active source signal
from the at least one video source (104, 106, 108, 110) and automatically convert that
signal, if necessary, to an appropriate output signal; and one or more receiver devices
(102-2) constructed and adapted to receive wireless signals, the receiver device (102-2)
connected to at least one video output device, (112, 114, 118) wherein the at least one
receiver device (102-2) is further constructed and adapte to produce, automatically an
appropriate signal for the at least one video output device, (112, 114, 118).
]52[
]72[
]71[
]17[
]74[
]57[
318
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
APPARATUS AND METHOD FOR
USING A COUNTERPROPAGATING SIGNAL
METHOD FOR LOCATING
EVENTS
]11[
]32[
]52[
]72[
15.12.2005
2005900109
]31[ 11.01.2005
Int. Cl.(2010.01) G02B 06/27
FUTURE FIBRE TECHNOLOGIES
PTY. LTD., AUSTRALIA
WO/2006/074502
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
319
184304
–‫התקן ושיטה לשימוש בשיטה הנוגדת‬
‫התפשטות אותות לאיכון מאורעות‬
]33[
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An apparatus and method for using a counter-propagating signal method for locating
events is disclosed. The apparatus and method uses a Mach Zehnder interferometer
through which counter-propagating signals can be launched. If the sensing zone of the
Mach Zehnder interferometer is disturbed, modified counter-propagating signals are
produced and the time difference between receipt of those signals is used to determine
the location of the event. Polarisation controllers (43, 44) receive feedback signals so
that the polarisation states of the counter-propagating signals can be controlled to
match the amplitude and/or phase of the signals. Detectors are provided for detecting
the modified signals.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
184439
‫–דומותמרות פניל כמעכבי‬4 ,5 ‫תולדות מתאנון‬
‫) לטיפול‬GLYT–1( 1 ‫גליצין טרנספורטר‬
‫בהפרעות נוירולוגיות ונוירופסיכיאטריות‬
]54[
2,5-DISUBSTITUTED PHENYL
METHANONE DERIVATIVES AS
GLYCINE TRANSPORTER 1
(GLYT-1) INHIBITORS FOR THE
TREATMENT OF
NEUROLOGICAL AND
NEUROPSYCHIATRIC
DISORDERS
]11[
]32[
]52[
10.01.2006
05100280.6
]31[ 18.01.2005
]33[ EP
Int. Cl.(2010.01) A61K 31/397, 31/4015, 31/45, 31/5355, A61P 25/28, C07D 205/04,
207/12, 213/643, 401/12, 413/10
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/077026
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of the general formula (I) wherein R1 is OR1 , -SR1 or is a heterocycloalkyl group; R1 is lower alkyl, lower alkyl substituted by
halogen, or is -(CH2)n-cycloalkyl; R2 is -S(O)2-lower alkyl or -S(O)2NH-lower alkyl;
R3 is aryl or heteroaryl, which are unsubstituted or substituted by one to three
substituents, selected from the group consisting of lower alkyl, lower alkoxy, CN,
NO2, -C(O)-lower alkyl, -C(O)O-lower alkyl, halogen or lower alkyl substituted by
halogen; n is 1 or 2; m is 1 or 2; and to pharmaceutically acceptable acid addition salts
thereof. It has been found that the compounds of general formula (I) are good
inhibitors of the glycine transporter 1 (GIyT-I).
]72[
]17[
]74[
]57[
__________________
320
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
184608
‫צנתר עבור השתלה דרך כלי דם של שסתומי‬
‫לב תותבים‬
]54[
CATHETER FOR THE
TRANSVASCULAR
IMPLANTATION OF PROSTHETIC
HEART VALVES
]11[
]32[
]52[
]72[
12.01.2006
102005003632.5 ]31[ 20.01.2005
]33[ DE
Int. Cl.(2010.01) A61F 02/24
JENAVALVE TECHNOLOGY, INC.,
U.S.A.
WO/2006/076890
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a catheter for the transvascular implantation of prosthetic heart
valves, in particular comprising self-expanding anchorage supports (10), which allow a
minimally invasive implantation of prosthetic heart valves. The aim of the invention is
to reduce the risk to the patient during the implantation. To achieve this, according to
the invention a prosthetic heart valve comprising anchorage supports is temporarily
housed in a folded form in a cartridge-type unit (4) during the implantation. The
cartridge-type unit can be fixed on the proximal end of a guide system (1), which
comprises a flexible region (9) that can be guided through the aorta. Actuating
elements (2, 3) run through the interior of the hollow guide system, said elements
permitting sections of the cartridge-type unit to be displaced radially about their
longitudinal axis and/or laterally in a proximal direction, thus allowing individual
sections of the anchorage support and the associated prosthetic heart valve to be
sequentially released.
]17[
]74[
]57[
The applications for division
from this application have not
yet been published
,12/2/1
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
321
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
BODY ARMOR WITH IMPROVED
KNIFE-STAB RESISTANCE
FORMED FROM FLEXIBLE
COMPOSITES
]11[
]32[
]52[
]72[
22.12.2005
11/037680
]31[ 18.01.2005
Int. Cl.(2010.01) F41H 01/02
HONEYWELL INTERNATIONAL
INC., U.S.A.
JHRG, LLC, U.S.A.
WO/2007/084104
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
184693
‫מגן שריוני לגוף הנוצר מחומרים מרוכבים‬
‫גמישים עם עמידות לדקירות סכין‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Flexible body armor formed from flexible composites which have improved knife-stab
resistance. The body armor is formed from composites which include layers of a fabric
base. formed from high tenacity fibers. and a rubber layer bonded to the fabric base. A
thermoplastic bonding layer may be used to bond the fabric and rubber layers together.
To provide ballistic resistance, the body armor may also include a ballistic resistant
composite of a network of high tenacity fibers.
__________________
]22[]12[
184699
]54[
FUSION PROTEIN COMPRISING
A TNF RELATED APOPTOSIS
INDUCING LIGAND (TRAIL)
PEPTIDE AND ITS PREPARATION
]11[
]32[
25.06.1996
08/496632
]31[ 29.06.1995
]33[ US
119541341
1222222995
US
Int. Cl.(2010.01) A61K 38/19, C07H 21/04, C07K 14/52, 14/705, 19/00, C12N 15/09,
15/19, 15/62, 15/63, C12P 21/02
DIVISION FROM 122408
IMMUNEX CORPORATION, U.S.A.
WO/1997/001633
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
]52[
]41[
]72[
]17[
]74[
322
‫ המשרה‬TNF–‫חלבון איחוי המכיל ליגנד דומה ל‬
‫) והכנתו‬TRAIL( ‫אפופטיזה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A fusion protein comprising:
(a) a TRAIL polypeptide having an amino acid sequence that is at least 80% identical
to an amino acid sequence selected from amino acids 1 to 281 of SEQ ID NO:2 or a
fragment thereof that is capable of inducing apoptosis of Jurkat cells, or amino acids 1
to 291 of SEQ ID NO:6 or a fragment thereof that is capable of inducing apoptosis of
Jurkat cells, wherein said TRAIL polypeptide is capable of inducing apoptosis of
Jurkat cells and
(b) a polypeptide heterologous to a peptide of (a).
__________________
]22[]12[
184717
]54[
IMIDAZO (1,2-A)PYRIDINE
COMPOUNDS AS VEGF-R2
INHIBITORS
]11[
]32[
]52[
]72[
]17[
]74[
23.02.2006
60/655981
]31[ 24.02.2005
]33[ US
Int. Cl.(2010.01) A61K 31/437, 31/496, 31/5377, A61P 31/04, 35/00, C07D 471/04
ELI LILLY AND COMPANY, U.S.A.
WO/2006/091671
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides compounds that are inhibitors of VEGF-R2 of the
formula: (I) and methods of using these compounds.
]57[
‫ ) פירידין כמעכבי‬A– 2, 1( ‫תרכובות אימידזו‬
R–VEGF4
__________________
323
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
184761
‫מדיה כרומטוגרפית‬
]54[
CHROMATOGRAPHIC MEDIA
]11[
]32[
]52[
]72[
16.12.2005
60/646780
]31[ 25.01.2005
]33[ US
Int. Cl.(2010.01) B01J 20/285, G01N 30/00, 33/68
AVANTOR PERFORMANCE
MATERIALS, INC., U.S.A.
WO/2006/081002
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
This invention concerns the preparation and use of novel polymeric chromatographic
media and preferably mixed mode polymeric chromatographic media. In accordance
with the present invention, polymeric media is prepared using polymeric particles
derivatized with polyethyleneimine, and preferably such polyethyleneimine derivatized
polymeric particles further functionalized with appropriate reactants. The polymeric
chromatographic media is especially useful for bioseparations.
]17[
]74[
]57[
__________________
]22[]12[
184818
‫מכשיר לחקר תאים כבודדים‬
]54[
DEVICE FOR STUDYING
INDIVIDUAL CELLS
]11[
]32[
]52[
]72[
]71[
]17[
]74[
26.07.2005
60/646512
]31[ 25.01.2005
]33[ US
Int. Cl.(2010.01) B01J 19/00, B01L 03/00, C12M 01/00, 03/00, G01N 33/48
SENG ENTERPRISES LTD., CYPRUS
MORDECHAI DEUTSCH
‫מרדכי דויטש‬
WO/2006/080000
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A device for the study of individual cells including a picowell array (such as an array
of microwells, dimples, depressions, tubes or enclosures) and a fluid reservoir in fluid
communication with the picowells through channels is disclosed. Preferably, the
device has a movable lid that in one rest location allows loading of cells into the
]57[
324
November 30, 2011-‫ד' בכסלו התשע"ב‬
picowell array. Preferably the channels of the device are capillary channels. Also
disclosed is a device for the automated study of cells including a picowell-bearing
device having a picowell array with a movable lid, a lid-moving component, at least
one solution dispensing component and a control system functionally associated with
the lid-moving component as well as with the solution dispensing component.
__________________
]22[]12[
184951
‫תולדות מליאימיד ותכשירי רוקחות המכילים‬
‫אותן לטיפול באי–סדרים הקשורים לחלוקת‬
‫התא‬
]54[
MALEIMIDE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM FOR TREATING CELL
PROLIFERATIVE DISORDER
]11[
]32[
]52[
09.02.2006
60/650951
]31[ 09.02.2005
]33[ US
Int. Cl.(2010.01) A61K 31/473, 31/551, 31/661, A61P 35/00, C07D 471/06, 487/06,
C07F 09/12
ARQULE, INC., U.S.A.
WO/2006/086484
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
325
The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and
pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of
these compounds. The present invention also relates to pharmaceutical compositions
comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinylpyrrolidine-2,5-dione compounds. The present invention provides methods of treating
a cell proliferative disorder, such as a cancer, by administering to a subject in need
thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione
compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present
invention.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
184960
‫התקן רפואי לערבוב תרופות נוזליות במקום‬
‫במיכלים רפואיים‬
]54[
MEDICAL DEVICE FOR IN SITU
LIQUID DRUG RECONSTITUTION
IN MEDICINAL VESSELS
]11[
]32[
]52[
]72[
13.02.2006
60/651999
]31[ 14.02.2005
]33[ US
Int. Cl.(2010.01) A61J 01/00
MEDIMOP MEDICAL PROJECTS
‫ רעננה‬,‫מדימופ פרויקטים רפואיים בע"מ‬
LTD.
WO/2006/085327
MEDIMOP MEDICAL PROJECTS
,‫מדימופ פרויקטים רפואיים בע"מ‬
LTD.,
11 ‫התדהר‬
17 HATIDHAR ST.
‫רעננה‬5466 .‫ד‬.‫ ת‬,
P.O.B. 2499
RA'ANANA 43665
Medical device for in situ liquid drug reconstitution in medicinal vessels containing
drug contents. The medical device includes a body member having a vessel port for
insertion into a medicinal vessel containing drug contents, and a syringe port for
receiving a syringe containing a diluent for reconstituting the drug contents into a
reconstituted liquid drug. The medical device includes a one-way flow restriction
mechanism between the two ports for positively restricting injection of diluent into a
medicinal vessel but only slightly restricting aspiration of reconstituted liquid drug
therefrom, if at all.
]17[
]74[
]57[
__________________
326
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
REAL-TIME IMAGE DETECTION
USING POLARIZATION DATA
]11[
]32[
]52[
]72[
01.02.2006
60/649260
]31[ 02.02.2005
Int. Cl.(2010.01) G06K 07/10
INTERGRAPH SOFTWARE
TECHNOLOGIES COMPANY, U.S.A.
WO/2006/083944
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
184987
‫גילוי תמונה בזמן אמת תוך שימוש בנתוני‬
‫פולריזציה‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention relates to a system and method of detecting polarized
identification indicia in real-time. A frame of image data is provided (110) having a
plurality of pixels, wherein each pixel includes polarized light intensity information.
An intensity value is determined for each of the pixels from the polarized light
intensity information (120). A first portion of the pixels having intensity values within
an intensity range is selected (130, 140). The pixels in the first portion having similar
angle of linear polarization values within a tolerance range are analyzed (180), thereby
detecting the polarized identification indicia in the image data (190).
__________________
]22[]12[
]54[
327
PROCESS FOR PREPARING 2,3-
185135
‫–דומותמרים‬3 ,4 ‫תהליך להכנת אינדולים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
DISUBSTITUTED INDOLES
]11[
]32[
]52[
]72[
]17[
]74[
]57[
10.02.2006
60/652072
]31[ 11.02.2005
Int. Cl.(2010.01) C07D 403/04
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
WO/2006/086657
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Disclosed are processes for making 2, 3 disubstituted indole compounds such as
compounds of general formula I comprised of the steps of a) reacting a bromoindole
compound (i) with a dialkoxyl C1-5 borane in the presence of a ligand, a palladium
catalyst and a base to make a compound of general formula (ii); or alternatively
reacting compound (i) with a trialkyl magnesiate reagent, followed by treatment with a
borate; b) reacting the product of step a with a R2-Hal where R2-Hal is defined herein.
,1211//
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
AIRCRAFT ENGINE FUEL
SUPPLY
]11[
]32[
]52[
]72[
]71[
17.02.2006
0501640
]31[ 17.02.2005
Int. Cl.(2010.01) F02C 09/26
SNECMA, FRANCE
JEAN MARIE BROCARD, REGIS
DELDALLE, PHILIPPE GALOZIO,
MICHEL MARTINI, ALAIN
VARIZAT
WO/2006/087377
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
]17[
]74[
328
185234
‫אספקת דלק למנוע של כלי טייס‬
]33[
FR
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention concerns a centrifugal pump (100) driven by being mechanically
coupled with the engine (14) has a low pressure input receiving fuel from a fuel circuit
(11) of the aircraft and a high pressure output connected to a circuit (120) regulating
the flow of fuel supplied to the engine, and an electrically-controlled auxiliary
pumping unit (10) having an input connected to the aircraft fuel circuit and an output
connected to the flow regulating circuit, to deliver on its fuel output at a predetermined
minimum pressure, the pressure of the fuel supplied to the regulating circuit being the
highest of those delivered by the centrifugal pump (100) and the auxiliary pumping
unit (110).
__________________
]22[]12[
185274
‫תכשיר עמילן צבור ושיטות להכנתו‬
]54[
AGGLOMERATED STARCH
COMPOSITION AND METHODS
FOR THE PRODUCTION
THEREOF
]11[
]32[
]52[
]72[
]17[
]74[
16.03.2006
60/664447
]31[ 23.03.2005
]33[ US
Int. Cl.(2010.01) A61K 09/20, C08B 30/00, C09D 103/00
BPSI HOLDINGS, LLC., U.S.A.
WO/2006/101945
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Agglomerated starch compositions containing native starch and pre-compacted starch
powder is disclosed. The agglomerated starch compositions have superior flow and
less pH sensitivity than simple blends of the two components at equivalent ratios.
]57[
329
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
185545
–2 ‫שיטה להכנת נגזרות של אתר‬
‫פירולידינופנילבנזיל טהור ותרכובות בינים‬
]54[
METHOD OF PREPARATION OF
PURE 4PYRROLIDINOPHENYLBENZYL
ETHER DERIVATIVES AND
INTERMEDIATE COMPOUNDS
]11[
]32[
]52[
]72[
14.03.2006
05102030.3
]31[ 15.03.2005
]33[ EP
Int. Cl.(2010.01) C07D 207/26
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/097270
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a method for preparing enantiomerically pure 4pyrrolidinophenylbenzyl ether derivatives of formula I wherein R1, R21, R22, R23, R24
and n are as defined in the description and claims and to intermediates useful in the
method of the invention as well as salts thereof.
]17[
]74[
]57[
__________________
330
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
185568
,‫אנלוגים בי וטרי ציקליים של נוקלאוזידים‬
‫נוקלאוטידים ואוליגונוקלאוטידים‬
]54[
BI- AND TRI-CYCLIC
NUCLEOSIDE, NUCLEOTIDE AND
OLIGONUCLEOTIDE
ANALOGUES
]11[
]32[
14.09.1998
1054/97
]31[ 12.09.1997
]33[ DK
2491997
2922122997
DK
1142991
2421222991
DK
1114991
1321322991
DK
1515991
1921422991
DK
419111319
1521422991
US
PA00750/98
1121422991
DK
PA00982/98
1121722991
DK
Int. Cl.(2010.01) C07H 01/00, 19/02, 21/00, C07K 02/00, C12N 09/00
DIVISION FROM 135000
EXIQON A/S, DENMARK
JESPER WENGEL, POUL NIELSEN
WO/1999/014226
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to novel bicyclic and tricyclic nucleoside and nucleotide
analogues of formula (I) as well as to oligonucleotides comprising such elements. The
nucleotide analogues, LNAs (Locked Nucleoside Analogues), are able to provide
valuable improvements to oligonucleotides with respect to affinity and specificity
towards complementary RNA and DNA oligomers. The novel type of LNA modified
oligonucleotides, as well as the LNAs as such, are useful in a wide range of diagnostic
applications as well as therapeutic applications. Among these can be mentionned
antisense applications, PCR applications, strand displacement oligomers, as substrates
for nucleic acid polymerases, as nucleotide based drugs, etc. The present invention
also relates to such applications.
]52[
]41[
]72[
]71[
]17[
]74[
]57[
__________________
]22[]12[
]54[
331
CRYSTALLISATION AND
185576
‫גיבוש וזיכוך של ברומיד גליקופיררוניום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
PURIFICATION OF
GLYCOPYRRONIUM BROMIDE
]11[
]32[
]52[
]72[
]17[
]74[
]57[
03.03.2006
0504463.1
]31[ 03.03.2005
]33[ GB
Int. Cl.(2010.01) C07D 207/12
SOSEI R&D LTD, UNITED
KINGDOM
WO/2006/092617
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A method for the production of crystalline glycopyrronium bromide, comprises the
reaction of glycopyrronium base with methyl bromide in a solvent, in which the
solvent is selected such that the diastereoisomeric ratio of the product favours the R,S
and S,R diastereoisomers over the R,R, and S,S diastereoisomers, and separating the
desired diastereoisomers by one or more controlled crystallisation steps. This method
gives a product having a particle size of narrow distribution.
__________________
]22[]12[
185701
]54[
METHOD AND SYSTEM FOR
AUTONOMOUS VEHICLE
NAVIGATION
]11[
]32[
]52[
]72[
04.09.2007
11/470120
]31[ 05.09.2006
]33[
Int. Cl.(2010.01) B64C 19/00, G05D 01/02
HONEYWELL INTERNATIONAL
INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
332
‫שיטה ומערכת לניווט עצמאי של כלי רכב‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system are provided for autonomous vehicle navigation. In the method
and system, one or more Global Positioning System (GPS) sensors, one or more
inertial sensors, and one or more image sensors are provided on an autonomous
vehicle. During operation of the autonomous vehicle, one or more GPS measurements,
one or more inertial measurements, and one or more image measurements are obtained
from the respective GPS sensors, inertial sensors, and image sensors. Each of the GPS
November 30, 2011-‫ד' בכסלו התשע"ב‬
measurements, inertial measurements, and image measurements are integrated together
to estimate a position of the autonomous vehicle over time.
__________________
]22[]12[
185702
‫שיטה למניעת התנגשות בין כלי טייס בלתי‬
‫מאוייש עם כלי טייס אחר‬
]54[
METHOD FOR COLLISION
AVOIDANCE OF UNMANNED
AERIAL VEHICLE WITH OTHER
AIRCRAFT
]11[
]32[
]52[
]72[
04.09.2007
11/470099
]31[ 05.09.2006
]33[
Int. Cl.(2010.01) G05D 01/10, G08G 05/04
HONEYWELL INTERNATIONAL
INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for collision avoidance of an unmanned aerial vehicle (UAV) (110, figure
1A) with other aircraft l120, figure 1A) such as a manned aircraft or another UAV is
provided. The method comprises detecting an aircraft approaching a flight path (114,
figure 1A) of an unmanned aerial vehicle, and estimating a position, range, and
velocity of the aircraft. An estimated path of the aircraft is determined from the
position, range, and velocity. A new flight path (130, figure 1B) is then calculated for
the unmanned aerial vehicle to a waypoint (118, figure 1B) to avoid the estimated path
of the aircraft.
__________________
]22[]12[
185851
‫ירוט חוקי של מנויים וציודים בלתי מורשים‬
]54[
LAWFUL INTERCEPTION OF
UNAUTHORIZED SUBSCRIBERS
AND EQUIPMENTS
]11[
]52[
]72[
18.03.2005
Int. Cl.(2010.01) H04L 12/26, H04M 03/22, H04W 12/02
TELEFONAKTIEBOLAGET L M
333
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
ERICSSON (PUBL), SWEDEN
WO/2006/098668
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to methods and arrangements in a telecommunication
system to override current access rights. The telecommunication system comprises an
Access Point IAP; MSC, SGSN associated with a Configuration Unit ICU. The
method comprises the following steps: - Receiving to the Access Point IAP; MSC,
SGSN from the Configuration Unit ICU, a request (1) to monitor a system member
MS, SIM. - Receiving to the Access Point from the Configuration Unit, a request (2)
to override deprived access rights for the system member MS, SIM. - Overriding in
the Accept Point IAP; MSC, SGSN, the deprived access rights for the member.
__________________
]22[]12[
]54[
METHOD FOR MAKING 1SUBSTITUTED 1H-IMIDAZO[4,5C]QUINOLIN-4-AMINE
COMPOUNDS AND
INTERMEDIATES THEREFOR
]11[
]32[
]52[
]72[
20.03.2006
05102229.1
]31[ 21.03.2005
Int. Cl.(2010.01) C07D 471/14
FERRER INTERNACIONAL, S.A.,
SPAIN
WO/2006/100226
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]17[
]74[
334
186040
–5,2[ ‫– אימידזו‬H 1 ‫שיטה להכנת תרכובות של‬
‫ ותוצרי‬1 ‫–אמין מותמר בעמדה‬2–‫] קוינולין‬C
‫ביניים שלהן‬
]33[
EP
,'‫ד"ר שלמה כהן ושות‬
154 ‫אבן גבירול‬
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
The present invention concerns a method for manufacturing 1-substituted 1H-imidazo
[4, 5-c] quinolin-4-amine compounds through their corresponding formamides. The
invention also concerns new formamide intermediates.
__________________
]22[]12[
]54[
ECONOMICAL LOUDNESS
MEASUREMENT OF CODED
AUDIO
]11[
]32[
]52[
]72[
23.03.2006
60/671381
]31[ 13.04.2005
Int. Cl.(2010.01) H04S 07/00
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2006/113047
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
186046
‫מדידה חסכונית של קולניות אודיו מוצפן‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Measuring the loudness of audio encoded in a bitstream that includes data from which
an approximation of the power spectrum of the audio can be derived without fully
decoding the audio is performed by deriving the approximation of the power spectrum
of the audio from said bitstream without fully decoding the audio, and determining an
approximate loudness of the audio in response to the approximation of the power
spectrum of the audio. The data may include coarse representations of the audio and
associated finer representations of the audio, the approximation of the power spectrum
of the audio being derived from the coarse representations of the audio. In the case of
subband encoded audio, the coarse representations of the audio may comprise scale
factors and the associated finer representations of the audio may comprise sample data
associated with each scale factor.
__________________
335
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
186074
‫שיטה לאיזומריזציה של תמיסה של נגזרת‬
‫ בנוכחות פוטוקטליזטור במהלך זרימה‬D ‫ויטמין‬
‫בפוטוראקטור‬
]54[
METHOD OF ISOMERIZING A
SOLUTION OF A VITAMIN D
DERIVATIVE IN THE PRESENCE
OF A PHOTOCATALYST IN A
FLOW-THROUGH
PHOTOREACTOR
]11[
]32[
]52[
]72[
]17[
]74[
08.05.2006
60/783076
]31[ 17.03.2006
]33[
Int. Cl.(2010.01) A61K 31/59, C07C 401/00
LEO PHARMA A/S, DENMARK
WO/2007/082533
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to an isomerisation method of vitamin D analogues, such
as compounds useful for the synthesis of calcipotriol, and to and to the use of a flowthrough photoreactor or continuous flow photoreactor reactor for making said vitamin
D analogues. The present invention relates further to the use of intermediates produced
with said method for making calcipotriol or calcipotriol monohydrate, or
pharmaceutical formulations thereof.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
186108
‫שיטות לחישוב נקודת הסוף בתהליך ניקוי או‬
‫הכשרה במערכת לעיבוד פלאזמה‬
]54[
METHODS FOR DETERMINING
THE ENDPOINT OF A CLEANING
OR CONDITIONING PROCESS IN
A PLASMA PROCESSING
SYSTEM
]11[
]32[
]52[
]72[
24.03.2006
11/092737
]31[ 28.03.2005
]33[
Int. Cl.(2010.01) B05C 11/00, C23C 16/52
LAM RESEARCH CORPORATION,
U.S.A.
ERIC HUDSON, KEIL, DOUGLAS,
ALEXEI MARAKHTANOV
WO/2006/104841
]71[
]17[
336
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]74[
]57[
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A method of determining an endpoint of a process by measuring a thickness of a layer,
the layer being deposited on the surface by a prior process is disclosed. The method
includes providing a sensor that is coplanar with the surface, wherein the sensor is
configured to measure the thickness. The method also includes exposing the plasma
chamber to a plasma, wherein the thickness is changed by the exposing, and
determining the thickness as a function of time. The method further includes
ascertaining a steady state condition in the thickness, the steady state condition being
characterized by a substantially stable measurement of the thickness, a start of the
steady state condition representing the endpoint.
__________________
]22[]12[
186192
]54[
CONTAINER OPENING TOOL
]11[
]32[
22.03.2006
60/664439
]31[ 22.03.2005
]33[
229314244
1121321114
Int. Cl.(2010.01) B67B 07/00, 07/40, 07/44
PROGRESSIVE INTERNATIONAL
CORPORATION, U.S.A.
WO/2006/102489
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
337
‫פותחן למיכלים‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A container opening tool includes first and second legs hingedly secured to one
another. Each leg has proximal and distal portions each having an aperture wall
including a gripping material. The aperture walls form of the first and second legs are
positionable to form proximal and distal apertures. The aperture walls of the distal
November 30, 2011-‫ד' בכסלו התשע"ב‬
portions define an elongate aperture, such as an oval or ellipse. Bottle opening flanges
secure to the first and second legs and project into the proximal aperture. When the
legs are pivoted together, the flanges are positioned adjacent one another and function
as a single bottle opener. A blade secures to the second leg near the distal end
positioned within a recess formed proximate the distal end of the second leg. A
projection is formed on the distal end of the first leg and positionable proximate the
blade to press a bag against the blade.
__________________
]22[]12[
]54[
INSULATED CONDUCTOR
TEMPERATURE LIMITED
HEATER FOR SUBSURFACE
HEATING COUPLED IN A THREEPHASE WYE CONFIGURATION
]11[
]32[
]52[
]72[
21.04.2006
60/674081
]31[ 22.04.2005
Int. Cl.(2010.01) E21B 36/00, 36/04
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116078
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
338
186208
‫מוליך מבודד עבור מחמם בעל טמפרטורה‬
‫מוגבלת לחימום תת פני שטח המצומד בתצורה‬
Y ‫תלת פאזית‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A heating system for a subsurface formation is described. The heating system includes
a first heater (212) , a second heater (212) , and a third heater (212) placed in an
opening in the subsurface formation. Each heater includes an electrical conductor
(218) , an insulation layer (220) at least partially surrounding the electrical conductor,
and an electrically conductive sheath (222) at least partially surrounding the insulation
layer. The electrical conductor is electrically coupled to the sheath at a lower end
portion of the heater. The lower end portion is the portion of the heater distal from a
November 30, 2011-‫ד' בכסלו התשע"ב‬
surface of the opening. The first heater, the second heater, and the third heater are
electrically coupled at the lower end portions of the heaters. The first heater, the
second heater, and the third heater are electrically coupled in a three-phase wye
configuration.
__________________
]22[]12[
186221
‫חומר ביניים גבישי של רוסובסטטין‬
]54[
CRYSTALLINE ROSUVASTATIN
INTERMEDIATE
]11[
]32[
16.08.2006
60/708920
]31[ 16.08.2005
]33[ US
419721931
1321121115
US
Int. Cl.(2010.01) A61K 31/505, A61P 03/06, C07D 239/42
TEVA PHARMACEUTICAL
‫ פתח‬,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.
‫תקוה‬
]52[
]72[
]71[
]17[
]74[
339
SHLOMIT WIZEL, NATALIA
SHENKAR, VALERIE NIDDAMHILDESHEIM
WO/2007/022488
TEVA PHARMACEUTICAL
INDUSTRIES LTD.,
,‫טבע תעשיות פרמצבטיות בע"מ‬
‫ מחלקת פטנטים‬5 ‫בזל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
5 BASEL ST.,
‫פתח תקוה‬2160 .‫ד‬.‫ ת‬,
P.O.B. 3190,
PETAH TIQVA 49131
Provided is a crystalline rosuvastatin intermediate and processes for preparation
thereof.
__________________
]22[]12[
‫ שיטות להכנתו ושימושיו‬,‫מוצר חלבוני מותסס‬
]54[
FERMENTED PROTEIN
PRODUCT, METHODS OF
PREPARING THE SAME AND
USES THEREOF
]11[
]32[
30.03.2006
60/667046
]31[ 01.04.2005
PA200500454
1221421115
Int. Cl.(2010.01) A23L 01/211
HAMLET PROTEIN A/S, DENMARK
WO/2006/102907
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
186224
]33[
US
DK
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Protein products with improved nutritional value and enhanced organoleptic properties
and uses thereof. In particular, the present invention provides fermented protein rich
products on basis of fermented pulses and yeast, wherein the fermentation is followed
by a heating step.
__________________
]22[]12[
186318
‫הידרוגנציה של אסטרים עם קומפלקסי‬
‫בידנטאטים‬/‫ליגנדים רו‬
]54[
HYDROGENATION OF ESTERS WITH
RU/BIDENTATE LIGAND COMPLEXES
]11[
]32[
]52[
]72[
04.04.2006
PCT/IB2005/000938 ]31[ 05.04.2005
]33[ IB
Int. Cl.(2010.01) C07B 41/00, 41/02, C07C 29/00, 29/149, C07F 15/00
FIRMENICH S.A., SWITZERLAND
340
November 30, 2011-‫ד' בכסלו התשע"ב‬
]71[
]17[
]74[
]57[
LIONEL SAUDA, PHILIPPE DUPAU,
JEAN-JACQUES RIEDHAUSER, PATRICK
WYSS
WO/2006/106483
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to the field of catalytic hydrogenation and, more
particularly, to the use of Ru complexes with bidentate ligands, having one amino or
imino coordinating group and one phosphino coordinating group, in hydrogenation
processes for the reduction of esters or lactones into the corresponding alcohol or diol
respectively.
__________________
]22[]12[
186319
‫הידרוגנציה של אסטרים עם קומפלקסי‬
‫טטראדנדאט‬/‫ליגנדים רו‬
]54[
HYDROGENATION OF ESTERS WITH
RU/TETRADENTATE LIGAND
COMPLEXES
]11[
]32[
]52[
]72[
]17[
]74[
04.04.2006
PCT/IB2005/000938 ]31[ 05.04.2005
]33[ IB
Int. Cl.(2010.01) C07B 41/00, 41/02, C07C 29/00, 29/149, C07F 15/00
FIRMENICH S.A., SWITZERLAND
WO/2006/106484
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to the field of catalytic hydrogenation and, more
particularly, to the use of Ru complexes with tetradentate ligands, having at least one
amino or imino coordinating group and at least one phosphino coordinating group, in
hydrogenation processes for the reduction of esters or lactones into the corresponding
alcohol or diol respectively.
]57[
__________________
341
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
186343
‫שיטה ומערכת לבחירת נקודת גישה רבת–פסים‬
‫לקישור עם תחנה ניידת רבת–פסים‬
]54[
METHOD AND APPARATUS FOR
SELECTING A MULTI-BAND
ACCESS POINT TO ASSOCIATE
WITH A MULTI-BAND MOBILE
STATION
]11[
]32[
30.03.2006
60/667523
]31[ 01.04.2005
]33[ US
229114141
1222221115
US
Int. Cl.(2010.01) H04M 01/00, H04W 48/20, 88/06
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/107698
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and apparatus for selecting one of a plurality of multi-band access points
(APs) to associate with a multi-band wireless transmit/receive unit (WTRU) are
disclosed. The multi-band APs broadcast frequency band information regarding
multiple frequency bands on which the multi-band AP is configured to operate. The
multi-band WTRU selects a particular multi-band AP to associate with and a
frequency band to use to communicate with the selected multi-band AP based on the
frequency band information. If the multi-band WTRU receives frequency band
information from the selected multi-band AP which indicates that a characteristic,
(e.g., throughput, path loss, load, capacity, backhaul), of the selected frequency band is
unacceptable, the multi-band WTRU determines whether to disassociate with the
selected multi-band AP or to continue to associate with the selected multi-band AP via
a different frequency band.
__________________
]22[]12[
342
186370
November 30, 2011-‫ד' בכסלו התשע"ב‬
]54[
INJECTION DEVICE (MODIFIED
TRIGGER)
]11[
]32[
]52[
]72[
21.03.2006
0507009.9
]31[ 06.04.2005
Int. Cl.(2010.01) A61M 05/20
CILAG GMBH INTERNATIONAL,
SWITZERLAND
WO/2006/106293
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
)‫מכשיר הזרקה (הדק משופר‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An injection device (110) is provided which includes a syringe (122) having a
discharge nozzle (118). The syringe is movable between a retracted position in which
the discharge nozzle is contained within the housing and an extended position in which
the discharge nozzle extends from the housing. A trigger (114) is activatable to allow
the contents of the syringe to be discharged through the discharge nozzle. There is also
a releasable locking mechanism (116) which, when engaged, prevents the trigger from
moving into an active position. The trigger includes a first portion (150) having a cutout (152) which extends from a first end of the trigger in a direction substantially
parallel to the first axis (101). The releasable locking mechanism includes a protrusion
(154) along a second axis (181) for communicating with the first portion of the trigger
when the releasable locking mechanism is engaged and for communicating with the
cut-out when the releasable locking mechanism is disengaged. Such an injection
device provides improved protection against accidental activation of the trigger.
__________________
]22[]12[
]54[
343
INJECTION DEVICE
(ADAPTABLE DEVICE)
186379
)‫מכשיר להזרקה (מכשיר הניתן להתאמה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
21.03.2006
0507016.4
]31[ 06.04.2005
Int. Cl.(2010.01) A61M 05/145
CILAG GMBH INTERNATIONAL,
SWITZERLAND
WO/2006/106295
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An injection device (110) comprises a housing (112) adapted to receive a syringe (116)
having a discharge nozzle (118) and a dispensing piston (114) movable in the syringe
to expel the contents of the syringe through the discharge nozzle. There is also a drive
(130) adapted to act on the syringe to advance it from a retracted position in which the
discharge nozzle is contained within the housing to an extended position in which the
discharge nozzle extends from the housing. A drive coupling (134) extends from the
drive to the dispensing piston of the syringe so as to transfer movement of the drive to
the piston. The drive coupling comprises a fixed-length drive coupling and an
interchangeable drive coupling. There is also a method of manufacturing an injection
device by assembling a first sub-assembly (210) and second sub-assembly (220) .
__________________
]22[]12[
]54[
INJECTION DEVICE
]11[
]32[
]52[
]72[
21.03.2006
0507002.4
]31[ 06.04.2005
Int. Cl.(2010.01) A61M 05/20
CILAG GMBH INTERNATIONAL,
SWITZERLAND
WO/2006/106294
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
344
186380
‫מכשיר להזרקה‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An injection device (110) comprises a housing (112) adapted to receive a syringe (122)
having a discharge nozzle (118) , an actuator (114) and a drive (120) acted upon by the
November 30, 2011-‫ד' בכסלו התשע"ב‬
actuator which acts upon the syringe to advance it from a retracted position in which
the discharge nozzle is contained within the housing to an extended position in which
the discharge nozzle extends from the housing. There is a locking mechanism (HS) in
communication with the actuator and activatable to be moved from a locked position
in which the actuator is prevented from releasing the drive to an unlocked position in
which the actuator is operable to act upon the drive to advance the syringe. The
locking mechanism or the housing includes integrally formed biasing means (210)
adapted to return the locking mechanism to a locked position when it is not activated.
There is no need for separate springs to be used to bias the releasable locking
mechanism out of the housing.
__________________
]22[]12[
186481
‫תמיכה העברה של מסוף נייד‬
]54[
SUPPORTING HANDOVER OF
MOBILE TERMINAL
]11[
]32[
10.04.2006
10-2005]31[ 09.04.2005
]33[ KR
0029750
21-11151321921115
KR
1112991
21-11141321321114
KR
1111191
Int. Cl.(2010.01) H04L 12/28, 29/06, H04W 36/14
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/109963
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to supporting a handover of a mobile terminal.
]52[
]72[
]17[
]74[
]57[
345
November 30, 2011-‫ד' בכסלו התשע"ב‬
Preferably, the present invention performs a scan of a neighboring network different
from a current network of the mobile terminal to determine the presence of an
accessible link of the neighboring network for performing a handover, wherein the
mobile terminal comprises a heterogeneous network handover module that is
configured to provide convergence of information from at least one network interface
module associated with one of a homogeneous and heterogeneous network into a
unified presentation. An information message is then received from the neighboring
network, wherein the information message comprises an information element
associated with whether the neighboring network is capable of communicating with
the heterogeneous network handover module of the mobile terminal.
__________________
]22[]12[
186925
‫תכשירים רוקחיים בשחרור מושהה למתן פומי‬
‫המכילים גרגרים ממוסים של אימאטיניב‬
‫ומעכב שחרור ושיטות להכנתם‬
]54[
ORAL SUSTAINED RELEASE
PHARMACEUTICAL
COMPOSITIONS COMPRISING
MELT GRANULES OF IMATINIB
AND A RELEASE RETARDANT
AND METHODS FOR PREPARING
SAME
]11[
]32[
]52[
]72[
]17[
]74[
08.05.2006
60/679607
]31[ 10.05.2005
]33[ US
Int. Cl.(2010.01) A61K 09/16, 09/20, 31/506
NOVARTIS AG, SWITZERLAND
WO/2006/121941
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Sustained release pharmaceutical compositions that contain imatinib or a
pharmaceutically acceptable salt thereof. The pharmaceutical compositions further
contain a release retardant, for example a water soluble, a water swellable and/or a
water insoluble polymer. The present invention also features a particularly useful
process of making such sustained release pharmaceutical compositions by using an
]57[
346
November 30, 2011-‫ד' בכסלו התשע"ב‬
extruder.
__________________
]22[]12[
]54[
PYRAZOLE-1-CARBOXYLIC
ESTER DERIVATIVE, METHOD
FOR PRODUCING THE SAME
AND METHOD FOR PRODUCING
PYRAZOLE DERIVATIVES
]11[
]32[
]52[
]72[
22.05.2006
2005-148889 ]31[ 23.05.2005
Int. Cl.(2010.01) C07D 231/20
KAKEN PHARMACEUTICAL CO.,
LTD., JAPAN
SAGAMI CHEMICAL RESEARCH
INSTITUTE, JAPAN
WO/2006/126692
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
187260
‫ שיטה‬,‫ – אסטר קרבוקסילי‬1 –‫תולדת פיראזול‬
‫ליצורה ושיטה ליצור תולדות פיראזול‬
]33[
JP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A pyrazole-1-carboxylic ester derivative represented by the general formula (1): (the
symbols in the formula are as defined in the description), a method for producing the
same and a method for producing a 3-aryloxypyrazole-1-carboxamide derivative
having an herbicide activity and an intermediate thereof using the compound are
disclosed. According to the invention, a 3-aryloxypyrazole-1-carboxamide derivative
which shows an excellent herbicide activity to weed which inhibits the growth of crop
without causing a chemical damage to the crop can be industrially advantageously
produced.
__________________
347
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
187274
‫שימוש של גליצרידים דוקוסאהקסאנוייים‬
‫להכנת תרופות עבור הטיפול במחלות של‬
‫גידולים‬
]54[
USE OF DOCOSAHEXAENOIC
GLYCERIDES FOR THE
PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF TUMORAL
DISEASES
]11[
]32[
]52[
]72[
26.04.2006
P-200501141 ]31[ 12.05.2005
]33[ ES
Int. Cl.(2010.01) A61K 31/232, C07C 53/00
PROYECTO EMPRESARIAL
BRUDY, S.L., SPAIN
WO/2006/120120
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention relates to the use of an oil enriched in docosahexaenoic acid,
which is conjugated to triglyceride, for manufacturing a pharmaceutical composition
for the treatment of a tumorous disease, said oil being enriched in a concentration of up
to 70% by weight in relation to the total weight of said pharmaceutical composition,
and said docosahexaenoic acid being in a percentage of at least 50% in relation to the
total fatty acids in said oil.
]17[
]74[
]57[
__________________
]22[]12[
187351
‫מברשת שיניים הפולטת קרינה אלקטרומגנטית‬
‫ומערכת תכשיר לניקוי שיניים‬
]54[
ELECTROMAGNETIC
RADIATION EMITTING
TOOTHBRUSH AND DENTIFRICE
SYSTEM
]11[
]32[
18.05.2006
60/682752
]31[ 18.05.2005
]33[
419411219
1421421115
419739324
1322221115
Int. Cl.(2010.01) A61C 03/00, 15/00, 17/16
BIOLASE TECHNOLOGY, INC.,
U.S.A.
WO/2006/125204
]52[
]72[
]17[
348
US
US
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]74[
]57[
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A device includes a handle coupled with an activated textured surface that can be
implemented using a repetitive movement mechanism and a treatment energy source,
such as an electromagnetic radiation source. The handle may be used to provide
detection, treatment and/or management of sundry conditions including, for example,
tooth discoloration, tissue damage, periodontal disease, tumors, pain, halitosis, and
bronchitis. The activated textured surface may include a surface topography including
corrugations, bristles, protuberances, or pits, or other surfaces for facilitating agitation,
cleaning or other surface treatments.
__________________
]22[]12[
187370
‫תהליך בעלות נמוכה להשגת שטחי מים של יותר‬
,‫ מטר קוב המיועדים לבילוי בצבע‬15111 –‫מ‬
‫שקיפות וניקיון הדומים לבריכות או ימים‬
‫טרופיים‬
]54[
PROCESS TO OBTAIN WATER
BODIES LARGER THAN 15,000 M3
FOR RECREATIONAL USE WITH
COLOR, TRANSPARENCY AND
CLEANNESS CHARACTERISTICS
SIMILAR TO SWIMMING POOLS
OR TROPICAL SEAS AT LOW
COST
]11[
]32[
]52[
]72[
14.11.2007
3225-2006
]31[ 21.11.2006
]33[
Int. Cl.(2010.01) E02B 03/00, E04H 03/16
CRYSTAL LAGOONS
CORPORATION LLC., U.S.A.
FERNANDO BENJAMIN
FISCHMANN TORRES
SIMON LAVIE,
21 HERZOG ST.,
JERUSALEM
]71[
]74[
]57[
349
CL
,‫שמעון לביא‬
51 ‫הרצוג‬
‫ירושלים‬
A process to implement and maintain water bodies larger than 15,000 m3 for
recreational use, such as lakes or artificial lagoons, with excellent color, transparency
and cleanness properties at low cost, wherein said process comprises: (a) providing a
structure with skimmers able to contain a large water body larger than 15,000 m3; (b)
November 30, 2011-‫ד' בכסלו התשע"ב‬
feeding the structure of step (a) with inlet water having iron and manganese levels
lower than 1.5 ppm and turbidity lower than 5 NTU; (c) measuring water pH, ideally it
should be within a range lower than 7.8; (d) adding an oxidizing agent to the water
contained in the structure of step (a), with which a 600 mV minimal ORP is controlled
in water for a minimal period of 4 hours and in maximal cycles of 48 hours; (e) adding
a flocculating agent in concentrations within 0.02 and 1 ppm with maximal frequencies
of 6 days and cleaning the bottom of the structure of step (a) with a suction device to
remove precipitated impurities from the bottom of said structure, together with the
additional flocculants and; (f) generating a displacement of surface water containing
impurities and surface oils by means of the injection of inlet water according to step
(b), which generates said displacement in such a way to remove said surface water by
means of a system for impurities and surface oils removal arranged in the structure of
step (a), which together with step (e) replaces traditional filtering.
__________________
]22[]12[
187421
]54[
PROCESS FOR THE SYNTHESIS
OF 5-(METHYL-1H-IMIDAZOL-1YL)-3-(TRI FLUOROMETHYL)BENZENEAMINE
]11[
]32[
07.06.2006
60/688977
]31[ 09.06.2005
]33[ US
419715591
1421121115
US
Int. Cl.(2010.01) C07D 401/04
NOVARTIS AG, SWITZERLAND
WO/2006/135641
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides a new method of making compounds of formula (I):
wherein R1 is mono- or polysubstituted aryl; R2 is hydrogen, lower alkyl or aryl; and
R4 is hydrogen, lower alkyl or halogen.
]52[
]72[
]17[
]74[
]57[
350
–‫ –אימידזול‬H1 –‫ –(מתיל‬5 ‫תהליך לסינתזה של‬
‫ – (טריפלואורומתיל)–בנזנאמין‬3 –)‫ –איל‬1
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
187446
‫התקן אסלה‬
]54[
TOILET DEVICE
]11[
]32[
]52[
]72[
]17[
]74[
18.06.2006
PCT/IL2005/00653 ]31[ 19.06.2005
]33[ IB
Int. Cl.(2010.01) A47K 13/00, E03D 11/00
MEDLOGIC LTD.
‫ברק‬-‫ בני‬,‫מדלוג'יק בע"מ‬
WO/2006/137055
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A toilet device for facilitating defecation by a user in a natural squatting posture over a
conventional toilet. The toilet device comprises a platform adapted to support a user
with areas for a user's feet and an opening therethrough aligned with the toilet bowl;
and a urinal pan located to serve as a urinal when the user is in the squatting posture.
The urinal pan is adapted to be pivotably adjustable between an operative position and
an inoperative position and comprises front and side walls. In particular embodiments,
the urinal pan walls are constituted by front and side plates, U-shaped inter-cooperating
plates or a sheet such as a urine-resistant cloth or plastic. The device may also
comprise a water hose for rinsing the urinal pan; and may further comprise an
automatically controlled valve for automatic rinsing of the urinal pan upon use of
thereof.
]57[
__________________
]22[]12[
351
187471
November 30, 2011-‫ד' בכסלו התשע"ב‬
]54[
QUADRAPHASIC CONTINUOUS
GRADUATED ESTROGEN
CONTRACEPTIVE
]11[
]32[
]52[
]72[
29.06.2006
60/695093
]31[ 29.06.2005
Int. Cl.(2010.01) A61K 45/06
WARNER CHILCOTT COMPANY,
LLC, PUERTO RICO
WO/2007/002910
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
‫אמצעי ארבע פאזי אסטרוגני המשכי והדרגתי‬
‫למניעת הריון‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A quadraphasic estrogenic/progestogenic contraceptive regimen that provides for a
low level of estrogen in the initial phase and in the fourth phase is disclosed. Also
described is a contraceptive kit that may be used to practice the method of the
invention.
__________________
]22[]12[
]54[
SECURITY DEVICE HAVING A
HOOKING ELEMENT
]11[
]32[
]52[
]72[
22.05.2006
60/683657
]31[ 23.05.2005
Int. Cl.(2010.01) E05B 47/00, 73/00
SENSORMATIC ELECTRONICS,
LLC, U.S.A.
WO/2006/127674
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
352
187472
‫התקן בטיחות המכיל גוף לכידה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A security device (102) for an article, comprising a security tag, a locking mechanism,
a locking element (186) and a housing (130) comprising means for securing the
security tag, locking mechanism and locking element thereto.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
187481
‫שיטות תבחין אימוני‬
]54[
IMMUNOASSAY METHODS
]11[
]32[
26.05.2006
60/685422
]31[ 27.05.2005
]33[
152194324
1721521115
Int. Cl.(2010.01) G01N 33/53, 33/564, 33/574
ONCIMMUNE LIMITED, UNITED
KINGDOM
WO/2006/126008
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
US
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method of detecting a disease state or disease susceptibility
in a mammalian subject which comprises detecting an antibody in a test sample
comprising a bodily fluid from said mammalian subject wherein said antibody is a
biological marker of a disease state or disease susceptibility, the method comprising:
(a) contacting said test sample with a plurality of different amounts of an antigen
specific for said antibody, (b) detecting the amount of specific binding between said
antibody and said antigen, (c) plotting or calculating a curve of the amount of said
specific binding versus the amount of antigen for each amount of antigen used in step
(a) and (d) determining the presence or absence of said disease state or disease
susceptibility based upon the amount of specific binding between said antibody and
said antigen at each different antigen concentration used.
The applications for division
from this application have
not yet been published
,12//12,12//11
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
353
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
187531
‫שימוש במווסת של תעלות סידן בהכנת תרופות‬
‫לטיפול באוסטאוארטריטיס‬
]54[
USE OF CALCIUM ION-CHANNEL
REGULATOR IN THE
PREPARATION OF A
MEDICAMENT FOR TREATING
OSTEOARTHRITIS
]11[
]32[
04.05.2006
11/138744
]31[ 25.05.2005
]33[ US
229231731
1521521115
US
Int. Cl.(2010.01) A61K 45/00
CALOSYN PHARMA, INC., U.S.A.
WO/2006/127249
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A method and composition for treating osteoarthritis with ion-channel regulators is
disclosed. The ion-channel regulators are used alone or in combination with other
osteoarthritis treatment agents, including but not limited to injectable agents such as
viscosupplements and steroids. A composition comprising one or more ion-channel
regulator(s) and one or more osteoarthritis treatment agent(s) is also disclosed.
]52[
]72[
]17[
]74[
]57[
__________________
]22[]12[
187588
‫תאים אאוקריוטיים מבודדים או מתורבתים‬
‫ סינתאז אורתוגונלי היכול לבצע‬tRNA ‫המכילים‬
tRNA –‫ פנימי ו‬tRNA ‫אמינואצילציה של‬
–‫אורתוגונלי העובר אמינואצילציה על ידי ה‬
‫ סינתאז האורתוגונלי‬tRNA
]54[
ISOLATED OR CULTURED
EUKARYOTIC CELL
COMPRISING AN ORTHOGONAL
TRNA SYNTHASE
AMINOACYLATING
ENDOGENOUS TRNA AND AN
ORTHOGONAL TRNA THAT IS
AMINOACYLATED BY THE
ENDOGENOUS TRNA SYNTHASE
]11[
]32[
19.04.2002
60/285030
]31[ 19.04.2001
]33[ US
419355524
1421121111
US
Int. Cl.(2010.01) C12N 09/00, 15/09, 15/52, C12P 21/00
DIVISION FROM 158418
]52[
]41[
354
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
THE SCRIPPS RESEARCH
INSTITUTE, U.S.A.
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2002/085923
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention provides methods and compositions for in vivo incorporation of
unnatural amino acids. Also provided are compositions including proteins with
unnatural amino acids.
The parent application from which
this application has been divided has
not yet been published
The applications for division
from this application have
not yet been published
2/2122
‫בקשת הורה לבקשה זו שטרם פורסמה‬
,2//1/1
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
IMMUNOGENIC COMPOSITIONS
WITH N. MENINGITIDIS
CAPSULAR POLYSACCHARIDES,
VACCINES AND KITS
INCLUDING THEM, PROCESSES
TO MAKE THEM AND THEIR USE
IN MANUFACTURE OF
MEDICINES
]11[
]32[
23.06.2006
0513071.1
]31[ 27.06.2005
152314925
1721421115
152555429
1121721115
151411425
1122221115
151414122
1222121115
151414229
1222121115
Int. Cl.(2010.01) A61K 39/095, 39/102
GLAXOSMITHKLINE
BIOLOGICALS S.A., BELGIUM
]52[
]72[
355
187924
‫תכשירים אימונוגניים המכילים רב–סוכרים‬
‫ חיסונים‬, N. MENINGITIDIS ‫ממקור‬
‫ תהליכי יצורם ושימושם‬,‫וערכות הכוללים אותם‬
‫לייצור תרופות‬
]33[
GB
GB
GB
GB
GB
GB
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
WO/2007/000314
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present application discloses an immunogenic composition comprising N.
meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and
Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide
conjugate, wherein the average size of each N. meningitidis polysaccharide is above
50kDa.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
PHOSPHORAMIDATE
ALKYLATOR PRODRUGS,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME AND USES THEREOF
]11[
]32[
]52[
]72[
29.06.2006
60/695755
]31[ 29.06.2005
Int. Cl.(2010.01) C07F 09/00, 09/6506
THRESHOLD PHARMACEUTICALS,
INC., U.S.A.
WO/2007/002931
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
356
188236
,‫אלקילטורים פוספוראמידטים טרום תרופתיים‬
‫תכשירים רוקחיים המכילים אותם והשימושים‬
‫בהם‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered
alone or in combination with one or more anti-neoplastic agents.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
188370
‫מכשיר הנעה על בסיס חומר מניע מסוג ג'ל‬
‫ושיטה להעביר חומר מניע‬
]54[
DRIVE DEVICE ON THE BASIS OF
A GEL-TYPE PROPELLANT AND
METHOD FOR CONVEYING
PROPELLANT
]11[
]32[
]52[
]72[
21.06.2006
102005030437.0 ]31[ 30.06.2005
]33[ DE
Int. Cl.(2010.01) F02K 09/00, 09/44, 09/70
DEUTSCHES ZENTRUM FUER LUFTUND RAUMFAHRT E.V., GERMANY
WO/2007/003270
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a gel-type fuel based drive device, in particular, for a missile,
which comprises at least one tank for gel-type fuel, a combustion chamber and a fuel
supply device for the combustion chamber. The aim of the invention is to produce said
device such that is has a simple construction. As a result, at least one radiation
impinging device which is used to impinge on gel-type fuel by means of
electromagnetic radiation and/or at least one heating device which is used to warm geltype fuel is provided in order improve the fluidity.
]17[
]74[
]57[
__________________
]22[]12[
]54[
357
TAPING KNIFE WITH ANGLED
HANDLE
188621
‫כף שפכטל בעל ידית זוויתית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]32[
]52[
]72[
]17[
]74[
]57[
05.06.2006
11/187569
]31[ 22.07.2005
Int. Cl.(2010.01) E04F 21/16
UNITED STATES GYPSUM
COMPANY, U.S.A.
WO/2007/018704
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A taping knife has a web, a working edge, two side edges, and a handle edge opposite
the working edge. The handle is connected to the blade to have an angular orientation
relative to the working edge of the blade such that the handle is neither parallel nor
perpendicular to the blade working edge.
__________________
]22[]12[
]54[
DIGITAL APPLICATION
OPERATING ACCORDING TO
AGGREGATION OF PLURALITY
OF LICENSES
]11[
]32[
11.07.2006
60/699143
]31[ 14.07.2005
229159477
1422121115
Int. Cl.(2010.01) G06Q 99/00
MICROSOFT CORPORATION,
U.S.A.
WO/2007/011584
REINHOLD COHN AND PARTNERS,
]52[
]72[
]17[
]74[
358
188622
‫תפעול ישום דיגיטלי בהתאם למצבור של‬
‫רשיונות מגוונים‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A plurality of digital licenses correspond to a piece of content, including a base license
and at least one add-on license. Each add-on license includes a reference to the base
license, and each of the base license and each add-on license sets forth rules specifying
how the content may be employed. Each add-on license is identified by way of the
reference therein to the base license, and the rules in the base license and in each
identified add-on license are aggregated into an aggregated set of rules that is
evaluated to determine if such aggregated set of rules allows employing the content in
a particular manner.
__________________
]22[]12[
]54[
WEB PAGE RENDERING
PRIORITY MECHANISM
]11[
]32[
]52[
]72[
27.07.2006
11/204833
]31[ 15.08.2005
Int. Cl.(2010.01) G06F 15/00, 17/00
MICROSOFT CORPORATION,
U.S.A.
WO/2007/021514
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
359
188663
‫דף רשת המשתמש במנגנון זכות קדימה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A web page rendering mechanism for generating a web page based on a rendering
November 30, 2011-‫ד' בכסלו התשע"ב‬
priority of three or more tiers of rendering instructions. A control object associated
with a web page definition representing a second or middle tier of rendering
instructions is generated. Next, a rendering priority mechanism is applied. The
rendering priority mechanism causes properties associated with the control object
found in the first or higher tier of rendering instructions to always be applied to the
control object. Properties associated with the control object in the second tier of
rendering instructions are applied to the control object if they do not conflict with the
properties in the first tier. In like manner, properties associated with the control object
in third or lower tier of rendering instructions are applied to the control object if they
do not conflict with the properties in the first and second tiers of rendering
instructions.
__________________
]22[]12[
]54[
ACTIVE IR SIGNATURE
TARGET SIMULATION SYSTEM
AND A METHOD THEREOF
]11[
]52[
]72[
08.01.2008
Int. Cl.(2010.01) F41J 02/02
ISRAEL AEROSPACE
INDUSTRIES LTD.
SHIMON COHEN, EDI MAOR
REINHOLD COHN AND
PARTNERS,
]71[
]74[
360
188678
‫מערכת ושיטה להדמיה של חתימת חום‬
‫אקטיבית של מטרה‬
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
‫ אדי מאור‬,‫שמעון כהן‬
,‫ריינהולד כהן ושותפיו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An active IR signature target simulation system, comprising: an airborne platform
having a known temperature profile and a preplanned trajectory; a heat source that
comprises pyroelectric material and which is carried onboard the platform, capable of
producing heat following a controlled heating plan; a control unit coupled to the heat
source and configured for initiating said heat source by igniting the pyroelectric
material, thereby modifying said known temperature profile and generating a desired
temperature profile required for sensing a simulated target IR signature during a
simulation time window at a desired line of sight from the platform to an observing
sensor.
__________________
]22[]12[
]54[
APPARATUS AND METHOD FOR
UPFINDING IN SPINNING
PROJECTILES USING A PHASELOCK-LOOP OR CORRELATOR
MECHANISM
]11[
]32[
]52[
]72[
24.07.2006
11/189905
]31[ 26.07.2005
Int. Cl.(2010.01) F41G 07/22, 07/30
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2007/015996
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
361
189012
‫אמצעים ושיטה עבור הערכת זווית סיבוב‬
‫בקליעים מסתובבים על ידי שימוש במנגנון של‬
‫חוג נעול או של קורלטור‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to the field of gun-launched guidance systems and to a
navigation system based on inertial sensors mounted in a spinning projectile using at
least one rotation sensing device with input components perpendicular to the spinning
body's longitudinal axis, and an appertaining method for upfmding. The phase of the
sinusoidal angular rate as detected by a phase-locked loop or correlator is used to
determine the local vertical orientation. This invention may be used to align the inertial
navigation system in spinning projectiles in ballistic trajectories, which can include
artillery shells, satellites or underwater torpedoes.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
189034
‫ מכשיר ליטוגרפי ותא‬,‫מכשיר ושיטת בדיקה‬
‫עבוד ליטוגרפי‬
]54[
INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS AND
LITHOGRAPHIC PROCESSING
CELL
]11[
]32[
]52[
]72[
24.01.2008
11/701516
]31[ 07.02.2007
]33[ US
Int. Cl.(2010.01) B82B 03/00, G01N 21/00, G03B 27/42
ASML NETHERLANDS B.V., THE
NETHERLANDS
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An inspection apparatus configured to determine a value related to a parameter of a
target pattern printed on a substrate by a lithographic process used to manufacture a
device layer on a substrate, the apparatus comprising: a radiation source arranged to
selectively emit a first beam of radiation having a first wavelength in a first
wavelength range or a second beam of radiation having a second wavelength in a
second wavelength range, the second wavelength range being distinct from the first
wavelength range; an optical system arranged to direct the selected one of the first or
second beams of radiation on to the target pattern and to project radiation redirected by
the target pattern onto a detector to obtain a scatterometric spectra; and an adjustable
optical element arranged to selectively effect a chromatic correction of the optical
system according to whether the first or second beam of radiation is emitted by the
radiation source.
]74[
]57[
362
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
189095
‫שיטה ומערכת לאישור מאובטח של הפעל‬
‫פונקציה קריטית על טיסן‬
]54[
METHOD AND SYSTEM FOR
SECURELY AUTHORISING THE
ACTIVATION OF A CRITICAL
FUNCTION ON A DRONE
]11[
]32[
]52[
]72[
29.01.2008
0752984
]31[ 31.01.2007
]33[ FR
Int. Cl.(2010.01) B64D 07/00, G05B 09/02, G05D 01/00
SAGEM DEFENSE SECURITE,
FRANCE
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The system has a ground control station (100) with an activation module (130)
comprising a signing module for generating an activation message to activate critical
functions (A-1B, A-1C, A-2B) for a designated effector module from a set of effector
modules (230, 240, 330) of robotized platforms (200, 300). Each effector module has a
verification unit for authenticating the message from the station. The verification unit
verifies whether the received message is a signed integrated message for the effector
module and authorizes the realization of the critical functions based on needs. An
independent claim is also included for a method for authorizing activation of a critical
function by a robotized platform.
__________________
363
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
189174
‫מערכת דיכוי אנפרא–אדום‬
]54[
INFRARED SUPPRESSION
SYSTEM
]11[
]32[
]52[
]72[
27.07.2006
11/194229
]31[ 01.08.2005
]33[ US
Int. Cl.(2010.01) F02C 07/00
SIKORSKY AIRCRAFT
CORPORATION, U.S.A.
WO/2008/041964
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
An InfraRed Suppression System (IRSS) includes an exhaust manifold and a high
aspect ratio exhaust duct along a longitudinal length thereof. The IRSS minimizes
impingement of engine exhaust onto adjacent aircraft structure by discharging the flow
upwardly and/or outwardly, away from the fuselage at relatively high velocity to
reduce fuselage heating due to plume impingement in both hover and forward flight
thus minimizing fuselage IR signature contributions. Furthermore, by directing the
exhaust stream upward, a direct line of sight to the exhausted IR energy is masked
from ground threats. The high aspect ratio exhaust duct and exhaust manifold are also
preferably shrouded by an aerodynamic fairing which provides an aerodynamic
contour to minimize aerodynamic impact to the aircraft and defines an air-cooled
ejector gap to augment airflow to further insulate and obscure the high temperature
exhaust gas exhausted through the exhaust duct.
]17[
]74[
]57[
__________________
]22[]12[
]54[
364
METHOD FOR PREPARATION OF
189225
–‫שיטה להכנת תרחיפים יציבים הכוללים ננו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫חלקיקים של תחמוצת מתכת‬
STABLE METAL OXIDE
NANOPARTICLES SUSPENSIONS
]11[
]32[
]52[
]72[
]71[
]17[
]74[
]57[
03.08.2006
60/705190
]31[ 04.08.2005
]33[ US
Int. Cl.(2010.01) B82B 01/00, C01G 19/00, C09C 01/00
3G SOLAR LTD.
‫ ירושלים‬,‫ג'י סולאר בע"מ‬2
ASHER OFIR, LARISSA GRINIS,
‫ אריה צבן‬,‫ לריסה גריניס‬,‫אשר אופיר‬
ARIE ZABEN
WO/2007/015248
BEN-AMI & ASSOCIATES,
,'‫בן עמי ושות‬
8 MENACHEM PIAUT ST.,
1 ‫מנחם פלאוט‬
PARK TAMAR,
‫רחובות‬64 .‫ד‬.‫ ת‬,
P.O.B. 94,
REHOVOT 76100
The invention relates to a method for the preparation of stable suspensions of metal
oxide nanopareticles, in which uncharged metal oxide nanoparticles are first treated
with a non-ionic surfactant in a polar organic solvent under certain conditions, and the
suspension obtained is then treated with a charging solution. The suspensions of the
invention can be used for preparation of high quality metal oxide films by
electrophoresis deposition (EPD).
__________________
]22[]12[
]54[
ATOM CHIP DEVICE AND A
METHOD FOR TRAPPING,
MANIPULATING AND
MEASURING ATOMS IN AN
ULTRA HIGH VACUUM
CHAMBER
]11[
]32[
]52[
]72[
05.02.2008
60/969218
]31[ 30.08.2007
Int. Cl.(2010.01) B82B 01/00
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
RON FOLMAN, TAL DAVID,
YONATHAN JAPHA, VALERY
DIKOVSKY
YAIR DAVID,
]71[
]74[
365
189283
‫ שליטה‬,‫התקן שבב אטומי ושיטה ללכידה‬
‫ומדידה של אטומים בתא על–ריק‬
]33[
US
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ באר שבע‬,‫ופיתוח‬
‫ ולרי דיקובסקי‬,‫ יונתן יפה‬,‫ טל דוד‬,‫רון פולמן‬
,‫יאיר דוד‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫ רמת השרון‬1 ‫אנקור‬
‫השרון‬-‫רמת‬
Ultra-cold (nano-Kelvin) neutral atoms can be trapped, manipulated, and measured,
using integrated current carrying micro-structures on a nearby surface (Atom Chips).
This can be utilized for the realization of ultra-sensitive sensors and quantum
computation devices based on the quantum mechanical properties of the trapped
atoms. However, harmful processes arise from the interactions between the atoms and
the nearby surface. According to the present invention these harmful processes can be
highly suppressed by using electrically anisotropic materials. It is shown that timeindependent trapping potential corrugation leading to fragmentation of the trapped
atom cloud can be suppressed, and that time dependent noise processes arising from
the coupling of atoms to the nearby surface, and leading to loss of atoms from the trap,
heating and loss of coherence can be significantly reduced.
6 ANKOR ST., RAMAT HASHARON
]57[
__________________
]22[]12[
189389
‫פפטידים אנטיגניים דוחי גידולים אשר הינם‬
‫) היעילים‬GPC3( 3–‫תולדות של גליפיקאן‬
‫לשימוש בחולים אשר‬
‫ חיובי ותכשירי רוקחות‬A–HLA4–‫מסווגים כ‬
‫המכילים אותם‬
]54[
GLYPICAN-3 (GPC3)-DERIVED
TUMOR REJECTION ANTIGENIC
PEPTIDES USEFUL FOR HLA-A2
POSITIVE PATIENTS AND
PHARMACEUTICAL
COMPRISING THE SAME
]11[
]32[
]52[
08.08.2006
2005-230702 ]31[ 09.08.2005
]33[ JP
Int. Cl.(2010.01) A61K 38/00, A61P 35/00, 37/04, C07K 07/06, 14/47, 16/18, C12N
15/00
ONCOTHERAPY SCIENCE, INC.,
JAPAN
WO/2007/018199
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]72[
]17[
]74[
]57[
366
Means for enabling an immunotherapy which is effective in 40% of various types of
Japanese cancer patients who express a high level of Glypican-3 by identifying a
GPC3-derived peptide that can bind to HLA-A2 thereby to activate a human killer Tcell. A peptide selected from the following peptides (A) and (B): (A) a peptide
comprising the amino acid sequence depicted in any one of SEQ ID NOs:1-3; and (B)
a peptide having the substitution or addition of one or two amino acid residues in the
amino acid sequence depicted in any one of SEQ ID NOs:1-3 and capable of inducing
a killer T-cell2
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
DRUM FOR A CREASING DEVICE
]11[
]32[
]52[
]72[
16.08.2006
0517115.2
]31[ 20.08.2005
Int. Cl.(2010.01) B31F 01/10
TECH-NI-FOLD LTD., UNITED
KINGDOM
WO/2007/023258
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
367
189419
‫תוף להתקן מקמט‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A drum (2) for mounting the resilient creasing ring (8) of a creasing device is formed
in two parts (14, 15), each having a cylindrical outer surface (12) and a bore for
mounting the drum part about a shaft (4). The first and second drum parts (14, 15) are
shaped such that they may abut one another to define between them the base (18) and
two side walls (20, 21) of a channel (6) for receiving the resilient creasing ring (8). At
least one side wall (20, 21) of the channel (6) is recessed so that a resilient creasing
ring (8) located in the channel (6) and projecting laterally into the recess cannot be
withdrawn radially from the channel (6). As a result, it is no longer required that the
ring (8) be under tension to hold it in place so a split ring (8) can be used and
replacement rings can be added to the device without removing the shaft (4) from the
machine in which it is mounted.
__________________
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
LOCALIZATION OF A RADIOACTIVE
SOURCE
]11[
]32[
10.08.2006
PCT/IL2005/000871 ]31[ 11.08.2005
419773932
2421121114
419773931
2421121114
419114271
1121421114
Int. Cl.(2010.01) A61B 05/00, 19/00
NAVOTEK MEDICAL LTD.
GIORA KORNBLAU, DAVID MAIER
NEUSTADTER
WO/2007/017846
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]52[
]72[
]71[
]17[
]74[
]57[
‫מיקום של מקור רדיואקטיבי‬
]33[
WO
US
US
US
‫ יוקנעם עלית‬,‫נבוטק מדיקל בע"מ‬
‫ דוד נוישטטר‬,‫גיורא קורנבלאו‬
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
‫רחוב מנחם‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 ‫בגין‬
‫רמת גן‬
An angle-responsive sensor, comprising: a radiation detector adapted to detect ionizing
radiation; at least one radiation absorbing element arranged to block radiation from
reaching said detector in a manner dependent on a relative orientation of a radiation
source, said detector and said element, said detector and said element defining an aim
for said sensor; and circuitry coupled to said detector and which generates an output
signal which varies as a function of said relative orientation, wherein said detector and
said element are arranged to have a working volume of at least 10 cm in depth and
having an angular width, such that said signal defines an accuracy of better than 3 mm
within one standard deviation, over said working volume.
The applications for division from
this application have not yet been
published
368
189442
,18/2/2,18/2/8,18/2//,18/2/2
‫בקשות חלוקה מבקשה‬
0‫זו שטרם פורסמו‬
__________________
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
189621
‫מונה ביצים לספירת ביצים המועברות באמצעות‬
‫מסוע של ערימת ביצים‬
]54[
EGG COUNTER FOR COUNTING
EGGS TRANSFERRED BY EGG
COLLECTION CONVEYER
]11[
]52[
]72[
]17[
]74[
31.08.2005
Int. Cl.(2010.01) A01K 43/00, B65G 43/08, G06M 07/00
AGRO SYSTEM CO. LTD, JAPAN
WO/2007/029316
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An egg counter for counting eggs transferred by an egg collection conveyor has an
infrared light receiving element row, a first infrared light emitting element row placed
at one side section of the infrared light receiving element row, a second infrared ray
emmitting element row placed at the other side section of the infrared light receiving
element row, and a control means for processing reflection infrared light received by
the infrared light receiving element row. The infrared light emitting element rows and
the infrared light receiving element row are placed such that infrared light emitted
from each of the first and second infrared light emitting element rows is reflected at
the surface of an egg passing directly below the infrared light receiving element row
and then the reflected infrared light is received by the infrared light receiving element
row. The control means measures the intensity of the reflected infrared light to detect a
peak value of the light intensity and then counts eggs based on two peak values of the
light intensity relative to the first and second infrared light emitting element rows.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
369
ANTI-EFFRACTION SAFETY
189761
‫מערכת בטיחות נגד פריצות עבור דלת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫ומסגרות של חלונות‬
SYSTEM FOR DOOR AND WINDOW
FRAMES
]11[
]32[
]52[
]72[
]74[
]57[
25.02.2008
TO2007A000780 ]31[ 05.11.2007
]33[ IT
Int. Cl.(2010.01) B66B 13/00, E05C 09/00
SAVIO S.P.A., ITALY
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An anti-effraction safety system for a door or window frame comprising a fixed frame
and a mobile frame, in which the mobile frame comprises at least one sectional
element with a longitudinal groove with two undercut portions set on opposite sides of
a longitudinal central opening and in which at least one transmission rod slidably
engages said groove and can be displaced in a longitudinal direction by means of a
control handle. Fixed to the transmission rod is at least one closing element cooperating with a complementary detent fixed to the fixed frame. The transmission rod
has two through openings both open on respective longitudinal edges of the rod.; The
closing element comprises two separate complementary parts fixed to one another, in
which each of said separate parts engages a respective through opening of the
transmission rod and has a respective tenon that slidably engages in a longitudinal
direction a respective undercut portion of the groove.
__________________
]22[]12[
189815
‫שיטה ליצור אנרגיה תרמית‬
]54[
METHOD FOR PRODUCING
THERMAL ENERGY
]11[
]32[
]52[
]72[
]17[
]74[
09.08.2006
05019473.7
]31[ 07.09.2005
]33[ EP
Int. Cl.(2010.01) B23K 10/00
PURRATIO AG, GERMANY
WO/2007/028471
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a method for producing thermal energy, wherein light, initial
material is introduced into a plasma arc (10) which is located between a cathode (4)
and an anode (3) and which is adapted to fusion processes by supplying electric energy
into the plasma state. A metal cathode, which allows particles which are produced in
the plasma to be diffused, is used and allows a fusion process to take place in the metal
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
370
grid. The invention has a high degree of efficiency in corresponding systems such that
said method can be used anywhere where fossils and/or renewable and/or chemical
fuel can be used, in order to use the thermal energy directly or by conversion.
__________________
]22[]12[
189987
–1,5[‫–אוקסדיאזוליל פירזולו‬1,4,2 ‫תולדות של‬
‫ ושימושן‬,‫ תהליך להכנתן‬,‫]פירימידין‬a
MGLUR4–‫כאנטגוניסטים ל‬
]54[
1,2,4-OXADIAZOLYL
PYRAZOLO[1,5-A]PYRIMIDINE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION AND
THEIR USE AS MGLUR2
ANTAGONISTS
]11[
]32[
]52[
]72[
18.09.2006
05108910.0
]31[ 27.09.2005
]33[ EP
Int. Cl.(2010.01) A61K 31/437, A61P 25/00, 35/00, C07D 471/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2007/039439
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to compounds of formula (I) wherein A, E, G, J, L, R1,
R2 and R3 are as defined in the description and claims, a process for the manufacture
thereof, their use for the preparation of medicaments for treating CNS disorders and
pharmaceutical compositions containing them
]17[
]74[
]57[
__________________
]22[]12[
371
190139
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫שיטה לקביעת פולאוקסאמרים‬
]54[
METHOD FOR THE
DETERMINATION OF
POLOXAMERS
]11[
]32[
14.09.2006
05108439.0
]31[ 14.09.2005
]33[ EP
419727441
2421921115
US
Int. Cl.(2010.01) C07K 19/00, G01N 33/487, 33/68
ARES TRADING S.A.,
SWITZERLAND
MARA ROSSI
WO/2007/031566
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The invention relates to the analytical determination of poloxamers in a liquid protein
sample.
]52[
]72[
]71[
]17[
]74[
]57[
__________________
]22[]12[
190222
‫תולדות נפתירידין‬
]54[
NAPHTHYRIDINE DERIVATIVES
]11[
]32[
]52[
]72[
25.09.2006
05109241.9
]31[ 05.10.2005
]33[ EP
Int. Cl.(2010.01) A61K 31/435, A61P 25/00, C07D 471/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2007/039512
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to heterocyclic derivatives of the general formula (I)
wherein R1, R2 and R3 are as defined in the description and claims, which compounds
are metabotropic glutamate receptor antagonists.
]17[
]74[
]57[
372
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
SUPPORT ARM, CYLINDRICALPARABOLIC SOLAR
COLLECTOR SUPPORT AND
METHOD OF PRODUCING SAID
ARM
]11[
]32[
]52[
]72[
18.07.2006
200502280
]31[ 19.09.2005
Int. Cl.(2010.01) F24J 02/14, 02/54
SENER, INGENIERIA Y SISTEMAS,
S.A., SPAIN
JORGE VAZQUEZ INGELMO,
MIGUEL DOMINGO OSLE
WO/2007/034008
SIMON LAVIE,
21 HERZOG ST.,
JERUSALEM
]71[
]17[
]74[
]57[
373
190285
‫זרוע תמיכה לקולט שמש צילינדרי מעוגל‬
‫והשיטה לייצורו‬
]33[
ES
,‫שמעון לביא‬
51 ‫הרצוג‬
‫ירושלים‬
The invention relates to a support arm for a cylindrical-parabolic collector, which is
intended to be coupled to a central body (1) of the collector in the form of a bracket in
a direction that is essentially perpendicular to a focal line (2) of the collector. The
inventive arm takes the form of a wedge comprising: a first side (10) which is
equipped with support devices (11) for supporting at least one mirror (3), a second side
(20), and a third side (30) which is equipped with support devices (31) such that the
arm is supported by the central body (1). The arm is formed by at least one pressformed plate such as to produce a resistant structure that provides stiffness and a
carrying capacity by means of a plurality of ribs (42) which form a lattice comprising a
plurality of laminar segments (41) between said ribs.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
190353
‫מרכך אנרגטי עבור מטעני חומר נפץ‬
]54[
ENERGETIC PLASTICIZER FOR
EXPLOSIVE CHARGES
]11[
]52[
]41[
]72[
29.08.2004
Int. Cl.(2010.01) C06B 25/12
DIVISION FROM 163785
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]74[
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
An energetic material suitable for high-energy, plastic-bonded, explosive charges, the
material comprising an energetic plasticizer including an energetic nitro formal,
wherein a composition of said energetic plasticizer contains at least 80%, by weight,
of said energetic nitro formal.
]57[
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
,‫ד"ר מרק פרידמן בע"מ‬
1 ‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
__________________
]22[]12[
]54[
]11[
374
METHOD AND SYSTEM FOR
TREATING ORGANICALLY
CONTAMINATED WASTE
WATER
190562
‫שיטה ומערכת לטיפול בשפכים המכילים זיהום‬
‫אורגני‬
15.10.2006
November 30, 2011-‫ד' בכסלו התשע"ב‬
]32[
]52[
]72[
]17[
]74[
]57[
60/723986
]31[ 06.10.2005
]33[ US
Int. Cl.(2010.01) C02F 03/00, 101/30
RONI WEISSMAN
‫ שער חפר‬,‫רוני ויסמן‬
WO/2007/039910
PATENTICK-IP PORTFOLIO
,‫ניהול תיקי קניין רוחני‬-‫פטנתיק‬
MANAGEMENT,
‫בית חנניה‬
P.O.B. 151
151 .‫ד‬.‫ ת‬,
BEIT HANANYA 37807
A method and system for treating organically contaminated waste water (2) for reuse,
by: introducing the waste water into a sedimentation tank (3) to remove a significant
portion of the organic contaminants; circulating the waste water from the
sedimentation tank to an anoxic mixing chamber (6) for denitrifying the waste water;
circulating the waste water from the anoxic mixing chamber to a rotary biological
contactor (9a) to nitrify the waste water by aeration, and to assimilate organic
materials therein by bringing the waste water into contact with a biological medium, to
thereby output nitrified waste water; and recirculating a portion (15) of the nitrified
waste water outputted from the rotary biological contactor back to the anoxic mixing
chamber (6) to enhance the nitrifying and denitrifying of the waste water 2
__________________
]22[]12[
190648
]54[
APPARATUS, METHOD AND KIT
FOR UNCLOGGING AN
OBSTRUCTION IN A PIPE AND A
JUNCTION HAVING A
PLURALITY OF PIPE STUBS
THEREFOR
]11[
]52[
]72[
]74[
07.04.2008
Int. Cl.(2010.01) E02B 08/02, E03F 05/14
RAFAEL MALKA
BENARI IP,
8 YOHANAN BADER ST. 1ST
FLOOR
RAMAT-GAN 52366
]57[
375
‫ שיטה וערכה לפתיחת סתימות בצינור‬,‫התקן‬
‫והצטלבות בעלת מספר רב של הסתעפויות עבורו‬
‫ אשדוד‬,‫רפאל מלכא‬
,‫ארי עורכי פטנטים‬-‫בן‬
1/1 1 ‫יוחנן בדר מגדל הארז קומה‬
‫ גן‬- ‫רמת‬
An apparatus and method for unclogging an obstructed conduit such as a wastewater
pipe. The apparatus comprises at least one tube disposed in the drain pipe; and a fluid
supply pipe for providing fluid from a fluid source, the supply pipe connected to the at
least one tube that delivers the fluid to unclog the obstruction.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
190894
‫מכשיר להכנת מים חמים ומכונת קפה הכוללת‬
‫את המכשיר להכנת מים חמים‬
]54[
DEVICE FOR PREPARING HOT
WATER AND COFFEE MACHINE
PROVIDED WITH SUCH A
DEVICE
]11[
]32[
]52[
]72[
17.10.2006
1030235
]31[ 20.10.2005
]33[ NL
Int. Cl.(2010.01) A47J 31/36, 31/54
BRAVILOR HOLDING B.V., THE
NETHERLANDS
JOHANNES THEODORUS
EMERENTIA HUIBERTS
WO/2007/046702
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
The invention relates to a device for preparing hot water provided with a pressure
pump with a supply pipe for supplying relatively cold water to the pressure pump and
an outlet connected to a heating pipe which is in heat-exchanging contact with a
heating body, with an outlet valve in the heating pipe and a coffee holder, connected to
the heating pipe, for accommodating a bed of coffee, whereby the heating body
comprises a reservoir that is openly connected to the environment, with a heating
element and water in the reservoir as a heat-exchange medium. A bypass pipe (54)
connects the inlet (57) and outlet (35) of the pressure pump (34) to each other, with a
pressure- operated valve (56) in the by-pass pipe.
]71[
]17[
]74[
]57[
376
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
BRACE-LOCKING DEVICE FOR
AN AIRCRAFT UNDERCARRIAGE
]11[
]32[
]52[
]72[
28.04.2008
0703175
]31[ 03.05.2007
Int. Cl.(2010.01) B64C 25/26
MESSIER-BUGATTI-DOWTY,
FRANCE
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
377
191116
‫התקן נעילה עבור תושבת מטוס‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A wind-brace device for an aircraft undercarriage, the device comprising: a
hinged brace movable between a folded position and a stabilization position for
stabilizing the undercarriage in the deployed position; a stabilizer member for
stabilizing the brace and comprising two hinged-together arms, one of the arms
having one end hinged to the brace about a hinge axis, and abutments defining a
locked position of the arms in which the brace is held in the stabilization position;
and a spring member for returning the arms of the stabilizer member towards
the locked position; the device being characterized in that the spring member is
connected to a lever hinged to the brace, the lever presenting a slot in which there
is engaged a finger secured to the arm that is hinged to the brace, the lever being
movable between: a confirmation position in which the finger is engaged in a
turned-back portion of the slot, while the stabilizer member is in the locked
position, the lever co-operating with the finger to confirm that the stabilizer
member is in the locked position; and a release position in which the finger is
engaged in a curved portion of the slot that extends along a circular arc centered
on the hinge axis, while the stabilizer member is not in the locked position.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
191154
‫גלאי רנטגן הסופר פוטונים עם שליטה לוגית‬
‫בטווח–על‬
]54[
PHOTON COUNTING X-RAY DETECTOR WITH
OVERRANGE LOGIC CONTROL
]11[
]32[
]52[
]72[
]74[
29.04.2008
11/744292
]31[
04.05.2007
]33[
US
Int. Cl.(2010.01) A61B 06/03, G01N 23/083
GENERAL ELECTRIC COMPANY, U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A radiographic imaging system comprising: a radiation source configured to project x-rays toward a
subject to be scanned; a detector assembly comprising a first detector layer (252) and a second detector
layer (254), the second layer (254) positioned to receive x-rays from the radiation source that pass through
the first detector layer (252), each of the first and second layers configured to receive x-rays projected from
the radiation source and convert radiographic energy to electrical signals representative of energy sensitive
radiographic data; and
a controller (262) configured to: receive a logic output signal (256, 258, 260 ) from the second detector
layer (254) indicative of a saturation level of the first detector layer (252); compare the logic output signal
to a threshold value; and output electrical signals from the first detector layer (252), the second detector
(254), or a combination thereof to an image chain (264) for image reconstruction based on the received
data.
]57[
378
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
VARIABLE LENGTH DATA
ENCAPSULATION AND
ENCODING
]11[
]32[
]52[
]72[
]17[
]74[
29.11.2006
11/292693
]31[ 02.12.2005
Int. Cl.(2010.01) H03M 07/40
VIASAT, INC., U.S.A.
WO/2007/064764
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
379
191686
‫אנקפסולציה וקידוד של נתונים באורך משתנה‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Systems, apparatus, and methods of encoding variable length data for efficient
transport over a wireless channel. A wireless terminal can determine a frame size to
encode, and can encode and transmit the frame data as one or more encoded blocks
selected from a family of block sizes. Each block size can correspond to a particular
encoder rate. The frame is parsed into a number of segments having a block size
selected from the family of block sizes. The block sizes are selected to maximize the
spectral efficiency of the frame. Each segment is then encoded with an encoder
November 30, 2011-‫ד' בכסלו התשע"ב‬
corresponding to the block size and having a coding rate that is configured to provide a
substantially equal energy per symbol for all of the blocks. The encoded blocks are
then aggregated and the smallest block zero padded. The aggregate of encoded blocks
can be transported in one or more bursts.
__________________
]22[]12[
191873
‫יחידת טעינה עבור מתקן המייצר דמות‬
]54[
CHARGING MEMBER FOR AN
IMAGE FORMING APPARATUS
]11[
]32[
]52[
]72[
30.11.2006
11/291379
]31[ 01.12.2005
]33[ US
Int. Cl.(2010.01) G03G 15/02
HEWLETT-PACKARD
DEVELOPMENT COMPANY, L.P.,
U.S.A.
WO/2007/064975
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A charging member (30) for charging an image forming apparatus (10) includes a
support member (72) and a conductive polymer material (74) surrounding an outer
periphery (82) of the support member (72) . An inner portion (76) of the conductive
polymer material (74) is loaded with a supplemental conducting agent (78) , and an
outer portion (80) of the conductive polymer material (74) is substantially free of the
supplemental conducting agent (78) .
]17[
]74[
]57[
380
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
191903
‫גורם לתכנות גרעיני מחדש של תא סומטי‬
‫ושיטות המשתמשות בו‬
]54[
NUCLEAR REPROGRAMMING
FACTOR FOR A SOMATIC CELL
AND METHODS UTILIZING THE
SAME
]11[
]32[
]52[
]72[
]17[
]74[
06.12.2006
2005-359537 ]31[ 13.12.2005
]33[ JP
Int. Cl.(2010.01) C07K 14/47, C12N 05/00, 15/09
KYOTO UNIVERSITY, JAPAN
WO/2007/069666
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Means for inducing the reprogramming of a differentiated cell without using any
embryo or ES cell and establish an inducible pluripotent stem cell having similar
pluripotency and growing ability to those of an ES cell in a simple manner and with
good reproductivity. As the means, a nuclear reprogramming factor for a somatic cell
is provided, which comprises products of the following three genes: an Oct family
gene; a Klf family gene dand an Myc family gene2
]57[
__________________
]22[]12[
]54[
381
LINE SYSTEM AND METHOD
FOR AUTOMATIC PROCESSING
AND SORTING OF FLOWERS
192018
‫מערכת פס ושיטה לעיבוד ומיון אוטומטי של‬
‫פרחים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]11[
]52[
]72[
]74[
05.06.2008
Int. Cl.(2010.01) A01G 05/00
RAPHAEL PELED
RAPHAEL PELED,
MOSHAV BNEI ATAROT
]57[
A line system (2) for automatic processing and sorting of flowers (88) comprising: an
optical imaging station (14), for imaging the length of a flower after being placed
horizontally in a conveying cell (16) of said line system, providing that the top portion
of the petal thereof appears in an image, and sending said image to a computerized
device (84) for obtaining the length of the flower when cut, from said image; and a
cutting station (18) for adjusting length of said flower based on said obtained length,
said cutting station comprising a sliding mechanism (104) to which a cutting element
(60) is attached, said sliding mechanism being controlled by said computerized device.
‫רפאל פלד‬
,‫רפאל פלד‬
‫מושב בני עטרות‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬1/ ‫פירוט זה נבחן בהתאם לתקנה‬
2//2 – ‫ תשכ"ח‬,‫הפטנטים‬
__________________
]22[]12[
192071
‫התקן ושיטה לטיפול בפני שטח של מצעים‬
]54[
DEVICE AND METHOD FOR THE
SURFACE TREATMENT OF
SUBSTRATES
]11[
]32[
]52[
]72[
15.12.2006
102005062527.4 ]31[ 16.12.2005
]33[ DE
Int. Cl.(2010.01) H01L 21/00
GEBR. SCHMID GMBH & CO.,
GERMANY
WO/2007/073887
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a device for treating the surfaces of silicon wafers, comprising
transport rollers for transporting the silicon wafer, and at least one conveyor device
which wets the surface of the silicon wafer with an aqueous medium on a transport
plane which is determined by the transport rollers. The conveyor device is configured
such that it can apply the process medium to the surface of the silicon wafer, which is
oriented in a downward manner and which is arranged on the transport plane. Several
suction pipes for suctioning gaseous and/or mist-like distributed process mediums from
the area surrounding the conveyor device are provided. The suction pipes are arranged
]17[
]74[
]57[
382
November 30, 2011-‫ד' בכסלו התשע"ב‬
in the vertical direction below the transport plane.
__________________
]22[]12[
192178
‫סטנט מפולג‬
]54[
BIFURCATED STENT
]11[
]32[
]52[
]41[
]72[
]74[
30.04.1997
08/642297
]31[ 03.05.1996
]33[ US
Int. Cl.(2010.01) A61F 02/06, 02/82, A61M 29/00
DIVISION FROM 179676
MEDINOL LTD.
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O.B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A bifurcated stent comprising:(a) a first tubular member having a proximal end and a
distal end and a longitudinal bore therethrough, said first tubular member provided
with a branch aperture disposed between said proximal end and said distal end, said
branch aperture communicating with said longitudinal bore and said aperture sized and
adapted to receive and secure a second expandable tubular member; (b) a second
tubular member having a proximal end and a distal end and having a longitudinal bore
therethrough said second tubular member disposed within said branch aperture so that
said proximal end of said second tubular member is disposed within said longitudinal
bore of said first longitudinal member and (c) a branch securing lip disposed on said
branch aperture to secure said second tubular member in said branch aperture.
]57[
__________________
383
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
192191
‫ראי כסף לשימוש במחזירור שמשי‬
]54[
SILVER MIRROR FOR USE IN A
SOLAR REFLECTOR
]11[
]32[
]52[
]72[
13.12.2006
11/303836
]31[ 16.12.2005
]33[ US
Int. Cl.(2010.01) F21V 09/04
ALLIANCE FOR SUSTAINABLE
ENERGY, LLC
WO/2007/076282
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A silver mirror construction that maintains a high percentage of hemispherical
reflectance throughout the UV and visible spectrum when used in solar reflectors,
comprising: a) a pressure sensitive adhesive layer positioned beneath a silver overlay;
b) a polymer film disposed on the silver overlay; c) an adhesive layer positioned on the
polymer film; and d) a UV screening acrylic film disposed on the adhesive layer.
]17[
]74[
]57[
__________________
]22[]12[
192321
‫מכשיר חימום ותהליך למשיכת סיבי פוליאולפין‬
]54[
HEATING APPARATUS AND
PROCESS FOR DRAWING
POLYOLEFIN FIBERS
]11[
]32[
07.12.2006
60/751895
]31[ 20.12.2005
]33[ US
229592191
1222221114
US
Int. Cl.(2010.01) B29C 47/88, D02J 01/22, 13/00, F26B 21/00
]52[
384
November 30, 2011-‫ד' בכסלו התשע"ב‬
]72[
]17[
]74[
]57[
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2007/078569
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A heating apparatus and process useful for drawing ultrahigh molecular weight
polyolefln fibers, such as polyethylene libers. The heating apparatus includes a first set
of rolls and a plurality of aligned ovens. The apparatus includes a second set of rolls at
the exit of the ovens which rolls are adapted to provide the desired drawing of the
polyolefin fibers. The apparatus and process provide a single draw step in a heated
environment, with the use of preferably four or six horizontal ovens.
__________________
]22[]12[
]54[
FLOW-TYPE LABORATORY
OZONOLYSIS APPARATUS AND
METHOD OF PERFORMING
OZONOLYSIS REACTION
]11[
]32[
]52[
]72[
22.12.2006
P0501206
]31[ 23.12.2005
Int. Cl.(2010.01) B01J 19/00
THALESNANO
NANOTECHNOLOGIAI ZRT.,
HUNGARY
WO/2007/072097
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
385
192390
‫התקן אוזונוליזה רציף מעבדתי ושיטה לביצוע‬
‫תגובת אוזונולוזיה‬
]33[
HU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A flow-type laboratory scale ozonolysis apparatus (100) according to the invention
comprises a reservoir (104), a feed pump (102), a mixing element (120) with two inlets
and an outlet, a reactor unit (110) and a pressure-adjusting means (160), all connected
into a flow path. The ozonolysis apparatus (100) further comprises an ozone source
(110), as well as a dispensing valve (112) transmitting a gas stream only in a single
direction and installed between the ozone source (110) and one of the inlets of the
November 30, 2011-‫ד' בכסלו התשע"ב‬
mixing element (120). The feed pump (102) of the ozonolysis apparatus (100)
according to the invention is a liquid pump generating a constant volume rate, the
reservoir (104) contains at least the substance, as a solute, to be subjected to the
ozonolysis reaction and the reactor unit consists of first and second reactor zones
differing in function from one another. In the flow path, the outlet of the first reactor
zone is connected to the inlet of the second reactor zone. Furthermore, an inlet for
feeding in substances is inserted into the flow path between the reactor zones, and the
pressure-adjusting means (160) is installed into the flow path after the reactor unit and
is provided with an electrically governed control.
__________________
]22[]12[
192404
‫מערכת ניידת לחימום נוזל תואם – ביולוגי‬
]54[
PORTABLE WARMER OF
BIOCOMPATIBLE FLUID
]11[
]52[
]72[
28.12.2005
Int. Cl.(2010.01) F23D 14/12, 14/14, F24H 01/06
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
BRIJESH GILL, CHARLES COX
WO/2007/075169
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
The present invention relates to a portable apparatus for warming biocompatible fluids
for use in the treatment of injured patients. The present invention may be used to
warm intravenous fluids for trauma resuscitation or to warm air from a ventilator
circuit. The portable nature of the present invention makes it highly suitable for field
applications, such as a forward surgical hospital near a combat zone.
]71[
]17[
]74[
]57[
386
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
192449
‫תמרור דרכים מואר ושיטה להארת תמרור דרכים‬
]54[
ILLUMINATED ROAD SIGN AND
METHOD FOR ILLUMINATING
A ROAD SIGN
]11[
]52[
]72[
]71[
]74[
26.06.2008
Int. Cl.(2010.01) C09K 11/70, G09F 13/08, 13/22, H05B 33/12
PANEL E.L LTD.
‫ רענננה‬,‫פנל אי אל בע"מ‬
DROR KOREN
‫דרור קורן‬
RECHES PATENTS,
,‫רכס פטנטים‬
P.O.B. 2148, HERZLIYA PITUACH
11 ‫מגדלי אקרשטיין המנופים‬
]57[
‫הרצליה פיתוח‬5141 .‫ד‬.‫ ת‬,
An illuminated road sign, comprising: a supporting element, a front element, and
multiple electroluminescent lamps located between the supporting element and the
front element; wherein the front element comprises multiple regions, wherein at least
one region is defined by a translucent reflecting element; wherein the
electroluminescent lamps are shaped and placed according to the multiple regions;
wherein the electroluminescent lamps are adapted to blink, during at least one blinking
period.
__________________
]22[]12[
]54[
ANCHORING DEVICE FOR
FOLDING CRATES
]11[
]32[
]52[
]72[
26.12.2006
P200503207
]31[ 27.12.2005
Int. Cl.(2010.01) B65D 06/26
SP BERNER PLASTIC GROUP, S.L.,
SPAIN
387
192466
‫התקן עגון לארגזים מתקפלים‬
]33[
ES
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
WO/2007/074194
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to an anchoring device for folding crates. According to the
invention, the crates include a base and fours side walls which are articulated with the
edges of the base. In addition, two of the opposing walls are provided with anchoring
devices which are used to unfold the crate and which generally consist of a central part
that can be moved vertically and side locks that can be moved horizontally in order to
anchor the side walls at the adjacent edges thereof. The invention is characterised in
that it includes elastic spring elements (5) which connect the central control part (1) to
the pairs of locks (6) and which, in the rest position, maintain the locks in the lock
anchoring and locked position. In the lock release position, the spring elements pull the
locks towards the release position against the resistance of the elastic elements.
__________________
]22[]12[
]54[
MULTI-LAYER PIXELLATED
GAMMA-RAY DETECTOR
]11[
]32[
05.04.2007
60/790037
]31[ 07.04.2006
229731421
1421421117
Int. Cl.(2010.01) G01T 01/24
RAYTHEON COMPANY, U.S.A.
WO/2007/117495
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]72[
]17[
]74[
]57[
388
192510
‫גלאי קרני גמא רב–שכבתי מפוקסל‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method and apparatus for detecting gamma-rays is provided, wherein the gammaray detector apparatus includes a plurality of detector elements arranged in a stacked
configuration. Each of the plurality of detector elements may include, a detector wafer
November 30, 2011-‫ד' בכסלו התשע"ב‬
(202) having at least one anode (206) separated from a cathode (208) via a wafer
material, wherein the wafer material includes a wafer material thickness d, and a wafer
interface, wherein the wafer interface is electrically connected to the at least one
anode.
__________________
]22[]12[
192831
‫שיטה לייצור תרכובת אלכוהולית פעילה אופטית‬
]54[
METHOD FOR PRODUCING
OPTICALLY ACTIVE ALCOHOL
COMPOUND
]11[
]32[
]52[
]72[
31.01.2007
2006-024214 ]31[ 01.02.2006
]33[ JP
Int. Cl.(2010.01) C07C 41/03, 43/23, 43/295
SUMITOMO CHEMICAL
COMPANY, LIMITED, JAPAN
WO/2007/089025
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Disclosed is a method for producing an optically active alcohol compound, which is
characterized in that a cyclic ether compound and a phenol compound are reacted in
the presence of an asymmetric complex which is obtained by reacting an optically
active metal complex represented by the formula (1) below with a metal sulfonate. (In
the formula, R1, R2, R3, R4, R5, R6, R7 and R8 independently represent a hydrogen
atom, an alkyl group or the like; one of R9 and R10 represents a hydrogen atom and the
other represents a substituted or unsubstituted phenyl group or the like; Q represents a
single bond, an alkylene group having 1-4 carbon atoms or the like; M represents a
metal ion; and there is no A when the ionic valency of the metal ion is equal to the
coordination number of ligands, while A represents a counter ion or a ligand when the
ionic valency is different from the coordination number).
]17[
]74[
]57[
389
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
192832
‫שיטה לייצור תרכובת אלכוהלית פעילה אופטית‬
]54[
METHOD FOR PRODUCING
OPTICALLY ACTIVE ALCOHOL
COMPOUND
]11[
]32[
]52[
]72[
31.01.2007
2006-024213 ]31[ 01.02.2006
]33[ JP
Int. Cl.(2010.01) C07C 37/00, 41/03
SUMITOMO CHEMICAL
COMPANY, LIMITED, JAPAN
WO/2007/089022
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Disclosed is a method for producing an optically active alcohol compound, which is
characterized in that a cyclic ether compound and a phenol compound are reacted in
the presence of an asymmetric complex which is obtained by reacting an optically
active metal complex represented by the formula (1) below with a zirconium alkoxide
or a hafnium alkoxide. (In the formula (1) R1, R2, R3, R4, R5, R6, R7 and R8
independently represent a hydrogen atom, an alkyl group or the like; one of R 9 and R10
represents a hydrogen atom and the other represents a substituted or unsubstituted
phenyl group or the like; Q represents a single bond, an alkylene group having 1-4
carbon atoms or the like; M represents a metal ion; and there is no A when the ionic
valency of the metal ion is equal to the coordination number of ligands, while A
represents a counter ion or a ligand when the ionic valency is different from the
coordination number)1
]17[
]74[
]57[
390
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
192945
‫כיסוי לעגלת ילדים‬
]54[
COVER FOR BABY CARRIAGE
]11[
]52[
]72[
]74[
22.07.2008
Int. Cl.(2010.01) B60N 02/60, B62B 09/12
NATHALIE ROBIN, FRANCE
AIME TANGY,
,‫עו"ד אמה טנג'י‬
65 MENAHEM BEGIN AVE.
14 )5‫ (קומה‬15 ‫דרך מנחם בגין‬
2 FLOOR
‫תל אביב‬
TEL-AVIV 67138
The cover has openings (2) for passing safety belts, and an elastic joint (1) arranged at
ends of the cover for installing the cover on a push chair. Elastic attachments (3) are
arranged at top of the cover, and are adjusted by buttons (4). Fabric attachments (5)
are provided at bottom of the cover for permitting fixation to bars of the push chair,
where the cover is maintained by the fabric attachment and an edge band. A
Velcro(RTM: hook-and-loop fastener) band is placed at back of the cover.
]57[
__________________
]22[]12[
]54[
NIGHT VISION COMPATIBLE
DISPLAY BACKLIGHT
]11[
]32[
]52[
]72[
24.01.2007
11/338314
]31[ 24.01.2006
Int. Cl.(2010.01) G01D 11/28
ASTRONAUTICS CORPORATION
OF AMERICA, U.S.A.
WO/2007/087409
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
391
192951
‫תאורה אחורית של מסך המתאימה לראיית‬
‫לילה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A system and method of backlighting a display using LEDs (26) is night vision
viewing compatible and requires no filters The backlight includes an array of LEDs
(26) and a controller (58) configured to selectively illuminate the LEDs (26) in the
array The array of LEDs (26) includes orange LEDs (40) that are illuminated during a
night vision viewing mode and may include red LEDs (34) that are illuminated in a
November 30, 2011-‫ד' בכסלו התשע"ב‬
non-night vision viewing mode.
__________________
]22[]12[
192964
‫תרכיב חיסון נגד גידולים המכיל תאים גידוליים‬
‫של אלוג'נאיק או קסנוג'נאיק וליזאט של תא‬
‫גידול סינגני‬
]54[
TUMOUR VACCINE
COMPRISING ALLOGENEIC OR
XENOGENEIC TUMOUR CELLS
AND A LYSATE OF A SYNGENEIC
TUMOUR CELL
]11[
]32[
]52[
]72[
26.01.2007
0601598.6
]31[ 26.01.2006
]33[ GB
Int. Cl.(2010.01) A61K 35/30, 39/00, A61P 35/00
APOSTOLOS STATHOPOULOS,
BELGIUM
WO/2007/085648
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention provides a composition for the treatment of a tumour,
comprising: (i) allogeneic or xenogeneic tumour cells; and (ii) a pharmaceutically
acceptable excipient. If two or more heterozygous individuals have the same
cancer/tumour of the same or similar histological grade, then transplantation of
tumour/cancer tissue/cells from one individual to another will not only induce rejection
of the transplanted tissue/cancer, but will also increase the immunological awareness
of the immune system to peptides shared between the tumours/cancers and other
tumours possessing similar peptides.
]17[
]74[
]57[
__________________
392
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
MULTIPHASIC METHOD OF
CONTRACEPTION AND KIT
ASSOCIATED THEREWITH
]11[
]32[
09.02.2007
60/778067
]31[ 02.03.2006
419791453
2121421114
Int. Cl.(2010.01) A61K 09/00
WARNER CHILCOTT COMPANY,
LLC, PUERTO RICO
WO/2007/106264
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
193013
‫שיטה לאמצעי מניעה רב–שלבי וקיטים‬
‫המבוססים על השיטה‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A multiphasic method of contraception comprising the steps of sequentially
administering to a female of child bearing age a Phase I composition containing a
progestogen in an amount equivalent to about 0.3 to about 1.5 mg norethindrone
acetate and an estrogen in an amount equivalent to about 5 to aboμt 15 mcg of ethinyl
estradiol for about 7 to about 14 days; a Phase II composition containing a progestogen
in an amount equivalent to about 0.3 to about 1.5 mg of norethindrone acetate and an
estrogen in an amount equivalent to about 10 to about 25 meg of ethinyl estradiol for
about 14 to about 22 days; a Phase III composition containing a progestogen in an
amount equivalent to about 0.3 to about 1.5 mg of norethindrone acetate and an
estrogen in an amount equivalent to about 15 to about 35 meg of ethinyl estradiol for
about 20 to about 31 days; and an optional Phase IV composition containing (i) an
estrogen in an amount equivalent to about 5 to about 20 meg of ethinyl estradiol, or (ii)
a placebo or a non-steroidal component, or (iii) a combination of (i) and (ii), for about
2 to about 8 days. The ethinyl estradiol equivalent amount of estrogen in each of the
successive Phases II and III is at least 5 meg greater than the ethinyl estradiol
equivalent amount of estrogen in the immediately-preceding phase.
__________________
]22[]12[
]54[
393
DEVICE FOR COUPLING
BETWEEN A PLASMA ANTENNA
AND A POWER SIGNAL
193280
‫התקן לצימוד בין אנטנת פלסמה לבין מחולל אות‬
‫כוח חשמלי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
GENERATOR
]11[
]32[
]52[
]72[
]17[
]74[
07.02.2007
0601075
]31[ 07.02.2006
Int. Cl.(2010.01) H01J 37/32
THALES, FRANCE
WO/2007/090850
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to a device for coupling between a plasma column
functioning as an antenna and a power signal electrical generator, associated with a
laser, and this device is characterized in that it comprises at least two conducting
electrodes (1, 2) each drilled with a hole (3, 4), these holes being coaxial, the
electrodes being connected on the one hand to a high DC voltage source (8) and on the
other hand to an AC power signal source (13), the laser (lasers) being disposed in such
a way that its (their) beam arrives along the axis (5) of said holes of the electrodes.
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
ABERRATION-CORRECTING
CATHODE LENS MICROSCOPY
INSTRUMENT
]11[
]32[
]52[
]72[
]17[
]74[
14.02.2007
11/364299
]31[ 28.02.2006
Int. Cl.(2010.01) H01J 37/05
IBM CORPORATION, U.S.A.
WO/2007/100978
IBM LABORATORIES,
394
193703
‫מכשיר בעל עדשה קאתודית לתיקון ליקויים‬
]33[
US
,‫מעבדות יבמ מחלקת קנין רוחני‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
An aberration-correcting microscopy instrument is provided. It has a first magnetic
deflector (206) disposed for reception of a first non-dispersed electron diffraction
pattern. The first magnetic deflector is also configured for projection of a first energy
dispersed electron diffraction pattern in an exit plane (A2) of the first magnetic
deflector. An electrostatic lens (224) is disposed in the exit plane of the first magnetic
deflector. A second magnetic deflector (222) substantially identical to the first
magnetic deflector is disposed for reception of the first energy dispersed electron
diffraction pattern from the electrostatic lens. The second magnetic deflector is also
configured for projection of a second non-dispersed electron diffraction pattern in a
first exit plane (B2) of the second magnetic deflector. An electron mirror (226) is
configured for correction of one or more aberrations in the second non-dispersed
electron diffraction pattern. The electron mirror is disposed for reflection of the second
non-dispersed electron diffraction pattern to the second magnetic deflector for
projection of a second energy dispersed electron diffraction pattern in a second exit
plane (B3) of the second magnetic deflector.
HAIFA UNIVERSITY,
HAIFA 31905
]57[
__________________
]22[]12[
]54[
395
APPARATUS AND METHOD FOR
GENERATING AUDIO SUBBAND
193786
‫התקן ושיטה ליצירת ערכי תת–פס של אודיו‬
‫והתקן ושיטה ליצירת דגימות אודיו של תחום‬
‫זמן‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
VALUES AND APPARATUS AND
METHOD FOR GENERATING
TIME-DOMAIN SAMPLES
]11[
]32[
]52[
]72[
]17[
]74[
]57[
396
23.10.2007
60/862954
]31[ 25.10.2006
]33[ US
Int. Cl.(2010.01) G10L 19/02
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
WO/2008/049590
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An embodiment of an apparatus (100) for generating audio subband values in audio
subband channels comprises an analysis windower (110) for windowing a frame (120)
of time-domain audio input samples being in a time sequence extending from an early
sample to a later sample using an analysis window function (190) comprising a
sequence of window coefficients to obtain windowed samples. The analysis window
function comprises a first number of window coefficients derived from a larger
window function comprising a sequence of a larger second number of window
coefficients, wherein the window coefficients of the window function are derived by
an interpolation of window coefficients of the larger window function. The apparatus
(100) further comprises a calculator (170) for calculating the audio subband values
using the windowed samples.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
VEHICLE RESTRAINT SYSTEM
FOR PROTECTING TRAFFIC
ROUTES
]11[
]32[
]52[
]72[
10.09.2008
102007043139.4 ]31[ 11.09.2007
Int. Cl.(2010.01) E01F 15/04, 15/08
VOLKMANN & ROSSBACH GMBH &
CO. KG, GERMANY
HERMANN SPENGLER GMBH &
CO.KG
VANESSA VOLKMANN, BERND
SPENGLER
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]71[
]74[
]57[
194016
‫מערכת מעקה בטיחות להגנת נתיבי תנועה‬
]33[
DE
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
The system has a protective plank structure overlapped with a stationary wall section
(12) within overlapping area (22) and attached to the wall section. The structure
extends along a traffic path based on the overlapping area. The structure includes a
connection element (24) with an elongated oblong tensile load section (38) for
attaching to a side of the wall section turning towards a roadway within the
overlapping area. A retaining section (44) of the connection element retains or attaches
a component of the structure running along the traffic path.
__________________
397
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
CUTTING TOOL AND METHOD
OF PRODUCING THE SAME
]11[
]32[
26.03.2007
2006-086773 ]31[ 28.03.2006
1114-197321
3221321114
Int. Cl.(2010.01) B23B 27/14
SUMITOMO METAL INDUSTRIES,
LTD., JAPAN
WO/2007/111293
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
]52[
]72[
]17[
]74[
]57[
398
194149
‫מכשיר חיתוך ושיטה להפקתו‬
]33[
JP
JP
,'‫דניאל פריימן ושות‬
10 ‫ בית כלל קומה‬5 ‫דרויאנוב‬
‫תל אביב‬
A cutting tool comprising a cutting tool base metal of superhard material and,
superimposed thereon, a coating layer composed of a substratum layer of AlTiN, an
interlayer of TiN and an outermost layer of Al2O3. This cutting tool is preferably one
obtained by subjecting the surface of sintered metal of superhard material to surface
cleaning, and surface configuration working, by soft particle jet before the formation
of the coating layer. In the cutting tool, the total thickness of the coating layer on the
flank thereof is preferably in the range of 2 to 80 μm, and the total thickness of the
coating layer on the cutting face thereof is preferably in the range of 2 to 40 μm.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
194445
‫אחיזת חבור לטיפול במודולים מעוגלים צרובים‬
‫ומכשיר חיתוך לצרור‬
]54[
GRAPPLE ATTACHMENT FOR
HANDLING WRAPPED ROUND
MODULES AND INCLUDING A
WRAP CUTTER
]11[
]32[
]52[
]72[
]74[
28.09.2008
11/927967
]31[ 30.10.2007
]33[
Int. Cl.(2010.01) A01F 29/00, B65B 69/00
DEERE & COMPANY, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A grapple attachment is equipped with driven rollers for selectively turning a wrapped
round module about its axis so as to position it for having the wrapping slit at the
bottom side of the module. When the module is properly located for having the
wrapping slit, a powered cutting blade is caused to move into engagement with the
wrapping and slit it across the length of the module. An interlock is provided for
preventing operation of the grapple cylinders and driven roller motors unless the
cutting blade assembly is located in a standby position wherein it is removed from a
zone normally occupied by the round module when the latter is supported by the fixed
and moveable grapple sections of the grapple attachment.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
]11[
]32[
]52[
]41[
]72[
]17[
]74[
399
COMPOUND FOR THE
MODIFICATION OF A
BIOLOGICAL SUBSTANCE AND
PROCESS FOR ITS PRODUCTION
194501
‫תרכובת לשינוי של מוצר ביולוגי ותהליך‬
‫להכנתה‬
20.11.2003
2002-337113 ]31[ 20.11.2002
]33[ JP
Int. Cl.(2010.01) A61K 38/43, 47/48, C08G 02/00, 65/32
DIVISION FROM 168238
NOF CORPORATION, JAPAN
WO/2004/046222
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A compound of the formula I as depicted in the specification wherein R is a
hydrocarbon group having 1 to 24 carbon atoms, the groups represented by R are the
same or different from each other in one molecule; OA1 and OA2 are oxyethylene
groups, n and m (which are each average numbers of moles of the oxyethylene groups)
are respectively 1 to 1000 and 10 to 1000; and X represents a functional group capable
of chemically reacting with an unmodified bio-related substance.
__________________
]22[]12[
]54[
DEVICE FOR CONVERTING
SOLAR ENERGY
]11[
]32[
]52[
]72[
05.04.2007
1031544
]31[ 07.04.2006
Int. Cl.(2010.01) F24J 02/06
SUNCYCLE INTERNATIONAL
GMBH, SWITZERLAND
WO/2007/117136
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
400
194536
‫מתקן להמרת אנרגיה סולרית‬
]33[
NL
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a device (10) for converting solar energy, comprising a solar
radiation capturing unit (11) comprising at least one lens having a entry surface (11a)
for the incident solar radiation and an exit surf ace (11b) for emitting the solar
radiation in refracted form to a solar radiation concentrating unit (12) comprising a
reflector surface (12a) for reflecting the solar radiation incident on the reflector surface
(12a) from the exit surface of the lens (11b) to at least one target area (13) of the solar
radiation concentrating unit (12). The device (10) comprises positioning means (14)
for orienting the solar radiation capturing unit (11) and the solar radiation
concentrating unit (12) with respect to each other through rotation about at least one
axis (11') perpendicular to a plane formed by the lens.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
194766
‫בקר כוח לאות משודר מלווין עבור מספר רב של‬
‫אותות משודרים בחריצי זמן במערכת תקשורת‬
TDD
]54[
DOWNLINK POWER CONTROL
FOR MULTIPLE DOWNLINK
TIME SLOTS IN TDD
COMMUNICATION SYSTEMS
]11[
]32[
]52[
]41[
]72[
30.04.2001
60/200756
]31[ 01.05.2000
]33[ US
Int. Cl.(2010.01) H04B 07/005, 07/26, H04J 03/00, 13/00, H04L 01/00, H04N 01/00
DIVISION FROM 152556
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/084740
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]17[
]74[
]57[
401
A method for using time slots for communication, implemented in a user equipment
(UE), comprising:
Receiving data in a command per coded composite transport channel (CCTrCH)
transmitted over a plurality of time slots;
measuring an interference power for each time slot of the plurality of time slots;
transmitting a single power command for the entire CCTrCH in response to a signal to
interference ratio of the received CCTrCH and the measured interference power
measurement for each time slot; and receiving a subsequent data in the CCTrCH
communication having a transmission power level for each downlink communication
time slot set individually in response to the interference power measurement for that
time slot and the single power command for the entire CCTrCH.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
194840
‫מערכת שדה סולרי היפרבולי בצורה שקע‬
]54[
HYPERBOLIC SOLAR TROUGH
FIELD SYSTEM
]11[
]52[
]72[
]17[
]74[
05.05.2006
Int. Cl.(2010.01) F24J 02/10, 02/38, 02/46, 02/54
RAHMI OGUZ CAPAN, TURKEY
WO/2007/129146
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The subject matter of the invention of hyperbolic solar trough field system (B, H)
comprises hyperbolic reflectors (20, 20m) in which the beams that come from the sun
parallel, but of which the angle of incident changes at a fixed rate of 15 degrees per
hour throughout the day are concentrated on the focal axis in the bottom part thereof,
thermal receiver tubes (21 ) which extend throughout said focal axis and are at a fixed
position, and side supports (23, 23') which are at a ground-fixed position on the both
sides of the reflectors. The reflectors (20, 20m) are connected to the ground from at
least one rotary joint (22) point such that said reflectors can rotate around the central
axis of the thermal receiver tubes (21 ). The bottom part of hyperbolic reflectors (20,
20m) has been produced as circular sectioned such that it surrounds the thermal
receiver tubes (21 ) somewhat, on the continuation; a hyperbola form has been given
to its arms extending towards two sides. Other hyperbolic reflectors (20m) are also
provided with a bigger second hyperbola form which starts from the point where said
hyperbola form finishes.
]57[
__________________
]22[]12[
402
195097
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫שיטת גילוי עבור וירוסי שפעת‬
]54[
DETECTION METHOD FOR
INFLUENZA VIRUSES
]11[
]32[
18.05.2007
06114170.1
]31[ 18.05.2006
]33[
1422939123
1321121114
419139425
1321121114
Int. Cl.(2010.01) C12Q 01/34, G01N 33/569
VETERINARMEDIZINISCHE
UNIVERSITAT WIEN,, AUSTRIA
WO/2007/135099
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
EP
EP
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method of rapid detection of influenza viruses and/or virus particles comprising a
hemagglutinin and a neuraminidase component, said method comprising the steps of:
a) binding the viruses and/or virus particles to a support containing at least one type of
carbohydrate receptor selected from the group consisting of natural or synthetic
oligosaccharide, which is conjugated to, or situated in composition with glycoproteins
like glycophorin, al-acid glycoprotein, a2-macroglobulin, ovomucoid, and
combinations thereof which carbohydrate receptor binds to the hemagglutinin
component of the viruses and/or virus particles; b) reacting the neuraminidase
component of the bound viruses and/or virus particles with its labelled enzyme
substrate, causing the generation of a detectable signal; and c) detecting the signal
generated in step b).
__________________
]22[]12[
195200
‫גליצרידים המשמשים כגורמי הגנת כימו‬
]54[
GLYCERIDES FOR USE AS
CHEMOPROTECTIVE AGENTS
]11[
]32[
]52[
18.04.2002
60/284458
]31[ 18.04.2001
]33[ US
Int. Cl.(2010.01) A61K 31/18, 31/194, 31/20, 31/23, 31/255, 31/70, A61P 07/00,
37/00, 43/00, C07C 233/31, 235/06, 237/22
DIVISION FROM 158322
PROMETIC BIOSCIENCES INC.,
CANADA
WO/2002/083120
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
]41[
]72[
]17[
]74[
403
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A composition and method for promoting neutrophil survival and activation such as
the treatment of neutropenia arising as an undesirable side effect of chemotherapy and
radiation therapy. A composition containing medium-chain fatty acids, such as capric
acid or caprylic acid, or salts or triglycerides thereof, or mono- or diglycerides or other
analogues thereof or medium-chain triglycerides (MCT) is administered to a human or
animal needing treatment in an amount sufficient to reduce or eliminate neutropenia.
The composition is administered in an amount effective to treat the disorder. The
methods are also useful in the management of bone marrow transplantation and in the
treatment of various neutropenic diseases2
__________________
]22[]12[
195253
–‫–אלפא–אצטוקסי‬11 ‫תהליך תעשייתי להכנת‬
–11–]‫–דימתיל–אמינו)–פניל‬N,N[–2[–‫–ביתא‬11
‫–דיאון וחומרי ביניים‬41,3–‫–דיאן‬1,2 ‫נורפרגנא‬
‫שלו‬
]54[
INDUSTRIAL PROCESS FOR THE
SYNTHESIS OF 17-ALPHAACETOXY-11ß-[4-(N,NDIMETHYLAMINO)-PHENYL]-19NORPREGNA-4,9-DIENE-3,20DIONE AND INTERMEDIATES
THEREOF
]11[
]32[
]52[
]72[
18.05.2007
P0600491
]31[ 14.06.2006
]33[
Int. Cl.(2010.01) C07J 21/00, 31/00, 41/00
RICHTER GEDEON NYRT.,
HUNGARY
WO/2007/144674
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
404
HU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a new industrial process for the synthesis of solvatefree 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20November 30, 2011-‫ד' בכסלו התשע"ב‬
dione [CDB -2914] of formula (I) which is a strong antiprogestogene and
antiglucocorticoid agent. The invention also relates to compounds of formula (VII) and
(VIII) used as intermediates in the process. The process according to the invention is
the following: i) 3-(ethylene-dioxy)-estra-5(10),9(11)-diene-17-one of formula (X) is
reacted with potassium acetilyde formed in situ in dry tetrahydrofuran by known
method, ii) the obtained 3-(ethylene-dioxy)-17α-ethynyl-17β-hydroxy-estra5(10),9(11)-diene of formula (IX) is reacted with phenylsulfenyl chloride in
dichloromethane in the presence of triethylamine and acetic acid, iii) the obtained
isomeric mixture of 3-(ethylene-dioxy)-21-(phenyl-sulfinyl)-19-norpregna5(10),9(11),17(20),20-tetraene of formula (VIII) is reacted first with sodium
methoxide in methanol, then with trimethyl phosphite, iv) the obtained 3-(ethylenedioxy)-17α-hydroxy-20-methoxy-19-norpregna-5(10),9(11),20-triene of formula (VII)
is reacted with hydrogen chloride in methanol, then v) the obtained 3-(ethylene-dioxy)17α-hydroxy-19-norpregna-5(10),9(11l)-diene-20- one of formula (VI) is reacted with
ethylene glycol hi dichloromethane in the presence of trimethyl orthoformate and ptoluenesulfonic acid by known method, vi) the obtained 3,3,20,20-bis(ethylene-dioxy)17α-hydroxy-19-norpregna- 5(10),9(11)-diene of formula (V) is reacted with hydrogen
peroxide in a mixture of pyridine and dichloromethane in the presence of
hexachloroacetone by known method, vii) the obtained 3,3,20,20-bis(ethylene-dioxy)17α-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene of formula (IV), containing
approximately a 1:1 mixture of 5α,10α- and 5β,10β-epoxides, is isolated from the
solution and reacted with a Grignard reagent obtained from 4-bromo-N,N-dimethylaniline in tetrahydrofuran in the presence of copper(I) chloride catalyst without
separation of the isomers by known method, viii) the obtained 3,3,20,20-bis(ethylenedioxy)-5α,17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl]-19-norpregn-9(11)ene of formula (III) is reacted with potassium hydrogensulfate in water by known
method, ix) the obtained 11β-[4-(N,N-dimethylamino)-phenyl]-17α-hydroxy-19norpregn-4,9-diene-3,20-dione of formula (II) is acetylated with acetic anhydride in
the presence of perchloric acid by known method, finally x) the solvate-free compound
of formula (I) is liberated from the obtained solvate containing compound of formula
(I) in a 1 : 1 mixture of ethanol and water at 70° C.
405
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
195332
‫מפתח ומנעול צילינדר‬
]54[
KEY AND DISC TUMBLER
CYLINDER LOCK
]11[
]32[
]52[
]72[
]17[
]74[
11.06.2007
20065422
]31[ 19.06.2006
Int. Cl.(2010.01) E05B 19/00, 21/06
ABLOY OY, FINLAND
WO/2007/147933
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to a disc tumbler cylinder lock and a key for it. The key
according to the invention comprises a groove (6) that is transverse to the key shank
(2). The groove comprises a bottom section (6A) and side sections (6B) that are
transverse to the bottom section between the bottom section and the outer surface (2A)
of the key shank. The bottom section of the groove is the key's main driving surface
used to transfer turning force to the disc tumbler cylinder lock. This reduces wear on
the O-surfaces of the key because the O-surfaces do not transfer the majority or any of
the key turning force to the disc tumbler cylinder lock.
406
]33[
FI
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
195610
‫רשתות עצביות עם יכולות לימוד וביטוי‬
]54[
NEURAL NETWORKS WITH
LEARNING AND EXPRESSION
CAPABILITY
]11[
]32[
]52[
]41[
]72[
21.06.2004
PI20032400
]31[ 26.06.2003
]33[ MY
Int. Cl.(2010.01) G06F 15/18, G06N 03/02, 03/08
DIVISION FROM 172201
NEURAMATIX SDN. BHD.,
MALAYSIA
ROBERT GEORGE HERCUS
WO/2004/114145
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
‫ רחוב ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
1
7 JABOTINSKY ST.,
‫גן‬
‫רמת‬
RAMAT GAN 52520
]71[
]17[
]74[
]57[
407
A method of creating an artificial neural network for processing elemental data inputs
using a processor, comprising: (a) creating data structures on a storage device that
represent elemental neurons for each elemental data input, wherein the processor is
configured to modify the data structures to represent the activation of elemental
neurons in response to receipt of the corresponding elemental data input; (b) activating
elemental neurons in an order corresponding to the order or proximity of elemental
data inputs; (c) creating data structures on the storage device representing the addition
of structural neurons to the artificial neural network where necessary to create
associations between neurons, wherein the processor is configured to modify the data
structures to represent the activation of the structural neurons in response to the
activation of one of: elemental neurons, structural neurons and elemental and structural
November 30, 2011-‫ד' בכסלו התשע"ב‬
neurons, associated with each structural neuron; and (d) activating structural neurons
in response to the order of the activation of elemental and/or structural neurons.
__________________
]22[]12[
195734
‫תהליך לייצור של בנזנדומתאנול מותמר בהלוגן‬
]54[
PROCESS FOR PRODUCTION OF
HALOGEN-SUBSTITUTED
BENZENEDIMETHANOL
]11[
]32[
]52[
]72[
21.06.2007
2006-176479 ]31[ 27.06.2006
]33[ JP
Int. Cl.(2010.01) C07C 29/147
SUMITOMO CHEMICAL
COMPANY, LIMITED, JAPAN
WO/2008/001826
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A process for the production of a halogen-substituted benzenedimethanol represented
by the formula (2), comprising the step of reacting a halogen-substituted terephthalic
acid diester represented by the formula (1), a metal borohydride compound and an acid
with one another in the presence of an ether solvent, wherein the acid is used in an
November 30, 2011-‫ד' בכסלו התשע"ב‬
]17[
]74[
]57[
408
amount of 0.2 to 3 moles per 1 mole of the halogen-substituted terephthalic acid
diester represented by the formula (1) expressed in terms of protons, and the reaction is
conducted under the condition where the liquid phase of the reaction mixture is a
single phase. (1) wherein X1, X2, X3 and X4 independently represent a hydrogen atom
or a halogen atom, provided that at least one of X1, X2, X3 and X4 represents a halogen
atom; and R1 and R2 independently represent an unsubstituted or substituted alkyl
group. (2) wherein X1, X2, X3 and X4 are as defined above.
__________________
]22[]12[
196063
‫ רקמת החיבור‬,‫ במיוחד לעיסוי‬,‫מכשיר לטיפול‬
‫של העור‬
]54[
DEVICE FOR TREATING, IN
PARTICULAR MASSAGING, THE
CONNECTIVE TISSUE OF THE
SKIN
]11[
]32[
]52[
]72[
18.06.2007
0605423
]31[ 19.06.2006
]33[ FR
Int. Cl.(2010.01) A61H 01/00
LOUISIN RESEARCH AND
DEVELOPMENT LIMITED,
IRELAND
WO/2007/147964
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
This device (1) comprises two parallel rollers (20) which are used to work the skin (3)
and which are mounted in a casing (10) so as to rotate about their respective axis (XX). To treat the skin by aspiration in a reliable and effective manner, without using
excessive vacuum levels, at least one of the rollers is hollow and delimits transverse
]17[
]74[
]57[
409
November 30, 2011-‫ד' בכסלו התשע"ב‬
aspiration passages (64). These passages each have an outer end (641), which opens
out on the periphery (20A) of the roller, and an inner end (642) which, at least when
the outer end is directed towards the skin, is designed to be connected to a vacuum
source via a control means (22) inside the roller. These passages are distributed about
the periphery of the roller in such a way that, for each position of the roller about its
axis, at least one of the passages has its outer end directed towards the skin and has its
inner end in fluidic communication, via the control means, with the inner end of at
least one other of the passages, of which the outer end opens out in a free volume (18,
62) defined inside the casing.
__________________
]22[]12[
196359
]54[
CONE-BEAM CT
]11[
]52[
]72[
]71[
]17[
]74[
10.04.2007
Int. Cl.(2010.01) A61B 06/03
ARINETA LTD.
‫ קסריה‬,‫ארינטה בע"מ‬
DAFNI EHUD
‫דפני אהוד‬
WO/2008/122971
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Apparatus for CT cone beam scanning, comprising: a table for holding a subject; a
gantry; a first detector array, having a given number of rows of detector elements
spaced along an rotation axis of the gantry, mounted on the gantry; a first plurality of
x-ray sources mounted on the gantry for rotation about the patient table on a rotation
axis, the number of rows being at least twice the number of sources; and a controller
that acquires data responsive to radiation from the sources from the detector array
attenuated by at least part of the common volume of the subject irradiated by the
]57[
410
‫ עם קרן בצורת כונוס‬CT ‫מערכת‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
plurality of radiation sources.
__________________
]22[]12[
197296
‫שימוש של אימטיניב לייצור תרופה לטיפול‬
‫בלוקמיה חיובית לפילדלפיה‬
]54[
USE OF IMATINAB FOR THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF
PHILADELPHIA-POSITIVE
LEUKEMIA
]11[
]32[
20.09.2007
60/826622
]31[ 22.09.2006
]33[ US
419111171
1522121114
US
Int. Cl.(2010.01) A61K 49/00, C07D 237/00
NOVARTIS AG, SWITZERLAND
WO/2008/036792
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides a method of treating Philadelphia positive (Ph+)
leukemia, such as Philadelphia chromosome positive acute lymphoblastic leukemia
(Ph+ ALL) or chronic myeloid leukemia (CML), in a human patient population
comprising the steps of (a) administering a predetermined fixed amount of a Bcr-Abl
tyrosine kinase inhibitor, such as Imatinib, or a pharmaceutically acceptable salt
November 30, 2011-‫ד' בכסלו התשע"ב‬
]52[
]72[
]17[
]74[
]57[
411
thereof to human patients suffering from a Ph+ leukemia, (b) collecting at least one
blood sample from said patients, (c) determining the plasma trough level (Cmin) of the
Bcr-Abl tyrosine kinase inhibitor or of a metabolite thereof as well as the MMR rates,
(d) assessing a discrimination potential of trough plasma concentrations for MMR and
identifying a Cmin threshold for optimal sensitivity and specificity and (e) adjusting
the dose of the inhibitor of the Bcr-Abl tyrosine kinase or a pharmaceutically
acceptable salt thereof applied to the individual patients from said patient population
and, optionally, future patients suffering from a Ph+ leukemia in a manner that a Cmin
is achieved in each single patient equal to or higher than the Cmin threshold obtained
under step (d).
__________________
]22[]12[
197989
,‫שיטה ומערכת לייצור לוח בעל פני שטח גדולים‬
‫לוח בעל פני שטח גדולים המיוצר ומערכת של‬
‫לוחות אינדיבידואלים‬
]54[
METHOD OF AND APPARATUS
FOR MANUFACTURING A LARGE
SURFACE PANEL, A LARGE
SURFACE PANEL PRODUCED
THEREBY AND A SET OF
INDIVIDUAL PANELS
]11[
]32[
03.10.2007
06121829.3
]31[ 05.10.2006
]33[ EP
1721421729
2321421117
EP
Int. Cl.(2010.01) B41M 03/06, B44B 05/00, B44C 01/24, 05/04, B44F 09/02, E04F
13/18
SPANOLUX N.V. -DIV. BALTERIO,
BELGIUM
WO/2008/040760
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]72[
]17[
]74[
]57[
412
The invention provides a method of manufacturing a large surface panel (1), which has
a decoration layer with a repetitive decoration layer pattern (5), and a repetitive surface
structure pattern (4), wherein the frequencies of the repetitive patterns of the surface
structure and the decoration layer are different. The invention also provides a set of
individual panels (3). The individual panels (3) are cut out from the large surface panel
(1) and can be collected and wrapped into a package. The package comprises at least a
plurality of individual panels (3) having identical decoration layer patterns (5), but
different surface structure patterns (4). The invention provides large surface panels and
individual panels (3) which present a very good imitation of panels made of a natural
November 30, 2011-‫ד' בכסלו התשע"ב‬
material.
__________________
]22[]12[
199988
]54[
USE OF PYY THERAPEUTICS
FOR PREPARING
COMPOSITIONS FOR TREATING
GLUCOSE METABOLIC
DISEASES
]11[
]32[
]52[
]41[
]72[
]17[
]74[
10.02.2000
60/119577
]31[ 10.02.1999
]33[ US
Int. Cl.(2010.01) A61K 35/39, 38/22, 45/00, 45/06, A61P 03/06, 03/08, 03/10, 05/48
DIVISION FROM 144703
CURIS INC., U.S.A.
WO/2000/047219
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
Methods for potentiating, enhancing or restoring glucose responsivity in pancreatic
islets or cells. The methods can be used as therapies for diseases caused by, or
coincident with aberrant glucose metabolism, such as Type II Diabetes Mellitus2
‫ להכנת תכשיר לטיפול‬PYY ‫שימוש בתרפויטי‬
‫במחלות של חילוף חומרים בנוגע לגלוקוז‬
__________________
]22[]12[
]54[
413
METHODS FOR THE DETECTION
OF 193P1E1B PROTEIN AND USE
OF COMPOSITIONS
200608
‫ ושימושים‬B1E1P193 ‫שיטות לזיהוי החלבון‬
‫ או‬B1E1P193 ‫בתכשירים המכילים את החלבון‬
‫נוגדן הנקשר לו‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
CONTAINING A 193P1E1B
PROTEIN OR AN ANTIBODY
BINDING THERETO
]11[
]32[
]52[
]41[
]72[
]17[
]74[
]57[
06.12.2002
10/013312
]31[ 07.12.2001
]33[ US
Int. Cl.(2010.01) C07K 14/47, 16/18, 16/30, C12N 15/12
DIVISION FROM 162274
AGENSYS, INC., U.S.A.
WO/2003/050255
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A novel gene 0193P1E1B (also designated 193P1E1B) and its encoded protein, and
variants thereof, are described wherein 193P1E1B exhibits tissue specific expression
in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I.
Consequently, 193P1E1B provides a diagnostic, prognostic, prophylactic and 9or
therapeutic target for cancer. The 193P1E1B gene or fragment thereof, or its encoded
protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or
cellular immune response; antibodies or T cells reactive with 193P1E1B can be used in
active or passive immunization.
The applications for division
from this application have
not yet been published
,18/111
‫בקשות חלוקה מבקשה זו‬
0‫שטרם פורסמו‬
__________________
]22[]12[
]54[
METHOD OF PREPARING A
DESIRED DIASTEREOMER OF A
TETRAHYDRO-ß-CARBOLINE
AND USE THEREOF FOR
PREPARING AN INDOLE-1,4DIONE DERIVATIVE
]11[
]32[
14.07.2003
60/400386
]31[ 31.07.2002
419441242
1321421113
Int. Cl.(2010.01) C07D 471/04, 471/14
]52[
414
200692
‫שיטה להכנת דיאסטריומר רצוי של‬
‫–קרבולין והשימוש בו להכנת‬ß–‫טטראהידרו‬
‫–דיאון‬2,1–‫תולדות אינדול‬
]33[
US
US
November 30, 2011-‫ד' בכסלו התשע"ב‬
]41[
]72[
]17[
]74[
DIVISION FROM 166255
ICOS CORPORATION, U.S.A.
WO/2004/011463
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A method of introducing a second stereogenic center into a tetrahydro-ß-carboline
have two stereogenic centers using a modified Pictet-Spengler reaction is disclosed.
The method provides a desired cis- or trans-isomer in high yield and purity, and in
short processes times.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
201324
‫התקן לבקרת נוזלים בעל מפעיל לחוץ באופן ידני‬
]54[
FLUID CONTROL DEVICE WITH
MANUALLY DEPRESSED
ACTUATOR
]11[
]32[
]52[
]72[
16.04.2008
182605
]31[ 17.04.2007
]33[ IL
Int. Cl.(2010.01) A61J 01/20
MEDIMOP MEDICAL PROJECTS
‫ רעננה‬,‫מדימופ פרויקטים רפואיים בע"מ‬
LTD.
WO/2008/126090
MEDIMOP MEDICAL PROJECTS
,‫מדימופ פרוייקטים רפואיים בע"מ‬
LTD.,
11 ‫רח' התדהר‬
17 HATIDHAR ST.
‫רעננה‬5466 .‫ד‬.‫ ת‬,
P.O.B. 2499
RA'ANANA 43665
Fluid control device (70) including a housing (31) with a syringe port (33) for
receiving a syringe, a vial adapter port (36) with a vial adapter (86) for snap fit
receiving a vial, and a drug administration port (34) for administering a liquid drug.
The vial adapter is intended to be rotationally detached after a mixing procedure for
discarding together with a spent vial. The fluid control device additionally includes a
manually depressed actuator (74) for sealing pathways which may lead to leakage of
liquid drug subsequent to vial adapter detachment, thereby facilitating their use for
handling and administration of hazardous liquid drugs. The manually depressed
actuator preferably precludes vial adapter detachment prior to actuation, thereby
ensuring failsafe operation.
]17[
]74[
]57[
415
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
]54[
AUTOMATIC LIQUID DRUG
PREPARATION APPARATUS FOR
THE PREPARATION OF A
PREDETERMINED DOSAGE OF
LIQUID DRUG
]11[
]32[
]52[
]72[
04.05.2008
182922
]31[ 02.05.2007
Int. Cl.(2010.01) A61J 01/20
MEDIMOP MEDICAL PROJECTS
LTD.
WO/2008/135989
MEDIMOP MEDICAL PROJECTS
]17[
]74[
416
201325
‫מתקן אוטומטי להכנת תרופה נוזלית עבור הכנת‬
‫מנת תרופה נוזלית שנקבע מראש‬
]33[
IL
‫ רעננה‬,‫מדימופ פרויקטים רפואיים בע"מ‬
,‫מדימופ פרוייקטים רפואיים בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
]57[
LTD.,
11 ‫רח' התדהר‬
17 HATIDHAR ST.
‫רעננה‬5466 .‫ד‬.‫ ת‬,
P.O.B. 2499
RA'ANANA 43665
Automatic liquid drug preparation apparatus for preparing a liquid drug assemblage
with a predetermined dosage of liquid drug. The liquid drug assemblage is prepared
from a preparatory assemblage including a fluid control device having a body member
with a syringe port, a vial adapter, and an administration port, a vial pre-filled with
powder or liquid medicament, and a syringe pre-filled with diluent for mixing with the
medicament. The automatic liquid drug preparation apparatus includes a housing, a
cradle for receiving the preparatory assemblage, and a controller for controlling a
motorized syringe drive unit for selectively transferring liquid contents between the
syringe and the vial, a motorized cradle drive unit for selectively rotating the cradle
relative to the housing, and a motorized vial adapter release unit for selectively
detaching the vial adapter with its attached spent vial from the body member to form
the liquid drug assemblage2
__________________
]22[]12[
]54[
417
METHOD AND COMPUTER
PROGRAM FOR ORGANISING A
DATABASE AND A DATABASE
ORGANISED ACCORDING TO
202125
‫שיטה ותוכנת מחשב עבור סידור של מסד‬
‫נתונים ומסד נתונים מסודר בהתאם לשיטה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
SUCH A METHOD
]11[
]32[
]52[
]41[
]72[
]17[
]74[
]57[
28.11.2001
0029238.3
]31[ 30.11.2000
]33[ GB
Int. Cl.(2010.01) G06F 12/00, 17/30
DIVISION FROM 156117
COPPEREYE LIMITED, UNITED
KINGDOM
WO/2002/044940
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of organising a database incorporating an index, wherein the index can be
navigated using a composite key comprising a plurality of search keys, and wherein
one or more of the search keys are represented in a compressed form.
__________________
]22[]12[
204015
‫שיטה ומערכת לאימות הקצב המזוהה של‬
‫מסגרות שמיעה נכנסות בעלות קצב משתנה‬
]54[
METHOD AND SYSTEM FOR
VALIDATING DETECTED RATES
OF RECEIVED VARIABLE RATE
SPEECH FRAMES
]11[
]32[
]52[
]41[
]72[
29.11.2001
09/730147
]31[ 04.12.2000
]33[ US
Int. Cl.(2010.01) H04B 01/707, 07/26, H04L 01/00, 01/08, 29/08
DIVISION FROM 156249
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/047316
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]17[
]74[
]57[
418
A system and method for detection of rate determination algorithm errors in variable
rate communications system receivers. The disclosed embodiments prevent rate
determination algorithm errors from causing audible artifacts such as screeches or
beeps. The disclosed system and method detects frames with incorrectly determined
data rates and performs frame erasure processing and/or memory state clean up to
prevent propagation of distortion across multiple frames. Frames with incorrectly
determined data rates are detected by checking illegal rate transitions, reserved bits,
validating unused filter type bit combinations and analyzing relationships between
November 30, 2011-‫ד' בכסלו התשע"ב‬
fixed code-book gains and linear prediction coefficient gains.
__________________
]22[]12[
204686
‫מערכות ושיטות להספקת יחידת עיבוד נתונים‬
‫דינמית ומודולרית‬
]54[
SYSTEMS AND METHODS FOR
PROVIDING A DYNAMICALLY
MODULAR PROCESSING UNIT
]11[
]32[
22.10.2003
60/420127
]31[ 22.10.2002
]33[ US
419455719
2921321113
US
219492224
1122121113
US
Int. Cl.(2010.01) G06F 01/16, H05K 05/00, 07/00
DIVISION FROM 168314
JASON A. SULLIVAN, U.S.A.
WO/2004/038527
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]52[
]41[
]72[
]17[
]74[
]57[
419
,'‫ד"ר שלמה כהן ושות‬
154 ‫אבן גבירול‬
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
Systems and methods for providing a dynamically modular processing unit (40). A
modular processing unit (40) is provided as a platform that is lightweight, compact,
and is configured to be selectively used alone or oriented with one or more additional
processing units in an enterprise. In some implementations, a modular processing unit
(40) includes a non-peripheral based encasement (42), a cooling process (e.g., a
thermodynamic convection cooling process, a forced air cooling process, and/or a
liquid cooling process), an optimized circuit board configuration (64), optimized
processing and memory ratios, and a dynamic back plane (44) that provides increased
flexibility and support to peripherals and applications. The modular processing unit
(40) is customizable and may be employed in association with all types of computer
enterprises. The platform allows for a plethora of modifications that may be made with
minimal impact to the dynamically modular unit, thereby enhancing the usefulness of
the platform across all types of application.
November 30, 2011-‫ד' בכסלו התשע"ב‬
2/2121
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
]54[
METHODS FOR MAKING 3-OPROTECTED MORPHINONES
AND 3-O-PROTECTED
MORPHINONE DIENOL
CARBOXYLATES
]11[
]32[
]52[
]41[
]72[
04.02.2005
60/542711
]31[ 06.02.2004
Int. Cl.(2010.01) C07D 489/02
DIVISION FROM 177281
EURO-CELTIQUE S.A.,
LUXEMBOURG
WO/2005/077957
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]17[
]74[
]57[
420
205596
‫–מוריפינונים מותמרים‬O–3 ‫שיטות להכנת‬
‫–מוריפינון דיאנול‬O–3–‫בקבוצת הגנה ו‬
‫קרבוקסילטים מותמרים בקבוצת הגנה‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
154 ‫אבן גבירול‬
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
Disclosed are methods for making aldehydes and ketones comprising allowing the
corresponding primary or secondary alcohol to react in the presence of
trichloroisocyanuric acid, a compound of formula R1SR2 and a base. In one
embodiment, the alcohol is a compound of formula (I) wherein R 3 is a protecting
group. Also disclosed are methods for making 3-O-protected morphine dienol
carboxylates comprising allowing a compound of formula (I) to oxidize in the presence
of a chlorine-containing compound and a compound of formula R1SR2; and allowing
the product of the oxidation step to react with an acylating agent.
November 30, 2011-‫ד' בכסלו התשע"ב‬
The parent application from which
this application has been divided has
not yet been published
211122
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
206483
]54[
USE OF AN ANTI-ANGPTL4
ANTAGONIST ANTIBODY IN THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION FOR INHIBITING
PROLIFERATION OF
HEPATOCYTES
]11[
]32[
]52[
]41[
]72[
]17[
]74[
19.07.2005
60/589875
]31[ 20.07.2004
]33[ US
Int. Cl.(2010.01) A61K 39/395, C07K 14/515, 16/22
DIVISION FROM 180752
GENENTECH, INC., U.S.A.
WO/2006/014678
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
ANGPTL4 compositions and methods of using such compositions and agonists or
antagonists thereof, for the diagnosis and treatment of diseases or disorders are
included, including methods to modulate cell proliferation, cell adhesion and cell
migration.
The parent application from which
this application has been divided has
not yet been published
421
ANGPTL4 ‫שימוש בנוגדן אנטאגוניסטי כנגד‬
‫בהכנת תרכובת רוקחית לעיכוב התרבות‬
‫הפטוציטים‬
2281/1
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
November 30, 2011-‫ד' בכסלו התשע"ב‬
]22[]12[
]54[
SOLVENTLESS MICROBIAL
LIPID COMPRISING
DOCOSAHEXANOIC ACID
]11[
]32[
]52[
]41[
]72[
19.01.2001
60/177125
]31[ 19.01.2000
Int. Cl.(2010.01) C12P 07/64
DIVISION FROM 201756
MARTEK BIOSCIENCES
CORPORATION, U.S.A.
WO/2001/053512
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]17[
]74[
]57[
206961
‫ליפיד מיקרוביאלי ללא ממיס המכיל חומצה‬
‫דוקוזאהקסאנואית‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A crude microbial lipid having greater than about 30% docosahexaenoic acid and less
than about 3 ppm residual nonpolar organic solvent.
__________________
]22[]12[
207023
‫מיתוג ערוצים לתמיכה בשירותי מולטימדיה‬
‫לשידור רחב ולמנויים‬
]54[
CHANNEL SWITCHING FOR
SUPPORT OF MULTIMEDIA
BROADCAST AND MULTICAST
SERVICES
]11[
]32[
]52[
]41[
]72[
06.08.2003
60/402161
]31[ 07.08.2002
]33[
Int. Cl.(2010.01) H04B 01/16, 01/69, 07/26
DIVISION FROM 166558
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2004/015876
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]17[
]74[
]57[
422
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for transferring multimedia broadcasts/multimedia services (MBMS) in a
November 30, 2011-‫ד' בכסלו התשע"ב‬
wireless communication system comprising: detterminiting a number of users in a cell
to receive an MBMS service,determine whether a dedicated channel or a
shared/common channel is to be used for the MBMS; receiving MBMS data and
mapping the MBMS data to the determined dedicated or shared/common channel.
wherein the determined dedicated channel os shared/common channel is at least based
on threshold test.wherein on a condiition that the determined number of users is below
a threshold a dedicated channel is used for the MBMS service and on a condition that
the detrmined number of users is above the threshold a shared/common channel is used
for the MBMS service2
__________________
]22[]12[
]54[
SEALING BETWEEN A CANNULA
PART AND A FLUID PATH
]11[
]32[
12.02.2009
PA200800202 ]31[ 13.02.2008
429111159
2321121111
Int. Cl.(2010.01) A61M 05/158, 39/00
UNOMEDICAL A/S, DENMARK
WO/2009/101130
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]72[
]17[
]74[
]57[
423
207221
‫איטום בין חלק קני ונתיב נוזלים‬
]33[
DK
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The application relates to an infusion part comprising a cannula part (7) and a fluid
path, whereby a sealing (18) is positioned between the cannula part and the inlet/outlet
opening (12) of the fluid path when the cannula part is in position for use in order to
keep the fluid path to the cannula tight. The sealing (18) is surrounding the inlet/outlet
opening (12) and/or the distance di between a centre line c of the cannula part and a
point on the outer surface of the cannula part positioned at or above the upper edge of
the sealing (18) is larger than the distance 02 between the centre line c of the cannula
part and a point on the outer surface of the cannula part positioned at or below the
lower edge of the sealing.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
209568
–4(–2–‫–אמינו‬4[–5 ‫תהליך להכנת‬
4–‫–מתילפירידין‬1–]‫–איל‬5–‫פוריל)פירימידין‬
‫) – און ונגזרים שלו‬H1(
]54[
PROCESS FOR PREPARING 5-[2AMINO-4-(2-FURYL)PYRIMIDIN5-YL]-1-METHYLPYRIDIN-2(1H)ONE AND DERIVATIVES
THEREOF
]11[
]32[
]52[
]41[
]72[
20.03.2006
60/663580
]31[ 21.03.2005
]33[ US
Int. Cl.(2010.01) A61K 31/506, 38/00, C07D 405/06, 405/14
DIVISION FROM 184984
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
HITOSHI HARADA, HIROSHI
ISHIHARA, YOSHIAKI SATO,
HIROYUKI CHIBA, YUKI
KOMATSU, SUSUMU INOUE,
NAOKI OZEKI
WO/2006/101082
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A proccess for preparing a compound of formula I or a salt or hydrate thereof
Wherein R1 reprepesents C1-6 alkyl and R2 and R3 independently represents
hydrogen or C1-6 alkyl,
by allowing a compound of formula II wherein R1 is as defined above, to react with a
compound of formula III wherein R2 and R3 are as defined above.
]71[
]17[
]74[
]57[
424
November 30, 2011-‫ד' בכסלו התשע"ב‬
221/21
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
]54[
SYSTEM AND METHOD FOR
PROCESSING AND REUSING
GRAYWATER INCLUDING FOR
USE IN HOME AND GARDEN
]11[
]32[
]52[
]72[
]71[
]17[
]74[
11.10.2009
194661
]31[ 07.10.2008
Int. Cl.(2010.01) C02F 03/32
MOSHE ELAZAR ERNEST
MOSHE ELAZAR ERNEST
WO/2010/041246
MARC PHILLIP BODNER,
65 YIGAL ALON ST., TEL AVIV
]57[
425
212155
‫מערכת ושיטה לעיבוד ולשימוש חוזר של מים‬
‫אפורים כולל לשימוש בבית ובגן‬
]33[
IL
‫ ירושלים‬,‫משה אלעזר ארנסט‬
‫משה אלעזר ארנסט‬
,‫מרק בדנר‬
15 ‫ רח' יגאל אלון‬,‫בית טויוטה‬
‫תל אביב‬
A system and method for processing and reusing graywater. At least two vertical flow
wetland units are provided, each of which comprising a container filled with at least
one granular substrate and at least one species of a hygrophilous plant, and an outlet.
At least one of the wetland units is set to an inactive state during a predetermined
period of time such that influx of graywater to each of the inactive units is prevented,
whereby to regenerate each inactive wetland units. At least one of the wetland units is
set to an active state to allow introduced graywater to be purified. Purified graywater is
discharged from the outlet of each active unit to a sink. At least a portion of the
purified graywater is recirculated to each active wetland units so that a portion of the
purified graywater, when desired, is discharged to a domestic site for reuse.
November 30, 2011-‫ד' בכסלו התשע"ב‬
__________________
]22[]12[
212626
‫מתקן חידוש לניקוי אוויר שאינו מנוצל ושיטה‬
‫עבור ייצור מתקן חידוש לניקוי אוויר שאינו‬
‫מנוצל‬
]54[
REGENERATIVE WASTE AIR
PURIFICATION DEVICE AND
METHOD FOR PRODUCING A
REGENERATIVE WASTE AIR
PURIFICATION DEVICE
]11[
]32[
]52[
]72[
24.10.2009
102008055851.6 ]31[ 04.11.2008
]33[ DE
Int. Cl.(2010.01) F23G 07/06
KBA-METALPRINT GMBH,
GERMANY
WO/2010/051914
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The invention relates to a regenerative waste air purification device, comprising at
least one heated bed (1) which is flown through by an exhaust air flow representing a
first medium. According to the invention, at least one heat exchanger pipe (11, 12)
carrying a second medium extends through the heated bed (1) for the formation of a
heat exchanger (14) having separate media flows, the media flows being formed by the
first and the second medium. The invention further relates to a method for producing a
regenerative waste air purification device.
]17[
]74[
]57[
426
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫__________________‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫‪427‬‬
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
234119
251414
253124
271931
272521
272911
271413
271495
273413
274421
274719
275171
275551
274114
274447
242921
254524
251319
259194
277211
277494
277911
271151
271591
279142
279155
279444
279132
211244
211471
212241
212445
211491
291323
291117
291151
293953
297151
241434
242311
428
234421
251411
254515
271971
272511
272971
271447
271932
273713
274521
274797
275177
275751
274211
274521
242924
254414
251344
259311
277139
277511
277913
271211
271414
279111
279111
279471
279131
211151
211741
212139
212747
211747
291319
292244
291171
294111
297159
244251
242379
235141
251547
254594
272151
272551
271119
271511
271995
273924
274511
274141
275121
275159
274251
274549
255177
257315
251349
259452
277315
277557
277934
271199
271725
279213
279115
279547
279955
211113
211131
212195
212919
211141
291527
292121
291214
294174
297493
241251
242519
251111
251451
254144
272291
272431
271175
271519
273151
273949
274414
274151
275127
275974
274171
274421
255443
257515
251374
259414
277317
277441
277974
271319
271713
279219
279114
279554
279914
211117
211922
212373
211317
211141
291541
292424
291421
294744
297511
241394
242742
251911
251731
255197
272119
272444
271241
271542
273212
274141
274421
274174
275111
275979
274332
274435
254313
257433
251412
274711
277341
277414
277911
271342
271121
279222
279311
279749
211115
211331
211974
212414
211344
211914
291425
292792
291417
295313
297143
241491
242744
252244
253224
255271
272121
272493
271293
271541
273323
274275
274441
274913
275131
274113
274334
274455
254421
257147
251514
274727
277421
277497
277913
271441
271145
279227
279354
279741
211144
211314
211991
212497
211494
211914
291441
292134
291745
295551
297993
241459
242714
252529
253551
271113
272137
272144
271119
271444
273451
274173
274474
274941
275139
274152
274371
211724
254412
257912
251411
274744
277413
277747
277994
271447
271921
279214
279411
279779
211224
211423
212132
212513
211554
211975
291724
292174
293224
295411
211244
242152
241324
251211
253541
271159
272114
272144
271313
271411
273441
274333
274721
275112
275311
274175
274433
231114
254417
251127
259159
277229
277443
277111
271131
271535
279114
279232
279452
279131
211219
211425
212147
212441
211441
291244
291711
292114
293143
294141
241119
242114
241321
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫‪241424‬‬
‫‪243342‬‬
‫‪244111‬‬
‫‪245135‬‬
‫‪213354‬‬
‫‪213115‬‬
‫‪214314‬‬
‫‪214771‬‬
‫‪215171‬‬
‫‪215344‬‬
‫‪215912‬‬
‫‪214324‬‬
‫‪214419‬‬
‫‪217411‬‬
‫‪211249‬‬
‫‪211717‬‬
‫‪219297‬‬
‫‪219914‬‬
‫‪299391‬‬
‫‪112947‬‬
‫‪115441‬‬
‫‪111111‬‬
‫‪249111‬‬
‫‪245319‬‬
‫‪244312‬‬
‫‪244912‬‬
‫‪247751‬‬
‫‪241313‬‬
‫‪241431‬‬
‫‪249343‬‬
‫‪249774‬‬
‫‪271552‬‬
‫‪241411‬‬
‫‪243142‬‬
‫‪244122‬‬
‫‪244917‬‬
‫‪213191‬‬
‫‪213714‬‬
‫‪214111‬‬
‫‪214771‬‬
‫‪215141‬‬
‫‪215342‬‬
‫‪215921‬‬
‫‪214321‬‬
‫‪214417‬‬
‫‪217223‬‬
‫‪211124‬‬
‫‪211474‬‬
‫‪219227‬‬
‫‪219141‬‬
‫‪291149‬‬
‫‪112944‬‬
‫‪114941‬‬
‫‪117441‬‬
‫‪241311‬‬
‫‪245179‬‬
‫‪244143‬‬
‫‪244111‬‬
‫‪247451‬‬
‫‪241117‬‬
‫‪241432‬‬
‫‪249337‬‬
‫‪249714‬‬
‫‪271354‬‬
‫‪217374‬‬
‫‪217552‬‬
‫‪217597‬‬
‫‪217741‬‬
‫‪211113‬‬
‫‪211113‬‬
‫‪211212‬‬
‫‪211171‬‬
‫‪215329‬‬
‫‪217357‬‬
‫‪217545‬‬
‫‪217592‬‬
‫‪217742‬‬
‫‪217144‬‬
‫‪212911‬‬
‫‪211279‬‬
‫‪211151‬‬
‫‪215115‬‬
‫‪241514‬‬
‫‪243211‬‬
‫‪244235‬‬
‫‪244921‬‬
‫‪213191‬‬
‫‪213747‬‬
‫‪214144‬‬
‫‪214729‬‬
‫‪214957‬‬
‫‪215191‬‬
‫‪215194‬‬
‫‪214114‬‬
‫‪214551‬‬
‫‪217211‬‬
‫‪217147‬‬
‫‪211529‬‬
‫‪219223‬‬
‫‪219744‬‬
‫‪291474‬‬
‫‪112713‬‬
‫‪114199‬‬
‫‪117493‬‬
‫‪247432‬‬
‫‪245144‬‬
‫‪245974‬‬
‫‪244414‬‬
‫‪247442‬‬
‫‪241117‬‬
‫‪241414‬‬
‫‪249254‬‬
‫‪249413‬‬
‫‪271117‬‬
‫‪241543‬‬
‫‪243111‬‬
‫‪243111‬‬
‫‪244142‬‬
‫‪213274‬‬
‫‪213715‬‬
‫‪214117‬‬
‫‪214717‬‬
‫‪214114‬‬
‫‪215179‬‬
‫‪215442‬‬
‫‪214244‬‬
‫‪214511‬‬
‫‪217131‬‬
‫‪217131‬‬
‫‪211413‬‬
‫‪211943‬‬
‫‪219541‬‬
‫‪291457‬‬
‫‪112754‬‬
‫‪113191‬‬
‫‪117491‬‬
‫‪247411‬‬
‫‪251312‬‬
‫‪245944‬‬
‫‪244411‬‬
‫‪247435‬‬
‫‪241221‬‬
‫‪241513‬‬
‫‪249114‬‬
‫‪249477‬‬
‫‪271131‬‬
‫‪241541‬‬
‫‪241994‬‬
‫‪243121‬‬
‫‪244113‬‬
‫‪213231‬‬
‫‪213413‬‬
‫‪213934‬‬
‫‪214452‬‬
‫‪214145‬‬
‫‪215133‬‬
‫‪215435‬‬
‫‪214234‬‬
‫‪214311‬‬
‫‪214913‬‬
‫‪217713‬‬
‫‪211419‬‬
‫‪211947‬‬
‫‪219559‬‬
‫‪291441‬‬
‫‪111473‬‬
‫‪113344‬‬
‫‪114714‬‬
‫‪247511‬‬
‫‪251114‬‬
‫‪245729‬‬
‫‪244413‬‬
‫‪247445‬‬
‫‪241119‬‬
‫‪241511‬‬
‫‪241911‬‬
‫‪249457‬‬
‫‪249991‬‬
‫‪271741‬‬
‫‪241534‬‬
‫‪241953‬‬
‫‪243453‬‬
‫‪244411‬‬
‫‪213172‬‬
‫‪213441‬‬
‫‪213929‬‬
‫‪214419‬‬
‫‪214113‬‬
‫‪215131‬‬
‫‪215531‬‬
‫‪214111‬‬
‫‪214371‬‬
‫‪214195‬‬
‫‪217713‬‬
‫‪211411‬‬
‫‪211192‬‬
‫‪219551‬‬
‫‪291121‬‬
‫‪299924‬‬
‫‪111475‬‬
‫‪114454‬‬
‫‪244475‬‬
‫‪249951‬‬
‫‪245727‬‬
‫‪244541‬‬
‫‪247311‬‬
‫‪241154‬‬
‫‪241554‬‬
‫‪241153‬‬
‫‪249575‬‬
‫‪249975‬‬
‫‪271712‬‬
‫‪241513‬‬
‫‪241951‬‬
‫‪243411‬‬
‫‪244377‬‬
‫‪213145‬‬
‫‪213554‬‬
‫‪213927‬‬
‫‪214525‬‬
‫‪214112‬‬
‫‪215241‬‬
‫‪215451‬‬
‫‪214125‬‬
‫‪214342‬‬
‫‪214111‬‬
‫‪217445‬‬
‫‪211413‬‬
‫‪211125‬‬
‫‪219443‬‬
‫‪291124‬‬
‫‪299177‬‬
‫‪111314‬‬
‫‪115792‬‬
‫‪244421‬‬
‫‪249933‬‬
‫‪245513‬‬
‫‪244452‬‬
‫‪247213‬‬
‫‪247915‬‬
‫‪241523‬‬
‫‪241739‬‬
‫‪249535‬‬
‫‪249912‬‬
‫‪271599‬‬
‫‪241374‬‬
‫‪241771‬‬
‫‪243491‬‬
‫‪244111‬‬
‫‪213145‬‬
‫‪213392‬‬
‫‪213149‬‬
‫‪214491‬‬
‫‪214111‬‬
‫‪215242‬‬
‫‪215314‬‬
‫‪215933‬‬
‫‪214327‬‬
‫‪214141‬‬
‫‪217453‬‬
‫‪211192‬‬
‫‪211717‬‬
‫‪219344‬‬
‫‪219991‬‬
‫‪299431‬‬
‫‪111311‬‬
‫‪115493‬‬
‫‪219715‬‬
‫‪249422‬‬
‫‪245521‬‬
‫‪244445‬‬
‫‪247154‬‬
‫‪247154‬‬
‫‪241374‬‬
‫‪241454‬‬
‫‪249444‬‬
‫‪249775‬‬
‫‪271511‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪217312‬‬
‫‪217533‬‬
‫‪217517‬‬
‫‪217721‬‬
‫‪217134‬‬
‫‪212955‬‬
‫‪211273‬‬
‫‪211151‬‬
‫‪215115‬‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫‪217143‬‬
‫‪217531‬‬
‫‪217514‬‬
‫‪217721‬‬
‫‪217111‬‬
‫‪212921‬‬
‫‪211253‬‬
‫‪211151‬‬
‫‪214472‬‬
‫‪217132‬‬
‫‪217514‬‬
‫‪217574‬‬
‫‪217419‬‬
‫‪217792‬‬
‫‪212141‬‬
‫‪211214‬‬
‫‪211133‬‬
‫‪211444‬‬
‫‪217131‬‬
‫‪217511‬‬
‫‪217544‬‬
‫‪217474‬‬
‫‪217711‬‬
‫‪212591‬‬
‫‪211111‬‬
‫‪211131‬‬
‫‪211472‬‬
‫‪217111‬‬
‫‪217441‬‬
‫‪217554‬‬
‫‪217435‬‬
‫‪217749‬‬
‫‪212321‬‬
‫‪211151‬‬
‫‪211115‬‬
‫‪211421‬‬
‫‪217217‬‬
‫‪217453‬‬
‫‪217555‬‬
‫‪217432‬‬
‫‪217755‬‬
‫‪212295‬‬
‫‪211137‬‬
‫‪211217‬‬
‫‪211314‬‬
‫‪429‬‬
‫‪219154‬‬
‫‪219311‬‬
‫‪219531‬‬
‫‪219431‬‬
‫‪219115‬‬
‫‪219911‬‬
‫‪219911‬‬
‫‪231142‬‬
‫‪231122‬‬
‫‪231519‬‬
‫‪241393‬‬
‫‪244127‬‬
‫‪244431‬‬
‫‪244474‬‬
‫‪251373‬‬
‫‪251799‬‬
‫‪251171‬‬
‫‪254594‬‬
‫‪255171‬‬
‫‪255179‬‬
‫‪255315‬‬
‫‪255454‬‬
‫‪255445‬‬
‫‪255475‬‬
‫‪255523‬‬
‫‪255412‬‬
‫‪255441‬‬
‫‪255744‬‬
‫‪255143‬‬
‫‪255919‬‬
‫‪254125‬‬
‫‪254227‬‬
‫‪254271‬‬
‫‪254342‬‬
‫‪254931‬‬
‫‪259311‬‬
‫‪242511‬‬
‫‪241411‬‬
‫‪243121‬‬
‫‪245135‬‬
‫‪247413‬‬
‫‪241374‬‬
‫‪241494‬‬
‫‪249543‬‬
‫‪271151‬‬
‫‪272119‬‬
‫‪272494‬‬
‫‪211355‬‬
‫‪219195‬‬
‫‪219517‬‬
‫‪219415‬‬
‫‪219751‬‬
‫‪219911‬‬
‫‪219914‬‬
‫‪231142‬‬
‫‪231211‬‬
‫‪231333‬‬
‫‪231114‬‬
‫‪244124‬‬
‫‪244413‬‬
‫‪244519‬‬
‫‪251244‬‬
‫‪251735‬‬
‫‪251231‬‬
‫‪254521‬‬
‫‪255122‬‬
‫‪255177‬‬
‫‪255343‬‬
‫‪255453‬‬
‫‪255442‬‬
‫‪255471‬‬
‫‪255493‬‬
‫‪255591‬‬
‫‪255445‬‬
‫‪255731‬‬
‫‪255141‬‬
‫‪255915‬‬
‫‪254114‬‬
‫‪254222‬‬
‫‪254249‬‬
‫‪254174‬‬
‫‪254711‬‬
‫‪259111‬‬
‫‪242311‬‬
‫‪241514‬‬
‫‪243142‬‬
‫‪244917‬‬
‫‪244141‬‬
‫‪241341‬‬
‫‪241454‬‬
‫‪249559‬‬
‫‪271117‬‬
‫‪272251‬‬
‫‪272515‬‬
‫‪211174‬‬
‫‪219194‬‬
‫‪219529‬‬
‫‪219514‬‬
‫‪219754‬‬
‫‪219177‬‬
‫‪219941‬‬
‫‪231137‬‬
‫‪231213‬‬
‫‪231314‬‬
‫‪235719‬‬
‫‪244257‬‬
‫‪244391‬‬
‫‪244541‬‬
‫‪249154‬‬
‫‪251473‬‬
‫‪251211‬‬
‫‪254119‬‬
‫‪254955‬‬
‫‪255174‬‬
‫‪255359‬‬
‫‪255451‬‬
‫‪255441‬‬
‫‪255472‬‬
‫‪255492‬‬
‫‪255511‬‬
‫‪255414‬‬
‫‪255719‬‬
‫‪255151‬‬
‫‪255911‬‬
‫‪255977‬‬
‫‪254211‬‬
‫‪254244‬‬
‫‪254149‬‬
‫‪254499‬‬
‫‪251411‬‬
‫‪241993‬‬
‫‪241321‬‬
‫‪243111‬‬
‫‪244142‬‬
‫‪244414‬‬
‫‪241117‬‬
‫‪241414‬‬
‫‪249541‬‬
‫‪271221‬‬
‫‪271914‬‬
‫‪272517‬‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫‪214411‬‬
‫‪219147‬‬
‫‪219521‬‬
‫‪219579‬‬
‫‪219749‬‬
‫‪219152‬‬
‫‪219941‬‬
‫‪231134‬‬
‫‪231243‬‬
‫‪231111‬‬
‫‪235479‬‬
‫‪244232‬‬
‫‪244371‬‬
‫‪244534‬‬
‫‪249154‬‬
‫‪251472‬‬
‫‪252529‬‬
‫‪253143‬‬
‫‪254112‬‬
‫‪255171‬‬
‫‪255357‬‬
‫‪255444‬‬
‫‪255459‬‬
‫‪255471‬‬
‫‪255491‬‬
‫‪255543‬‬
‫‪255421‬‬
‫‪255491‬‬
‫‪255141‬‬
‫‪255199‬‬
‫‪255974‬‬
‫‪254194‬‬
‫‪254241‬‬
‫‪254133‬‬
‫‪254491‬‬
‫‪251412‬‬
‫‪241131‬‬
‫‪241324‬‬
‫‪243111‬‬
‫‪244114‬‬
‫‪244441‬‬
‫‪241154‬‬
‫‪241413‬‬
‫‪249414‬‬
‫‪271131‬‬
‫‪271125‬‬
‫‪272521‬‬
‫‪214442‬‬
‫‪219141‬‬
‫‪219474‬‬
‫‪219571‬‬
‫‪219745‬‬
‫‪219144‬‬
‫‪219941‬‬
‫‪231127‬‬
‫‪231244‬‬
‫‪231179‬‬
‫‪231473‬‬
‫‪245917‬‬
‫‪244341‬‬
‫‪244515‬‬
‫‪241311‬‬
‫‪251447‬‬
‫‪252215‬‬
‫‪253541‬‬
‫‪254143‬‬
‫‪255143‬‬
‫‪255311‬‬
‫‪255443‬‬
‫‪255451‬‬
‫‪255449‬‬
‫‪255413‬‬
‫‪255541‬‬
‫‪255424‬‬
‫‪255495‬‬
‫‪255139‬‬
‫‪255191‬‬
‫‪255941‬‬
‫‪254142‬‬
‫‪254254‬‬
‫‪254131‬‬
‫‪254412‬‬
‫‪251349‬‬
‫‪259944‬‬
‫‪241291‬‬
‫‪241953‬‬
‫‪244411‬‬
‫‪244413‬‬
‫‪247915‬‬
‫‪241513‬‬
‫‪249427‬‬
‫‪249975‬‬
‫‪271741‬‬
‫‪272415‬‬
‫‪215774‬‬
‫‪219251‬‬
‫‪219444‬‬
‫‪219541‬‬
‫‪219414‬‬
‫‪219145‬‬
‫‪219959‬‬
‫‪231124‬‬
‫‪231231‬‬
‫‪231141‬‬
‫‪231229‬‬
‫‪245711‬‬
‫‪244323‬‬
‫‪244495‬‬
‫‪247121‬‬
‫‪251429‬‬
‫‪251911‬‬
‫‪251711‬‬
‫‪254153‬‬
‫‪255141‬‬
‫‪255317‬‬
‫‪255415‬‬
‫‪255457‬‬
‫‪255441‬‬
‫‪255411‬‬
‫‪255537‬‬
‫‪255425‬‬
‫‪255411‬‬
‫‪255135‬‬
‫‪255193‬‬
‫‪255945‬‬
‫‪254149‬‬
‫‪254242‬‬
‫‪254293‬‬
‫‪254429‬‬
‫‪251344‬‬
‫‪259911‬‬
‫‪241122‬‬
‫‪241951‬‬
‫‪244122‬‬
‫‪244411‬‬
‫‪247154‬‬
‫‪241511‬‬
‫‪249343‬‬
‫‪249774‬‬
‫‪271429‬‬
‫‪272111‬‬
‫‪215771‬‬
‫‪219227‬‬
‫‪219417‬‬
‫‪219542‬‬
‫‪219479‬‬
‫‪219131‬‬
‫‪219951‬‬
‫‪231125‬‬
‫‪231237‬‬
‫‪231142‬‬
‫‪232441‬‬
‫‪244251‬‬
‫‪244154‬‬
‫‪244451‬‬
‫‪244114‬‬
‫‪251493‬‬
‫‪251979‬‬
‫‪251451‬‬
‫‪254719‬‬
‫‪255271‬‬
‫‪255311‬‬
‫‪255413‬‬
‫‪255454‬‬
‫‪255447‬‬
‫‪255412‬‬
‫‪255517‬‬
‫‪255422‬‬
‫‪255454‬‬
‫‪255117‬‬
‫‪255111‬‬
‫‪255941‬‬
‫‪254131‬‬
‫‪254241‬‬
‫‪254219‬‬
‫‪254411‬‬
‫‪257715‬‬
‫‪259414‬‬
‫‪242794‬‬
‫‪241154‬‬
‫‪244294‬‬
‫‪244312‬‬
‫‪247711‬‬
‫‪241554‬‬
‫‪249331‬‬
‫‪249447‬‬
‫‪271511‬‬
‫‪272137‬‬
‫‪215749‬‬
‫‪219155‬‬
‫‪219312‬‬
‫‪219553‬‬
‫‪219474‬‬
‫‪219119‬‬
‫‪219942‬‬
‫‪219992‬‬
‫‪231145‬‬
‫‪231111‬‬
‫‪231794‬‬
‫‪241434‬‬
‫‪244153‬‬
‫‪244443‬‬
‫‪244114‬‬
‫‪251445‬‬
‫‪251912‬‬
‫‪251541‬‬
‫‪254721‬‬
‫‪255219‬‬
‫‪255329‬‬
‫‪255411‬‬
‫‪255455‬‬
‫‪255444‬‬
‫‪255474‬‬
‫‪255514‬‬
‫‪255411‬‬
‫‪255451‬‬
‫‪255791‬‬
‫‪255171‬‬
‫‪255922‬‬
‫‪254117‬‬
‫‪254221‬‬
‫‪254211‬‬
‫‪254414‬‬
‫‪257132‬‬
‫‪259411‬‬
‫‪242421‬‬
‫‪241771‬‬
‫‪243111‬‬
‫‪245974‬‬
‫‪247554‬‬
‫‪241524‬‬
‫‪241744‬‬
‫‪249514‬‬
‫‪271153‬‬
‫‪272121‬‬
‫‪430‬‬
‫‪272924‬‬
‫‪271172‬‬
‫‪271519‬‬
‫‪274712‬‬
‫‪275294‬‬
‫‪275492‬‬
‫‪274371‬‬
‫‪277375‬‬
‫‪271141‬‬
‫‪271921‬‬
‫‪279132‬‬
‫‪211242‬‬
‫‪211441‬‬
‫‪212479‬‬
‫‪211192‬‬
‫‪211421‬‬
‫‪211117‬‬
‫‪211942‬‬
‫‪213111‬‬
‫‪213191‬‬
‫‪213471‬‬
‫‪213929‬‬
‫‪214111‬‬
‫‪214154‬‬
‫‪214159‬‬
‫‪214913‬‬
‫‪217147‬‬
‫‪211717‬‬
‫‪219344‬‬
‫‪291319‬‬
‫‪292115‬‬
‫‪295551‬‬
‫‪291474‬‬
‫‪111331‬‬
‫‪117493‬‬
‫‪272113‬‬
‫‪271145‬‬
‫‪271442‬‬
‫‪274173‬‬
‫‪275271‬‬
‫‪275411‬‬
‫‪274141‬‬
‫‪277315‬‬
‫‪271131‬‬
‫‪271725‬‬
‫‪279113‬‬
‫‪211213‬‬
‫‪211434‬‬
‫‪212414‬‬
‫‪212919‬‬
‫‪211545‬‬
‫‪211774‬‬
‫‪211955‬‬
‫‪213145‬‬
‫‪213149‬‬
‫‪213447‬‬
‫‪213925‬‬
‫‪214151‬‬
‫‪214145‬‬
‫‪214111‬‬
‫‪214141‬‬
‫‪217131‬‬
‫‪211717‬‬
‫‪219124‬‬
‫‪291323‬‬
‫‪292792‬‬
‫‪295372‬‬
‫‪291232‬‬
‫‪112713‬‬
‫‪114454‬‬
‫‪272111‬‬
‫‪272914‬‬
‫‪271413‬‬
‫‪274119‬‬
‫‪275112‬‬
‫‪275417‬‬
‫‪274114‬‬
‫‪277144‬‬
‫‪277994‬‬
‫‪271591‬‬
‫‪279554‬‬
‫‪211141‬‬
‫‪211425‬‬
‫‪212373‬‬
‫‪212141‬‬
‫‪211544‬‬
‫‪211754‬‬
‫‪211917‬‬
‫‪213151‬‬
‫‪213131‬‬
‫‪213453‬‬
‫‪213137‬‬
‫‪214129‬‬
‫‪214112‬‬
‫‪215912‬‬
‫‪214417‬‬
‫‪217713‬‬
‫‪211437‬‬
‫‪219247‬‬
‫‪291295‬‬
‫‪292424‬‬
‫‪294744‬‬
‫‪297911‬‬
‫‪112244‬‬
‫‪115525‬‬
‫‪272144‬‬
‫‪272949‬‬
‫‪271171‬‬
‫‪274277‬‬
‫‪274941‬‬
‫‪275414‬‬
‫‪274175‬‬
‫‪277211‬‬
‫‪277934‬‬
‫‪271591‬‬
‫‪279311‬‬
‫‪211115‬‬
‫‪211572‬‬
‫‪212275‬‬
‫‪212134‬‬
‫‪211542‬‬
‫‪211724‬‬
‫‪211192‬‬
‫‪213111‬‬
‫‪213254‬‬
‫‪213311‬‬
‫‪213115‬‬
‫‪214241‬‬
‫‪214771‬‬
‫‪215531‬‬
‫‪214511‬‬
‫‪217751‬‬
‫‪211419‬‬
‫‪219227‬‬
‫‪219991‬‬
‫‪292244‬‬
‫‪293953‬‬
‫‪297143‬‬
‫‪111473‬‬
‫‪114551‬‬
‫‪272792‬‬
‫‪272947‬‬
‫‪271174‬‬
‫‪273949‬‬
‫‪274913‬‬
‫‪275441‬‬
‫‪275979‬‬
‫‪277139‬‬
‫‪277511‬‬
‫‪271447‬‬
‫‪279241‬‬
‫‪211124‬‬
‫‪211415‬‬
‫‪212221‬‬
‫‪212117‬‬
‫‪211533‬‬
‫‪211491‬‬
‫‪211145‬‬
‫‪213129‬‬
‫‪213231‬‬
‫‪213351‬‬
‫‪213741‬‬
‫‪214117‬‬
‫‪214729‬‬
‫‪215314‬‬
‫‪214414‬‬
‫‪217743‬‬
‫‪211317‬‬
‫‪219124‬‬
‫‪219914‬‬
‫‪291117‬‬
‫‪293143‬‬
‫‪297493‬‬
‫‪299924‬‬
‫‪114199‬‬
‫‪272771‬‬
‫‪272953‬‬
‫‪271293‬‬
‫‪273713‬‬
‫‪274912‬‬
‫‪275311‬‬
‫‪275112‬‬
‫‪274741‬‬
‫‪277511‬‬
‫‪271199‬‬
‫‪279142‬‬
‫‪279919‬‬
‫‪211445‬‬
‫‪212141‬‬
‫‪212747‬‬
‫‪211443‬‬
‫‪211441‬‬
‫‪211141‬‬
‫‪213117‬‬
‫‪213231‬‬
‫‪213351‬‬
‫‪213747‬‬
‫‪214115‬‬
‫‪214452‬‬
‫‪215344‬‬
‫‪214371‬‬
‫‪217445‬‬
‫‪211322‬‬
‫‪211943‬‬
‫‪219141‬‬
‫‪291425‬‬
‫‪293224‬‬
‫‪297411‬‬
‫‪299145‬‬
‫‪113791‬‬
‫‪272713‬‬
‫‪272941‬‬
‫‪271241‬‬
‫‪273271‬‬
‫‪274111‬‬
‫‪275139‬‬
‫‪275751‬‬
‫‪274744‬‬
‫‪277494‬‬
‫‪271112‬‬
‫‪279114‬‬
‫‪279194‬‬
‫‪211414‬‬
‫‪212132‬‬
‫‪212721‬‬
‫‪211413‬‬
‫‪211447‬‬
‫‪211153‬‬
‫‪211914‬‬
‫‪213221‬‬
‫‪213335‬‬
‫‪213414‬‬
‫‪213993‬‬
‫‪214491‬‬
‫‪215314‬‬
‫‪214342‬‬
‫‪217447‬‬
‫‪211197‬‬
‫‪211947‬‬
‫‪219744‬‬
‫‪291523‬‬
‫‪291393‬‬
‫‪294123‬‬
‫‪299143‬‬
‫‪113711‬‬
‫‪272499‬‬
‫‪272911‬‬
‫‪271171‬‬
‫‪273151‬‬
‫‪274117‬‬
‫‪275131‬‬
‫‪275711‬‬
‫‪274559‬‬
‫‪277413‬‬
‫‪271211‬‬
‫‪271945‬‬
‫‪279131‬‬
‫‪211331‬‬
‫‪211417‬‬
‫‪212535‬‬
‫‪211317‬‬
‫‪211413‬‬
‫‪211133‬‬
‫‪211971‬‬
‫‪213192‬‬
‫‪213191‬‬
‫‪213477‬‬
‫‪213934‬‬
‫‪214419‬‬
‫‪215179‬‬
‫‪214324‬‬
‫‪217211‬‬
‫‪211124‬‬
‫‪211141‬‬
‫‪219371‬‬
‫‪291522‬‬
‫‪292134‬‬
‫‪294111‬‬
‫‪291149‬‬
‫‪111475‬‬
‫‪111211‬‬
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪213132‬‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫‪247531‬‬
‫‪431‬‬
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
97111
432
97934
91411
211553
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫פטנטים שלגביהם הוגשו‬
‫בקשות להארכת תקופת‬
‫ההגנה על פי פרק ד' סימן‬
‫ לחוק הפטנטים‬1'‫ב‬
Patents for which
applications have been filed
for extension of the patent
term under chapter 4, part
B1 of the Patens Law
No. of basic patent:
2181/1
:‫מס' פטנט בסיסי‬
:‫שם המבקש‬
Proprietors:
IMMUNEX CORPORATION
Date of application:
433
1.6.5011
:‫תאריך הגשת הבקשה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫הודעה‬
NOTICE
‫ לחוק‬10 ‫לפי סעיף‬
1611-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
21/211
1/1881
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
TDF
:‫שם האמצאה‬
‫שיטת מעקב אחר איכות השירות בחיבור טלוויזיוני דיגיטלי‬
METHOD FOR SURVEILLANCE OF THE QUALITY OF SERVICE IN A DIGITAL
TELEVISION LINK
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
65 ‫ לחוק ובתקנה‬11 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1611
Title of invention:
434
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
435
2/1112
//1828
,‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
1611-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬11 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.1611
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
436
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
41911
22l12a
1521221121
‫סוג פרסום‬
‫צביקה לב‬
‫תליון לשרשרת‬
ZVIKA LEV
Chain pendant
Class
49145
9l12a
1321121121
‫סוג פרסום‬
BAVARIA N.V2
‫בקבוק‬
Bottle
Class
41491 ,41495
15l12a
1422221119
‫סוג פרסום‬
‫) בע"מ‬1662( ‫שרמר תעשיות אלומיניום‬
SCHREMER ALUMINIUM
INDUSTRIES (1993) LTD.
‫פרופיל‬
Profile
Class
YARDEN KARAKO
Pendant
437
41945
22l12a
1221121121
‫סוג פרסום‬
‫ירדן קרקו‬
‫תליון‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
41941
9l17a
1521221121
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Cap for a container
Convention date (U.S.A.)
Class
3221721119
49142
25l11a
2121121121
‫מכסה עבור מיכל‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫אלי שפיר‬
‫מתקן לאספקת מים‬
ELI SAPHIR
Water dispenser
Class
49149 ,49141
29l14a
1421121121
‫סוג פרסום‬
‫שוגון תיקים ומוצרי עור בע"מ‬
SHUGON BAGS &
LEATHERGOODS LTD.
‫אוגדן‬
Folder
Class
49193
1l12a
1121321121
‫סוג פרסום‬
‫שרה כהן‬
‫לבוש תחתון‬
SARAH COHEN
Under garment
Class
49241
9l12a
2221321121
‫סוג פרסום‬
OBSHCHESTVO S OGRANICHENNOI
438
November 30, 2011-‫ד' בכסלו התשע"ב‬
Bottle
Convention date (Russia)
439
1322221119
‫בקבוק‬
)‫תאריך האמנה (רוסיה‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
49314
7l14a
1121421121
‫סוג פרסום‬
DRAX INDUSTRIES PTY LTD2
Fruit and vegetable shaping mould
Convention date (Australia)
Class
1322121119
49319
9l12a
1521421121
‫תבנית לעיצוב פירות וירקות‬
)‫תאריך האמנה (אוסטרליה‬
‫סוג פרסום‬
‫ אריזות בע"מ‬.‫א‬.‫א‬
‫בקבוק‬
A.A PACKAGING LTD.
Bottle
Class
49422
7l14a
2521421121
‫סוג פרסום‬
‫מיטל פאלס‬
‫מחזיק בקבוקי תינוקות‬
MEITAL PALACE
Baby bottle holder
Class
49532
1l19a
3221521121
‫סוג פרסום‬
‫קליל תעשיות בע"מ‬
‫אביזר לחלון‬
KLIL INDUSTRIES LTD.
Accesory window
Class
49419
1l15a
2721421121
‫סוג פרסום‬
LEATHERMAN TOOL GROUP, INC2
Hand tool
Convention date (U.S.A.)
440
2122121119
‫כלי עבודה ידני‬
)‫תאריך האמנה (ארצות הברית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
49111
21l11a
2421721121
‫סוג פרסום‬
GM GLOBAL TECHNOLOGY OPERATIONS, INC2
Vehicle
Convention date (U.S.A.)
Class
2721121121
51124
1l14a
1421121121
‫כלי תחבורה‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
SSL HEALTHCARE ITALIA S.P.A2
Sole for footwear
Convention date (WIPO)
‫סוליה לנעל‬
)‫תאריך האמנה (ויפו‬
1421121121
Class
51192
9l17a
2921921121
‫סוג פרסום‬
‫סנו מפעלי ברונוס בע"מ‬
SANO BRUNOS ENTERPRISES
LTD.
‫מכסה למיכל‬
Cap for container
Class
51193
9l13a
2921921121
‫סנו מפעלי ברונוס בע"מ‬
SANO BRUNOS ENTERPRISES
LTD.
‫מיכל‬
Container
Class
441
‫סוג פרסום‬
51243
25l11a
‫סוג פרסום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
2422121121
‫שטראוס מים בע"מ‬
‫מתקן לטיהור ואספקת נוזלים‬
STRAUSS WATER LTD.
Liquid dispenser and purifier
Class
51211
11l12a
2922121121
‫סוג פרסום‬
‫תמיר פורת‬
‫מקלע‬-‫תת‬
TAMIR PORAT
Sub-machine gun
Class
51313
14l12a
1122121121
‫סוג פרסום‬
MEDICIS TECHNOLOGIES CORPORATION
Ultrasound therapy base unit
Convention date (U.S.A.)
Class
1421421121
51434 ,51433
24l11a
2922121121
‫קוליות‬-‫יחידת בסיס לתראפיה על‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
BROTHER INDUSTRIES LTD2
Ink cartridge
Convention date (JAPAN)
Class
‫מחסנית דיו‬
)‫תאריך האמנה (יפן‬
2721421121
51455
4l11a
1722121121
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Oral care implement
Convention date (U.S.A.)
442
3121421121
‫מכשיר לטיפול בפה‬
)‫תאריך האמנה (ארצות הברית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
51334
25l11a
1422221121
Q-TRADE INTERNATIONAL LTD.
Device for supplying water
443
‫סוג פרסום‬
‫קיו טרייד בינלאומי בע"מ‬
‫מתקן להספקת מים‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
51441
25l11a
3122121121
Class
‫סוג פרסום‬
‫שטראוס מים בע"מ‬
‫מתקן לטיהור ואספקת נוזלים‬
STRAUSS WATER LTD.
Liquid dispenser and purifier
51591
15l12a
1221121122
Class
‫סוג פרסום‬
‫אלום זוהר ובניו בע"מ‬
‫פרופיל‬
ALUM ZOHAR AND SUNS LTD.
Profile
51422
4l14a
1721121122
Class
‫שוקת אלומיניום בע"מ‬
‫פרופיל‬
SHOKET ALUMINIUM LTD.
Profile
Class
‫סוג פרסום‬
51432 ,51414 ,51413
51434 ,51433
15l12a
1921121122
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫פרופיל‬
EXTAL LTD.
Profile
Class
51441
1l17a
2521121122
ALBA LOCKING PRODUCTS TLD.
Locking device for frame
444
‫סוג פרסום‬
‫אלבא מוצרי נעילה בע"מ‬
‫אביזר נעילה למשקוף‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
49374 ,49375
22l12a
1321521121
‫סוג פרסום‬
‫איי תכשיטים בע"מ‬.‫אם‬
‫תכשיט‬
M.I. JEWELRY LTD
Jewel
Class
49121
3l11a
1521321121
‫סוג פרסום‬
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Pill dispenser
Convention date (OHIM)
Class
3121921119
49591
4l11a
2421421121
‫מושיט גלולות‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
Class
2522121119
51591
9l17a
1121421121
‫מברשת שיניים‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
KRALLMANN KUNSTSTOFFVERARBEITUNG GMBH
Fastener
Convention date (OHIM)
Class
1222121119
49192
9l13a
2121421121
MOR AGENCIES (MOTI-DAVID)
445
‫פקק‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫דוד) בע"מ‬-‫מור סוכנויות (מוטי‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
LTD.
Cup with spoon
446
‫גביע עם כפית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
Class
49191
7l13a
2121421121
MOR AGENCIES (MOTI-DAVID)
LTD.
‫סוג פרסום‬
‫דוד) בע"מ‬-‫מור סוכנויות (מוטי‬
‫כפית‬
Spoon
Class
49193
9l13a
2121421121
MOR AGENCIES (MOTI-DAVID)
LTD.
‫סוג פרסום‬
‫דוד) בע"מ‬-‫מור סוכנויות (מוטי‬
‫אריזה‬
Packing
Class
51491 ,51493
12l12a
1121121122
‫סוג פרסום‬
‫גדעון משיח‬
‫מערכת לוח ציור‬
GIDON MACHIACH
Drawing board apparatus
Class
51112
9l13a
2421921121
‫קבוצת אלון בע"מ‬
‫מיכל לאיסוף מוצרי מיחזור‬
ALON GROUP LTD.
Container for collecting recycling material
Class
SHUGON BAGS &
LEATHERGOODS LTD.
447
‫סוג פרסום‬
51195
3l12a
2921921121
‫סוג פרסום‬
‫שוגון תיקים ומוצרי עור בע"מ‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫תיק צד‬
Shoulder bag
Class
51491 ,51492
21l11a
1121121122
ALUMA ALUMINUM SOLUTIONS
LTD.
‫סוג פרסום‬
‫אלומה פתרונות באלומיניום בע"מ‬
‫פרופיל לעגלה‬
Profile for handcart
Class
49371
13l12a
1921421121
‫סוג פרסום‬
GIORDANO VINCENZA
Part of pipe fitting
Convention date (Italy)
3122121119
Class
51559
4l15a
1321221122
‫סוג פרסום‬
‫איה זהבי‬
‫שידה עם כסא מוסווה‬
AYA ZEHAVI
A desk with a hidden chair
Class
‫חלק של מתאם לצינור‬
)‫תאריך האמנה (איטליה‬
51744 ,51745
22l12a
1321321122
‫סוג פרסום‬
‫ראובן גרש‬
‫יהלום‬
RUVEN GERSH
Diamond
Class
448
51754 ,51755
15l13a
1121321122
‫סוג פרסום‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫אריכא ובניו בע"מ‬.‫שחם י‬
SHAHAM Y. ARICHA AND SONS
LTD.
‫פרגולה‬
Pergola
Class
51751
9l13a
1121421121
‫סוג פרסום‬
CURVER LUXEMBOURG SARL
Box with cover
Convention date (OHIM)
Class
1222121119
51797
3l12a
2521321122
‫קופסא עם מכסה‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
APPLE INC2
Cover
Convention date (U.S.A.)
449
2721921121
‫כיסוי‬
)‫תאריך האמנה (ארצות הברית‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מדגמים שבוטלו‬
DESIGNS VOID
14943
35117
37413
14949
35111
14951
35132
14992
35131
14991
35133
34973
35135
35122
35147
35121
35141
34973
35135
35122
35147
35121
35141
‫מדגמים שחודשו‬
DESIGN RENEWED
14943
35117
37413
14949
35111
14951
35132
14992
35131
‫ רשם‬Asa Kling
‫וסימני‬Commissioner of Patents,
Designs and Trade Marks
450
14991
35133
‫אסא קלינג‬
‫ המדגמים‬,‫הפטנטים‬
‫מסחר‬
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫טל דוד ‪116512 -‬‬
‫‪2‬ג'י סולאר בע"מ ‪116555 -‬‬
‫יונתן יפה ‪116512 -‬‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח ‪116512 -‬‬
‫אוניברסיטת בר‪-‬אילן ‪116555 -‬‬
‫אופיר פרומוביץ ‪111616 -‬‬
‫אליום בע"מ ‪110161 -‬‬
‫אלפא ביו טק בע"מ ‪111616 -‬‬
‫אמיר זהבי ‪115410 -‬‬
‫אנימה סל מטרולוג'י ‪111155 -‬‬
‫אריאל‪-‬חברה אוניברסיטאית למחקר‬
‫ופיתוח בע"מ ‪111114 -‬‬
‫ארינטה בע"מ ‪161256 -‬‬
‫ביואקסטרים בע"מ ‪111514 -‬‬
‫גיוון אימג'ינג בע"מ ‪114555 , 116401 -‬‬
‫דבלוגן ישראל בע"מ ‪114151 -‬‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ ‪-‬‬
‫‪150451‬‬
‫התעשייה האוירית לישראל בע"מ ‪111055 -‬‬
‫‪111111 , 112466 , 110162 , 111521 ,‬‬
‫כנרות‪-‬פתוח ויזמות בע"מ ‪151151 -‬‬
‫כתר פלסטיק בע"מ ‪116511 -‬‬
‫מדיגוס בע"מ ‪115125 -‬‬
‫מדיגייד בע"מ ‪116211 -‬‬
‫מדימופ פרויקטים רפואיים בע"מ ‪, 114610 -‬‬
‫‪501255 , 501254‬‬
‫מדינול בע"מ ‪165111 -‬‬
‫מדלוג'יק בע"מ ‪111441 -‬‬
‫מוסד הטכניון למחקר ופיתוח בע"מ ‪-‬‬
‫‪155220‬‬
‫מוסד הטכניון למחקר ופתוח בע"מ ‪116100 -‬‬
‫מרדכי אלדר ‪115526 -‬‬
‫משה אלעזר ארנסט ‪515155 -‬‬
‫נבוטק מדיקל בע"מ ‪116445 -‬‬
‫ניני בלומן ‪111514 -‬‬
‫פי‪ .‬אייץ‪ .‬טו‪ .‬או טכנולוגיות מים בע"מ ‪-‬‬
‫‪115612‬‬
‫פנל אי אל בע"מ ‪165446 -‬‬
‫פרוקוגניה (ישראל) בע"מ ‪111211 -‬‬
‫ולרי דיקובסקי ‪116512 -‬‬
‫וסקולר ביוג'ניק בע"מ ‪110151 -‬‬
‫צבי שילר ‪114221 -‬‬
‫זלמן פלס ‪112515 -‬‬
‫קופרגייט תקשורת בע"מ ‪116116 -‬‬
‫חניתה מפעלי מתכת בע"מ ‪111554 -‬‬
‫ראל כימיקלים אקספורט (‪ )1611‬בע"מ ‪-‬‬
‫‪111651‬‬
‫רון פולמן ‪116512 -‬‬
‫רוני ויסמן ‪160515 -‬‬
‫טבע תעשיות פרמצבטיות בע"מ ‪, 115511 -‬‬
‫‪111551‬‬
‫ד' בכסלו התשע"ב‪November 30, 2011-‬‬
‫‪451‬‬
165011 - ‫רפאל פלד‬
115410 - ‫שי ניסים‬
3G SOLAR LTD. - 22/11/
3M INNOVATIVE PROPERTIES
COMPANY - 183556
ABLOY OY - 195332
ABT HOLDING COMPANY - 157332
ACTIVE BIOTECH AB - 176255
AFFITECH RESEARCH AS - 181928
AGENSYS, INC. - 158860 , 200608
AGRO SYSTEM CO. LTD - 189621
AICURIS GMBH & CO.KG - 171513
AKOO INTERNATIONAL, INC. - 180876
ALBIREO AB - 160691
ALCON, INC. - 184150
ALEXION PHARMACEUTICALS, INC. 170590
ALKEN, INC. D/B/A POLHEMUS 168461
ALLIANCE FOR SUSTAINABLE
ENERGY, LLC - 192191
ALLIUM LTD. - 170698
ALMIRALL, S.A. - 179684 , 179687
ALPHA BIO TEC. LTD. - 181989
AMANO ENZYME INC. - 178962
AMIR ZAHAVI - 172480
ANIMA CELL METROLOGY - 168822
ANIMAS CORPORATION - 181053
APOSTOLOS STATHOPOULOS - 192964
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. - 180682 , 183106
ARACLON BIOTECH, S.L. - 171651
ARES TRADING S.A. - 171913 , 190139
ARIEL-UNIVERSITY RESEARCH AND
DEVELOPMENT COMPANY LTD. 168184
ARINETA LTD. - 196359
ARM LIMITED - 175901
ARQULE, INC. - 184951
452
- ‫רפא"ל מערכות לחימה מתקדמות בע"מ‬
111125
160141 - ‫רפאל מלכא‬
- ‫רפאל מערכות לחימה מתקדמות בע"מ‬
116411
- ‫רפאל מערכות לחימה מתקדמות בע"מ‬
160252
ARRAY BIOPHARMA, INC - 170527
ARRAY BIOPHARMA, INC. - 173593
ASML NETHERLANDS B.V. - 189034
ASTELLAS PHARMA INC. - 178249 ,
179437
ASTRAZENECA AB - 160691 , 179906
ASTRONAUTICS CORPORATION OF
AMERICA - 192951
ATHEROGENICS, INC. - 161522
AVANTOR PERFORMANCE
MATERIALS, INC. - 184761
AVENTIS PHARMACEUTICALS INC. 155189
AVOCENT CALIFORNIA
CORPORATION - 184298
AVOCENT HUNTSVILLE
CORPORATION - 184298
BAE SYSTEMS BOFORS AB - 153619
BAR-ILAN UNIVERSITY - 189225
BAYER PHARMA
AKTIENGESELLSCHAFT - 171513
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 189283
BIOLASE TECHNOLOGY, INC. - 187351
BIOSENSE WEBSTER, INC. - 157016 ,
175188
BIOXTREME LTD. - 171514
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH - 180247 ,
182397 , 185135
BPSI HOLDINGS, LLC. - 185274
BRANOFILTER GMBH - 181130
BRAVILOR HOLDING B.V. - 190894
BRISTOL-MYERS SQUIBB COMPANY 149139
November 30, 2011-‫ד' בכסלו התשע"ב‬
CALOSYN PHARMA, INC. - 187531
CENTRE NATIONAL D'ETUDES
SPATIALES - 183991
CHILDREN'S MEDICAL CENTER
CORPORATION - 180332
CHUGAI SEIYAKU KABUSHIKI
KAISHA - 163354
CHUGAI SEIYAKU KABUSHIKI
KAISHA - 174794
CILAG GMBH INTERNATIONAL 186370 , 186379 , 186380
CMLA, LLC - 181206
COMMONWEALTH SCIENTIFIC AND
INDUSTRIAL RESEARCH
ORGANISATION - 148270
COPPEREYE LIMITED - 202125
COPPERGATE COMMUNICATIONS
LTD. - 169189
CORCEPT THERAPEUTICS, INC. 158744
CORIXA CORPORATION - 180599
CORNELL RESEARCH FOUNDATION,
INC. - 170954
CRYSTAL LAGOONS CORPORATION
LLC. - 187370
CURIS INC. - 199988
CYTOKINETICS, INC. - 180026
DANIEL MATOSES VERCHER - 182784
DAVID D. WADDELL - 187531
DAVID MUNOZ MUNOZ - 182784
DEBIOTECH S.A. - 173444
DEERE & COMPANY - 194445
DEUTSCHES ZENTRUM FUER LUFTUND RAUMFAHRT E.V. - 188370
DEVAN BALACHARI - 170527
DEVELOGEN ISRAEL LTD. - 164127
DOLBY LABORATORIES LICENSING
CORPORATION - 186046
DOW AGROSCIENCES LLC - 163529
DOW GLOBAL TECHNOLOGIES INC. 179426
DR. REDDY'S LABORATORIES LTD. 155036
E.I. DU PONT DE NEMOURS AND
COMPANY - 181750
453
EGIS GYOGYSZERGYAR NYRT 179029
EISAI CO., LTD. - 163868
EISAI R&D MANAGEMENT CO., LTD. 163868 , 177087 , 209568
ELAN PHARMA INTERNATIONAL
LIMITED - 176250
ELAN PHARMACEUTICALS, INC. 176250
ELI LILLY AND COMPANY - 154671 ,
179599 , 184717
ES CELL INTERNATIONAL PTE LTD. 179726
ESK CERAMICS GMBH & CO, KG 181737
EURO-CELTIQUE S.A. - 205596
EXIQON A/S - 135000 , 185568
F. HOFFMANN-LA ROCHE AG - 171686
, 177662 , 184439 , 185545 , 189987 ,
190222
FERRER INTERNACIONAL, S.A. 163452 , 186040
FIDELINE - 165755
FIRMENICH S.A. - 186318 , 186319
FONDAZIONE IRCCS ISTITUTO
NAZIONALE DEI TUMORI - 178508
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 183488 , 184608 ,
193786
FUTURE FIBRE TECHNOLOGIES PTY.
LTD. - 184304
GEBR. SCHMID GMBH & CO. - 192071
GENENTECH, INC. - 206483
GENERAL ELECTRIC COMPANY 183311 , 191154
GENOMIC HEALTH, INC. - 178508 ,
182929
GENPHARM INTERNATIONAL INC. 168028
GEORGIA TECH RESEARCH
CORPORATION - 172451
GIESECKE & DEVRIENT GMBH 176378
GIVEN IMAGING LTD. - 169401 , 174552
November 30, 2011-‫ד' בכסלו התשע"ב‬
GLAXO GROUP LIMITED - 169091
GLAXOSMITHKLINE BIOLOGICALS
S.A. - 187924
GRT, INC. - 180804
H.C. STARCK INC. - 178252
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD. 150458
HAMLET PROTEIN A/S - 186224
HANITA METAL WORKS LTD. - 177254
HANS JOSEF VAN ELS - 168779
HARMONIC INC. - 181631
HARVEY J. KLIMAN - 151265
HERMANN SPENGLER GMBH &
CO.KG - 194016
HEWLETT-PACKARD DEVELOPMENT
COMPANY, L.P. - 191873
HISPANO-SUIZA - 185234
HONEYWELL INTERNATIONAL INC. 184287 , 184693 , 185701 , 185702 ,
189012 , 192321
HUAWEI TECHNOLOGIES CO, LTD. 182475
IBM CORPORATION - 193703
ICHOR MEDICAL SYSTEMS , INC 177942
ICOS CORPORATION - 200692
ILS TECHNOLOGY LLC - 175962
IMMUNEX CORPORATION - 184699
IMMUNOMEDICS, INC. - 169769
INDENA S.P.A. - 183933
INFINITY DISCOVERY, INC. - 179904
INTERDIGITAL TECHNOLOGY
CORPORATION - 173216 , 181221 ,
186343 , 194766 , 207023
INTERGRAPH SOFTWARE
TECHNOLOGIES COMPANY - 184987
ISRAEL AEROSPACE INDUSTRIES
LTD. - 176022 , 177236 , 180693 , 183499 ,
188678
JANSSEN PHARMACEUTICA, N.V. 175755 , 180382 , 181747
JASON A. SULLIVAN - 204686
JENAVALVE TECHNOLOGY GMBH 454
184608
JENAVALVE TECHNOLOGY GMBH 184608
JENAVALVE TECHNOLOGY, INC. 184608
JHRG, LLC - 184693
JOHN CLAUDE SAVOIR - 172466
KAKEN PHARMACEUTICAL CO., LTD.
- 187260
KBA-METALPRINT GMBH - 212626
KETER PLASTIC LTD. - 179588
KINAROT-INITIATION AND
DEVELOPMENT COMPANY LTD. 156856
KISSEI PHARMACEUTICAL CO., LTD. 177513
KUMAMOTO UNIVERSITY - 189389
KYOTO UNIVERSITY - 191903
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES - 172844
LABORATORIES BESINS
INTERNATIONAL, S.A. - 163981
LAM RESEARCH CORPORATION 186108
LDR MEDICAL - 178842
LEA-ANN KIRKHAM - 178885
LEO PHARMA A/S - 160442 , 165086 ,
186074
LG ELECTRONICS INC. - 177931 ,
182031 , 186481
LILLY ICOS LLC - 200692
LOUISIN RESEARCH AND
DEVELOPMENT LIMITED - 196063
MAGD AHMED KOTB ABDALLA 183317
MANNKIND CORPORATION - 176699
MANTROSE-HAEUSER CO. INC. 165320
MARTEK BIOSCIENCES
CORPORATION - 206961
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY - 169100
MEDIGUIDE LTD. - 179316
November 30, 2011-‫ד' בכסלו התשע"ב‬
MEDIGUS LTD. - 182132
MEDIMOP MEDICAL PROJECTS LTD. 184960 , 201324 , 201325
MEDINOL LTD. - 192178
MEDLOGIC LTD. - 187446
MERCK SERONO S.A. - 180682 , 183106
MERCK SHARP & DOHME CORP. 171067
MESSIER-BUGATTI-DOWTY - 191116
MICROSOFT CORPORATION - 188622 ,
188663
MIDWEST RESEARCH INSTITUTE 192191
MITSUBISHI TANABE PHARMA
CORPORATION - 170461
MORDECHAI ELDAR - 162539
MOSHE ELAZAR ERNEST - 212155
MOTOROLA, INC. - 174173
NATHALIE ROBIN - 192945
NAVOTEK MEDICAL LTD. - 189442
NERVIANO MEDICAL SCIENCES S.R.L.
- 169019
NESTEC S.A. - 182016
NEURALAB LIMITED - 176250
NEURALSTEM, INC. - 183092
NEURAMATIX SDN. BHD. - 195610
NINI BLUMAN - 171514
NISSAN CHEMICAL INDUSTRIES LTD.
- 178854
NOF CORPORATION - 194501
NORTH CAROLINA STATE
UNIVERSITY - 178252
NORTHROP GRUMMAN
CORPORATION - 172640
NORTHROP GRUMMAN GUIDANCE
AND ELECTRONICS COMPANY, INC. 172640
NORTHROP GRUMMAN SYSTEMS
CORPORATION - 172640
NOVARTIS AG - 169183 , 179600 ,
186925 , 187421 , 197296
NSABP FOUNDATION, INC. - 182929
NUTRINOVA NUTRITION
SPECIALTIES & FOOD INGREDIENTS
GMBH - 178614
455
ONCIMMUNE LIMITED - 187481
ONCOTHERAPY SCIENCE, INC. 189389
OPHIR FROMOVICH - 181989
OTTAWA HOSPITAL RESEARCH
INSTITUTE - 171133
P. & P. MILKER LTD. - 163585
P.M.L - PARTICLES MONITORING
TECHNOLOGIES LTD. - 156856
PANEL E.L LTD. - 192449
PAPYRUS AUSTRALIA LIMITED 181624
PFIZER INC. - 176349 , 176564
PFIZER ITALIA S.R.L - 169019
PFIZER PRODUCTS, INC. - 161851
PH2O WATER TECHNOLOGIES LTD. 182973
PHENOMIX CORPORATION - 175550
PIERRE FABRE MEDICAMENT - 170743
POKKA CORPORATION - 178962
PRC-DESOTO INTERNATIONAL, INC. 180279 , 181646
PRINCETON UNIVERSITY - 164602
PROBIODRUG AG - 171339
PROCOGNIA (ISRAEL) LTD. - 176376
PROGEN PHARMACEUTICALS, INC. 146127
PROGRESSIVE INTERNATIONAL
CORPORATION - 186192
PROMETIC BIOSCIENCES INC. - 195200
PROYECTO EMPRESARIAL BRUDY,
S.L. - 187274
PURRATIO AG - 189815
QUALCOMM INCORPORATED - 151261
, 174944 , 204015
RAEL CHEMICALS EXPORT (1981)
LTD. - 161927
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 169481
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 177832
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 190353
RAFAEL MALKA - 190648
November 30, 2011-‫ד' בכסלו התשע"ב‬
RAHMI OGUZ CAPAN - 194840
RAPHAEL PELED - 192018
RAYTHEON COMPANY - 177147 ,
192510
REGENESYS, LLC - 157332
REGENTS OF THE UNIVERSITY OF
MINNESOTA - 143289
RELIANCE LIFE SCIENCES PVT. LTD. 173889
RGB NETWORKS, INC. - 173993
RICHTER GEDEON NYRT. - 195253
ROCKWELL COLLINS CONTROL
TECHNOLOGIES, INC. - 179775
RON FOLMAN - 189283
RONI WEISSMAN - 190562
SAGAMI CHEMICAL RESEARCH
INSTITUTE - 187260
SAGEM DEFENSE SECURITE - 189095
SAMSUNG ELECTRO-MECHANICS CO.
LTD. - 173276
SAMSUNG ELECTRONICS CO., LTD. 182719
SANGENIC INTERNATIONAL LIMITED
- 175105
SANOFI - 170461
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 164536 , 166780
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 166345
SARL GALENIX INNOVATIONS 170507
SAVIO S.P.A. - 189761
SCHERING CORPORATION - 140450 ,
140451
SCHERING-PLOUGH LTD. - 165252
SECURED EMAIL GOTEBORG AB 174176
SEMBIOSYS GENETICS INC. - 148270
SENER, INGENIERIA Y SISTEMAS, S.A.
- 190285
SENG ENTERPRISES LTD. - 184818
SENSORMATIC ELECTRONICS, LLC 187472
SHAI NISSIM - 172480
SHELL INTERNATIONALE RESEARCH
MAATSCHAPPIJ B.V. - 186208
456
SHERWOOD SERVICES AG - 181374
SIEGFRIED GENERICS
INTERNATIONAL AG - 166304
SIEGFRIED LTD. - 166304
SIKORSKY AIRCRAFT CORPORATION
- 189174
SILVERBROOK RESEARCH PTY. LTD.
- 168247
SLIL BIOMEDICAL CORPORATION 146127
SNECMA - 185234
SOPRO - 173288
SOSEI R&D LTD - 185576
SP BERNER PLASTIC GROUP, S.L. 192466
SPANOLUX N.V. -DIV. BALTERIO 197989
SUMITOMO CHEMICAL COMPANY,
LIMITED - 192831 , 192832 , 195734
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 167898 , 178001 , 179505
SUMITOMO METAL INDUSTRIES,
LTD. - 194149
SUNCYCLE INTERNATIONAL GMBH 194536
SYNGENTA PARTICIPATIONS AG 173566
SYNTA PHARMACEUTICALS CORP. 159773
TAL DAVID - 189283
TDA ARMEMENTS S.A.S. - 180186
TECH-NI-FOLD LTD. - 189419
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD. 155330
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD. 169100
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 184110 , 185851
TEVA PHARMACEUTICAL
INDUSTRIES LTD. - 175511 , 186221
THALES - 193280
THALESNANO NANOTECHNOLOGIAI
ZRT. - 192390
THE BOARD OF REGENTS OF THE
November 30, 2011-‫ד' בכסלו התשע"ב‬
UNIVERSITY OF TEXAS SYSTEM 192404
THE FORCE, INC. - 182377
THE GOVERNING COUNCIL OF THE
UNIVERSITY OF TORONTO - 164643
THE GOVERNMENT OF THE UNITED
STATE OF AMERICA AS
REPRESENTED BY THE
SECRETARY,DEPARTMENT OF
HEALTH AND HUMAN SERVICES 162949
THE GOVERNMENT OF THE UNITED
STATES OF AMERICA, AS
REPRESENTED BY THE SECRETARY
OF HEALTH AND HUMAN SERVICES 162949
THE PROCTER & GAMBLE COMPANY
- 168119
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 187588
THE SCRIPPS RESEARCH INSTITUTE 174947 , 187588
THE UNIVERSITY COURT OF THE
UNIVERSITY OF GLASGOW - 178885
THE UNIVERSITY OF BRITISH
COLUMBIA - 167621
THE WALTER REED ARMY INSTITUTE
OF RESEARCH - 162949
THOMSON LICENSING S.A. - 154273
THRESHOLD PHARMACEUTICALS,
INC. - 188236
TIMOTHY JOHN MITCHELL - 178885
TRIDENT PHARMACEUTICALS, INC. 139467
TRUSTEES OF TUFTS COLLEGE 177643
UNILEVER PLC - 172322
UNIMED PHARMACEUTICALS, LLC 163981
UNITED STATES GYPSUM COMPANY
- 188621
UNIVERSIDAD DE ZARAGOZA 171651
UNIVERSITY OF BRISTOL - 139467
457
UNOMEDICAL A/S - 207221
VALERY DIKOVSKY - 189283
VASCULAR BIOGENICS LTD. - 180628
VERTEX PHARMACEUTICALS
INCORPORATED - 154671
VERTEX PHARMACEUTICALS
INCORPORATED - 156031
VETERINARMEDIZINISCHE
UNIVERSITAT WIEN, - 195097
VIASAT, INC. - 191686
VOLKMANN & ROSSBACH GMBH &
CO. KG - 194016
VP HOLDING, LLC - 179292
WARATEK PTY LIMITED - 178527
WARNER CHILCOTT COMPANY, LLC 168119 , 174893 , 187471 , 193013
WELLSTAT BIOLOGICS
CORPORATION - 171133
WICELL RESEARCH INSTITUTE, INC 182143
WICELL RESEARCH INSTITUTE, INC. 182143
WILLFRED-RAMIX, INC. - 167391
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 181437
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 182143
WYETH LLC - 182312
WYETH LLC - 176250
YONATHAN JAPHA - 189283
ZALMAN PELES - 163585
ZAMBON GROUP S.P.A. - 175156 ,
179871
ZVI SHILLER - 174331
November 30, 2011-‫ד' בכסלו התשע"ב‬
SUBJECT MATTER INDEX
A01G - 162539, 192018
A01H - 148270, 173566
A01K - 163585, 189621
A01N - 181750
A23B - 165320
A23G - 172322, 182016
A23L - 186224
A24C - 171514
A47J - 190894
A61B - 157016, 169401, 173288,
174552, 175188, 179316,
182132, 184150, 189442,
191154, 196359
A61C - 181989, 187351
A61F - 170698, 178842, 184608,
192178
A61H - 196063
A61J - 184960, 201324, 201325
A61K - 139467, 140450, 140451,
143289, 158744, 158860,
161522, 161851, 163354,
163981, 164536, 165755,
167391, 167621, 168184,
169769, 170507, 171339,
171651, 172466, 172844,
174893, 176250, 176255,
176699, 178962, 179684,
179687, 186074, 186925,
187471, 187531, 187924,
192964, 193013, 197296,
199988, 206483, 209568
A61L - 169100
A61M - 173444, 180332, 181053,
183556, 186370, 186379,
186380, 207221
A61N - 177942
B01D - 181130
B01J - 192390
B23B - 194149
B23C - 177254
B23K - 189815
458
‫מפתח ענייני‬
B29C - 179588
B31F - 189419
B41J - 168247
B62B - 192945
B64C - 176022, 183499, 185701,
191116
B64D - 189095
B65B - 194445
B65D - 192466
B65F - 175105
B66B - 189761
B67B - 186192
B81C - 178252
B82B - 164602, 189283
C01G - 189225
C02F - 168779, 182973, 190562,
212155
C04B - 172451
C06B - 190353
C07B - 186318, 186319
C07C - 146127
C07C - 149139, 159773, 160442,
175156, 176564, 179599,
180804, 181747, 182312,
187274, 192831, 192832,
195200, 195734
C07D - 154671, 155036, 155189,
156031, 160691, 163452,
165086, 165252, 166780,
167898, 168119, 169019,
169091, 169183, 170461,
170527, 170743, 171513,
171686, 173593, 175511,
175755, 176349, 177087,
177643, 177662, 178001,
178249, 178854, 179029,
179437, 179505, 179600,
179871, 179904, 179906,
180026, 180247, 180382,
180682, 182397, 183933,
184439, 184717, 184951,
November 30, 2011-‫ד' בכסלו התשע"ב‬
185135, 185545,
186040, 186221,
187421, 189987,
200692, 205596
C07F - 175550, 180628,
C07H - 135000, 177513,
185568
C07J - 166304, 195253
C07K - 150458, 163868,
164643, 168028,
171133, 171913,
178885, 183106,
200608
C08B - 179426, 185274
C08G - 194501
C08L - 181646
C09D - 180279
C12M - 184818
C12N - 162949, 163529,
173889, 174947,
181437, 182143,
184699, 187588,
191903
C12P - 206961
C12Q - 178508, 178614,
C23C - 186108
C40B - 181928
D02J - 192321
D21B - 181624
E01F - 194016
E03B - 183317
E03D - 187446
E03F - 190648
E04F - 188621, 197989
E04H - 187370
E05B - 187472, 195332
E06B - 182784
E21B - 186208
F01D - 181737
F02C - 185234, 189174
F02K - 188370
F21V - 192191
F23D - 192404
F23G - 212626
459
185576,
187260,
190222,
188236
180599,
164127,
170590,
174794,
190139,
171067,
179726,
183092,
189389,
182929
F24J - 190285, 194536, 194840
F41A - 169481
F41G - 189012
F41H - 184693
F41J - 188678
F42B - 153619, 180186
G01B - 168461
G01C - 177236,
G01D - 192951
G01K - 181374
G01L - 177832
G01M - 183488
G01N - 151265,
166345,
176376,
195097
G01S - 177147
G01T - 192510
G02B - 155330,
184287,
G03B - 189034
G03G - 191873
G06F - 169189,
176378,
188663,
204686
G06K - 172480,
G06Q - 188622
G06T - 183991
G08G - 185702
G09B - 161927
G09F - 192449
G10L - 193786
G11B - 180876
179775
156856, 157332,
168822, 170954,
184761, 187481,
172640, 179292,
184304
175901, 175962,
178527, 182377,
195610, 202125,
174331, 184987
H01J - 193280, 193703
H01L - 192071
H03M - 191686
H04B - 182719, 207023
H04K - 181206
H04L - 173276, 174176, 174944,
180693, 181221, 181631,
182475, 204015
H04M - 184110
H04N - 154273, 173993, 184298,
194766
November 30, 2011-‫ד' בכסלו התשע"ב‬
H04S - 186046
H04W - 151261, 173216, 174173,
177931, 182031, 185851,
186343, 186481
H05K - 183311
460
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
461
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
November 30, 2011-‫ד' בכסלו התשע"ב‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
462
November 30, 2011-‫ד' בכסלו התשע"ב‬